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“You	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  pass,"	  he	  said.	  The	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  and	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Abstract	  
	  
Acute	   kidney	   injury	   (AKI)	   induced	   by	   renal	   ischaemia	   reperfusion	   injury	   (IRI)	   is	  
characterised	   by	   renal	   failure,	   acute	   tubular	   necrosis	   (ATN),	   inflammation	   and	  
microvascular	   congestion.	   Apoptotic	   cell	   administration	   reduces	   inflammation	   in	  
experimental	   models	   of	   acute	   inflammation	   in	   the	   lung,	   joints	   and	   peritoneum.	  
Preliminary	   data	   suggested	   that	   administration	   of	   20x106	   apoptotic	   thymocytes	   to	  
mice	  24-­‐hours	  prior	  to	  renal	  IRI	  ameliorated	  renal	  function	  without	  affecting	  ATN	  24-­‐
hours	   following	   IRI.	   This	   thesis	   attempted	   to	   validate	   these	   finding	   and	   explore	  
underlying	  hypothetical	  mechanisms.	  These	  studies	  examined	  if	  functional	  protection	  
was	   conferred	   by	   apoptotic	   cell	   modulation	   of	   (a)	   circulating	   IgM	   antibodies	   or	   (b)	  
coagulation	  status	  leading	  to	  improved	  intrarenal	  microvascular	  blood	  flow.	  	  
	  
Pathogenic	  IgM	  antibodies	  bind	  ischaemic	  cardiac	  or	  skeletal	  muscle	  and	  the	  intestine	  
leading	   to	   complement	   activation	   and	   worse	   injury.	   We	   examined	   IgM	   binding	   to	  
human	   renal	   (HK-­‐2)	   cells	   by	   flow	   cytometry	   and	   to	   ischaemic	  murine	   kidney	   tissue.	  
H2O2	   or	   Antimycin	   A	   treated	   HK-­‐2	   cells	   incubated	   with	   human	   serum	   (IgM	   source)	  
exhibited	  no	  IgM	  binding.	  Medullary	  IgM	  deposition	  assessed	  by	  immunofluorescence	  
was	  minimal	  following	  IRI.	  We	  also	  assessed	  IgM	  deposition	  by	  immunohistochemistry	  
following	  hepatic	  IRI	  and	  discovered	  dramatic	  deposition.	  These	  data	  suggest	  that	  IgM	  
antibodies	  exhibit	  differential	  binding	  to	  injured	  tissues	  and	  are	  not	  directly	  involved	  in	  
renal	  IRI,	  but	  may	  have	  a	  role	  in	  hepatic	  IRI.	  
	  
To	   support	   our	   second	   hypothesis	   we	   studied	   apoptotic	   cell	   modulation	   of	  
coagulation.	   A	   thrombin	   generation	   assay	   revealed	   that	   early	   apoptotic	   cell-­‐treated	  
mice	  exhibited	  delayed	  thrombin	  generation.	  Furthermore,	   in	  vitro	  studies	  confirmed	  
direct	   apoptotic	   cell-­‐platelet	   binding.	   To	   replicate	   apoptotic	   cell	   derived	   functional	  
protection	  Balb/c	  mice	  underwent	  20,	  24	  or	  25-­‐minutes	  of	   ischaemia	  to	   induce	  mild,	  
moderate	  or	  severe	  kidney	  dysfunction.	  Renal	  function	  and	  injury	  was	  determined	  24-­‐
hours	  following	  IRI	  by	  plasma	  creatinine	  measurement	  and	  ATN	  scoring.	  Unexpectedly,	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intravenous	  pretreatment	  of	  mice	  with	  apoptotic	  thymocytes	  conferred	  no	  protection.	  
Indeed,	  apoptotic	   thymocytes	   further	   impaired	  renal	   function	  depending	  upon	   injury	  
severity.	   Impairment	  of	   renal	   function	  was	  not	  secondary	   to	   increased	  microvascular	  
congestion,	   inferred	   by	   fibrin	   and	   platelet	   deposition,	   neither	   increased	   ATN	   nor	  
inflammation,	   assessed	   by	   neutrophil	   infiltration.	   These	   data	   indicate	   that	   apoptotic	  
cell	  administration	  does	  not	  protect	  from	  subsequent	  renal	  IRI	  and	  that	  apoptotic	  cells	  
are	  thus	  not	  inherently	  anti-­‐inflammatory	  in	  all	  models	  of	  acute	  inflammation.	  
	  
Unable	   to	   replicate	   apoptotic	   cell	   derived	   functional	   protection	   we	   explored	   the	  
binding	  of	  IgM	  antibodies	  to	  apoptotic	  cells	  which	  acts	  to	  facilitate	  dead	  cell	  clearance.	  
We	  characterised	  IgM	  binding	  to	  non-­‐apoptotic	  and	  apoptotic	  murine	  thymocytes	  and	  
human	   Jurkat	   cells	   using	   flow	   cytometry,	   confocal	   and	   electron	   microscopy.	   We	  
demonstrated	   specific	   IgM	   binding	   to	   a	   subset	   of	   late	   apoptotic	   cells.	   Electron	  
microscopy	   indicated	   that	   IgM+	  apoptotic	   cells	   exhibited	   marked	   plasma	  membrane	  
disruption,	   suggesting	   that	   access	   to	   intracellular	   epitopes	   was	   required	   for	   IgM	  
binding.	  Binding	  of	  IgM	  to	  permeabilised	  non-­‐apoptotic	  and	  apoptotic	  cells	  suggested	  
that	  IgM	  bound	  epitopes	  are	  ‘apoptosis	  independent’	  such	  that	  IgM	  may	  bind	  any	  cell	  
with	  profound	  plasma	  membrane	  disruption.	  Interestingly,	  permeabilised	  erythrocytes	  
exhibited	   significant	   IgM	   binding	   thus	   supporting	   the	   importance	   of	   cell	   membrane	  
epitopes.	  These	  data	  suggest	  that	  IgM	  may	  recognise	  and	  tag	  damaged	  nucleated	  cells	  
or	  erythrocytes	  that	  exhibit	  significant	  cell	  membrane	  disruption.	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Lay	  Abstract	  
	  
Acute	  kidney	  injury	  (AKI)	  is	  common	  and	  may	  affect	  many	  critically	  ill	  patients	  when	  it	  
increases	  morbidity	   and	  mortality.	   Current	   treatments	   for	   AKI	   are	   purely	   supportive	  
with	   no	   specific	   treatment	   options	   available.	   AKI	   involves	   acute	   inflammation	   and	  
disruption	  of	  blood	  flow	  through	  the	  microvasculature	  (system	  of	  small	  blood	  vessels)	  
and	   these	   areas	   urgently	   require	   novel	   treatments.	   Apoptotic	   cells	   (dying	   cells)	   can	  
influence	   inflammation	   and	   the	   coagulation	   system	   with	   apoptotic	   cell	   treatment	  
improving	  outcome	  in	  several	  experimental	  animal	  models	  of	  disease.	  Preliminary	  data	  
that	  gave	  rise	  to	  these	  studies	  suggested	  that	  the	  administration	  of	  apoptotic	  cells	  to	  
mice	  prior	  to	  the	  experimental	  induction	  of	  AKI	  protected	  mice	  from	  functional	  injury.	  
In	   this	   thesis,	   we	   investigated	   two	   hypothetical	   mechanisms	   that	   may	   explain	   how	  
apoptotic	  cells	  can	  protect	  mice	  from	  AKI.	  These	  examined	  the	  interaction	  of	  apoptotic	  
cells	   with	   (a)	   a	   specific	   type	   of	   antibody	   known	   as	   IgM	   and	   (b)	   the	   blood	   clotting	  
system.	  
	  
IgM	  antibodies	  are	  known	  to	  be	  harmful	  in	  heart,	  skeletal	  muscle	  and	  intestinal	  injury.	  
We	  first	  aimed	  to	  confirm	  that	  IgM	  antibodies	  were	  involved	  in	  AKI.	  Studies	  in	  a	  mouse	  
model	  of	  AKI	  and	  human	  kidney	  cell	  culture	  assays	  clearly	  indicated	  that	  IgM	  antibody	  
did	  not	  bind	  to	  injured	  kidney	  cells.	  Our	  findings	  suggested	  that	  IgM	  is	  not	  a	  key	  player	  
in	  AKI.	  As	  the	  role	  of	  IgM	  in	  liver	  injury	  was	  unknown,	  we	  also	  studied	  the	  involvement	  
of	   IgM	   antibodies	   in	   a	   mouse	   model	   of	   liver	   injury.	   In	   contrast	   to	   the	   kidney,	   IgM	  
antibodies	  bound	  strongly	  to	  injured	  liver	  tissue.	  Perplexed	  by	  this	  we	  next	  wanted	  to	  
try	  and	  explain	  why	  IgM	  bound	  differently	  to	  different	  cells.	  Using	  cell	  culture	  assays,	  
flow	   cytometry,	   confocal	   and	   electron	  microscopy	  we	   investigated	   IgM	   binding	   to	   a	  
range	   of	   different	   cell	   types.	   These	   included	   healthy,	   apoptotic	   and	   permeabilised	  
human	  and	  mouse	  immune	  cells	  and	  mouse	  red	  blood	  cells.	  We	  discovered	  that	  before	  
IgM	  binding	  can	  take	  place,	  the	  outside	  surface	  of	  the	  cell	  must	  be	  sufficiently	  ‘open’	  
to	  allow	  the	  large	  IgM	  antibodies	  access	  to	  the	  cell	  interior.	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We	   next	   focused	   our	   attention	   to	   how	   apoptotic	   cells	   might	   alter	   blood	   clotting.	  
Through	   the	  use	  of	   blood	   clotting	   assays	   and	   flow	   cytometry	  we	  demonstrated	   that	  
apoptotic	   cells	   could	   directly	   bind	   platelets	   (key	   particles	   that	   affect	   clotting)	   and	  
modify	   the	   rate	   at	   which	   blood	   clots.	   These	   findings	   indicated	   that	   apoptotic	   cells	  
might	   be	   able	   to	   alter	   blood	   clotting	   such	   that	   blood	   flow	   after	   AKI	   was	   improved	  
resulting	   in	   protected	   renal	   function.	   Lastly,	   multiple	   experiments	   attempted	   to	  
unequivocally	  determine	  whether	  apoptotic	  cell	  administration	  prior	  to	  mice	  prior	  to	  
AKI	   was	   protective	   but	   no	   protection	   was	   seen.	   Indeed,	   the	   injury	   was	   actually	  
worsened	   in	   some	   settings.	   This	   was	   found	   not	   to	   be	   the	   result	   of	   increased	   blood	  
clotting	  in	  the	  microvasculature,	  increased	  structural	  injury	  or	  inflammation.	  
	  
The	   totality	   of	   these	   results	   indicates	   that	   IgM	  antibodies	   are	  not	   likely	   to	  be	   viable	  
targets	   of	   novel	   therapeutics	   in	   the	   treatment	   of	   AKI.	   In	   addition	   ‘apoptotic	   cell	  
therapy’	  does	  not	  have	  translational	  relevance	  for	  patients	  with	  AKI.	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FCS	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  calf	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  minus	  one	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  and	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   Nuclear	  factor-­‐	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   Platelet	  activating	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PDGF	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  growth	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PE	   Phycoerythrin	  
PerCp-­‐Cy5.5	   Peridinin-­‐chlorophyll-­‐protein	  Complex	  
PFA	   Paraformaldehyde	  
PI	   Propidium	  Iodide	  
PtdSer	   Phosphatidylserine	  
RAG-­‐1	   Recombination	  Activation	  Gene-­‐1	  
ROS	   Reactive	  oxygen	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RPMI	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  Park	  Memorial	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sCR1	   Soluble	  complement	  receptor	  type	  1	  
SEM	   Standard	  error	  of	  mean	  
SLE	   Systemic	  lupus	  erythematosus	  
SSC	   Side	  scatter	  
TEM	   Transmission	  electron	  microscopy	  
TGA	   Thrombin	  generation	  assay	  
TGF-­‐β	   Transforming	  growth	  factor-­‐β	  
Th-­‐#	   T	  helper-­‐#	  
TLR-­‐4	   Toll	  like	  receptor-­‐4	  
TNF-­‐α	   Tumour	  necrosis	  factor-­‐α	  
µMT	   B-­‐cell	  deficient	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Chapter	  1.	  Introduction	  
	  
1.1	  Basic	  overview	  of	  acute	  injury	  	  
	  
1.1.1	  What	  is	  acute	  injury?	  
Acute	  injury	  is	  a	  specific	  type	  of	  injury	  with	  symptoms	  or	  signs	  that	  manifest	  suddenly.	  
Despite	   being	   termed	   ‘acute’,	   these	   injuries	   may	   be	   life	   threatening.	   Patients	   with	  
acute	  injuries	  to	  the	  lung,	  brain,	   liver,	  heart	  or	  kidney	  are	  challenging	  to	  care	  for	  and	  
are	   vulnerable	   to	   complications	   such	   as	   downstream	   organ	   dysfunction.	   This	   is	   a	  
particular	   concern	   for	   patients	   with	   acute	   kidney	   injury	   (AKI).	   Unfortunately,	   injury	  
pathogenesis	  is	  often	  complex	  with	  only	  partial	  recovery	  of	  organ	  function.	  	  
	  
1.1.2	  What	  are	  the	  causes	  of	  acute	  injury?	  
Acute	   injury	   can	   arise	   as	   the	   result	   of	  multiple	   and	   varied	   insults	   including	   trauma,	  
ischaemia	   reperfusion	   injury,	   drug	   toxicity,	   sepsis	   and	   autoimmunity.	   The	   kidney	  
receives	  a	  large	  blood	  supply	  in	  order	  to	  effectively	  filter	  the	  blood	  and	  is	  particularly	  
vulnerable	  to	  injury	  resulting	  from	  drug	  toxicity	  and	  ischaemia	  reperfusion	  injury	  (IRI)	  
with	  the	  latter	  being	  of	  particular	  relevance	  to	  this	  thesis.	  The	  adverse	  impact	  of	  IRI	  is	  
often	  evident	  following	  organ	  transplantation	  or	  cardiac	  surgery	  that	  inevitably	  result	  
in	  a	  localized	  or	  global	  restriction	  of	  blood	  supply	  (Eltzschig	  and	  Eckle,	  2011).	  All	  tissues	  
are	   vulnerable	   to	   IRI	   including	   the	   intestine,	   kidney,	   liver,	   brain,	   cardiac	  muscle	   and	  
skeletal	  muscle.	   IRI	   results	   in	   two	  phases	  of	   injury	   (Eltzschig	   and	   Eckle,	   2011).	   Initial	  
injury	  occurs	  due	   to	   ischaemia	   and	   the	   resultant	   tissue	  de-­‐oxygenation	   and	   reduced	  
cellular	  metabolism	   that	  may	   lead	   to	   cell	   death.	   The	   second	   phase	   of	   injury	   occurs	  
when	  blood	  supply	   is	   restored	  and	   tissue	   is	   reperfused	  as	   this	  may	   lead	   to	  oxidative	  
stress	  and	  the	  generation	  of	  reactive	  oxygen	  species	  and	  subsequent	  inflammation	  and	  
cell	  injury.	  	  
	  
1.1.3	  What	  are	  the	  key	  players	  in	  acute	  injury?	  
Although	  the	  exact	  pathogenesis	  of	  acute	   injury	  may	  vary	  depending	  upon	  the	  mode	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of	   injury	   and	   the	   tissues	   affected,	   the	   molecular	   and	   cellular	   pathways	   of	   acute	  
inflammation	  are	  always	  a	  key	  driving	  force.	  
	  
1.1.3.1	  Mediators	  of	  inflammation	  
Reactive	   oxygen	   species	   (ROS)	   are	   key	   signaling	   molecules	   and	   mediators	   of	   acute	  
inflammation	   at	   sites	   of	   tissue	   injury	   (Mittal	   et	   al.,	   2014).	   These	   are	   highly	   reactive	  
compounds	  produced	  following	  tissue	  damage,	  such	  as	  hydrogen	  peroxide	  (H2O2).	  ROS	  
can	   induce	   the	   secretion	   of	   pro-­‐inflammatory	   cytokines	   such	   as	   tumour	   necrosis	  
factor-­‐α	   (TNF-­‐α)	   and	   interleukin-­‐1	   (Vinay	   et	   al.,	   2012).	   Through	   broad	   signaling	  
pathways,	  mediated	  by	   the	   transcriptional	   regulator	  nuclear	   factor-­‐κB	   (NF-­‐κB),	   these	  
cytokines	   stimulate	   the	   production	   of	   chemokines.	   These	   chemotactic	   factors	   act	   to	  
promote	  the	  rapid	  infiltration	  of	  key	  immune	  cells	  to	  sites	  of	  inflammation	  (Kindt	  et	  al.,	  
2007).	  
	  
1.1.3.2	  Immune	  cells	  
Rapid	   leukocyte	   infiltration	   is	   often	   a	   hallmark	   of	   acute	   injury.	   Whilst	   the	   exact	  
composition	  of	  this	  infiltrate	  varies	  depending	  upon	  the	  injury,	  key	  inflammatory	  cells	  
are	   prevalent	   in	   the	   pathogenesis	   of	   tissue	   injury.	   These	   include	   monocytes,	  
macrophages,	  neutrophils	  and	  platelets	   (Kindt	  et	  al.,	  2007).	  Monocytes	   infiltrate	   into	  
the	   tissue	   and	  may	   differentiation	   into	  macrophages	   depending	   upon	   the	   local	   pro-­‐
inflammatory	   mediators	   (Shi	   and	   Pamer,	   2011).	   Neutrophils	   are	   usually	   the	   first	  
leukocyte	  to	  reach	  sites	  of	  tissue	   injury	  and	  can	  potentiate	   injury	  by	  the	  secretion	  of	  
pro-­‐inflammatory	  mediators	  that	  drive	  further	  inflammation	  and	  cellular	  injury	  (Kindt	  
et	  al.,	  2007,	  Mittal	  et	  al.,	  2014).	  	  
	  
1.1.3.3	  Cellular	  injury	  
Cellular	   injury	   can	  be	   reversible	  or	   irreversible	   leading	   to	   cell	  death	  depending	  upon	  
the	  cell	  type	  and	  the	  duration	  and	  severity	  of	  the	  injurious	  insult	  (Vinay	  et	  al.,	  2012).	  
For	   instance	  short	  periods	  of	   ischaemia	  may	  result	   in	   reversible	  or	  sublethal	  damage	  
characterised	  by	  cell	  and	  mitochondria	   swelling	  and	  membrane	  blebbing.	  Conversely	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damage	  induced	  by	  longer	  durations	  of	  ischaemia	  can	  be	  irreversible	  and	  lethal	  leading	  
to	  apoptosis	  and/or	  necrosis.	  
	  
This	   thesis	  will	  primarily	  study	  acute	  kidney	   injury	   (AKI),	  and	  to	  a	   lesser	  extent	  acute	  
liver	  injury,	  induced	  by	  ischaemia	  reperfusion	  injury.	  
	  
1.2	  Acute	  Kidney	  Injury	  and	  Renal	  Ischaemic	  Reperfusion	  Injury	  
	  
1.2.1	  The	  kidney	  
The	  kidneys	  are	   the	  principal	   site	  of	  blood	   filtration	  and	   the	   regulation	  of	  water	  and	  
salt	   balance	   in	   the	   excretory	   system	   of	   mammals	   (Campbell	   and	   Reece,	   2011).	   A	  
diagrammatic	   representation	   of	   the	   major	   anatomical	   features	   of	   the	   kidney	   is	  
provided	  in	  figure	  1.1A.	  These	  paired	  bean	  shaped	  organs	  receive	  approximately	  20%	  
of	  resting	  cardiac	  blood	  flow,	  which	  is	  supplied	  by	  a	  renal	  artery	  and	  drained	  by	  a	  renal	  
vein.	  Urine	  flows	  from	  an	  individual	  kidney	  through	  a	  thin	  muscular	  tube,	  known	  as	  a	  
ureter,	  and	  drains	  into	  a	  urinary	  bladder.	  
	  
The	  kidney	  can	  be	  divided	  into	  two	  anatomically	  distinct	  regions	  comprising	  the	  renal	  
cortex	  and	  medulla.	   Travelling	   through	  both	  of	   these	   regions	   is	   the	  major	   functional	  
filtration	  unit	  of	  the	  kidney	  –	  the	  nephron	  (Figure	  1.1B).	  In	  the	  mammalian	  kidney	  the	  
nephron	   is	   an	   approximately	   30-­‐55	   mm	   long	   thin	   tubule.	   This	   tubule	   begins	   in	   the	  
cortex	  where	  one	  end	  is	  folded	  into	  a	  cuplike	  structure	  named	  the	  Bowman’s	  capsule.	  
This	   surrounds	   a	  ball	   of	   capillaries	   that	   forms	   the	   glomerulus.	  At	   this	   point	   filtration	  
begins	  as,	  due	   to	  hydrostatic	  pressure,	   fluid	   from	  the	  glomerular	  capillaries	   is	   forced	  
across	  the	  glomerular	  basement	  membrane	  into	  the	  lumen	  of	  the	  Bowman’s	  capsule.	  
The	   filtrate	   then	   passes	   into	   the	   proximal	   convoluted	   tubule.	   The	   nephron	   then	  
performs	  a	  hairpin	  bend	  into	  the	  renal	  medulla	  in	  an	  area	  of	  the	  tubule	  known	  as	  the	  
loop	   of	   Henle.	   Exiting	   the	   loop	   of	   Henle	   the	   filtrate	   then	   passes	   though	   the	   distal	  
convoluted	   tubule,	   located	   back	   in	   the	   renal	   cortex,	   before	   travelling	   to	   the	   renal	  
pelvis	  and	  ureter	  via	  a	   collecting	  duct	  which	   transverses	  both	   the	   renal	  medulla	  and	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cortex.	  The	  composition	  of	  the	  filtrate	  is	  altered	  to	  produce	  urine	  as	  the	  filtrate	  passes	  
through	  the	  nephron	  by	  a	  combination	  of	  active	  and	  passive	  transport	  of	  water,	  salts,	  




Figure	   1.1	  Overview	   of	   the	   kidney	   (A)	   and	   the	   functional	   unit	   of	   the	   kidney	   –	   the	  
nephron	   (B).	   Drawn	   on	   the	   basis	   of	   the	   information	   provided	   in	   Chapter	   44:	  
Osmoregulation	  and	  Excretion	  in	  Campbell	  Biology	  (Seventh	  Edition)	  by	  Campbell	  and	  
Reece	  (2011).	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1.2.2	  Acute	  Kidney	  Injury	  (AKI)	  
AKI	   is	   a	   serious	  and	  unfortunately	   common	  condition	   that	  affects	  hospital	   inpatients	  
worldwide	  and	  is	  associated	  with	  a	  high	  mortality	  and	  long-­‐term	  complications	  (Kerr	  et	  
al.,	  2014).	  The	   typical	   clinical	   characteristics	  of	  AKI	   include	  a	   rapid	   reduction	   in	   renal	  
excretory	   function,	  diagnosed	  by	  elevated	   levels	  of	   serum	  creatinine	  and	  blood	  urea	  
(products	   of	   muscle	   and	   nitrogen	   metabolism,	   respectively),	   accumulation	   of	  
metabolic	  acids	  and	  reduced	  urine	  output	  (Bellomo	  et	  al.,	  2012,	  Lameire	  et	  al.,	  2013).	  
AKI	  can	  arise	  as	  the	  result	  of	  extrarenal	  events,	  such	  as	  cardiac	  dysfunction,	  or	  due	  to	  
direct	  intrinsic	  kidney	  damage,	  such	  as	  renal	  IRI	  (Lameire	  et	  al.,	  2013).	  	  
	  
1.2.3	  Current	  treatments	  
Renal	   IRI	   and	   acute	   kidney	   injury	   place	   a	   significant	   burden	   upon	   the	   health	   service	  
with	  an	  estimated	  annual	  AKI-­‐related	   inpatient	  cost	  of	  £1.02	  billion	   in	  England	  alone	  
(Kerr	  et	  al.,	  2014).	  There	  is	  an	  urgent	  need	  for	  novel	  AKI	  treatments,	  as	  current	  clinical	  
treatments	   still	   remain	   purely	   supportive	   with	   no	   specific	   therapy	   available.	   Acute	  
renal	   failure	  may	  necessitate	   dialysis	   but	   this	   has	   no	   effect	   upon	   the	  underlying	  AKI	  
and	  a	  significant	  proportion	  of	  affected	  patients	  will	  either	  die	  or	  be	  left	  with	  chronic	  
kidney	  disease.	  As	  inflammation	  plays	  a	  key	  role	  following	  renal	  IRI	  it	  is	  not	  surprising	  
that	  the	  resultant	   injury	  may	  be	  attenuated	  by	  anti-­‐inflammatory	  treatments	  (Lutz	  et	  
al.,	  2010).	  Reduced	  chemokine	  generation	  by	  caspase,	  NF-­‐κB,	  and	  p38	  MAPK	  inhibition	  
ameliorates	   renal	   injury	   following	   ischaemia	   (Furuichi	   et	   al.,	   2008).	   Inflammatory	  
pathways	  and	  the	  microvascular	  system	  are	  two	  avenues	  in	  which	  novel	  therapeutics	  
can	  be	  developed.	  
	  
1.2.4	  Renal	  ischaemia	  reperfusion	  (IRI)	  injury	  pathophysiology	  
AKI	   induced	   by	   renal	   IRI	   is	   a	   significant	   risk	   factor	   for	   patients	   undergoing	   renal	  
transplantation	   or	   any	  major	   surgery	   that	   may	   transiently	   reduce	   renal	   blood	   flow,	  
such	   as	   cardiac	   surgery.	   Ischaemic	   AKI	   has	   a	   complex	   pathogenesis	   involving	   acute	  
inflammatory	  responses,	  endothelial	  and	  tubular	  epithelial	  cell	  injury	  (Patschan	  et	  al.,	  
2012a,	   Bonventre	   and	   Zuk,	   2004,	   Kinsey	   et	   al.,	   2008).	   Figure	   1.2	   provides	   a	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diagrammatic	   representation	  of	   the	  major	   changes	   that	  occur	   relevant	   to	   this	   thesis	  
following	  ischaemic	  injury.	  
	  
	  
Figure	  1.2	  –	  Normal	  and	   ischaemic	   renal	  microvasculature.	  Within	  small	  peritubular	  
capillaries	   the	   endothelium	   maintains	   a	   patent	   microvascular	   system	   by	   regulating	  
inflammatory	  cell	  migration,	  blood	  fluidity	  and	  preventing	  thrombus	  formation.	  Upon	  
IRI	  acute	  tubular	  necrosis	  occurs	  along	  with	  endothelial	  dysfunction.	  	  These	  alterations	  
lead	   to	   fibrin	   and	   platelet	   deposition,	   red	   blood	   cell	   sludging	   ultimately	   leading	   to	  
microvascular	   congestion,	   which	   impairs	   reperfusion	   and	   glomerular	   filtration.	  
Reperfused	  injured	  cells	  may	  express	  autoantigens	  that	  are	  recognised	  and	  bound	  by	  
IgM	  leading	  to	  complement	  activation	  that	  intensifies	  injury	  and	  delays	  the	  restoration	  
of	   renal	   function.	   Note	   that	   the	   presentation	   of	   autoantigens	   and	   IgM	   antibody	  
binding	  is	  introduced	  in	  ‘1.4	  IgM	  Antibodies	  and	  Ischaemic	  Tissue	  Injury’.	  
	  
1.2.4.1	  Inflammation	  and	  acute	  tubular	  necrosis	  
Inflammation	  has	  a	  major	  influence	  on	  the	  initiation	  and	  amplification	  of	  IRI,	  with	  both	  
the	  innate	  and	  adaptive	  immune	  system	  influencing	  the	  pathogenesis	  of	  renal	  IRI	  (Jang	  
et	  al.,	  2010).	  Pro-­‐inflammatory	  cytokines	  such	  as	  TNF-­‐α,	  interleukin	  (IL)-­‐1β	  and	  IL-­‐6	  are	  
released	   by	   infiltrating	   leukocytes	   and	   injured	   tubular	   epithelial	   cells	   and	   act	   to	  
potentiate	   inflammation	  and	  associated	   injury	   (Daha	  and	  van	  Kooten,	  2000,	  Ramesh	  
and	  Reeves,	  2004,	  Thurman,	  2007).	   	   Immune	  cell	   infiltration	  is	  a	  hallmark	  of	  renal	  IRI	  
with	   neutrophils	   and	  macrophages	   infiltrating	   into	   the	   interstitium	   (Patschan	   et	   al.,	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2012a,	   Friedewald	   and	   Rabb,	   2004).	   Inflammatory	   responses	   lead	   to	   further	  
endothelial	   dysfunction	   and	   injury	  with	   increased	   leukocyte	   infiltration	   and	   reduced	  
blood	   flow	   (Bonventre	   and	   Zuk,	   2004).	   Impaired	   renal	   blood	   flow,	   contributing	   to	   a	  
reduction	   in	   glomerular	   filtration	   rate,	   promotes	   renal	   medullary	   hypoxia	   and	  
amplification	  of	  cellular	  injury	  (Basile,	  2011).	  As	  a	  result	  of	  ischaemia	  the	  structure	  and	  
function	  of	   tubular	   epithelial	   cells	   are	   significantly	   altered,	   as	   they	  progress	   through	  
apoptosis	  or	  necrosis,	  leading	  to	  acute	  tubular	  necrosis	  (ATN)	  (Patschan	  et	  al.,	  2012b,	  
Patschan	   et	   al.,	   2012a).	   These	   alterations	   have	   a	   direct	   impact	   on	   the	  
microvasculature.	  
	  
1.2.4.2	  Ischaemic	  microvascular	  tissue	  injury	  
Alterations	   to	   the	   highly	   specialized	   renal	   microvascular	   architecture	   contribute	   to	  
both	  the	   initiation	  and	  exacerbation	  of	  renal	   IRI	   (Becherucci	  et	  al.,	  2009,	  Patschan	  et	  
al.,	   2012b).	   	   These	   microvascular	   effects	   are	   first	   observed	   in	   the	   medulla,	   which	  
receives	  only	  10%	  of	  the	  renal	  blood	  flow	  rendering	  it	  vulnerable	  to	  ischaemic	  damage	  
(Munshi	   et	   al.,	   2011,	   Friedewald	   and	   Rabb,	   2004).	   	   Endothelial	   cells	   regulate	  
inflammatory	  cell	  migration,	  blood	  fluidity	  and	  actively	  prevent	  thrombus	  formation	  by	  
controlling	  fluid,	  solutes,	  platelet	  and	  blood	  cell	  extravasation	  (Sutton	  et	  al.,	  2002).	  The	  
endothelium	   regulates	   tissue	   perfusion	   by	   controlling	   local	   vasoregulation	   (van	  
Hinsbergh,	   2012).	   	   Ischaemia	   results	   in	  multiple	   changes	   in	   endothelial	   morphology	  
including	   cell	   swelling,	   basement	   membrane	   detachment,	   increased	   leukocyte	  
adhesion	   molecule	   expression	   and	   blebbing	   (Sutton	   et	   al.,	   2002).	   This	   endothelial	  
dysfunction	   promotes	   inflammation,	   perturbs	   coagulation	   control	   and	   thrombus	  
formation	  thereby	  creating	  a	  prothrombotic	  environment	  (Becherucci	  et	  al.,	  2009,	  van	  
Hinsbergh,	   2012).	   These	  deleterious	   changes	   to	   the	  microvasculature	   can	  be	   further	  
complicated	  by	  the	  actions	  of	  platelets.	  
	  
1.2.4.3	  Platelets	  
Platelets,	  which	  accumulate	   in	  the	  vascular	  bed,	  become	  active	  following	  reperfusion	  
and	   may	   have	   a	   pathophysiological	   role	   in	   IRI.	   Platelets	   contain	   many	   pro-­‐
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inflammatory	  mediators	  and	  cell	  surface	  ligands	  (Morrell	  et	  al.,	  2007).	  Upon	  activation	  
platelets	   release	   ROS	   and	   pro-­‐inflammatory	   mediators	   including	   thromboxane	   A2,	  
leukotrienes	  and	  platelet-­‐derived	  growth	   factor	   (PDGF)	  and	   the	  chemokine	  mediator	  
platelet	  activating	  factor	  (PAF)	  (Massberg	  et	  al.,	  1998,	  Eppihimer	  and	  Granger,	  1997).	  	  
Through	  the	  selectin	  family	  of	  adhesion	  molecules,	  such	  as	  P-­‐selectin	  (ligand	  –	  PGSL-­‐1)	  
platelets	  are	  able	  to	  bind	  to	  subendothelial	  matrixes	  (Eppihimer	  and	  Granger,	  1997).	  	  
	  
1.2.4.4	  Microvascular	  congestion	  
The	  cumulative	  effect	  of	  the	  above	  alterations	  ultimately	  leads	  to	  the	  microvasculature	  
becoming	   congested	   with	   erythrocytes	   and	   platelet/fibrin	   aggregates.	   This	   limits	  
perfusion	   and	   propagates	   ischaemic	   injury	   (Patschan	   et	   al.,	   2012b,	   Eneström	   et	   al.,	  
1988),	   a	   phenomenon	   termed	   ‘no-­‐reflow’.	   By	   reducing	   microvascular	   congestion	  
reperfusion	   can	   occur	   more	   effectively	   eliminating	   prolonged	   ischaemic	   periods	  
(Patschan	  et	  al.,	  2012b).	  	  Studies	  have	  indicated	  that	  a	  reduced	  pre-­‐injury	  hematocrit	  
improves	  renal	  blood	  flow	  post	   ischaemia	  (Mason	  et	  al.,	  1987,	  Hellberg	  et	  al.,	  1990).	  
These	   studies	   suggest	   that	  microvascular	   congestion	  does	   indeed	   contribute	   to	  poor	  
re-­‐flow	  following	  ischaemia.	  	  
	  
1.2.5	  Experimental	  model	  of	  renal	  IRI	  
Experimental	  models	  that	  accurately	  and	  reproducibly	  recapitulate	  renal	  IRI	  are	  crucial	  
in	   dissecting	   the	   pathophysiology	   of	   AKI	   and	   the	   development	   of	   novel	   therapeutic	  
agents.	   In	   this	   thesis	   a	   surgical	  mouse	  model	   of	   renal	   IRI	   was	   used	   (Hesketh	   et	   al.,	  
2014,	  Wei	  and	  Dong,	  2012,	  Kumar	  et	  al.,	  2009,	  Oxburgh	  and	  de	  Caestecker,	  2012).	  This	  
model	   utilizes	   a	   midline	   laparotomy	   approach	   for	   the	   surgery	   with	   one	   incision	  
allowing	  both	  a	  right	  nephrectomy,	  which	  provides	  control	  tissue,	  and	  clamping	  of	  the	  
left	  renal	  pedicle	  to	  induce	  ischaemia	  of	  the	  left	  kidney.	  	  Sham	  controls	  are	  performed	  
by	  manipulation	   of	   the	   left	   and	   right	   renal	   pedicle	   only	   following	   a	   laparotomy.	   By	  
carefully	  monitoring	  the	  body	  temperature	  during	  the	  period	  of	  ischaemia	  this	  model	  
achieves	   reproducible	   functional	   and	   structural	   injury.	   In	   contrast	   to	   models	   that	  
utilise	  bilateral	   kidney	   ischaemia	   (Wei	   and	  Dong,	  2012)	   the	  unilateral	  model	  has	   the	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advantage	  of	  a	  right	  nephrectomy	  being	  undertaken	  at	  the	  time	  of	  surgery.	  The	  right	  
nephrectomy	  tissue	  serves	  as	  non-­‐injured	  control	  tissue.	  	  	  
	  
1.3	  Acute	  Liver	  Failure	  (ALF)	  
	  
1.3.1	  The	  Liver	  
As	   the	   largest	  organ	   in	   vertebrates	   the	  human	   liver	   can	  be	  broadly	  divided	   into	   two	  
lobes;	  however,	   the	  exact	   form	  of	   the	   liver	  can	  vary	  between	  species	   (Campbell	  and	  
Reece,	   2011).	   The	   liver	   receives	   a	   dual	   blood	   supply	   from	   the	   hepatic	   artery	   and	  
hepatic	   portal	   vein.	   Approximately	   60%	   of	   the	   liver	   consists	   of	   cells	   termed	  
hepatocytes	   that	   enable	   the	   liver	   to	   perform	   a	   diverse	   range	   of	   functions	   including	  
filtration	  of	   blood	   arising	   the	  digestive	   tract,	   blood	  detoxification,	   bile	   secretion	   and	  
synthesis	   of	  major	   complement	   and	   blood	   clotting	   proteins.	   As	   the	   liver	   performs	   a	  
diverse	  range	  of	  functions	  acute	  injuries	  can	  be	  devastating.	  
	  
1.3.2	  Overview	  and	  pathophysiology	  
Although	   rare,	   with	   a	  worldwide	   incidence	   of	   below	   10	   cases	   per	  million	   persons	   a	  
year,	   acute	   liver	   injury	  or	   acute	   liver	   failure	   (ALF)	   is	   a	   life	   threatening	   condition	   that	  
arises	  as	  a	  result	  of	  sudden	  and	  severe	  hepatic	   injury	  (Bernal	  et	  al.,	  2010,	  Bernal	  and	  
Wendon,	   2013).	   ALF	   is	   associated	   with	   a	  mortality	   rate	   of	   50%,	   with	  most	   patients	  
presenting	   with	   hepatic	   dysfunction,	   abnormal	   liver	   biochemical	   values,	   and	  
coagulopathy	   with	   some	   patients	   developing	   multi-­‐organ	   failure,	   including	   renal	  
dysfunction	  (Bernal	  and	  Wendon,	  2013,	  Moore,	  1999).	  Hepatic	  injury	  can	  originate	  as	  
the	  result	  of	  multiple	  causes;	  however,	  relevant	  to	  this	  thesis	  are	  IRI	  (hypoxic	  hepatitis)	  
and	   autoimmune	   hepatitis	   (AIH)	   both	   of	   which	   are	   highly	   inflammatory.	   Hypoxic	  
hepatitis	   is	   characterised	   by	   hepatocyte	   necrosis,	   neutrophil	   and	   Kupffer	   cell	  
activation,	   production	  of	   cytokines,	   chemokines	   and	  ROS	  with	   increased	   lymphocyte	  
and	  monocyte	  infiltration	  (Zhai	  et	  al.,	  2013).	   Ischaemic	  injury	  is	  an	  important	  form	  of	  
hepatic	   injury	   that	  may	   occur	   during	   hepatic	   tumour	   resections	   and	   liver	   transplant	  
surgery	  as	  interruption	  of	  the	  hepatic	  blood	  supply	  is	  unavoidable	  (Mendes-­‐Braz	  et	  al.,	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2012).	  	  AIH	  is	  a	  chronic	  inflammatory	  condition,	  involving	  progressive	  fibrosis	  and	  loss	  
of	  self	  tolerance	  with	  the	  development	  of	  autoantibodies	  (Mieli-­‐Vergani	  and	  Vergani,	  
2011).	   The	   pathogenesis	   is	   thought	   to	   involve	   antigen-­‐presenting	   cells	   (APCs)	   that	  
present	  liver	  peptides	  derived	  from	  self-­‐antigens	  to	  the	  T-­‐cell	  receptor	  of	  T-­‐helper	  cells	  
(Mieli-­‐Vergani	   and	   Vergani,	   2011,	   Liberal	   et	   al.,	   2013).	   Resultant	   autoantibodies	  
contribute	  to	  antibody-­‐mediated	  cellular	  cytotoxicity	  and	  complement	  mediated	  tissue	  
injury	  (Liberal	  et	  al.,	  2013).	  AIH	  patients	  often	  have	  elevated	  serum	  globulin	  levels	  with	  
IgG	   levels	   generally	   elevated	   1.2	   to	   3.0	   times	   (Krawitt,	   2006).	   To	   further	   dissect	   the	  
pathogenesis	  of	  ALF	  and	  AIH	  researchers	  need	  to	  study	  animal	  models	  that	  accurately	  
and	  reproducibly	  replicate	  the	  human	  disease.	  
	  
1.3.3	  Models	  of	  ALI	  
In	  this	  thesis	  hypoxic	  hepatitis	  was	  modeled	   in	  mice	  by	  warm	  (in	  situ)	  partial	  hepatic	  
IRI.	  To	   induce	   ischaemia	   the	  hepatic	  artery,	  portal	  vein	  and	  bile	  duct	  of	   the	   left	   liver	  
lobe	   are	   occluded.	   This	   results	   in	   only	   partial	   liver	   ischaemia	   as	   blood	   flow	   is	   still	  
supplied	   to	   the	   patent	   right	   and	   caudal	   lobes	   (Mendes-­‐Braz	   et	   al.,	   2012).	   AIH	   was	  
modeled	  in	  mice	  using	  the	  plant	  lectin	  Concanavalin	  A	  (ConA)	  model	  (Tiegs	  et	  al.,	  1992,	  
Wang	   et	   al.,	   2012).	   This	   model	   exhibits	   T-­‐cell	   activation	   and	   cytokine	   upregulation	  
indicative	  of	  chronic	  inflammation	  and	  autoantibody	  generation	  and	  closely	  replicates	  
human	   disease	   (Wang	   et	   al.,	   2012,	   Sass	   et	   al.,	   2002,	   Nakano	   et	   al.,	   2013).	   Tissue	  
necrosis	   occurs	   in	   both	   models,	   accompanied	   by	   elevated	   plasma	   levels	   of	   alanine	  
aminotransferase	  (ALT)	  that	  represents	  a	  useful	  biochemical	  marker	  of	  liver	  injury.	  
	  
1.4	  IgM	  Antibodies	  and	  Ischaemic	  Tissue	  Injury	  
	  
With	   autoantibodies	   present	   in	   patients	   with	   AIH,	   it	   is	   important	   to	   note	   that	  
autoantibodies	   of	   the	   IgM	   isotype	   are	   implicated	   in	   the	   pathogenesis	   of	   ischaemic	  
injury	  to	  the	  intestine,	  skeletal	  and	  cardiac	  muscle.	  Thus,	  the	  role	  of	  IgM	  antibodies	  in	  
AIH,	  renal	  and	  liver	  IRI	  merits	  investigation.	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1.4.1	  Function,	  structure	  and	  IgM	  production	  
Immunoglobulin	  class	  M	  (IgM)	  antibodies	  are	  produced	  by	  a	  subset	  of	  B	  cells	  (B1	  Cells)	  
and	  exist	  as	  two	  forms	  –	  a)	  on	  the	  surface	  membrane	  of	  B-­‐cells	  where	  it	  forms	  the	  B	  
cell	  receptor	  and	  b)	  as	  a	  secreted	  circulating	  form	  found	  in	  the	  blood	  (Ehrenstein	  and	  
Notley,	  2010).	  	  Circulating	  IgM	  can	  be	  further	  divided	  into	  immune,	  produced	  following	  
foreign	   antigen	   exposure,	   and	   IgM	   antibodies	   that	   are	   detectable	   in	   the	   absence	   of	  
antigenic	   stimuli	   and	   are	   present	   at	   birth	   (Lobo	   et	   al.,	   2010,	   Ehrenstein	   and	  Notley,	  
2010).	   	   The	   focus	   of	   this	   thesis	   is	   circulating	   IgM.	   Unlike	   IgG	   antibodies,	   IgM	   is	   not	  
transferred	   from	  mothers	   to	  newborns	  and	  as	   such	  newborns	  demonstrate	  a	   similar	  
IgM	  antibody	  repertoire	  that	  becomes	  highly	  diverse	  with	  age	  (Madi	  et	  al.,	  2012,	  Madi	  
et	  al.,	  2009).	  Encoded	  by	  minimally	  or	  non-­‐mutated	  germ	  line	  genes	  (Lobo	  et	  al.,	  2010)	  
IgM	  antibodies	  are	  polyreactive	  with	   low-­‐binding	  affinity	   (Fu	  et	   al.,	   2007,	   Ehrenstein	  
and	  Notley,	  2010).	  Circulating	  IgM	  has	  unique	  properties	  owing	  to	  its	  pentameric	  form	  
(Czajkowsky	  and	  Shao,	  2009),	  hence	   it	  can	   interact	  with	  several	  binding	  partners	  and	  
participate	   in	   diverse	   pathophysiologies	   such	   as	   infection,	   B	   cell	   homeostasis,	  
inflammation,	  atherosclerosis	  and	  autoimmunity	  (Ehrenstein	  and	  Notley,	  2010).	  	  Using	  
cryo-­‐atomic	   force	   microscopy	   of	   individual	   human	   IgM,	   Czajkowsky	   et	   al.,	   (2009)	  
revealed	  that	   IgM	  antibodies	  are	  mushroom-­‐shaped	  with	  a	  central	  protruding	  region	  
containing	  binding	  sites	  for	  complement	  protein	  C1q.	  IgM	  antibody-­‐antigen	  complexes	  
(immune	  complexes)	  have	   fully	  exposed	  C1q	  binding	   sites,	   allowing	  activated	  C1q	   to	  
bind	  and	  interact	  with	  downstream	  complement	  components.	  
	  
1.4.2	  The	  complement	  system	  
The	  complement	  system	  is	  a	  highly	  regulated	  major	  effector	  of	  humoral	  immunity	  and	  
consists	  of	  numerous	  interacting	  soluble	  serum	  and	  membrane	  proteins	  (Campbell	  and	  
Reece,	  2011).	   It	  should	  be	  appreciated	  that	  the	  complement	  system	  is	  quite	  complex	  
and	   this	   thesis	   will	   only	   provide	   a	   simplified	   overview	   of	   the	   major	   components	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1.4.2.1	  Three	  pathways	  of	  complement	  activation	  
The	   complement	   system	   becomes	   active	   and	   responsive	   upon	   the	   cleavage	   of	  
complement	  protein	  3	  (C3)	  into	  C3a,	  and	  importantly	  C3b.	  Three	  pathways	  can	  initiate	  
this:	  classical,	  mannose	  binding	  lectin	  (MBL),	  and	  the	  alternative	  pathway	  (Figure	  1.3).	  	  
	  
	  
Figure	   1.3	   –	   Simplified	   overview	   of	   the	   major	   steps	   and	   components	   of	   the	  
complement	   system.	   Three	   distinct	   pathways	   can	   activate	   the	   complement	   system:	  
alternative,	   mannose	   binding	   lectin	   and	   the	   classical	   pathway.	   All	   three	   pathways	  
result	   in	   increased	   production	   of	   C3b	   from	   C3.	   The	   final	   steps	   of	   each	   pathway	  
ultimately	   lead	   to	   formation	  of	   the	  membrane	  attack	   complex,	  with	   subsequent	   cell	  
lysis,	  or	  complement	  protein	  opsonisation	  and	  phagocytosis	  of	  a	  number	  of	  different	  
cells	   including	   pathogens	   and	   apoptotic	   cells.	   Figure	   created	   on	   the	   basis	   of	  
information	   in	  Chapter	  7:	   The	   complement	   System	  of	   Immunology	   (Sixth	  Edition)	  by	  
Kindt	  et	  al.,	  (2007).	  	  
	  
1.4.2.2	  The	  classical	  pathway	  
Of	  particular	  relevance	  to	  this	  thesis	  is	  the	  classical	  pathway	  of	  complement	  activation.	  
IgM	  and	  certain	  IgG	  subclasses	  (IgG1,	  IgG2	  and	  IgG3)	  activate	  the	  complement	  cascade	  
by	   binding	   to	   soluble	   antigens	   or	   antigenic	   surfaces	   such	   as	   bacterial	   cell	   walls.	   As	  
previously	   mentioned,	   the	   formation	   of	   IgM	   antibody/immune	   complexes	   exposes	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binding	   sites	   for	   C1q,	  which	   together	  with	   complement	   proteins	   C1r	   and	  C1s,	   forms	  
the	  macromolecular	  complex	  C1.	  C1	  facilitates	  the	  formation	  of	  complex	  C4b2a,	  called	  
C3	  convertase,	  which	  acts	  to	  catalyze	  the	  formation	  of	  C3b.	  	  
	  
1.4.2.3	  The	  mannose	  binding	  lectin	  pathway	  
The	  MBL	  pathway	  becomes	  activated	  following	  the	  binding	  of	  MBL,	  a	  member	  of	  the	  
collectin	   family,	   to	  mannose	  polysaccharide	   (mannans)	   containing	  bacterial	   surfaces.	  
Similar	   to	   the	   classical	   pathway	   this	   binding	   initiates	   the	   activation	   of	   a	   C1-­‐like	  
macromolecular	   complex	   which	   facilities	   C3	   convertase	   formation	   with	   subsequent	  
C3b	  production.	  	  
	  
1.4.2.4	  The	  alternative	  pathway	  
The	   alternative	   pathway	   does	   not	   require	   antibodies	   for	   activation.	   Due	   to	  
spontaneous	  cleavage	  of	  C3,	   low	  levels	  of	  C3b	  fragments	  are	  continuously	  present	   in	  
the	   serum.	   However,	   the	   complement	   cascade	   is	   only	   activated	   once	   stable	   C3b	  
binding	  to	  a	  variety	  of	  antigenic	  surfaces,	  such	  as	  bacterial	  lipopolysaccharides.	  
	  
1.4.2.5	  Termination	  of	  the	  cascade	  and	  effector	  functions	  
Although	   the	   initiating	   steps	   differ,	   all	   three	   pathways	   culminate	   in	   the	   increased	  
production	  of	  C3b.	  This	  leads	  to	  a	  number	  of	  basic	  functions;	  however,	  of	  relevance	  to	  
this	  thesis	  is	  increased	  phagocytosis	  and	  or	  cellular	  lysis.	  One	  of	  the	  terminal	  events	  of	  
the	  complement	  cascade	  is	  the	  requirement	  of	  complement	  proteins	  C5–C9	  to	  form	  a	  
macromolecular	  structure	  known	  as	   the	  membrane-­‐attack	  complex	   (MAC)	   in	   the	  cell	  
membranes	  of	  targeted	  cells.	  MAC	  mediates	  cell	  lysis	  by	  forming	  membrane	  pores	  that	  
allows	   unrestrictive	   ion	   and	   small	   molecule	   diffusion	   ultimately	   leading	   to	   a	   loss	   of	  
osmotic	   stability	   and	   subsequent	   cell	   death.	   Binding	   of	   complement	   factors	   to	  
antigenic	  cell	  surfaces	  including	  apoptotic	  cells	  also	  leads	  to	  opsonisation	  that	  acts	  to	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1.4.3	  Complement	  and	  IgM	  in	  ischaemic	  injury	  
Despite	   forming	   the	   first	   line	   of	   defense	   against	   foreign	   and	   endogenous	   antigens	  
evidence	   is	  accumulating	  for	  the	  pathogenic	   involvement	  of	  circulating	   IgM	  following	  
ischaemic	   injury.	   IgM	   antibodies	   have	   an	   important	   role	   in	   classical	   complement	  
activation	  that	  leads	  to	  organ	  and	  tissue	  injury	  as	  indicated	  by	  studies	  of	  ischaemia	  in	  
various	   organs	   (Burne-­‐Taney	   et	   al.,	   2003,	   Czajkowsky	   and	   Shao,	   2009,	   Zhang	   et	   al.,	  
2004,	  Weiser	  et	  al.,	  1996,	  Zhang	  et	  al.,	  2006a)	  (summarised	  in	  detail	  in	  Table	  1.1).	  	  For	  
instance,	   intestinal	   ischaemia	   reperfusion	   injury	   is	   dependent	   upon	   the	   classical	  
complement	  pathway	  and	  IgM	  (Williams	  et	  al.,	  1999).	  	  Weiser	  et	  al.,	  (1996)	  indicated	  
that	  complement	  may	  be	  activated	  by	  a	  natural	  antibody	  as	  Recombination	  Activation	  
Gene-­‐1	   (RAG-­‐1-­‐/1)	   mice,	   deficient	   in	   both	   mature	   B	   and	   T	   lymphocytes,	   did	   not	  
develop	  injury	  following	  hind	  limb	  ischaemia.	  Injury	  was,	  however,	  restored	  following	  
reconstitution	   of	   RAG-­‐1	   mice	   with	   fresh-­‐pooled	   serum.	   Williams	   et	   al,	   (1999)	  
subsequently	   demonstrated	   that	   mice	   deficient	   in	   Ig	   had	   significantly	   reduced	  
intestinal	  injury	  following	  IRI	  that	  was	  restored	  to	  wild-­‐type	  levels	  when	  reconstituted	  
with	   IgM.	   Furthermore	   IgM	   bound	   the	   reperfused	   injured	   endothelium,	   colocalizing	  
with	  C3	   in	  wild-­‐type	  mice,	  whilst	  minimal	  C3	  and	   IgM	  deposition	  was	  observed	   in	   Ig-­‐
deficient	   mice.	   	   Reperfusion	   injured	   cells	   express	   autoantigens,	   such	   as	   annexin	   IV	  
(intestinal	   villi)	   and	   non-­‐muscle	   myosin	   heavy	   chain	   II	   (NMHC-­‐II)	   (cardiac	   muscle,	  
skeletal	   endothelium	   and	   muscle	   fiber	   bundles	   and	   intestinal	   mucosa).	   These	  
autoantigens	   are	   recognised	   and	   bound	   by	   IgM	   antibodies	   leading	   to	   subsequent	  
classical	  complement	  activation	  that	  acts	  to	  promote	  further	  tissue	  injury	  (Ehrenstein	  
and	  Notley,	  2010,	  Zhang	  and	  Carroll,	  2007,	  Haas	  et	  al.,	  2010,	  Zhang	  et	  al.,	  2006b,	  Chan	  
et	  al.,	  2006).	  The	  exact	  role,	  if	  any,	  of	  IgM	  antibodies	  in	  renal	  or	  liver	  IRI	  is	  unknown.	  It	  
is	  possible	  that	  cells	  in	  the	  reperfused	  and	  injured	  renal	  microvasculature	  or	  the	  renal	  
tubules	  may	  also	  express	  neo-­‐epitopes	  that	  are	  recognised	  and	  bound	  by	  IgM	  (Figure	  
1.2	   provides	   a	   diagrammatic	   representation	   of	   this).	   Lastly,	   Burne-­‐Taney	   (2003)	  
discovered	   that	   B	   cell	   deficient	  mice	   	   (µMT)	  were	   protected	   	   from	   	   renal	   	   IRI,	   	  with	  
injury	   	   restored	   by	   serum	   reconstitution,	   but	   not	   by	   B	   cell	   transfer,	   suggesting	   a	  
circulating	  	  factor	  	  such	  as	  	  IgG	  or	  IgM	  	  may	  be	  	  involved.	  	  It	  should	  	  also	  be	  noted	  that	  a	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Table	  1.1	  –	  Summary	  of	  key	  papers	  demonstrating	  a	  pathogenic	  role	  for	  IgM	  during	  
ischaemic	  injury	  












- Cr2-­‐/-­‐	  (mice	  with	  a	  defective	  IgM	  repertoire	  due	  to	  defective	  B-­‐1	  
cells),	  RAG-­‐1	  and	  sIgM	  mice	  had	  significantly	  reduced	  infarct	  size,	  
with	  injury	  restored	  following	  IgM	  reconstitution	  
(Zhang	  et	  al.,	  
2006b)	  (Busche	  
et	  al.,	  2009)	  
- Pathogenic	  B-­‐1	  cell	  hybridoma	  clone	  IgMcm-­‐22	  identified	  
- Cardiac	  injury	  restored	  in	  RAG-­‐1	  mice	  reconstituted	  with	  IgMcm-­‐22	  
- Self	  reactive	  neo-­‐epitope	  non-­‐muscle	  myosin	  heavy	  chain	  II	  
(NMHC-­‐II)	  identified	  as	  IgMcm-­‐22	  target	  in	  cardiac	  muscle	  cells	  
- Synthetic	  peptide	  mimetope	  (N2)	  directed	  against	  NMHC-­‐II	  
administered	  60-­‐90min	  post	  ischaemia	  attenuated	  cardiac	  injury	  
- N2	  treated	  mice	  demonstrated	  reduced	  infarct	  size,	  IgM	  and	  C3d	  
deposition	  with	  reduced	  monocyte	  and	  neutrophil	  infiltration	  
















- Cr2,	  C3,	  C4	  deficient	  mice	  protected	  from	  injury	  	  
- RAG-­‐2	  mice	  protected,	  injury	  restored	  following	  serum	  transfer	  
- Endothelial	  C3	  and	  IgM	  deposition	  observed	  in	  wild	  type	  mice	  
(Weiser	  et	  al.,	  
1996)	  
- IgM	  deposited	  after	  5mins	  of	  ischaemia	  and	  increased	  up	  until	  
6hrs,	  and	  diminished	  during	  reperfusion	  	  
(Chan	  et	  al.,	  
2004)	  
- IgMcm-­‐22	  bound	  to	  NMHC-­‐II	  in	  injured	  endothelial	  and	  muscle	  fiber	  
- Injury,	  IgM	  and	  C3	  deposition	  restored	  in	  Cr2-­‐/-­‐	  mice	  reconstituted	  
with	  IgMcm-­‐22	  	  
(Austen	  et	  al.,	  
2004)	  
- Synthetic	  peptide	  mimetope	  (N2)	  treatment	  attenuated	  skeletal	  
ischaemic	  injury	  with	  decreased	  numbers	  of	  injured	  muscle	  fibers	  
(Chan	  et	  al.,	  
2006)	  













- C3	  and	  RAG-­‐1	  deficient	  mice	  had	  attenuated	  injury	  with	  reduced	  
IgM	  and	  C3	  deposition	  in	  ischaemic	  tissue	  
- Injury	  restored	  in	  RAG-­‐1	  mice	  following	  IgM	  reconstitution	  
- C3	  and	  IgM	  colocalized	  to	  reperfused	  mucosa	  in	  wild	  type	  mice	  
(Williams	  et	  al.,	  
1999)	  
- IgMcm-­‐22	  found	  to	  bind	  to	  NMHC-­‐II	  in	  injured	  skeletal	  muscle	  
- IgMcm-­‐22	  restored	  injury	  in	  RAG-­‐1	  mice	  with	  significant	  IgM,	  C4	  and	  
C3	  deposition	  that	  co-­‐localized	  with	  IgM	  in	  injured	  villi	  and	  mucosa	  
(Zhang	  et	  al.,	  
2004)	  
- N2	  treatment	  attenuated	  skeletal	  ischaemic	  injury	  in	  mice	  in	  a	  
dose	  dependent	  manner	  
(Zhang	  et	  al.,	  
2006a)	  
- IgM	  clone	  (mAb	  B4)	  identified	  which	  could	  restore	  injury	  in	  RAG-­‐1	  
mice	  by	  binding	  to	  annexin-­‐IV	  resulting	  in	  complement	  activation	  
and	  neutrophil	  infiltration	  












- Used	  in	  vitro	  ischaemic	  reperfusion	  injury	  model	  in	  human	  and	  
murine	  proximal	  tubular	  epithelial	  cells	  to	  investigate	  role	  of	  IgM	  
and	  C3	  deposition	  
- Following	  hypoxic	  injury	  to	  human	  renal	  tubular	  cells	  C3	  
deposition	  occurred	  which	  was	  dependent	  on	  IgM	  and	  C1q	  
activation	  of	  the	  classical	  complement	  pathway	  
- Alternative	  pathway	  required	  for	  C3	  deposition	  on	  necrotic	  human	  
renal	  tubular	  cells	  
- C3	  deposition	  following	  ischaemic	  and	  necrotic	  injury	  to	  murine	  
renal	  tubular	  cells	  occurs	  via	  the	  alternative	  pathway	  
(van	  der	  Pol	  et	  
al.,	  2011)	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recent	   paper	   by	   van	   der	   Pol	   et	   al.,	   (2011)	   suggested	   that	   IgM	  may	   bind	   to	   injured	  
ischaemic	  human	  renal	  tubular	  cells	  in	  vitro.	  
	  
1.4.4	  Complement,	  renal	  ischaemia	  and	  liver	  injury	  
Despite	   the	   role	   of	   IgM	   in	   renal	   ischaemia	   remaining	   unclear,	   there	   is	   growing	  
evidence	   indicating	   the	   complement	   system	   is	   a	   key	  amplifier	  of	   tissue	   injury	  during	  
renal	   ischaemia	   (Renner	   et	   al.,	   2010,	  Weisman	   et	   al.,	   1990a).	   	   Following	   ischaemia,	  
circulating	  complement	  factor	  3a	  (C3a)	  increases	  and	  C3	  deposition	  is	  observed	  along	  
the	   tubular	   basement	   membrane	   (Thurman,	   2007).	   	   Furthermore,	   mice	   deficient	   in	  
complement	  proteins	  C3,	  C5	  and	  C6	  are	  protected	  from	  renal	  IRI	  (Zhou	  et	  al.,	  2000a).	  
Similarly,	   as	   the	   main	   site	   of	   C3	   synthesis	   it	   is	   unsurprising	   that	   rat	   models	   have	  
suggested	  that	  complement	  may	  have	  an	  important	  role	  in	  liver	  injury	  (Lehmann	  et	  al.,	  
2001,	  Chavez-­‐Cartaya	  et	  al.,	  1995,	  Fondevila	  et	  al.,	  2008,	  Alper	  et	  al.,	  1969,	  Tu	  et	  al.,	  
2011).	  With	   complement	   seemingly	   implicated	   in	   renal	   ischaemia	   and	   liver	   injury	   it	  
may	   be	   possible	   that	   IgM	  might	   play	   an	   important	   role	   as	   well	   as	   other	   ischaemic	  
injury	   models	   that	   demonstrate	   a	   pathogenic	   role	   for	   IgM	   also	   exhibit	   strong	  
complement	  involvement.	  If	  IgM	  antibodies	  are	  involved	  in	  the	  injury	  pathogenesis	  of	  
renal	  and	  liver	  IRI	  they	  may	  representative	  novel	  therapeutic	  targets.	  
	  
1.4.5	  Therapeutic	  blockage	  of	  IgM	  
Therapeutic	  strategies	  designed	  to	  block	  various	  components	  of	  the	   immune	  system,	  
such	  as	  complement	   inhibition,	  have	  proven	  effective	   in	  experimental	   IRI	   (Lutz	  et	  al.,	  
2010,	  Riedemann	  and	  Ward,	  2003).	  	  Use	  of	  complement	  inhibitor	  recombinant	  soluble	  
CR1	   (sCR1)	   has	   prevented	   complement-­‐mediated	   tissue	   injury	   in	   experimental	  
intestinal,	   cardiac	   and	   skeletal	   muscle	   ischaemia	   (Riedemann	   and	   Ward,	   2003,	  
Weisman	   et	   al.,	   1990b,	   Zacharowski	   et	   al.,	   1999,	   Hill	   et	   al.,	   1992,	   Kyriakides	   et	   al.,	  
2001).	  In	  a	  similar	  line	  studies	  have	  successfully	  blocked	  IgM	  binding	  to	  injured	  cells	  in	  
a	  variety	  models	  of	   ischaemia.	  Studies	  have	  previously	  confirmed	  the	   involvement	  of	  
complement	  activation	  via	  a	  single	  IgM	  clone	  that	  recognized	  a	  neo-­‐epitope	  on	  hypoxic	  
cells	  (Zhang	  and	  Carroll,	  2007,	  Haas	  et	  al.,	  2010,	  Zhang	  et	  al.,	  2006b,	  Chan	  et	  al.,	  2006).	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This	  was	  identified	  as	  NMHC-­‐II	  that	  is	  accessible	  to	  IgM	  antibodies	  on	  cardiac	  muscle,	  
endothelium	   and	   muscle	   fibers	   and	   intestinal	   mucosa	   following	   ischaemia.	   These	  
studies	   have	   since	   demonstrated	   reduced	   IgM	   deposition	   and	   attenuated	   injury	  
following	   pretreatment	   with	   the	   synthetic	   antigenic	   N2	   epitope,	   which	   recognizes	  
NMHC-­‐II	   in	  a	  mouse	  model	  of	  acute	  myocardial	   infarction	  and	   intestinal	  and	  skeletal	  
IRI.	  	  Such	  a	  strategy	  may	  be	  amenable	  to	  renal	  and/or	  hepatic	  IRI	  if	  IgM	  does	  play	  a	  key	  
pathogenic	  role.	  
	  
1.5	  Apoptotic	  cells	  and	  Disease	  Modulation	  
	  
As	   discussed	   in	   ‘1.1.3.3	   Cellular	   Injury’	   acute	   injury	   can	   result	   in	   irreversible	   lethal	  
tissue	  damage	  that	  leads	  injured	  cells	  to	  undergo	  apoptosis	  and	  or	  necrosis.	  
	  
1.5.1	  Overview	  of	  apoptosis	  
Each	  day	  billions	  of	  cells	  undergoing	  programmed	  cell	  death,	  or	  apoptosis,	  are	  cleared	  
in	   the	   constant	   and	   crucial	   pursuit	   of	   normal	   tissue	   homeostasis	   (Kerr	   et	   al.,	   1972,	  
Elmore,	  2007,	  Wyllie	  et	  al.,	  1980,	  Savill,	  1994).	  During	  apoptosis,	  sequential	  activation	  
of	   initiator/effector	  caspases	   leads	   to	  morphological	   changes	   including	  cell	   shrinkage	  
and	  nuclear	  pyknosis,	  with	  maintenance	  of	  plasma	  membrane	  integrity	  (Elmore,	  2007,	  
Kerr	  et	  al.,	  1972,	  Galluzzi	  et	  al.,	  2007).	  In	  the	  absence	  of	  efficient	  phagocytic	  clearance,	  
apoptotic	  cells	  ultimately	  progress	  to	  secondary	  necrosis,	  with	  the	   loss	  of	  membrane	  
integrity	   and	   release	   of	   potentially	   immunogenic	   and	   inflammatory	   intracellular	  
contents,	   including	   organelles.	   This	   can	   be	   a	   highly	   inflammatory	   process	   as	   rapid	  
disruption	  of	  both	  organelle	  and	  cellular	  plasma	  membrane	  integrity	  occurs	  releasing	  
noxious	  intracellular	  contents	  (Ziegler	  and	  Groscurth,	  2004).	  Whilst	  some	  diseases	  are	  
characterised	  by	  apoptosis,	  high	   levels	  of	  necrotic	  death	  are	  found	   in	  some	  diseases,	  
following	   critical	   cell	   damage	   resulting	   from	   hypoxia,	   toxins	   or	   infection.	   Cells	  
undergoing	  primary	  necrosis	  exhibit	  catastrophic	  loss	  of	  membrane	  integrity	  and	  rapid	  
release	   of	   potentially	   pro-­‐inflammatory	   intracellular	   components	   (Savill	   et	   al.,	   2002,	  
Zong	   and	   Thompson,	   2006).	   Such	   a	   situations	   occurs	   in	   patients	   with	   thrombotic	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microangiopathy	   syndromes	   (George	   and	   Nester,	   2014)	   in	   which	   microvascular	  
thrombus	   formation	   and	   enhanced	   shear	   stress	   (Camus	   et	   al.,	   2012,	  Dhaliwal	   et	   al.,	  
2004)	  disrupt	  and	  fragment	  erythrocytes	  (Dhaliwal	  et	  al.,	  2004,	  Radhi	  and	  Carpenter,	  
2012,	  Colman,	  1969).	  Erythrocyte	  fragmentation	  with	  the	  release	  of	  cytotoxic	  cell-­‐free	  
haemoglobin	   and	   damage	   associated	  molecular	   pattern	   (DAMP)	   exposure	  would	   be	  
predicted	  to	  further	  drive	  inflammation	  (Chen	  et	  al.,	  2014,	  Gladwin	  and	  Ofori-­‐Acquah,	  
2014,	  Gladwin	  et	  al.,	  2012).	  It	  is	  therefore	  critical	  that	  apoptotic	  cells,	  necrotic	  cells	  and	  
severely	   damaged	   erythrocytes	   are	   rapidly	   removed	   in	   order	   to	   limit	   potential	  
autoimmunity	  and	  tissue	  and	  vascular	  inflammation.	  
	  
1.5.2	  Dead	  cell	  clearance	  
The	  immunogenicity	  of	  dying	  cells	  is	  not	  simply	  determined	  by	  the	  mode	  of	  cell	  death	  
(apoptosis	   versus	   necrosis),	   suggesting	   that	   there	   are	   additional	   molecular	  
determinants	   that	   influence	   autoantibody	   generation.	   The	   repertoire	   of	   membrane	  
alterations	   associated	   with	   cell	   death,	   (Fadeel,	   2004)	   including	   exposure	   of	  
phosphatidylserine	  (PtdSer)	  (Fadok	  et	  al.,	  2001)	  on	  the	  outer	  plasma	  membrane	  leaflet	  
together	  with	   binding	   of	   specific	   opsonins	   or	   bridging	  molecules,	   such	   as	   C-­‐reactive	  
protein,	  Protein	  S,	  milk	   fat	  globule-­‐EGF	   factor	  8,	  C1q,	  mannose-­‐binding	   lectin	  or	   IgM	  
antibodies	  (Ogden	  et	  al.,	  2001,	  Gershov	  et	  al.,	  2000,	  Hart	  et	  al.,	  2004)	  determine	  the	  
molecular	   pathways	   utilised	   in	   phagocytic	   uptake.	   Furthermore,	   the	   opsonisation	  
status	  of	  apoptotic	  or	  necrotic	  cells	  will	  govern	  the	  ultimate	  fate	  of	  internalised	  cellular	  
material	  within	  phagocytes	  and	  the	  capacity	  for	  presentation	  of	  antigens	  to	  T	  cells	  that	  
is	  necessary	  for	  B	  cell	  activation	  and	  autoantibody	  production	  (Savill	  et	  al.,	  2002).	  
	  
1.5.3	  Studies	  demonstrating	  modulation	  of	  disease	  by	  apoptotic	  cell	  administration	  	  
A	  key	  event	  in	  apoptosis	  is	  the	  surface	  exposure	  of	  PtdSer	  that	  signals	  the	  clearance	  of	  
apoptotic	   cells	   by	  macrophages	   (Fadok	   et	   al.,	   1992)	   and	   promotes	   the	   resolution	   of	  
inflammation	   (Serhan	   and	   Savill,	   2005,	   Fadok	   et	   al.,	   1998).	  Macrophages	   that	   ingest	  
apoptotic	   cells	   adopt	   an	   anti-­‐inflammatory	   and	   immunosuppressive	   phenotype	  with	  
secretion	  of	  anti-­‐inflammatory	  cytokines,	  including	  transforming	  growth	  factor-­‐β	  (TGF-­‐	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Table	   1.2	   –	   Summary	   of	   papers	   demonstrating	   apoptotic	   cell	   modulation	   of	  
experiment	   disease	   models.	   Abbreviations	   are	   as	   follows:	   apoptotic	   cell(s)	   (AC(s));	  
Lipopolysaccharide	  (LPS);	  Caecal	  ligation	  and	  puncture	  (CLP);	  Hepatocyte	  growth	  factor	  
(HGF);	  Inducible	  nitric	  oxide	  (iNOS).	  









- Cells:	  UV	  irradiated	  





Peritoneal	  =	  40x106	  
after	  3	  days	  
Lung	  =	  i.t	  20x106	  
after	  36-­‐48hrs	  of	  
LPS	  
- Apoptotic:	  60-­‐80%	  
apoptotic	  	  
- Mice	  treated	  with	  apoptotic	  Jurkat	  cells	  
following	  peritoneal	  or	  lung	  
inflammation	  had	  raised	  TGF-­‐β1	  levels	  
in	  lavage	  fluids	  
- In	  both	  models	  apoptotic	  cell	  clearing	  
macrophages	  were	  confirmed	  to	  be	  
responsible	  for	  elevated	  TGF-­‐β1	  levels	  
- Reduced	  intra-­‐alveolar	  neutrophil	  
counts	  and	  TNF-­‐α	  levels	  in	  broncho-­‐
alveolar	  lavages	  were	  observed	  1-­‐3	  
days	  following	  AC	  administration	  	  
- Administration	  of	  apoptotic	  PLB	  cells	  
(which	  do	  not	  express	  PtdSer)	  did	  not	  





shock	  and	  CLP	  
- Cells:	  aged	  human	  
polymorphonuclear	  
neutrophils	  (PMNs)	  
- Administration:	  i.v	  




For	  CLP	  =	  10x106	  	  
1hr	  later	  
- Apoptotic:	  early	  
- Mice	  treated	  with	  10x106	  ACs	  following	  
LPS	  &	  CLP	  exhibited	  improved	  health	  &	  
survival	  rate	  	  
- ACs	  given	  1,	  3,	  6	  &	  24hrs	  following	  LPS	  
were	  still	  protective	  
- AC	  treatment	  following	  LPS	  reduced	  
PMN	  infiltration,	  lowered	  IL-­‐12,	  TNF-­‐α,	  
IFN-­‐γ	  whilst	  IL-­‐10	  was	  upregulated	  
- 10x106	  	  &	  20x106	  ACs	  reduced	  [LPS],	  









- Cells:	  aged	  
apoptotic	  
thymocytes	  
- Administration:	  i.v	  
20x106	  0,1,2	  days	  
prior	  to	  CIA	  
- Apoptotic:	  early,	  
but	  late	  ACs	  also	  
protective	  
- AC	  treated	  mice	  had	  antigen-­‐specific	  
CD4+	  T	  cells	  producing	  IL-­‐10	  or	  IFN-­‐γ	  	  
- AC	  contact	  induced	  B	  cells	  to	  activate	  
IL-­‐10	  secreting	  T	  cells	  
- AC	  treated	  mice	  had	  a	  significantly	  
lower	  mean	  arthritis	  score	  	  
- AC	  administration	  after	  onset	  of	  CIA	  
conferred	  no	  protection	  








- Cells:	  UV	  irradiated	  
human	  Jurkat	  cells	  
- Administration:	  i.t	  
10x106	  	  2	  days	  after	  
bleomycin	  
treatment	  
- Apoptotic:	  early	  
	  
- AC	  exposure	  increased	  HGF	  production	  
which	  attenuated	  lung	  injury	  in	  mice	  
- 2	  days	  following	  AC	  administration	  HGF	  
mRNA	  production	  and	  alveolar	  
macrophage	  clearance	  was	  enhanced	  
- HGF	  remained	  elevated	  21	  days	  post	  AC	  
administration	  
- Levels	  of	  fibrosis	  reduced	  in	  lung	  tissue	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LPS	  induced	  
hepatitis	  
- Cells:	  UV	  irradiated	  
apoptotic	  
splenocytes	  	  
- Administration:	  3	  
days	  prior	  to	  LPS	  
treatment	  
Main	  experiment	  
1.5	  x107	  via	  portal	  
vein	  
Sub	  experiments:	  
1x107	  to	  3x107	  ACs,	  
and	  2x108	  ACs	  
- Apoptotic:	  early	  
- ACs	  primarily	  captured	  by	  Kupffer	  cells	  
- ACs	  significantly	  attenuated	  liver	  injury	  
in	  both	  C57BL/6	  &	  Balb/c	  mice	  
- ACs	  administration	  3-­‐7days	  prior	  to	  LPS	  
was	  maximally	  protective	  
- Maximum	  protection	  conferred	  with	  
1x107	  to	  3x107	  ACs,	  2x108	  ACs	  conferred	  
no	  protection	  
- Pro-­‐inflammatory	  cytokines	  (TNF-­‐α,	  IL-­‐
6,	  IL-­‐1	  β)	  reduced,	  whilst	  anti-­‐
inflammatory	  cytokines	  (IL-­‐4,	  IL-­‐10,	  






- Cells:	  UV	  irradiated	  
alveolar	  
macrophages	  
- Administration:	  i.t	  
1x104	  immediately	  
following	  infection	  
- Apoptotic:	  early	  
- ACs	  had	  no	  antimicrobial	  effect	  on	  
bacterial	  colonies	  
- However	  at	  12-­‐48hrs	  following	  
administration	  AC	  treated	  mice	  had	  
reduced	  lung	  inflammation	  indicated	  by	  
reduced	  neutrophil	  infiltration	  in	  iNOS-­‐/-­‐	  
and	  C57BL/6	  mice	  	  








- Cells:	  UV	  irradiated	  
donor	  splenocytes	  
- Administration:	  
50x106	  via	  penile	  
vein	  14,	  7	  or	  3	  days	  
prior	  to	  transplant	  
- Apoptotic:	  50%	  
apoptotic	  	  
- Mice	  treated	  with	  donor	  ACs	  exhibited	  
prolonged	  graft	  survival	  with	  reduced	  
lymphocyte	  infiltration	  and	  tissue	  
necrosis	  
- ACs	  administered	  7	  days	  prior	  to	  
transplant	  were	  most	  effective	  
- Inhibition	  of	  phagocytosis	  by	  
gadolinium	  chloride	  treatment	  and	  
PtdSer	  blockage	  abolished	  prolonged	  





β)	  and	  IL-­‐10	  (Savill	  et	  al.,	  2002).	  	  The	  consequences	  of	  apoptotic	  cell	  phagocytosis	  has	  
been	  reviewed	  by	  Erwig	  and	  Henson	  (2007).	  	  Apoptotic	  cells	  were	  first	  suspected	  to	  be	  
immuneregulatory	   due	   to	   the	   observation	   that	   kidney	   allograft	   survival	   was	   greatly	  
improved	   following	   repeated	  blood	   transfusions	   (Opelz	   and	   Terasaki,	   1978,	  Opelz	   et	  
al.,	   1997).	   Blood	   stored	   for	   clinical	   transfusions	   are	   known	   to	   contain	   apoptotic	  
granulocytes	  and	   lymphocytes	   (van	  Prooijen	  et	  al.,	  1994,	  Smit	  Sibinga,	  1999).	  To	   this	  
end	  the	  exogenous	  administration	  of	  apoptotic	  cells	   reduces	   inflammation	   in	  various	  
experimental	  models	  of	  disease	  including	  lipopolysaccharide	  (LPS)-­‐induced	  shock	  (Ren	  
et	  al.,	  2008),	  collagen	  induced	  arthritis	  (CIA)	  (Gray	  et	  al.,	  2007)	  as	  well	  as	  lung	  (Lee	  et	  
al.,	  2012,	  Huynh	  et	  al.,	  2002,	  Marriott	  et	  al.,	  2006)	  and	  liver	  inflammation	  (Zhang	  et	  al.,	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2011)	  (summarised	  in	  detail	  in	  Table	  1.2).	  The	  potential	  anti-­‐inflammatory	  mechanisms	  
of	  exogenous	  apoptotic	  cell	  administration	  are	  diverse	  and	  include:	  	  
	  
(i) PtdSer	   dependent	   induction	   of	   TGF-­‐β1	   secreting	   apoptotic	   cell	   ingested	  
macrophages	  in	  lung	  and	  peritoneal	  inflammation	  (Huynh	  et	  al.,	  2002),	  
(ii) the	   induction	   of	   IL-­‐10	   production	   by	   Kupffer	   cells	   by	   TGF-­‐β	   bound	   to	   the	  
apoptotic	  cell	  surface	  (Zhang	  et	  al.,	  2011),	  	  
(iii) the	   induction	  of	   IL-­‐10	   producing	  CD19+	  regulatory	   B	   cells	   that	   stimulate	   a	  
population	  of	  IL-­‐10	  secreting	  antigen-­‐specific	  CD4+	  T	  cells	  in	  CIA	  (Gray	  et	  al.,	  
2007)	  and	  	  
(iv) binding	   of	   LPS	   to	   apoptotic	   cells	   accompanied	   by	   reduced	   serum	   TNF-­‐α	  
levels	  and	  increased	  serum	  IL-­‐10	  levels	  in	  LPS	  shock	  (Ren	  et	  al.,	  2008).	  	  Ren	  
et	  al.,	  also	  observed	  reduced	  neutrophil	  infiltration	  in	  the	  kidney	  following	  
apoptotic	  cell	  administration	  in	  LPS-­‐induced	  shock.	  	  
	  
In	   addition,	   it	   has	   been	   shown	   that	   both	   apoptotic	   and	   necrotic	   cells	   exert	   anti-­‐
inflammatory	  effects	  (Miles	  et	  al.,	  2009)	  suggesting	  that	  these	  effects	  are	  not	  confined	  
to	  intact	  apoptotic	  cells.	  
	  
1.6	  Apoptotic	  cells	  and	  IgM	  antibodies	  
	  
1.6.1	  Perturbations	  of	  dead	  cell	  clearance	  	  
Perturbations	   of	   the	   complex	   regulated	   process	   of	   dead	   cell	   clearance	   have	   been	  
implicated	   in	   the	   pathophysiology	   of	   many	   autoimmune	   disease	   states.	   The	  
development	   of	   autoantibodies,	   particularly	   against	   cytoplasmic	   or	   nuclear	   antigens	  
which	   characterises	   diseases	   such	   as	   systemic	   lupus	   erythematosus	   (SLE),	   has	   been	  
suggested	  to	  be	  a	  consequence	  of	  excessive	   levels	  of	  apoptosis	  and/or	  compromised	  
clearance	   (Gaipl	   et	   al.,	   2005).	   Indeed,	   numerous	   developmental	   defects,	  
neurodegenerative	   disorders	   and	   diseases	   are	   characterised	   by	   increased	   cellular	  
turnover	   with	   excessive	   apoptosis	   including	   cancer	   (Elliott	   and	   Ravichandran,	   2010,	  
Elmore,	  2007).	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1.6.2	  IgM	  antibodies	  and	  phagocytosis	  
IgM	  antibodies	  have	  been	  shown	  to	  mediate	  and	  accelerate	  the	  clearance	  of	  apoptotic	  
cells	  by	  phagocytes	  (Peng	  et	  al.,	  2005,	  Ogden	  et	  al.,	  2005,	  Litvack	  et	  al.,	  2010,	  Litvack	  et	  
al.,	  2011)	  with	  this	  function	  involving	  recruitment	  of	  C1q	  (Chen	  et	  al.,	  2009b,	  Chen	  et	  
al.,	  2009a).	  Phagocytosis	  of	  apoptotic	  cells	  is	  markedly	  reduced	  in	  the	  absence	  of	  IgM	  
(Quartier	   et	   al.,	   2005),	   	   	   furthermore	   	   these	   	   	   IgM-­‐deficient	   	  mice	   	   exhibit	   	   a	   	   clear	  
autoimmune	  phenotype	  similar	  to	  that	  seen	  in	  SLE	  (Boes	  et	  al.,	  2000,	  Ehrenstein	  et	  al.,	  
2000).	  
	  
1.6.3	  IgM	  bound	  apoptotic	  cells	  and	  epitopes	  
Circulating	   IgM	   antibodies	   are	   of	   relatively	   low	   affinity	   and	   exhibit	   polyreactivity	  
(Avrameas	  et	   al.,	   1983,	  Avrameas,	  1991,	  Casali	   and	  Notkins,	   1989)	  as	   they	  bind	   to	  a	  
diverse	   range	  of	  non-­‐self	  and	  self-­‐antigens	   (summarised	   in	  detail	   in	  Table	  1.3)	   (Fu	  et	  
al.,	  2007,	  Williams	  et	  al.,	  1999,	  Zhang	  et	  al.,	  2006a,	  Briles	  et	  al.,	  1982).	  Late	  apoptotic	  
cells	   (Litvack	  et	  al.,	  2010,	  Fu	  et	  al.,	  2007,	  Zwart	  et	  al.,	  2004,	  Ciurana	  and	  Hack,	  2006,	  
Porcheray	   et	   al.,	   2013)	   and	   derived	   microparticles	   (Litvack	   et	   al.,	   2011)	   are	  
preferentially	   bound	   by	   IgM	   antibodies.	   Consequently,	   IgM	   antibodies	   have	   been	  
reported	   to	   bind	   neo-­‐epitopes	   that	   become	   accessible	   following	   plasma	  membrane	  
alterations	  associated	  with	  apoptosis,	  (Fu	  et	  al.,	  2007,	  Grönwall	  et	  al.,	  2012,	  Kim,	  2010)	  
such	  as	  exposure	  of	  phosphorylcholine	   (Briles	  et	  al.,	  1981)	  and	  PtdSer	   (Litvack	  et	  al.,	  
2011,	   Fu	   et	   al.,	   2007).	   In	   addition,	   membrane	   phospholipase	   (PLA2)	   has	   been	  
implicated	   in	   phospholipid	   remodeling	   and	   exposure	  of	   IgM	  bound	  epitopes	   (Kim	  et	  
al.,	   2002).	   Many	   IgM	   antibodies	   recognise	   oxidation-­‐specific	   epitopes	   and	   oxidised	  
low-­‐density	   lipoproteins	   that	   are	   present	   on	   apoptotic	   cells,	   (Chou	   et	   al.,	   2009a,	  
Rosenes	   et	   al.,	   2013,	   Chikazawa	   et	   al.,	   2013,	   Tsiantoulas	   et	   al.,	   2012)	   representing	  
immunodominant	  DAMPs	  (Leibundgut	  et	  al.,	  2013,	  Hartvigsen	  et	  al.,	  2009).	  Whilst	  the	  
precise	  molecular	  determinants	  on	  apoptotic	  cells	  that	  are	  recognised	  by	  IgM	  are	  yet	  
to	  be	  fully	  defined,	  an	  important	  role	  for	  IgM	  in	  the	  clearance	  of	  apoptotic	  cells	  is	  well	  
established	   (Peng	  et	   al.,	   2005,	  Ogden	  et	   al.,	   2005,	   Litvack	  et	   al.,	   2010,	   Litvack	  et	   al.,	  
2011,	  Boes	  et	  al.,	  2000,	  Ehrenstein	  et	  al.,	  2000).	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Table	  1.3	  –	  Epitopes	  and	  proteins	  bound	  by	  IgM.	  Only	  epitopes	  and	  proteins	  that	  are	  
fully	   identified	   and	   described	   with	   robust	   IgM	   binding	   are	   included.	   Epitopes	   and	  
proteins	   are	   divided	   into	   phospholipid/oxidised	   epitope,	   carbohydrate,	   nuclear	   and	  
protein	  related	  groups.	  
Name	   Brief	  Description	   Reference(s)	  
	   Phospholipid	  and	  oxidized	  epitope	  	  
Annexin-­‐IV	   Phospholipid	  binding	  protein	   (Kulik	  et	  al.,	  2009)	  
Cardiolipin	   Diphosphatidylglycerol	  lipid	  in	  mitochondria	  membrane	  
(Tuominen	  et	  al.,	  2006)	  (Sorice	  et	  
al.,	  2000)	  (Cvetkovic	  et	  al.,	  2002)	  
LDL-­‐malondialdehyde	  
Oxidised	  low-­‐density	  
lipoprotein	  produced	  by	  
reactive	  aldehyde	  
degradation	  
(Chou	  et	  al.,	  2009b)	  (Chen	  et	  al.,	  
2009b)	  (Cvetkovic	  et	  al.,	  2002)	  
(Rouhl	  et	  al.,	  2010)	  
Lysophosphatidylcholine	   Oxidised	  low-­‐density	  lipoprotein	  
(Mercolino	  et	  al.,	  1986)	  (Kim	  et	  
al.,	  2002)	  (Blanc	  et	  al.,	  2007b)	  
Phosphatidylserine	   Phospholipid	  exposed	  during	  apoptosis	  






lipoprotein	  head	  group	  
exposed	  during	  apoptosis	  
(Chou	  et	  al.,	  2009b)	  (Shaw	  et	  al.,	  
2003)	  (Briles	  et	  al.,	  1981)	  (Chen	  
et	  al.,	  2009b)	  (Anania	  et	  al.,	  
2010)	  (Shaw	  et	  al.,	  2000)	  (Fu	  et	  




Reactive	  aldehyde	  oxidation	  
specific	  epitope	  
(Chikazawa	  et	  al.,	  2013)	  (Chou	  et	  
al.,	  2009b)	  (Khatoon	  et	  al.,	  2012)	  
Carbohydrate	  




collectin	  group	  of	  innate	  
pattern	  recognition	  protein	  
(Litvack	  et	  al.,	  2010)	  
Pneumococcal	  bacterial	  
cell	  wall	  polysaccharide	   Polymeric	  carbohydrate	  
(Chou	  et	  al.,	  2009b)	  
Nuclear	  
dsDNA	   Nucleic	  acid	  
(Witte,	  2008)	  (Wellmann	  et	  al.,	  
2005)	  
Nuclear	  autoantigen	  lamin	  
B1	  	   Nuclear	  envelope	  protein	  
(Dieudé	  et	  al.,	  2002)	  (Senecal	  et	  
al.,	  1999)	  
Protein	  
Actin	   Cytoskeletal	  protein	   (Fu	  et	  al.,	  2007)	  
GRP78,	  BiP	  (Ig	  heavy-­‐
chain	  binding	  protein)	  
Heat-­‐shock	  protein	  70	  family	  
member	  
(Rosenes	  et	  al.,	  2013)	  
Non-­‐muscle	  myosin	  heavy	  
chain	  II	  and	  myosin	  
ATP	  dependent	  motor	  
proteins	  
(Zhang	  et	  al.,	  2006a)	  (Haas	  et	  al.,	  
2010)	  (Fu	  et	  al.,	  2007)	  
Β-­‐tubulin	   Cytoskeletal	  microtubule	  protein	  
(Connolly	  et	  al.,	  1997)	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1.7	  Apoptotic	  Cells	  and	  Coagulation	  
	  
1.7.1	  Relationship	  of	  apoptotic	  cells	  and	  coagulation	  
The	  surface	  exposure	  of	  PtdSer	  on	  apoptotic	  cells	  not	  only	  signals	   their	  clearance	  by	  
macrophages	  (Fadok	  et	  al.,	  1992),	  but	  also	  confers	  apoptotic	  cells	  with	  a	  procoagulant	  
tendency	   (Casciola-­‐Rosen	  et	  al.,	  1996).	  The	   first	   indication	  of	  a	  potential	   relationship	  
between	   apoptosis	   and	   thrombogenicity	   was	   seen	   in	   cancer	   patients	   undergoing	  
chemotherapy	  (Pickering	  et	  al.,	  2008,	  Wang	  et	  al.,	  2001).	  	  These	  patients	  had	  abnormal	  
levels	   of	   coagulation	   activation	   markers,	   and	   as	   the	   intensity	   of	   chemotherapy	  
increased,	  resulting	  in	  tumour	  apoptosis,	  thromboembolism	  risk	  also	  increased	  (Wang	  
et	   al.,	   2001,	   Lee	   and	   Levine,	   1999).	   This	   relationship	   has	   been	   further	   confirmed	  
through	  human	  tumour	  cell	  lines	  and	  non-­‐tumour	  cell	  lines	  (Wang	  et	  al.,	  2001).	  	  Wang	  
et	  al.,	  (2001)	  demonstrated	  a	  correlation	  between	  thrombin	  generation,	  tissue	  factor	  
activity	   and	   the	   degree	   of	   apoptosis	   in	   camptothecin	   (chemotherapeutic	   agent)	  
treated	  cell	   lines.	  Furthermore	   this	  correlation	  could	  be	  abolished	  by	   the	  addition	  of	  
Annexin-­‐V	   (AnnV),	  which	  binds	   to	  PtdSer.	  Thrombin	  can	  have	  a	  significant	   impact	  on	  
the	   progression	   of	   IRI	   as	   it	   results	   in	   the	   activation	   of	   endothelial	   cells,	   platelets,	  
monocytes,	  dendritic	  cells	  and	  T	  cells	  through	  a	  family	  of	  thrombin	  protease-­‐activate	  
receptors	  (Morrell	  et	  al.,	  2007).	  
	  
1.7.2	  Mechanisms	  of	  coagulation	  influence	  
Through	  a	  variety	  of	  mechanisms	  apoptotic	  cells	  can	  affect	  the	  coagulation	  status	  and	  
interact	  with	   components	   of	   the	   clotting	   system,	   such	   as	   platelets	   either	   directly	   or	  
indirectly.	   	  Apoptotic	  cells,	  bodies	  and	  surface	  blebs	   themselves	  confer	  procoagulant	  
activity	   (Casciola-­‐Rosen	   et	   al.,	   1996).	   	   	   Due	   to	   exposure	   of	   PtdSer,	   along	  with	   other	  
phospholipids,	   apoptotic	   cells	   provide	  a	   surface	   for	   the	  assembly	  of	  macromolecular	  
coagulation	  complexes	  essential	  for	  the	  formation	  of	  thrombin	  (Casciola-­‐Rosen	  et	  al.,	  
1996,	  Pickering	  et	  al.,	  2008).	  This	  PtdSer	  exposure	  on	  the	  apoptotic	  cells	  and	  surface	  
blebs	  can	  amplify	  the	  catalytic	  surface	  available	  for	  thrombin	  assembly	  (Casciola-­‐Rosen	  
et	  al.,	  1996).	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1.8	  Preliminary	  Data	  
	  
Previous	   unpublished	   work	   in	   the	   lab	   by	   Dr	   DA	   Ferenbach,	   which	   gave	   rise	   to	   this	  
project,	   demonstrated	   that	   the	   administration	   of	   20x106	   apoptotic	   thymocytes	   24-­‐
hours	   prior	   to	   renal	   IRI	   significantly	   preserved	   renal	   function	   (Figure	   1.4A),	   inferred	  
from	  reduced	  plasma	  creatinine,	  whilst	  ATN	  remained	  unaffected	  (Figure	  1.4B)	  in	  both	  
Balb/c	  and	  FVB	  mice.	  	  
	  
	  
Figure	   1.4	   –	   Preliminary	   data.	   Administration	   of	   20x106	   apoptotic	   thymocytes	   24-­‐
hours	  prior	  to	  renal	  IRI	  significantly	  preserved	  renal	  function	  (A),	  whilst	  ATN	  remained	  
unaffected	  (B)	  in	  Balb/c	  mice.	  C)	  Apoptotic	  cells	  administered	  8	  days	  prior	  to	  renal	  IRI	  
conferred	  no	  protection.	  	  Apoptotic	  cell	  treated	  mice	  did	  not	  have	  augmented	  levels	  of	  
IL-­‐10	  (D)	  and	  TGF-­‐	  β	  (E).	  F)	  The	  apoptotic	  cells	  are	  detectable	  in	  the	  kidney,	  spleen	  and	  
liver	  1-­‐hour	  following	  injection.	  	  	  
	  
The	  administration	  of	  apoptotic	  cells	  8	  days	  prior	  to	  renal	  IRI	  conferred	  no	  functional	  
or	   structural	   protection	   (Figure	   1.4C).	   This	   also	   provides	   evidence	   against	   the	  
involvement	  of	  B	  cells	  as	  this	  is	  the	  length	  of	  time	  required	  for	  B	  cell	  activation	  of	  IL-­‐10	  
secreting	   antigen-­‐specific	   T	   cells,	   as	   observed	   by	  Gray	  et	   al.,	   (2007)	   in	   CIA.	   Previous	  
investigations	  have	  suggested	  that	  the	  mechanism	  eliciting	  functional	  protection	  is	  not	  
due	   to	   an	   anti-­‐inflammatory	   tissue	  environment	   conferred	   from	   immunosuppressive	  
macrophage	   secreting	   IL-­‐10	   and	   TGF-­‐β.	   	   Apoptotic	   cell	   treated	   mice	   did	   not	   have	  
augmented	  serum	   levels	  of	   IL-­‐10	   (Figure	  1.4D)	  or	  TGF-­‐β	   (Figure	  1.4E)	   following	   renal	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IRI.	  The	  apoptotic	  cells	  were	  detectable	  in	  the	  blood,	  kidney,	  spleen	  and	  liver	  up	  to	  1-­‐
hour	   following	   administration	   (Figure	   1.4F).	   Severe	   Combined	   Immunodeficiency	  
(SCID)	  mice,	  which	   lack	   T	   and	  B	   lymphocytes	   and	   antibodies,	   treated	  with	   apoptotic	  
cells	   24-­‐hours	  prior	   to	   renal	   IRI	   are	  not	  protected	   suggesting	   that	   the	  mechanism	   in	  
part	  may	  be	  antibody	  mediated.	  Furthermore,	  IgM	  deposition	  was	  also	  evident	  in	  the	  
injured	  kidney.	  	  
	  
Although	  therapeutic	  interventions	  usually	  improve	  both	  renal	  function	  and	  structure,	  
protection	   of	   renal	   function	   alone	   has	   been	   observed	   in	   mice	   administered	   heme	  
oxygenase-­‐1	  overexpressing	  macrophages	  (Ferenbach	  et	  al.,	  2010)	  and	  was	  considered	  
to	  be	  secondary	  to	  improved	  microvascular	  blood	  flow	  thereby	  allowing	  the	  perfusion	  
of	  non-­‐injured	  functioning	  nephrons.	  	  
	  
1.9	  Hypothetical	  mechanisms	  of	  apoptotic	  cell	  derived	  functional	  protection	  
	  
In	   the	   light	  of	   the	  ability	  of	   apoptotic	   cells	   to	   interact	  with	  both	   IgM	  antibodies	  and	  
coagulation	  factors,	  the	  following	  two	  testable	  hypothetical	  mechanisms	  may	  explain	  
apoptotic	  cell	  mediated	  functional	  protection	  (Figure	  1.5):	  
	  
a) Apoptotic	  cells	  administered	  24-­‐hours	  before	  renal	  IRI	  actively	  bind	  circulating	  IgM	  
that	   may	   also	   be	   able	   to	   recognise	   injured	   cells.	   	   At	   the	   time	   of	   ischaemia	   the	  
intravascular	   level	   of	   self-­‐reactive	   IgM	   is	   decreased	   which	   limits	  
endothelium/epithelial	  injury	  and	  activation	  (Figure	  1.5B).	  	  	  
	  
b) Apoptotic	   cells	   administered	   24-­‐hours	   prior	   to	   renal	   IRI	   results	   in	   a	   transient	  
perturbation	   of	   coagulation	   status	   that	   acts	   to	   limit	  microvascular	   congestion	   at	  
the	  time	  of	  ischaemia	  (Figure	  1.5C).	  	  	  
	  
Both	   of	   these	   hypothetical	  mechanisms	  might	   improve	  microvascular	   flow	   and	   thus	  
improve	  renal	  function.	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Figure	   1.5	   -­‐	   Two	   hypothetical	   mechanisms	   examining	   whether	   AC-­‐mediated	  
protection	   was	   conferred	   by	   modulation	   of	   (B)	   natural	   IgM	   antibodies	   or	   by	   (C)	  
coagulation	   status.	   A)	   Normal	   renal	   microvasculature	   with	   no	   pre-­‐ischaemic	  
treatment	  may	   express	   IgM	   bound	   neo-­‐epitopes	   and	  microvascular	   congestion	  may	  
occur	   following	   ischaemia.	  B)	  Apoptotic	   cells	  given	  24-­‐hours	  before	   renal	   IRI	  actively	  
bind	  circulating	  IgM	  that	  may	  also	  recognise	  injured	  cells.	  	  At	  the	  time	  of	  ischaemia	  the	  
intravascular	  level	  of	  self-­‐reactive	  IgM	  is	  decreased	  which	  limits	  endothelium/epithelial	  
injury	   and	   activation.	   	   This	   leads	   to	   improved	   microvascular	   flow	   and	   therefore	  
improved	   renal	   function.	   C)	   Apoptotic	   cells	   administered	   24-­‐hours	   prior	   renal	  
ischaemia	   results	   in	   a	   transient	   perturbation	   of	   the	   coagulation	   system	   that	   acts	   to	  
limit	  microvascular	  congestion	  post	  ischaemia.	  	  This	  leads	  to	  more	  efficient	  reperfusion	  




The	  main	  aim	  of	  this	  thesis	  was	  to	  validate	  the	  previous	  findings	  and	  to	  elucidate	  the	  
mechanism	   behind	   the	   protection	   conferred	   from	   the	   intravenous	   administration	   of	  
apoptotic	  cells	  24-­‐hours	  prior	  to	  renal	  IRI.	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This	  was	  to	  be	  achieved	  by	  the	  following	  steps:	  
	  
1) Investigate	  IgM	  deposition	  following	  ischaemic	  injury	  in	  kidney	  and	  liver	  tissue	  
2) Confirm	  the	  ability	  of	  apoptotic	  cells	  to	  influence	  coagulation	  
3) Establish	  and	  optimise	  the	  murine	  IRI	  model	  
4) Establish	  and	  optimise	  parameters	  to	  study	  microvascular	  congestion	  
5) Recapitulate	  the	  functional	  protection	  conferred	  by	  apoptotic	  cell	  administration	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Chapter	  2.	  Materials	  and	  Methods	  
	  
2.1	  General	  	  
	  
2.1.1	  Chemicals	  and	  cell	  culture	  reagents	  –	  Unless	  stated	  otherwise	  chemicals	  and	  cell	  
culture	   reagents	   were	   purchased	   as	   detailed	   here.	   Cell	   culture	   reagents	   were	  
purchased	  from	  PAA	  Laboratories,	  UK	  or	  Life	  Technologies,	  Paisley,	  UK.	  Tissue	  culture	  
plastics	   were	   from	   Corning	   Incorporate,	   Netherlands	   or	   BD	   Biosciences,	   UK.	   Heat	  
inactivated	   fetal	   calf	   serum	   (FCS)	   was	   purchased	   from	   BioSera,	   Sussex	   or	   Life	  
Technologies,	  Paisley,	  UK.	  	  Chemicals	  were	  purchased	  from	  Sigma	  Aldrich,	  UK.	  
	  
2.1.2	  Mice	  -­‐	  Balb/c	  or	  RAG1-­‐deficient	  mice	  were	  purchased	  from	  Harlan,	  UK	  or	  Charles	  
River.	  All	  animal	  procedures	  were	  performed	  under	  a	  Project	  License	  (60/3339)	  and	  in	  
accordance	  with	   guidelines	   set	   out	   by	   the	  United	  Kingdom’s	  Home	  Office	  under	   the	  
Animal	  (Scientific	  Procedures)	  Act	  of	  1986	  and	  the	  University	  of	  Edinburgh’s	  Biological	  
Services	  Department.	  	  All	  animals	  were	  housed	  in	  the	  BRR	  unit	  and	  had	  free	  access	  to	  
food	  and	  water.	  	  	  
	  
2.2	  General	  cell	  culture	  and	  induction	  of	  apoptosis	  
	  
2.2.1	   Preparation	   of	   non-­‐apoptotic	   and	   apoptotic	   thymocytes	   –	   Following	   cervical	  
dislocation	  thymi	  were	  dissected	  from	  4	  –	  8	  week	  old	  male	  Balb/c	  mice.	  	  Thymocytes	  
were	   dissociated	   by	   gently	   grinding	   thymi	   through	   a	   cell	   strainer	   (40	   μM	   nylon,	   BD	  
Falcon)	  and	  washed	  through	  using	  RPMI	  1640	  medium.	  The	  cell	  suspension	  was	  made	  
up	  to	  10	  mL	  of	  RPMI,	  which	  on	  average	  resulted	   in	  a	  cell	  density	  of	  10x106	  cells/mL.	  
Thymocytes	  were	  used	  immediately	  or	  aged	  overnight	  at	  37°C	  and	  5%	  CO2	  in	  a	  T25	  cm2	  
flask	   (with	  0.2	  µM	  vent	  cap)	   to	  generate	  a	  population	  of	   cells	  with	  variable	   levels	  of	  
apoptosis.	   To	  elicit	   a	  predominantly	   late	   apoptotic	   cell	   population,	   thymocytes	  were	  
treated	   with	   1	   µM	   Dexamethasone	   for	   20-­‐hours.	   Following	   incubation,	   cell	  
suspensions	  were	  centrifuged	  at	  230	  x	  g	   for	  6-­‐minutes,	  and	  washed	  with	  PBS	  before	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the	  cell	  number	  per	  mL	  was	  determined	  using	  a	  Nucleocounter	  (Chemometec).	  Murine	  
apoptotic	   thymocytes	   were	   used	   to	   investigate	   the	   influence	   of	   apoptotic	   cells	   on	  
coagulation,	  confirm	  apoptotic	  cell	  mediated	  protection	  from	  renal	  IRI	  and	  to	  explore	  
circulating	   IgM	  binding	   to	  apoptotic	   cells.	  Non-­‐apoptotic	   cells	  were	  used	  as	  negative	  
controls	  or	  to	  investigate	  intracellular	  IgM	  antibody	  binding.	  
	  
2.2.2	   Culture	   of	   Jurkat	   cells	   and	   induction	   of	   apoptosis	   –	   Apoptosis	   was	   induced	   in	  
human	  Jurkat	  cells,	  which	  were	  then	  used	  to	  explore	  human	  circulating	  IgM	  antibody	  
binding.	   Human	   Jurkat	   cells	   were	   cultured	   in	   RPMI	   1640	   medium	   with	   10%	   heat-­‐
inactivated	   FCS,	   1%	   L-­‐glutamine	  and	  1%	  penicillin-­‐streptomycin	   at	   37°C	  and	  5%	  CO2.	  
Cells	  were	  cultured	  at	  a	  density	  of	  2x106/mL	  and	  apoptosis	  induced	  by	  incubation	  with	  
0.5µM	   camptothecin	   for	   16-­‐hours.	   In	   some	   experiments	   apoptosis	   was	   induced	   by	  
treatment	   with	   25	   µM	   hydrogen	   peroxide	   (H2O2)	   for	   2-­‐hours.	   Cells	   were	   then	  
centrifuged	   at	   300	   x	   g	   for	   6-­‐minutes,	   and	  washed	  with	   PBS.	   These	   conditions	  were	  
selected	  following	  dose	  titration	  experiments.	  
	  
2.2.3	  Culture	  of	  human	  proximal	  tubular	  epithelial	  cells	  (HK-­‐2)	  -­‐	  HK-­‐2	  cells	  were	  kindly	  
provided	  by	  Dr	  Mark	  Dockrell	   (SWT	  Institute	  for	  Renal	  Research,	  London).	  Cells	  were	  
cultured	   in	   RPMI	   1640	   medium	   with	   5%	   heat-­‐inactivated	   FCS,	   L-­‐glutamine	   and	  
penicillin-­‐streptomycin	  at	  37°C	  and	  5%	  CO2.	  HK-­‐2	  cells	  were	  detached	  with	  trypsin	  or	  
cell	   dissociation	   buffer.	   HK-­‐2	   cells	  were	   used	   to	   investigate	   circulating	   IgM	   antibody	  
binding	  following	  in	  vitro	  injury	  as	  described	  in	  ‘2.9.1	  Induction	  of	  ATP	  depletion	  in	  HK-­‐
2	  cells	  by	  Antimycin	  A’	  and	  ‘2.9.2	  Induction	  of	  cellular	  injury	  in	  HK-­‐2	  cells	  by	  H2O2’.	  
	  
2.3	  Assessment	  of	  apoptosis	  by	  flow	  cytometry	  
	  
2.3.1	  Annexin-­‐V	  (AnnV)	  and	  PI	  staining	  –	  All	  assessment	  of	  apoptosis	  was	  inferred	  from	  
AnnV	  and	  PI	  staining.	  An	  overview	  of	  where	  this	  protocol	  is	  placed	  when	  performed	  as	  
part	   of	   IgM	   binding	   assessment	   is	   provided	   in	   Figure	   2.1B.	   PtdSer	   exposure	   was	  
detected	   using	   either	   Alexa	   Fluor	   647,	   FITC	   or	   PE	   conjugated	   Annexin-­‐V	   (all	   1:100,	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BioLegend,	   UK)	   diluted	   in	   AnnV	   binding	   buffer	   (Hanks	   Balanced	   Salt	   Solution	   H6648	  
with	   5	   mM	   CaCl2	   final	   concentration)	   and	   incubated	   for	   15-­‐minutes.	   Exactly	   1	   µL	  
propidium	   iodide	   (PI)	   [1mg/mL]	   (Invitrogen,	   UK)	   diluted	   1:20	   in	   PBS	   was	   added	   to	  
samples	  before	  analysis.	  Cells	  were	  either	  designated	  non-­‐apoptotic	   (AnnV-­‐PI-­‐),	   early	  
(AnnV+PI-­‐)	  or	  late	  (AnnV+PI+)	  apoptotic.	  Staining	  was	  assessed	  by	  flow	  cytometry	  on	  a	  
BD	  FACSCalibur	  (10,000	  events	  collected)	  and	  analysed	  using	  FlowJo	  (TreeStar).	  	  
	  
2.4	  Flow	  cytometry	  phenotyping	  	  
	  
2.4.1	   Thymocyte	   phenotyping	   –	   Cell	   suspensions	   generated	   from	   dissociated	   thymi	  
were	   phenotyped	   to	   ensure	   that	   cell	   populations	  were	   predominantly	   T	   cells.	   Fresh	  
thymocytes	   were	   prepared	   as	   described	   and	   stained	   with	   the	   following	   anti-­‐mouse	  
antibodies	   conjugated	   to	   various	   fluorochromes:	   FITC	   CD3	   (1:200,	   Clone:	   145-­‐2C11,	  
BioLegend)	   PE	  CD4	   (1:200,	   Clone:	   RM4-­‐5,	   BD	  Pharmingen),	   APC	  CD8α	   (1:200,	   Clone:	  
53-­‐6.7,	   eBioscience),	   PerCp-­‐Cy5.5	   CD11b	   (1:200,	   Clone:	   M1/70,	   eBiosciences)	   and	  
Pacific	   Blue	   B220	   (1:100,	   Clone:	   RA3-­‐6B2,	   BD	   Pharmingen)	   before	   analysis	   by	   flow	  
cytometry	  on	  a	  BD	  LSR	  Fortessa.	  The	  following	  isotype	  controls	  were	  used	  to	  confirm	  
primary	  antibody	  specificity	  and	  cell	  positivity:	  PE	  Rat	  IgG2a	  κ	  (1:200,	  BioLegend),	  APC	  
Rat	   IgG2a	   κ	   (1:200,	   eBioscience),	   PerCP/Cy5.5	   Rat	   IgG2b	   κ	   (1:200,	   BioLegend)	   and	  
eFluor450	   Rat	   IgG2a	   κ	   (1:100,	   eBioscience).	   Fluorescent	   minus	   one	   (FMO)	   controls	  
were	  also	  included.	  
	  
2.5	  Flow	  cytometry	  methodology	  used	  to	  study	  in	  vitro	  circulating	  IgM	  antibodies	  	  
	  
2.5.1	  Permeabilisation	  –	  To	  explore	  IgM	  antibody	  binding	  to	  intracellular	  antigens	  cells	  
(excluding	   erythrocytes)	   were	   permeabilised	   using	   the	   following	   saponin	   based	  
reagents	   purchased	   from	   eBioscience	   and	   used	   according	   to	   the	   manufacturer’s	  
instructions:	   Fixation/Permeabilization	   Concentrate	   (Ref:	   00-­‐5123-­‐43),	  
Fixation/Permeabilization	   Diluent	   (Ref:	   00-­‐5223-­‐56)	   and	   Permeabilization	   Buffer	   10x	  
(Ref:	  00-­‐8333-­‐56).	  To	  confirm	  permeability	  PI	  was	  added	   to	   samples,	  as	  described	   in	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‘2.3.1	  Annexin-­‐V	   (AnnV)	   and	   PI	   staining’,	   before	   analysis	   by	   flow	   cytometry	   on	   a	   BD	  
FACSCalibur.	  	  
	  
2.5.2	   Assessment	   of	   IgM	   binding	   to	   cells	   –	   The	   following	   techniques	   were	   used	   to	  
detect	  murine	  and	  human	  IgM	  antibody	  binding	  to	  cells.	  An	  overview	  of	  this	  protocol	  is	  
provided	   in	   Figure	   2.1A	  &	  B.	   Approximately	   5x105	   cells	   (excluding	   injured	  HK-­‐2	   cells	  
and	   erythrocytes)	   were	   incubated	   in	   PBS	   or	   30%	   human	   serum	   (Jurkat	   and	  
permeabilised	   HK-­‐2	   cells)	   or	   12.5%	   Balb/c	   or	   RAG1-­‐deficient	   mouse	   plasma	  
(thymocytes)	   for	   30-­‐minutes.	   Some	  experiments	   used	  Balb/c	   serum.	   For	   thymocytes	  
APC	  Mouse	  (Balb/c)	  IgM	  κ	  isotype	  control	  (25µg/mL,	  Clone:	  G155-­‐228,	  BD	  Pharmingen)	  
was	   used	   as	   a	   control	   irrelevant	   murine	   IgM	   antibody	   to	   assess	   any	   non-­‐specific	  
interaction.	  This	  was	  used	  at	  a	  high	  concentration	  to	  be	  comparable	  to	   levels	  of	   IgM	  
found	   in	   murine	   plasma	   (0.22±0.036	   mg/L	   –	   Personal	   communication:	   George	   Tse,	  
University	   of	   Edinburgh).	   IgM	   binding	   (including	   injured	   HK-­‐2	   cells	   but	   excluding	  
erythrocytes)	  was	  detected	  by	  a	  30-­‐minute	  incubation	  with	  the	  following	  IgM	  µ	  chain	  
specific	  antibodies:	  FITC	  mouse	  anti-­‐human	  IgM	  (1:5,	  Clone:	  G20-­‐127,	  BD	  Pharmingen)	  
and	   APC	   rat	   anti-­‐mouse	   IgM	   	   (1:100,	   Clone	   ID:	   II/41,	   BD	   Pharmingen)	   diluted	   in	   1%	  
BSA.	   	  Annexin-­‐V	  and	  PI	  staining	  was	  then	  performed	  as	  described	  in	  ‘2.3.1	  Annexin-­‐V	  
(AnnV)	   and	   PI	   staining’.	   Cell	   number,	   antibody	   dilutions	   and	   diluents	   were	   selected	  
following	  titration	  and	  analysed	  using	  median	  fluorescent	  intensity	  (MFI).	  IgM	  binding	  
was	  assessed	  by	  flow	  cytometry	  on	  a	  BD	  Calibur	  or	  assay	  modifications	  made	  to	  allow	  
samples	   to	   be	   viewed	   by	   confocal	   or	   electron	   microscopy	   as	   described	   in	   ‘2.6.1	  
Confocal	   microscopy’	   and	   ‘2.6.2	   Transmission	   Electron	   Microscopy	   (TEM)’,	  
respectively.	   In	   some	   instances	   the	   level	   of	   C3	   deposition	   on	   the	   cell	   surface	   was	  
assessed	  as	  described	  below.	  
	  
2.5.3	  Assessment	  of	  C3	  deposition	  on	  the	  cell	  surface	  –	  To	  confirm	  that	  C3	  deposition	  
was	   detected	   following	   IgM	   binding,	   non-­‐apoptotic	   and	   apoptotic	   thymocytes	   were	  
treated	  with	   either	   12.5%	  normal	   plasma,	   or	   heat-­‐inactivated	  Balb/c	   plasma	   (1-­‐hour	  
incubation	  	  at	  	  55°C)	  	  for	  	  30-­‐minutes.	  	  	  	  C3	  	  deposition	  	  was	  	  detected	  	  by	  	  a	  	  30-­‐minute	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Figure	  2.1	  –	  Schematic	  detailing	  how	  the	  cells	  binding	  IgM	  binding	  were	  assessed	  by	  
flow	  cytometry	  (B),	  confocal	  (C)	  and	  electron	  (D)	  microscopy.	  A)	  In	  some	  experiments	  
non-­‐apoptotic	   and	   apoptotic	   murine	   thymocytes,	   human	   Jurkat	   cells	   and	   human	  
proximal	   tubular	   epithelial	   cells	   (HK-­‐2)	   were	   permeabilised	   (2.5.1	   Permeabilisation)	  
prior	  to	  assessment	  of	   IgM	  binding.	  B)	  Outline	  of	  how	  IgM	  binding	  was	  assessed	  and	  
any	  subsequent	  modifications	  made	  to	  allow	  samples	  to	  be	  viewed	  by	  confocal	  (C)	  or	  
electron	   (B)	   microscopy	   as	   described	   in	   ‘2.6.1	   Confocal	   microscopy’	   and	   ‘2.6.2	  
Transmission	  Electron	  Microscopy	  (TEM)’,	  respectively.	  
	  
incubation	   with	   FITC	   goat	   anti-­‐mouse	   C3	   (1:100,	  MP	   Biomedical).	   Annexin-­‐V	   and	   PI	  
staining	  was	  then	  performed	  and	  analysed	  as	  described	  in	  ‘2.3.1	  Annexin-­‐V	  (AnnV)	  and	  
PI	  staining’.	  
	  
2.5.4	  Fluorescence-­‐Activated	  Cell	  Sorting	  (FACS)	   -­‐	  To	  separate	  discrete	  populations	  of	  
IgM+	  and	  IgM-­‐	  cells,	  FACS	  sorting	  was	  undertaken.	  An	  overview	  of	  where	  this	  protocol	  
is	  placed	  when	  performed	  as	  part	  of	  IgM	  binding	  assessment	  is	  provided	  in	  Figure	  2.1C	  
&	  D.	  Thymocytes,	  treated	  and	  stained	  as	  above,	  were	  sorted	  on	  a	  BD	  FACSAria	  II	  with	  a	  
70µM	  nozzle.	  Post-­‐sorting	  checks	  were	  performed	  to	  ensure	  populations	  remained	  in	  
original	   FSC	   SSC	   regions	   and	   to	   assess	   staining.	   	   Following	   sorting	   thymocytes	  were	  
either	  viewed	  using	  confocal	  or	  electron	  microscopy.	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2.5.5	   Permeabilisation	   and	   assessment	   of	   IgM	   binding	   to	   murine	   erythrocytes	   –	  
Murine	   IgM	   antibody	   binding	   to	   erythrocytes,	   as	   a	   simple	   anucleated	   organelle	   free	  
cell,	   was	   undertaken	   as	   follows.	   As	   described	   in	   ‘2.8.1	   Murine	   plasma/serum	  
generation	   and	   erythrocyte	   isolation’	   erythrocytes	   were	   isolated	   and	   200µL	   of	   the	  
suspension	  was	   stained	  with	   Alexa	   Fluor-­‐488	   rat	   anti-­‐mouse	   TER-­‐119/Erythroid	   cells	  
antibody	   (1:100,	   Biolegend)	   for	   30-­‐minutes	   before	   being	   washed	   with	   PBS	   and	  
centrifuged	  at	  600	  x	  g	  for	  10-­‐minutes.	  Anti-­‐TER-­‐119	  recognizes	  a	  molecule	  associated	  
with	   erythrocyte	   cell-­‐surface	   glycophorin	   A	   (Kina	   et	   al.,	   2000).	   Permeabilisation	  was	  
achieved	  by	  a	  10-­‐minute	   incubation	   in	  0.05%	  saponin	  after	  which	  erythrocytes	  were	  
washed.	  	  Erythrocytes	  were	  incubated	  in	  PBS	  or	  Balb/c	  or	  RAG1-­‐deficient	  mice	  plasma	  
at	   a	   ratio	   of	   1:1	   (erythrocyte	   volume:plasma	   volume)	   for	   30-­‐minutes	   before	   being	  
washed.	   APC	   Mouse	   (Balb/c)	   IgM	   κ	   isotype	   control	   was	   used	   as	   control	   irrelevant	  
murine	  IgM	  antibodies.	  IgM	  binding	  was	  detected	  by	  a	  30-­‐minute	  incubation	  with	  APC	  
rat	   anti-­‐mouse	   IgM.	   	   AnnV	   staining	   was	   performed	   to	   confirm	   permeabilisation.	  
Samples	   were	   diluted	   in	   AnnV	   binding	   buffer	   before	   staining	   was	   assessed	   by	   flow	  
cytometry	   on	   a	   BD	   FACSCalibur.	   	   Erythrocytes	   were	   identified	   by	   TER-­‐119	   positivity	  
(cell	   positivity	  was	   defined	   by	   isotype	   control	   –	   1:100,	   Alexa	   Fluor-­‐488	   Rat	   IgG2b	   κ,	  
BioLegend).	  Between	  5000-­‐10000	  TER-­‐119+	  events	  were	  collected	  and	  analysed	  using	  
FlowJo.	  
	  
2.6	  Microscopy	  used	  to	  study	  in	  vitro	  circulating	  IgM	  antibody	  binding	  
	  
2.6.1	   Confocal	   microscopy	   –	   To	   visualise	   IgM	   binding	   to	   murine	   and	   human	   cells	  
confocal	   microscopy	   was	   performed.	   An	   overview	   of	   where	   this	   protocol	   is	   placed	  
when	  performed	  as	  part	  of	  IgM	  binding	  assessment	  is	  provided	  in	  Figure	  2.1C.	  Sorted	  
populations	  of	  thymocytes	  were	  treated	  with	  plasma	  and	  stained	  as	  described	  in	  ‘2.5.2	  
Assessment	   of	   IgM	   binding	   to	   cells’,	   with	   the	   following	   modifications.	   Prior	   to	  
apoptosis	   induction	   thymocytes	   were	   stained	   with	   CellTracker	   Green	   CMFDA	  
(Invitrogen)	  according	  to	  the	  manufacturer’s	  instructions.	  Texas	  Red	  goat	  anti-­‐mouse	  µ	  
chain	   specific	   IgM	   (SouthernBiotech)	  was	   used	   and	   samples	  were	   stained	  with	  DAPI	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(Invitrogen)	   and	   PI	   staining	   was	   omitted.	   Jurkat	   cells	   were	   treated	   and	   stained	   as	  
above	  with	  the	  addition	  of	  DAPI	  and	  omission	  of	  PI	  staining.	  Samples	  were	  mounted	  
using	  ProLong	  Gold	  antifade	  reagent	  (Life	  Technologies)	  and	  viewed	  using	  a	  Leica	  SP5	  
with	  an	  x63/1.4	  objective.	  Single	  stains	  were	  used	  to	  check	  for	  spectral-­‐bleed	  through.	  
Whole	  image	  contrast/brightness	  and	  pseudocolour	  was	  adjusted	  using	  ImageJ	  (NIH).	  
	  
2.6.2	  Transmission	  Electron	  Microscopy	   (TEM)	  –	  TEM	  was	  performed	   to	  gain	  a	  more	  
detailed	  view	  of	  membrane	  permeability	  in	  IgM+	  and	  IgM-­‐	  cells.	  An	  overview	  of	  where	  
this	  protocol	  is	  placed	  when	  performed	  as	  part	  of	  IgM	  binding	  assessment	  is	  provided	  
in	  Figure	  2.1D.	  TEM	  sample	  preparation	  was	  performed	  as	  follows	  by	  Stephen	  Mitchell	  
(University	  of	  Edinburgh).	  FACS	  sorted	  thymocytes	  were	  fixed	  in	  3%	  glutaraldehyde	  in	  
0.1	   M	   sodium	   cacodylate	   buffer,	   pH	   7.3,	   for	   2-­‐hours	   and	   washed	   thrice	   in	   0.1	   M	  
sodium	  cacodylate	   for	  10-­‐minutes	  each.	  Post-­‐fixation	  was	  performed	  by	  a	  45-­‐minute	  
incubation	   in	  1%	  osmium	  tetroxide	   in	  0.1	  M	  sodium	  cacodylate	  before	  samples	  were	  
washed	   thrice	   in	   0.1	   M	   sodium	   cacodylate	   for	   10-­‐minutes	   each.	   	   Samples	   were	  
dehydrated	   by	   10-­‐minute	   incubations	   in	   50%,	   70%,	   90%	   and	   100%	   normal	   grade	  
acetones	   before	   a	   further	   two	   10-­‐minute	  washes	   in	   analar	   acetone.	   	   Samples	   were	  
embedded	   in	   Araldite	   resin	   and	   1	   µM	   sections	   cut	   on	   a	   Reichert	   OMU4	  
ultramicrotome.	   	   Sections	   were	   stained	   with	   Toluidine	   Blue	   and	   suitable	   areas	   for	  
investigation	   selected	   by	   light	   microscopy.	   	   From	   selected	   areas	   60	   nM	   ultrathin	  
sections	  were	  cut	  and	  stained	  with	  uranyl	  acetate	  and	  lead	  citrate	  before	  viewing	  in	  a	  
Philips	  CM120	  transmission	  electron	  microscope.	  Images	  were	  taken	  on	  a	  Gatan	  Orius	  
CCD	  camera.	  Whole	  image	  contrast/brightness	  was	  adjusted	  using	  ImageJ.	  
	  
2.7	  General	  Histology	  
	  
2.7.1	  Cryosectioning	  –	  Tissue	  was	  snap	  frozen	  on	  dry	  ice	  and	  stored	  at	  -­‐20°C	  overnight	  
prior	  to	  sectioning.	   	  Tissue	  was	  embedded	   in	  cryomatrix	   (Thermo	  Scientific	  Shandon)	  
and	  cut	  at	  a	  thickness	  of	  4	  µM	  and	  placed	  on	  slides.	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2.7.2	  Paraffin	   sectioning	   –	  Tissue	  was	   fixed	   in	  4%	  PFA	  or	  Methacarn	   (60%	  methanol,	  
30%	  chloroform	  and	  10%	  glacial	  acetic	  acid)	  at	  4°C	  overnight	  before	  being	  transferred	  
to	   PBS	   or	   methanol	   respectively	   and	   then	   processed	   on	   an	   automated	   processor.	  	  
Kidney	   tissue	   was	   then	   embedded	   in	   paraffin	   and	   left	   to	   solidify	   overnight	   before	  
sectioning.	  	  Sections	  were	  cut	  at	  a	  thickness	  of	  4µm	  on	  a	  microtome	  (Thermo	  Scientific	  
Shandon	   Finesse	   3),	   and	   placed	   on	   slides.	   	   Paraffin	   embedding	   and	   sectioning	   was	  
performed	  by	  SuRF	  Histology	   facilities	  within	   the	  Queen’s	  Medical	  Research	   Institute	  
(QMRI)	  or	  EEH.	  
	  
2.7.3	   Haematoxylin	   &	   eosin	   (H&E)	   staining	   –	   Slides	   with	   paraffin	   embedded	  mouse	  
kidney	   sections	  were	   de-­‐waxed	  by	   two	   5-­‐minute	  washes	  with	   xylene.	   Sections	  were	  
rehydrated	   through	  an	  ethanol	   series:	  100%	   -­‐	  96%	   -­‐	  75%	   -­‐	  50%	  once	   for	  20-­‐seconds	  
each	   and	   stained	   with	   Haematoxylin	   for	   5-­‐minutes.	   Sections	   were	   then	   washed	   as	  
follows:	   water,	   10-­‐seconds	   with	   0.1%	   HCl,	   20-­‐seconds	   with	   Scotts	   tap	   water	   and	  
counterstained	  with	  Eosin	  for	  1-­‐minute	  and	  washed	  with	  water.	  An	  ethanol	  series	  was	  
used	   to	  dehydrate	   the	   sections:	   50%	   -­‐	   75%	   -­‐	   96%	   -­‐	   100%	  once	   for	  20-­‐seconds	  each.	  
Two	   5-­‐minutes	   washes	   with	   xylene	   were	   performed	   to	   clear	   the	   sections	   prior	   to	  
mounting	   with	   Pertex.	   H&E	   staining	   was	   performed	   by	   EEH	   using	   SuRF	   Histology	  
facilities	  within	  the	  QMRI.	  
	  
2.7.4	  Direct	  and	  indirect	  immunofluorescence	  (IF)	  of	  frozen	  sections	  –	  Frozen	  sections	  
were	   air	   dried	   for	   1-­‐hour.	   	   Following	   two	   5-­‐minute	   washes	   with	   PBS	   samples	   were	  
fixed	  with	  either	  4%	  PFA	  in	  PBS	  (for	  IgM	  and	  C3	  staining)	  or	  1%	  PFA	  2%	  Acetic	  Acid	  in	  
PBS	  (for	  Fibrin	  staining)	   for	  10-­‐minutes.	   	  Acetic	  acid	  degrades	  non-­‐cross	   linked	  fibrin.	  
Samples	   were	   washed	   twice	   for	   5-­‐minutes	   before	   being	   loaded	   into	   sequenza	   slide	  
racks	  (Thermo	  Scientific)	  and	  blocked	  for	  1-­‐hour	  in	  20%	  serum	  obtained	  from	  the	  same	  
species	   in	  which	  the	  antibody	  was	  raised.	   	  All	   serum	  used	  was	  obtained	   from	  Sigma.	  	  
Antibodies	  were	  then	  applied	  and	  left	  to	  incubate	  for	  1-­‐hour.	  The	  following	  antibodies	  
were	   used:	   Polyclonal	   Rabbit	   Anti-­‐Human	   Fibrinogen/FITC	   (1:200,	   Dako	   Cytomation)	  
which	   cross-­‐reacts	   with	   mouse	   fibrin;	   polyclonal	   Goat	   Anti-­‐Mouse	   IgM	   (µ	   chain	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specific)	  Texas	  Red®	  (1:200,	  SouthernBiotech)	  and	  polyclonal	  FITC	  goat	  anti-­‐mouse	  C3	  
(1:100,	  MP	   Biomedical).	   Sections	  were	  washed	   twice	  with	   PBS	   before	   being	   stained	  
with	  DAPI	  (1:20,000,	  Invitrogen)	  diluted	  in	  PBS	  for	  10-­‐minutes.	  Samples	  were	  washed	  
with	   PBS	   prior	   to	   mounting	   with	   either	   ProLong®Gold	   Antifade	   Reagent	   (Life	  
Technologies)	   or	   VECTASHIELD	   HardSet	   Mounting	   Medium	   (Vector	   Laboratories).	  	  
Samples	   were	   examined	   using	   a	   Zeiss	   Axioskop	   2mot+	  microsope	   and	   images	   were	  
captured	   using	   Openlab	   v4	   (PerkinElmer).	   Alternatively,	   the	   following	   modifications	  
were	  performed	   for	   indirect	   IF.	   	   For	   B220	  detection	   endogenous	  biotin	  was	   blocked	  
following	  a	  15-­‐minute	  incubation	  with	  Avidin/Biotin	  Blocking	  Kit	  (Vector	  Laboratories)	  
before	  biotinylated	  anti-­‐mouse	  CD45R/B220	  (1:200,	  Clone:	  RA3-­‐6B2,	  PharMingen)	  was	  
applied	   for	   1-­‐hour.	   	   Samples	   were	   washed	   prior	   to	   a	   1-­‐hour	   incubation	   with	  
streptavidin	   Alexa	   Fluor-­‐488	   (1:1000,	   Invitrogen).	   DAPI	   staining	   and	   mounting	   was	  
performed	  as	  detailed	  above.	  With	  the	  exception	  of	  C3	  the	  conditions	  described	  above	  
were	   selected	   following	  optimization.	   	   Each	  antibody	  was	   trialed	  with	   iced	   cold	  70%	  
methanol,	   4%	   PFA,	   acetone	   and	   no	   fixative	   and	   subjected	   to	   a	   titration	   of	   1:60	   –	  
1:1000.	   Control	   tissue,	   either	   IRI	   kidney	   tissue	   for	   fibrin	  or	   spleen	   for	   IgM	  and	  B220	  
was	   run	   in	   parallel	   when	   experimental	   tissue	   was	   stained	   as	   a	   positive	   control	   to	  
ensure	  staining	  had	  worked.	  	  
	  
2.7.5	   Immunohistochemistry	   (IHC)	   of	   frozen	   and	   paraffin	   sections	   –	   Frozen	   sections	  
were	  air	  dried	  for	  1-­‐hour,	  washed	  twice	  with	  PBS	  for	  5-­‐minutes	  and	  fixed	  in	  iced	  cold	  
70%	   methanol	   for	   10-­‐minutes.	   Paraffin	   sections	   were	   de-­‐waxed	   and	   rehydrated	   as	  
described	   in	   section	   ‘2.7.3	   Haematoxylin	   &	   eosin	   (H&E)	   staining’.	   Following	   two	   5-­‐
minute	  washes	  with	  PBS	  endogenous	  peroxidase	  activity	  was	  blocked	  by	  a	  15-­‐minute	  
incubation	   in	   0.3%	   H2O2	   diluted	   in	   methanol.	   Samples	   were	   washed	   twice	   for	   5-­‐
minutes	  before	  being	  loaded	  into	  sequenza	  slide	  racks.	  	  Endogenous	  avidin	  and	  biotin	  
activity	  was	  blocked	  using	  a	  Avidin/Biotin	  Blocking	  Kit	  (Vector	  Laboratories)	  performed	  
according	  to	  the	  manufacturer’s	  instructions.	  Samples	  were	  incubated	  in	  protein	  block	  
serum-­‐free	   ready-­‐to-­‐use	   (Dako)	   to	   block	   non-­‐specific	   binding.	   	   Primary	   antibodies,	  
diluted	  in	  REAL	  antibody	  diluent	  (Dako),	  were	  applied	  and	  left	  to	  incubate	  overnight	  at	  
	  
	  Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  Chapter	  2:	  Materials	  and	  Methods	   59	  
4°C.	   Primary	   antibodies	   used	   were	   rat	   anti-­‐mouse	   CD41	   (1:250,	   Clone:	   MWReg30,	  
AbDserotec),	   used	   either	   unconjugated	   or	   biotinylated,	   rat	   anti-­‐mouse	   Gr1	   (1:300,	  
Clone:	   RB6-­‐8C5,	   BioLegend),	   biotinylated	   rat	   anti-­‐mouse	   B220/CD45R	   (1:100,Clone:	  
RA3-­‐6B2,	   PharMingen)	   and	   polyclonal	   goat	   anti-­‐mouse	   µ	   chain	   specific	   IgM	   (Vector	  
Laboratories).	  A	  biotinylated	  secondary	  rabbit	  anti-­‐rat	  IgG	  or	  rabbit	  anti-­‐goat	  IgG	  (both	  
Vector	   Laboratories)	   was	   applied	   (1:300),	   diluted	   in	   REAL	   antibody	   diluent,	   for	   30-­‐
minutes	   after	   two	   5-­‐minute	  washes	   (this	   step	  was	   omitted	   for	   biotinylated	   primary	  
antibodies).	   After	   two	   5-­‐minute	   washes	   samples	   were	   incubated	   for	   30-­‐minutes	   in	  
R.T.U	   Vectastain	   Kit	   Elite	   Reagent	   (Vector	   Laboratories)	   which	   contains	   preformed	  
avidin/biotin	  enzyme	  complex.	  	  Samples	  were	  washed	  thrice	  before	  exposure	  to	  Dako	  
Liquid	   DAB	   +	   Substrate	   Chromogen	   System	   (Dako)	   for	   10-­‐minutes	   and	   then	  washed	  
thrice.	  Samples	  were	  counterstained	  with	  Haematoxylin	  for	  30-­‐seconds,	  washed	  with	  
tap	  water	  until	  clean	  and	  blued	  with	  Scotts	  Tap	  Water	  for	  20-­‐seconds.	  Paraffin	  sections	  
were	  dehydrated	  and	  mounted	  as	  previously	  detailed.	  Frozen	  sections	  were	  mounted	  
with	  VECTASHIELD	  HardSet	  Mounting	  Medium.	  The	  conditions	  described	  above	  were	  
selected	   following	  optimization,	  as	  described	  above	  with	   the	   following	  additions.	  For	  
frozen	  sections	  a	  small	  titration	  of	  H2O2	  concentration	  was	  performed	  diluted	  in	  either	  
PBS	  or	  methanol	  and	  a	  range	  of	  DAB	  incubation	  times	  were	  trialed.	  	  Control	  tissue	  was	  
also	   run	   in	   parallel	   when	   experimental	   tissue	   was	   stained	   to	   ensure	   staining	   had	  
worked.	   	   Isotype	  controls	   (Purified	  Rat	   IgG2b	  κ,	  1:300,	  BioLegend;	  unconjugated	  and	  
biotinylated	  Rat	  IgG1,	  1:250,	  AbDserotec)	  were	  used	  to	  confirm	  binding	  specificity.	  
	  
2.7.6	  Quantification	  of	  IF	  and	  IHC	  staining	  -­‐	  For	  each	  stained	  section	  (one	  per	  mouse)	  5	  
images	  of	  the	  OSOM	  were	  taken	  at	  either	  x100	  (fibrin	  and	  IgM	  (IF))	  or	  x200	  (for	  CD41,	  
Gr1,	  and	  IgM	  (IHC)).	   	  Positive	  staining	  was	  selected	  using	  ImageJ	  (NIH)	  and	  processed	  
using	   the	  macros	   detailed	   in	   Table	   2.1.	   Sections	  were	   examined	  using	   either	   a	   Zeiss	  
Axioskop	  2mot+	  and	  Hamamatsu	  Orca-­‐ER	  camera	  or	  a	  Zeiss	  Axioskop	  microscope	  and	  
QImaging	   Micropublisher	   3.3	   RTV	   camera.	   	   The	   number	   of	   positive	   pixels	   was	  
expressed	  as	  a	  percentage	  of	  the	  total	  number	  of	  pixels.	  Quantification	  was	  performed	  
in	  a	  blinded	  manner.	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Table	  2.1	  –	  Image	  J	  macros	  for	  IF	  (A	  -­‐	  Macro	  for	  RGB	  Colour	  image	  types	  and	  B	  -­‐	  Macro	  
for	  8-­‐bit	  image	  types)	  and	  DAB	  (C)	  staining	  quantification.	  





run("Convert	  to	  Mask",	  "	  ");	  




B	   setAutoThreshold("Default	  dark");	  
//run("Threshold...");	  
setThreshold(0,	  ###);	  
run("Convert	  to	  Mask");	  




C	   imgName=getTitle();	  	  
run("Colour	  Deconvolution",	  "vectors=[H	  DAB]");	  
selectWindow(imgName	  +	  "-­‐(Colour_3)");	  	  
close();	  	  
selectWindow(imgName	  +"-­‐(Colour_1)");	  	  
close();	  	  






run("Convert	  to	  Mask");	  





2.8	  Blood	  Collection	  and	  Processing	  	  
	  
2.8.1	   Murine	   plasma/serum	   generation	   and	   erythrocyte	   isolation	   -­‐	   Total	   blood	   was	  
collected	   via	   cardiac	   puncture	   from	   terminally	   anaesthetised	   mice	   into	   Multivette®	  
600	   Lithium	   Heparin	   coated	   tubes	   (Sarstedt).	   Plasma	   was	   collected	   following	  
centrifugation	   at	   1500	   x	   g	   for	   10-­‐minutes.	   The	   buffy	   coat	   was	   discarded	   and	   the	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erythrocyte	  pellet	  was	  washed	  in	  PBS	  and	  centrifuged	  at	  600	  x	  g	  for	  10-­‐minutes	  thrice	  
before	  being	  diluted	  x3.5	  in	  PBS.	  Total	  blood	  was	  collected	  via	  cardiac	  puncture	  from	  
terminally	   anaesthetised	  mice	   into	   a	   2	  mL	   syringe	   for	   serum	   generation,	  which	  was	  
later	  transferred	  into	  a	  1	  mL	  microfuge	  tube.	  	  Serum	  was	  collected	  by	  allowing	  blood	  
to	  clot	  overnight	  at	  4°C	  followed	  by	  centrifugation	  at	  10,000	  x	  g	  for	  5-­‐minutes.	  
	  
2.8.2	  Preparation	  of	  citrated	  whole	  blood	  and	  platelet-­‐poor-­‐	  and	  platelet-­‐rich-­‐plasma	  -­‐	  
Total	  blood	  was	  collected	  via	  cardiac	  puncture	  from	  terminally	  anaesthetised	  mice	  into	  
a	  syringe	  containing	  3.2%	  sodium	  citrate	  (9:1)	  diluted	  in	  Hanks	  Balanced	  Salt	  Solution	  
H6648.	   	   Citrated	   blood	  was	   transferred	   into	   1.5	  mL	  microcentrifuge	   tubes.	   Platelet-­‐
poor-­‐plasma	  was	  obtained	  following	  centrifugation	  at	  17,000	  x	  g	  twice	  for	  10-­‐minutes	  
and	   snap	   frozen	  on	  dry	   ice	  and	   stored	  at	   -­‐80°C	  before	  use.	  Platelet	   rich	  plasma	  was	  
collected	  following	  centrifugation	  at	  100	  x	  g	  for	  10-­‐minutes	  and	  was	  used	  immediately.	  
	  
2.9	   Assessment	   of	   IgM	   binding	   in	   in	   vitro	   models	   of	   renal	   ischaemia	   reperfusion	  
injury	  
	  
2.9.1	   Induction	   of	   ATP	   depletion	   in	  HK-­‐2	   cells	   by	  Antimycin	  A	   –	  An	  overview	  of	   this	  
assay	   is	   provided	   in	   Figure	   2.2A.	   Large-­‐scale	   intracellular	   ATP	   and	   glucose	   depletion	  
with	   elevated	   intracellular	   calcium	   levels	   are	   hallmarks	   of	   cellular	   ischaemic	   injury	  
(Kaushal	  et	  al.,	  2004,	  Greene	  and	  Paller,	  1994).	  In	  this	  thesis	  we	  used	  a	  combination	  of	  
a	   mitochondrial	   inhibitor	   (Antimycin	   A),	   a	   non-­‐metabolised	   glucose	   analogue	   (2-­‐
deoxyglucose),	   and	   a	   calcium	   ionophore	   (A23187)	   to	  mimic	   ‘ischaemia’	   in	  HK-­‐2	   cells	  
and	   investigated	   IgM	   binding.	   Incubation	   in	   human	   serum	   was	   used	   to	   mimic	  
‘reperfusion’.	  This	   is	  an	  extensively	  used	  and	  widely	  accepted	   in	  vitro	  model	  of	   renal	  
IRI	   injury	   (Iwata	   et	   al.,	   1995,	   Lee	   and	   Emala,	   2002,	   Breggia	   and	   Himmelfarb,	   2008).	  
Detailed	   methodology	   is	   as	   follows.	   HK-­‐2	   cells,	   detached	   with	   trypsin	   or	   cell	  
dissociation	  buffer,	  were	  seeded	  at	  a	  density	  of	  3x105	  cells/mL	  and	  allowed	  to	  adhere	  
overnight	   before	   injury	   was	   induced	   by	   a	   1-­‐hour	   or	   3-­‐hour	   incubation	   in	   10	   mM	  
antimycin	   A	   plus	   10	   mM	   2-­‐deoxyglucose	   plus	   1	   µM	   calcium	   ionophore	   or	   20	   mM	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antimycin	  A	  plus	  20	  mM	  2-­‐deoxyglucose	  plus	  2	  µM	  calcium	  ionophore.	  Cells	  were	  then	  
washed	  with	  PBS	  twice.	  Morphological	  injury	  was	  assessed	  by	  microscopy	  using	  a	  Zeiss	  
Axiovert	  S100	  with	  a	  32x/0.4	  objective	  and	  imaged	  using	  a	  CoolSnap	  RS	  Photometrics	  
camera	   and	   OpenLab	   software.	   To	   allow	   in	   vitro	   reperfusion	   HK-­‐2	   cells	   were	   either	  
incubated	  in	  RPMI	  1640	  supplemented	  with	  5%	  FCS	  or	  30%	  human	  serum	  for	  24-­‐hours.	  
HK-­‐2	   cells	  were	  washed	  with	  PBS	  and	  detached	  before	   IgM	  binding	  was	  detected	  as	  
described	  in	  ‘2.5.2	  Assessment	  of	  IgM	  binding	  to	  cells’.	  
	  
	  
Figure	  2.2	  –	  Overview	  of	  conditions	  used	  to	  induce	  cellular	  injury	  in	  human	  proximal	  
tubular	   epithelial	   (HK-­‐2)	   cells	   by	   Antimycin	   A	   (A)	   or	   H2O2	   (B).	   IgM	   binding	   was	  
detected	  as	  described	  in	  ‘2.5.2	  Assessment	  of	  IgM	  binding’.	  Apoptosis	  was	  inferred	  as	  
described	  in	  ‘2.3.1	  Annexin-­‐V	  (AnnV)	  and	  PI	  staining’.	  
	  
2.9.2	   Induction	  of	   cellular	   injury	   in	  HK-­‐2	   cells	  by	  H2O2	  –	  An	  overview	  of	   this	   assay	   is	  
provided	  in	  Figure	  2.2B.	  Another	  hallmark	  of	  IRI	  is	  ROS	  production,	  such	  as	  H2O2,	  which	  
acts	   to	  exacerbate	  cellular	   injury	   (Simonson	  et	  al.,	  1993,	  Aragno	  et	  al.,	  2003).	   In	   this	  
thesis	  we	  used	  an	  additional	   in	  vitro	  model	  of	   renal	   IRI	   induced	  by	  exposure	  of	  HK-­‐2	  
cells	   to	  H2O2	  prior	   to	   incubation	  with	  human	   serum,	   to	  mimic	   ischaemia	   reperfusion	  
injury	  (Yoshida	  et	  al.,	  2008,	  Park	  et	  al.,	  2012).	  Detailed	  methodology	  is	  as	  follows.	  HK-­‐2	  
cells	   were	   treated	   and	   seeded	   as	   above	   before	   injury	   was	   induced	   by	   a	   1-­‐hour	  
incubation	  in	  serum	  free	  RMPI	  1640	  medium	  supplemented	  with	  either	  0,	  2.5,	  5	  or	  500	  
mM	   H2O2.	  Morphology	   was	   assessed	   as	   above	   before	   HK-­‐2	   cells	   were	   incubated	   in	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RPMI	   1640	   supplemented	  with	   5%	   FCS	   or	   30%	   human	   serum	   for	   1-­‐hour.	   HK-­‐2	   cells	  
were	  washed	  with	  PBS	  and	  detached	  before	  IgM	  binding	  was	  detected	  as	  described	  in	  
‘2.5.2	  Assessment	   of	   IgM	  binding	   to	   cells’.	   These	   conditions	  were	   selected	   following	  
dose	  titration	  experiments.	  
	  
2.10	  In	  vivo	  model	  of	  renal	  ischaemia	  and	  murine	  thymocyte	  administration	  	  
	  
2.10.1	  Non-­‐apoptotic	  and	  apoptotic	  murine	  thymocyte	  administration	  –	  To	  explore	  the	  
influence	  of	  apoptotic	  cells	  on	  renal	   IRI	  or	  coagulation	  either	  200	  µL	  PBS	  (control)	  or	  
20x106	   non-­‐apoptotic	   or	   apoptotic	  murine	   thymocytes,	   generated	   from	  male	   Balb/c	  
mice	  as	  described	   in	   ‘2.2.1	  Preparation	  of	  non-­‐apoptotic	   and	  apoptotic	   thymocytes’,	  
were	  administered	  intravenously	  to	  mice	  24-­‐hours	  prior	  to	  renal	  IRI	  or	  sacrifice.	  
	  
2.10.2	   In	   vivo	   model	   of	   renal	   IRI	   –	   Detailed	   step	   by	   step	   methodology	   and	   an	  
accompanying	  video	  is	  described	  in	  Hesketh	  et	  al,.	  (2014),	  both	  of	  which	  are	  included	  
in	  this	  thesis.	  Male	  8-­‐week	  Balb/c	  mice	  were	  anaesthetised	  using	  ketamine	  (70	  mg/kg)	  
and	  medetomadine	  hydrochloride	  (1mg/kg)	  administered	  by	  intraperitoneal	  injection.	  
Subcutaneous	   buprenorphine	   analgesia	   (0.06mg/kg)	   was	   given	   pre-­‐operatively.	   A	  
contralateral	  right	  nephrectomy	  was	  performed	  before	  the	  renal	  pedicle	  was	  clamped	  
with	  an	  atraumatic	  clamp	  for	  22,	  24	  or	  25-­‐minutes.	  Body	  temperature	  was	  maintained	  
at	   37°C	   by	   a	   homeostatically	   controlled	   blanket	   (Harvard	   Apparatus,	   Boston	   MA)	  
during	   the	   ischaemic	   period.	   The	   peritoneum	  was	   then	   sutured	   and	   the	   skin	   closed	  
with	   metallic	   clips.	   Anaesthesia	   was	   reversed	   using	   atipamazole	   hydrochloride	  	  
(2mg/kg)	   and	  1	  mL	   sterile	   saline	  was	  administered	  by	  a	   subcutaneous	   injection	  post	  
surgery.	   Sham	  mice	  underwent	  a	   laparotomy	  with	  manipulation	  of	   the	   left	  and	   right	  
renal	   pedicle	   only.	   	   Mice	   were	   placed	   in	   an	   incubator	   at	   27°C	   immediately	   post-­‐
operatively.	   The	   left	   ischaemic	   kidney,	   spleen,	   liver	   tissue	   and	   total	   blood	   were	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2.10.3	   Assessment	   of	   renal	   function	   –	   Renal	   function	  was	   inferred	   from	   blood	   urea	  
nitrogen	   (BUN)	   [mmol/L]	   and	   creatinine	   [µmol/L]	   concentration	   assessed	   in	   plasma	  
samples	   using	   a	   creatinase	   based	   method	   by	   Dr	   Forbes	   Howie	   (MRC	   Centre	   for	  
Reproductive	  Health)	  on	  a	  Cobas	  Fara	  Centrifugal	  Analyser	  (Roche	  Diagnostics,	  UK).	  	  
	  
2.10.4	  Assessment	  of	  acute	   tubular	  necrosis	   (ATN)	  –	  ATN	  scoring	  was	  undertaken	   to	  
quantify	  the	  extent	  of	  structural	  injury	  following	  renal	  IRI.	  The	  number	  of	  viable	  (intact	  
cell	   membrane	   with	   normal	   morphology)	   and	   necrotic	   tubules	   (compromised	   and	  
disrupted	   cell	   membrane)	   were	   marked	   and	   counted	   in	   H&E	   stained	   kidney	   tissue	  
using	  ImageJ	  (NIH).	  	  The	  number	  of	  necrotic	  tubules	  was	  expressed	  as	  a	  percentage	  of	  
the	  total	  number	  of	  tubules	  (necrotic	  tubules	  %).	  	  ATN	  was	  assessed	  in	  5	  images	  taken	  
at	   x200	  magnification	   of	   the	   outer	   stripe	   of	   the	   outer	  medulla	   (OSOM)	   per	  mouse.	  	  
ATN	  was	  scored	  in	  a	  blinded	  manner.	  	  
	  
2.11	  Apoptotic	  cells	  and	  coagulation	  	  
	  
2.11.1	  Thrombin	  generation	  assay	  (TGA)	  –	  A	  TGA	  was	  used	  to	  investigate	  the	  ability	  of	  
apoptotic	  cells	  to	  modulate	  thrombin	  generation.	  The	  thrombin	  generated	  in	  citrated	  
platelet-­‐poor-­‐plasma	   collected	   from	   male	   Balb/c	   mice	   24-­‐hours	   following	  
administration	   of	   apoptotic	   cells	   was	   measured	   by	   Roger	   Preston	   (Department	   of	  
Clinical	  Medicine,	   Trinity	   College	   Dublin)	   as	   described	   previously	   (Tchaikovski	   et	   al.,	  
2007).	  	  
	  
2.11.2	  Detection	  of	  platelet	  binding	  to	  apoptotic	  thymocytes	  –	  To	  explore	  the	  ability	  of	  
apoptotic	   cells	   to	   interact	   with	   platelets	   an	   in	   vitro	   assay	   was	   established.	   Murine	  
thymocytes	   were	   stained	   with	   CellTracker	   Orange	   (Invitrogen),	   according	   to	   the	  
manufacturer’s	  instructions,	  prior	  to	  apoptosis	  induction	  by	  overnight	  ageing.	  Platelets	  
in	  5	  µL	  of	  citrated	  whole	  blood	  were	   labeled	  by	  a	  30-­‐minute	   incubation	  with	  5	  µL	  of	  
Alexa	   Fluor-­‐488	   Rat	   Anti-­‐Mouse	   CD41	   (1:200,	   Clone:	   MWReg30,	   BioLegend).	  
Approximately	   5x105	   CellTracker	   Orange	   stained	   apoptotic	   thymocytes	   were	   then	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added	   to	   whole	   blood,	   containing	   anti-­‐mouse	   CD41	   labeled	   platelets,	   and	   were	  
incubated	   for	   30-­‐minutes.	   The	   sample	   was	   then	   fixed	   with	   500	   µL	   1%	  
paraformaldehyde	  (PFA)	  for	  10-­‐minutes	  before	  10,000	  CD41+	  events	  were	  collected	  by	  
flow	   cytometry	   on	   a	   BD	   FACSCalibur.	   Anti-­‐mouse	   CD41	   binding	   specificity	   and	  
positivity	   was	   assessed	   using	   FITC	   Rat	   IgG1	   κ	   isotype	   control	   (1:200,	   BioLegend).	  





2.12.1	   Statistical	   analysis	   –	   Results	   are	   expressed	   as	   means	   ±	   SEM.	   Statistical	   tests	  
performed	   were	   student	   t-­‐test,	   Kruskal-­‐Wallis	   one-­‐way	   ANOVA,	   standard	   one-­‐way	  
ANOVA	   or	   two-­‐way	   ANOVA	   with	   a	   Dunn’s	   or	   Bonferroni	   multiple	   comparisons	   test	  
when	   appropriate.	   P<0.05	   was	   considered	   to	   be	   statistically	   significant.	   	   Statistical	  
analysis	  was	  performed	  using	  Prism	  6	  (GraphPad	  Software,	  San	  Diego).	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The	   role	   of	   IgM	  antibodies	   in	   ischaemic	   injury	   is	   an	   interesting	   and	   evolving	   area	  of	  
research	   meriting	   further	   study,	   as	   such	   we	   aimed	   to	   investigate	   and	   clarify	   the	  
potential	  involvement	  of	  IgM	  in	  renal	  and	  liver	  injury.	  
	  
IgM	   antibodies	   form	   an	   integral	   and	   crucial	   part	   of	   our	   innate	   immune	   system,	  
participating	   in	   diverse	   pathophysiologies	   such	   as	   infection,	   B	   cell	   homeostasis,	  
inflammation,	   and	   autoimmunity	   (Ehrenstein	   and	   Notley,	   2010).	   However,	   following	  
ischaemic	   reperfusion	   injury,	   endogenous	   IgM	   can	   be	   pathogenic	   by	   binding	   injured	  
cardiac	  muscle,	  skeletal	  muscle	  and	  the	   intestine	  where	   it	  activates	  complement	  and	  
augments	  tissue	  damage	  (reviewed	  in	  Table	  1.1).	  The	  role	  of	  IgM	  in	  renal	  IRI	  remains	  
unclear,	   some	   studies	   suggest	   that	   immunoglobulins	   may	   be	   implicated	   in	   injury	  
pathogenesis,	  whilst	  others	   indicate	  that	   immunoglobulins	  have	  no	   involvement	   (van	  
der	   Pol	   et	   al.,	   2011,	   Burne-­‐Taney	   et	   al.,	   2003,	   Park	   et	   al.,	   2002).	   Lobo	  et	   al.,	   (2012)	  
suggested	  that	  IgM	  had	  a	  protective	  role	  in	  renal	  IRI.	  Following	  bilateral	  renal	  IRI	  sIgM	  
KO	   had	   increased	   renal	   inflammation	   and	   dysfunction.	   Reconstitution	   with	   purified	  
IgM	  attenuated	   renal	   inflammation.	   In	   the	  same	  study	   in	  vitro	   studies	   indicated	   that	  
IgM	   binding	   to	   leukocytes	   inhibited	   TLR-­‐4–induced	   NF-­‐κB	   nuclear	   translocation.	   In	  
addition	   IgM	  antibody	  binding	  to	   leukocyte	  receptors	  prevented	  T	  cell	  differentiation	  
into	   pro-­‐inflammatory	   cells	   Th-­‐1	   and	   Th-­‐17.	   In	   contrast	   to	   this	   paper,	   there	   are	   a	  
number	  of	  papers	   indicating	  the	  pathogenic	  nature	  of	   IgM	  antibodies	   in	   ischaemia	   in	  
other	  organs	  (Haas	  et	  al.,	  2010,	  Zhang	  et	  al.,	  2006b,	  Zhang	  et	  al.,	  2006a,	  Zhang	  et	  al.,	  
2004,	   Chan	   et	   al.,	   2004).	   As	   such	   we	   were	   still	   keen	   to	   explore	   the	   role	   of	   IgM	  
antibodies	  during	   renal	   IRI	   in	  our	  own	   lab.	  Although	  ambiguity	   surrounds	   the	   role	  of	  
IgM	  antibodies	   in	   renal	   ischaemia	   reperfusion	   injury,	   the	   involvement	  of	   IgM	   in	   liver	  
ischaemic	   injury	   is	   unknown.	   If	   IgM	   antibodies	   are	   found	   to	   be	   involved	   then	  
therapeutic	  strategies	  designed	  to	  inhibit	  access	  to	  IgM	  bound	  epitopes	  may	  represent	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novel	   treatments	   for	   renal	  and	  hepatic	   IRI.	   Such	  approaches	  have	  been	  successful	   in	  
murine	  models	  of	  intestinal,	  cardiac	  and	  skeletal	  muscle	  ischaemia	  in	  which	  injury	  was	  
ameliorated	  by	  a	  synthetic	  N2	  peptide	  that	  blocked	  IgM	  binding	  to	  neo-­‐epitope	  NMHC-­‐
11	  (Haas	  et	  al.,	  2010,	  Zhang	  et	  al.,	  2006a).	  
	  
In	  this	  chapter	  we	  explored	  the	  binding	  of	   IgM	  antibodies	  to	  murine	  kidney	  tissue	  at	  
key	  time	  points	  following	  renal	   IRI,	  and	  to	  injured	  human	  renal	  cells	   in	  vitro.	  We	  also	  
characterized	  the	  kinetics	  of	  IgM	  deposition	  in	  mice	  following	  hepatic	  ischaemic	  injury,	  




3.1	   Non-­‐specific	   staining	   is	   evident	   following	   IHC	   detection	   of	   IgM	   in	   paraffin	  
embedded	  kidney	  tissue	  
Firstly	  attempts	  were	  made	  to	  detect	   IgM	  in	  paraffin	  embedded	  kidney	  tissue	  by	  IHC	  
as,	   once	   optimised,	   this	   method	   results	   in	   clear	   staining	   with	   excellent	   tissue	  
morphology.	   However,	   whilst	   ischaemic	   kidney	   tissue	   harvested	   24-­‐hours	   following	  
renal	   IRI	   appeared	   to	   show	   IgM	   deposition,	   this	   staining	   was	   also	   evident	   in	   non-­‐
injured	  control	  kidney	  tissue	  (Figure	  3.1).	  Also,	  some	  positive	  staining	  was	  observed	  in	  
immunoglobulin	   deficient	   RAG-­‐1	   kidney	   tissue	   indicating	   that	   the	   anti-­‐IgM	   antibody	  
used	   resulted	   in	   non-­‐specific	   staining	   in	   kidney	   tissue	   (Figure	   3.1).	   	   This	   non-­‐specific	  
staining	  was	  still	  detectable	  at	  antibody	  dilutions	  of	  1:20,000	  suggesting	  that	  IHC	  based	  
detection	  of	  IgM	  by	  unconjugated	  anti-­‐IgM	  in	  kidney	  tissue	  would	  not	  yield	  optimum	  
accurate	  results.	  
	  
3.2	  Specific	  IgM	  staining	  is	  evident	  following	  IF	  detection	  in	  frozen	  kidney	  tissue	  
Next,	  detection	  of	  IgM	  in	  frozen	  tissue	  using	  IF	  was	  trialed	  using	  a	  directly	  conjugated	  
Texas	  Red	  anti-­‐IgM	  antibody.	  Frozen	  spleen	  tissue	  was	  selected	  as	  a	  positive	  control,	  
due	  to	  the	  presence	  of	  membrane	  bound	  IgM	  on	  B	  cells,	  and	  used	  to	  optimise	  staining	  
conditions.	  	  	  	  A	  	  1:200	  	  dilution	  	  was	  	  	  selected	  	  following	  	  a	  	  titration	  	  and	  	  the	  	  optimum	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Figure	   3.1	   –	   Non-­‐specific	   staining	   evident	   following	   IHC	   based	   detection	   of	   IgM	   in	  
paraffin	   embedded	   non-­‐injured,	   ischaemic	   and	   RAG	   kidney	   tissue.	   Trials	   of	  
unconjugated	   IHC	   with	   an	   anti-­‐IgM	   antibody	   yielded	   non-­‐specific	   binding	   in	   non-­‐
injured,	   post	   IRI	   paraffin	   embedded	   kidney	   tissue.	   Non-­‐specific	   binding	   was	   also	  
evident	   in	   immunoglobulin	  deficient	  RAG	  kidney	  tissue.	   	  Kidney	  tissue	  stained	  with	  a	  
biotinylated	  secondary	  antibody	  alone	  illustrated	  no	  staining.	  Magnification:	  x200.	  
	  
fixation	  technique	  was	  then	  determined.	  Frozen	  spleen	  tissue	  was	  either	  left	  unfixed,	  
or	  the	  common	  fixatives	  70%	  MetOH	  or	  4%	  PFA	  were	  used,	  the	  latter	  of	  which	  resulted	  
in	   strong	   clear	   positive	   IgM	   staining	   (Figure	   3.2A).	   The	   absence	   of	   staining	   in	   frozen	  
RAG-­‐1	  spleen	  and	  kidney	  tissue,	  and	  isotype	  stained	  spleen	  tissue,	  confirmed	  anti-­‐IgM	  
specificity	  (Figure	  3.2B).	  	  
	  
Binding	   specificity	   was	   further	   confirmed	   in	   4%	   PFA	   fixed	   frozen	   spleen	   tissue	   dual	  
stained	  for	   IgM	  and	  the	  B	  cell	  marker	  B220	  as	  similar	  positive	  B220	  and	  IgM	  staining	  
patterns	  were	   evident	   in	  what	   appeared	   to	   be	   germinal	   centers	   (Figure	   3.3).	   Future	  
experiments	  therefore	  detected	  IgM	  deposition	  in	  4%	  PFA	  fixed	  kidney	  tissue	  using	  a	  
fluorochrome	  conjugated	  anti-­‐IgM	  antibody.	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Figure	  3.2	  –	  Specific	   IgM	  staining	  evident	   in	   frozen	  spleen	  tissue	  fixed	  with	  4%	  PFA	  
following	   IF	   based	   detection.	   A)	   Trials	   to	   determine	   which	   fixation	   technique	   yield	  
optimum	   staining	   with	   a	   directly	   conjugated	   Texas-­‐Red	   anti-­‐IgM	   antibody	   revealed	  
that	   frozen	   spleen	   tissue	   fixed	   with	   4%	   PFA	   exhibited	   clear	   positive	   staining.	  B)	   No	  
staining	   was	   detected	   in	   frozen	   RAG	   spleen	   and	   kidney	   tissue	   following	   anti-­‐IgM	  
staining.	  Frozen	  spleen	  tissue	  stained	  with	  an	  isotype	  antibody	  illustrated	  no	  staining.	  
Magnification	  of	  all	  images:	  x100.	  
	  
	  
Figure	  3.3	  –	  IgM	  and	  B220	  exhibit	  similar	  staining	  patterns	  in	  frozen	  spleen	  tissue.	  To	  
confirm	  anti-­‐IgM	  specificity	  4%	  PFA	  fixed	  frozen	  spleen	  tissue	  was	  stained	  for	  the	  B	  cell	  
marker	   B220	   and	   IgM.	   B220	   staining	   was	   evident	   in	   what	   appeared	   to	   be	   germinal	  
centers	  with	  IgM	  exhibiting	  a	  similar	  staining	  pattern.	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3.3	   Despite	   evident	   tissue	   necrosis	   minimal	   IgM	   deposition	   was	   detected	   following	  
renal	  ischaemic	  injury	  
As	   IgM	  antibodies	  have	  been	   shown	   to	  have	   a	  pathogenic	   role	   in	   skeletal,	   intestinal	  
and	   cardiac	   ischaemia	   (reviewed	   in	   Table	  1.1),	  we	  wanted	   to	   ascertain	  whether	   IgM	  
might	   be	   involved	   in	   renal	   ischaemic	   injury.	   To	   investigate	   this	   we	   first	   wanted	   to	  
confirm	   that	   IgM	   was	   present	   following	   injury.	   Therefore	   to	   assess	   IgM	   deposition	  
following	  renal	   ischaemic	  injury,	  8-­‐week	  old	  male	  Balb/c	  mice	  underwent	  25-­‐minutes	  
of	  ischaemia	  and	  were	  sacrificed	  30-­‐minutes,	  1-­‐hour	  or	  24-­‐hours	  later.	  An	  overview	  of	  
this	  experiment	  is	  provided	  in	  chapter	  4	  figure	  4.5A,	  however	  an	  additional	  30-­‐minute	  
time	  point	  was	  studied.	  Note	  that	  the	  tissue	  used	  from	  this	  experiment	  was	  also	  used	  
to	   study	   baseline	   injury	   and	  microvascular	   congestion	   as	   discussed	   in	   chapter	   4.	   As	  
figure	   3.4A	   illustrates	   tissue	   necrosis	   was	   evident	   at	   1-­‐hour	   and	   24-­‐hours	   post	  
ischaemia,	   whilst	   at	   30-­‐minute	   normal	   renal	   tubular	   morphology,	   similar	   to	   non-­‐
injured	  tissue,	  was	  observed.	  ATN	  for	  time	  points	  1-­‐hour	  and	  24-­‐hours	  was	  quantified	  
and	  is	  presented	  in	  figure	  4.6B,	  ATN	  was	  not	  present	  at	  30-­‐minutes.	  IgM	  staining	  was	  
present	  at	  1-­‐hour	  and	  24-­‐hours	  post	   ischaemia,	  but	  was	  absent	  at	  30-­‐minutes	  and	  in	  
non-­‐injured	  kidney	  tissue	  (Figure	  3.4A).	  As	  shown	  in	  figure	  3.4B	  quantification	  of	  IgM+	  
staining	   in	   the	  OSOM	   revealed	   that,	   although	   statistically	   significant,	   IgM	  deposition	  
was	  minimal	  at	  1-­‐hour	  with	  0.92	  ±0.46%	  IgM+	  and	  appeared	  reduced	  at	  24-­‐hours	  post	  
ischaemia	  (one-­‐way	  ANOVA,	  P	  ≤	  0.05,	  1-­‐hour	  and	  24-­‐hour	  (n	  =	  4),	  30-­‐minutes	  (n	  =	  3),	  
non-­‐injured	   (n	   =	   11)).	   In	   addition,	   quantification	   confirmed	   that	   IgM	  deposition	  was	  
largely	   absent	   30-­‐minutes	   post	   ischaemia	   and	   in	   non-­‐injured	   kidney	   tissue	   (Figure	  
3.4B).	  	  
	  
3.4	  Minimal	  C3	  deposition	  observed	  following	  renal	  ischaemic	  injury	  
As	  demonstrated	   in	   skeletal,	   intestinal	  and	  cardiac	   ischaemia	   (reviewed	   in	  Table	  1.1)	  
C3	  deposition	  is	  often	  observed	  following	  binding	  of	  IgM	  to	  injured	  tissue.	  We	  aimed	  
to	   investigate	  whether	   C3	  deposition	  was	  observed	   following	   renal	   ischaemic	   injury,	  
the	  absence	  of	  which	  would	   further	   support	  our	  data	   indicating	   that	   IgM	  antibodies	  
are	  	  not	  	  present	  	  in	  ischaemic	  	  kidney	  tissue.	  	  To	  	  detect	  	  C3	  	  deposition	  	  frozen	  	  kidney	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Figure	   3.4	   –	   Despite	   evident	   tissue	   necrosis	  minimal	   IgM	   deposition	  was	   detected	  
following	   renal	   ischaemic	   injury.	  To	  assess	   IgM	  deposition	   following	  renal	   ischaemic	  
injury,	   8-­‐week	   old	   male	   Balb/c	   mice	   underwent	   25-­‐minutes	   of	   ischaemia	   and	   were	  
sacrificed	  30-­‐minutes,	  1-­‐hour	  or	  24-­‐hours	   later.	  A)	  Representative	  photomicrographs	  
of	  H&E	  stained	  paraffin	  embedded	  kidney	  sections	  revealed	  that	  normal	  renal	  tubular	  
morphology	   is	   observed	   at	   30-­‐minutes,	  whilst	   tissue	   necrosis	  was	   evident	   at	   1-­‐hour	  
and	   24-­‐hours	   (indicated	  by	   grey	   arrows)	   following	   renal	   IRI.	  Minimal	   IgM	  deposition	  
was	  observed	  in	  4%	  PFA	  fixed	  frozen	  ischaemic	  kidney	  tissue	  stained	  with	  anti-­‐IgM.	  B)	  
Quantification	  of	  IgM	  deposition	  (expressed	  as	  IgM+	  area)	  in	  the	  OSOM	  demonstrated	  
that	   IgM	  was	  present	  1-­‐hour	   following	   IRI.	  Data	  expressed	  as	  ±SEM	  and	  analysed	  by	  
one-­‐way	  ANOVA.	  *	  =	  P	   ≤	  0.05.	  1-­‐hour	  and	  24-­‐hour	   (n	   =	  4),	   30-­‐minutes	   (n	   =	  3),	  non-­‐
injured	  (n	  =	  11).	  Magnification	  H&E:	  x200.	  Magnification	  IgM:	  x400.	  
	  
tissue	  harvested	  30-­‐minutes,	  1-­‐hour	  and	  24-­‐hours	  following	  renal	  IRI	  was	  fixed	  with	  4%	  
PFA	   and	   stained	  with	   an	   anti-­‐C3	   antibody.	   As	   presented	   in	   figure	   3.5	   C3	   deposition	  
appeared	  largely	  absent	  at	  30-­‐minutes	  and	  24-­‐hours,	  but	  was	  minimally	  detected	  at	  1-­‐
hour	   post	   ischaemia.	   Frozen	   liver	   tissue	   exhibiting	   injury	   secondary	   to	   carbon	  
tetrachloride	  administration	   (kindly	  provided	  by	  Alexandra	  Thompson)	  was	  used	  as	  a	  
positive	  control	  to	  validate	  the	  anti-­‐C3	  antibody	  (Figure	  3.5).	  Following	  staining	  it	  was	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discovered	  that	  some	  tissue	  from	  this	  experiment	  was	  all	  sectioned	  onto	  contaminated	  
slides,	  which	   interfered	  with	   IF	  staining.	   It	  was	  therefore	  decided	  that	  data	   from	  this	  
experiment	  would	  not	   be	  quantified	  due	   to	   a	   reduced	   sample	   size	   and	   as	   such	  only	  
representative	  data	  is	  presented.	  
	  
	  
Figure	   3.5	   -­‐	   Minimal	   C3	   deposition	   observed	   following	   renal	   ischaemic	   injury.	   C3	  
deposition	  was	  assessed	  in	  4%	  PFA	  fixed	  frozen	  kidney	  tissue	  harvested	  30-­‐minutes,	  1-­‐
hour	  or	  24-­‐hours	   following	  25-­‐minutes	  of	   ischaemia	   in	  8-­‐week	  old	  male	  Balb/c	  mice.	  
Minimal	  C3	  deposition	  was	  observed	   in	   ischaemic	  kidney	  tissue	  stained	  with	  anti-­‐C3.	  
C3	   staining	   was	   evident	   in	   frozen	   tetrachloride	   injured	   liver	   positive	   control	   tissue.	  
Representative	  photomicrographs.	  1-­‐hour	  and	  24-­‐hour	  (n	  =	  4),	  30-­‐minutes	  (n	  =	  3),	  non-­‐
injured	  (n	  =	  11).	  Magnification:	  x200.	  
	  
3.5	  IgM	  antibodies	  reactive	  to	  apoptotic	  cells	  are	  not	  reduced	  in	  plasma	  obtained	  from	  
mice	  following	  apoptotic	  cell	  administration	  or	  renal	  ischaemic	  injury	  
We	   sought	   to	   determine	   whether	   apoptotic	   cell	   administration	   or	   renal	   IRI	   might	  
reduce	   the	   level	   of	   IgM	   reactive	   to	   apoptotic	   cells.	   To	   assess	   this	   plasma	   samples,	  
obtained	  following	  20x106	  apoptotic	  cell	  administration	  or	  renal	   IRI,	  were	  exposed	  to	  
apoptotic	   cells	   and	   stained	   with	   anti-­‐IgM.	   The	   percentage	   of	   IgM+	   cells	   was	   then	  
assessed	  by	  flow	  cytometry.	  This	  technique	  is	  designed	  to	  determine	  the	  level	  of	  IgM	  
bound	   to	   apoptotic	   cells	   and	   is	   described	   in	   detail	   in	   chapter	   5.	   Normal	   plasma	  
generated	   from	   healthy	   8-­‐week	   old	  male	   Balb/c	  mice	   not	   undergoing	   renal	   IRI	   was	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used	  as	  a	  control.	  Firstly,	  plasma	  samples	  obtained	  from	  8-­‐week	  old	  male	  Balb/c	  mice	  
24-­‐hours	   following	  PBS	  or	   administration	  of	   20x106	   apoptotic	   cells	  was	   studied.	   This	  
indicated	   that	   levels	   of	   IgM	   reactive	   to	   apoptotic	   cells	   remained	   similar	   in	   plasma	  
samples	   obtained	   from	  normal	   or	   PBS/apoptotic	   cell	   treated	  mice	   (Figure	   3.6A).	  We	  
next	   determined	   if	   IgM	   levels	   reactive	   to	   apoptotic	   cells	   was	   reduced	   in	   plasma	  
samples	  obtained	  1-­‐hour	  and	  24-­‐hours	  following	  renal	   ischaemic	   injury.	   Interestingly,	  
whilst	  levels	  of	  IgM+	  cells	  in	  plasma	  obtained	  from	  normal	  mice	  and	  mice	  sacrificed	  1-­‐
hour	  following	  IRI	  remained	  similar,	  a	  slight	  non-­‐significant	  reduction	  was	  observed	  in	  
plasma	  from	  mice	  sacrificed	  24-­‐hours	  following	  renal	  ischaemia	  (Figure	  3.6B).	  	  
	  
	  
Figure	   3.6	   –	   IgM	   antibodies	   reactive	   to	   apoptotic	   cells	   are	   not	   reduced	   in	   plasma	  
obtained	  from	  mice	  following	  apoptotic	  cell	  administration	  or	  renal	  ischaemic	  injury.	  
Plasma	  was	  obtained	  from	  8-­‐week	  old	  male	  Balb/c	  mice	  24-­‐hours	  following	  (A)	  PBS	  or	  
administration	   of	   20x106	   apoptotic	   cells	   or	   (B)	   1-­‐hour	   or	   24-­‐hours	   following	   25-­‐
minutes	   of	   ischaemia.	  Normal	   plasma	  was	   generated	   from	  healthy	   8-­‐week	   old	  male	  
Balb/c	  mice	  not	  undergoing	  renal	  IRI	  or	  PBS/apoptotic	  cell	  administration.	  The	  level	  of	  
apoptotic	  cell	  reactive	  IgM	  antibodies	  following	  apoptotic	  cell	  administration	  or	  renal	  
IRI	   was	   assessed.	   To	   do	   this	   plasma	   samples	   were	   exposed	   to	   apoptotic	   cells	   and	  
stained	   with	   anti-­‐IgM.	   The	   percentage	   of	   IgM+	   cells	   was	   then	   assessed	   by	   flow	  
cytometry.	  A)	  Levels	  of	   IgM+	  cells	   remained	  similar	   in	  plasma	  samples	  obtained	  from	  
normal	   or	   PBS/apoptotic	   cell	   treated	   mice.	   B)	   Whilst	   levels	   of	   IgM+	   cells	   in	   plasma	  
obtained	  from	  normal	  mice	  and	  mice	  sacrificed	  1-­‐hour	  following	  IRI	  remained	  similar,	  a	  
slight	  non-­‐significant	  trend	  to	  a	  reduction	   is	  observed	   in	  plasma	  from	  mice	  sacrificed	  
24-­‐hours	   following	   renal	   IRI.	   Data	   expressed	   as	   ±SEM	   and	   analysed	   by	   one-­‐way	  
ANOVA.	  All	  groups	  (n	  =	  4	  mice).	  	  
	  
3.6	  H2O2	  exposure	  induced	  morphological	  injury	  and	  apoptosis	  in	  HK-­‐2	  cells	  
We	   next	   explored	   the	   relevance	   of	   these	   findings	   to	   human	   renal	   ischaemic	   injury	  
using	  human	  proximal	   tubular	   epithelial	   (HK-­‐2)	   cells;	   a	   cell	   line	  derived	   from	  normal	  
adult	  human	  kidney	  (Ryan	  et	  al.,	  1994).	  We	  aimed	  to	  validate	  and	  further	  explore	  the	  
findings	   of	   van	   der	   Pol	   et	   al.,	   (2011)	  which	   suggested	   that	   IgM	   bound	   to	   HK-­‐2	   cells	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injured	   by	   hypoxia.	   To	   further	   probe	   IgM	  binding	   to	   injured	  HK-­‐2	   cells	  we	   aimed	   to	  
have	   three	   stages	   of	   injury:	   1)	   morphological	   injury	   with	   limited	   apoptosis;	   2)	  
morphological	   injury	  with	  evident	  apoptosis	   and	  3)	   severe	  morphological	   injury	  with	  
high	  apoptosis.	  To	  induce	  injury	  HK-­‐2	  cells	  were	  exposed	  to	  between	  0mM	  to	  500mM	  
H2O2	   for	   1-­‐hour.	   H2O2	   was	   selected	   as	   this	   ROS	   is	   released	   during	   ischaemia	   and	  
induces	  cellular	  injury	  by	  oxidative	  stress	  (Simonson	  et	  al.,	  1993,	  Aragno	  et	  al.,	  2003).	  
The	  use	  of	  H2O2	  to	  induce	  cellular	  injury	  with	  subsequent	  incubation	  in	  human	  serum,	  
to	  mimic	   ‘ischaemia’	  and	   ‘reperfusion’,	   respectively,	   is	  an	  accepted	   in	  vitro	  model	  of	  
renal	  IRI	  (Yoshida	  et	  al.,	  2008,	  Park	  et	  al.,	  2012).	  The	  resulting	  degree	  of	  morphological	  
injury	   and	   apoptosis	   were	   assessed	   by	   phase	   contrast	  microscopy	   and	   AnnV	   and	   PI	  
staining	  measured	  by	   flow	  cytometry,	   respectively.	  HK-­‐2	  cells	  were	  classified	  as	  non-­‐
apoptotic	   (AnnV-­‐PI-­‐),	   early	   (AnnV+PI-­‐)	   or	   late	   apoptotic	   (AnnV+PI+).	   Out	   of	   the	  
conditions	  assessed	  2.5	  mM,	  5	  mM	  and	  500	  mM	  were	  selected	  for	  future	  experiments.	  
As	  illustrated	  in	  figure	  3.7	  these	  conditions	  resulted	  in	  increasing	  morphological	  injury	  
and	  apoptosis.	  
	  
3.7	  IgM	  bound	  minimally	  to	  increasingly	  H2O2	  injured	  HK-­‐2	  cells	  
We	   then	  aimed	   to	  determine	  whether	  human	   IgM	  would	  bind	   to	   injured	  HK-­‐2	   cells.	  
HK-­‐2	   cells	  were	   treated	  with	   2.5	  mM,	   5	  mM	  or	   500	  mM	  H2O2	   for	   1-­‐hour	   to	   induce	  
injury	   and	   were	   incubated	   in	   PBS	   or	   human	   serum	   as	   a	   source	   of	   IgM	   for	   1-­‐hour.	  
Samples	   were	   then	   stained	   with	   anti-­‐IgM	   and	   IgM	   binding	   was	   assessed	   by	   flow	  
cytometry.	  However,	   IgM	  did	  not	   convincingly	   bind	   to	   any	   injured	  HK-­‐2	   cells	   (Figure	  
3.8).	  Levels	  of	  apoptosis	  and	   injury	  were	  similar	  to	  that	   illustrated	   in	  figure	  3.7.	  Note	  
that	   these	   experiments	   were	   repeated	   using	   both	   trypsin	   and	   non-­‐enzymatic	   cell	  
dissociation	   buffer	   to	   ensure	   that	   the	   negative	   result	   was	   not	   due	   to	   enzymatic	  
cleavage	  of	   cell	   surface	  antigens.	  Upon	  careful	  evaluation	  of	   the	   resulting	   injury	  and	  
apoptosis	  it	  became	  apparent	  that	  following	  exposure	  to	  H2O2	  the	  HK-­‐2	  cells	  appeared	  
to	   progress	   straight	   to	   late	   apoptosis.	   	   As	   evident	   in	   figure	   3.7	   populations	   of	   early	  
apoptotic	  HK-­‐2	  cells	  were	  not	  observed.	  We	  hypothesized	  that	  IgM	  may	  bind	  to	  neo-­‐
epitopes	  generated	  during	  apoptotic	  progression	  and	  HK-­‐2	  cells	  therefore	  might	  need	  
to	  progress	  through	  early	  apoptosis	  in	  order	  for	  IgM	  to	  bind.	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Figure	  3.7	  –	  H2O2	  exposure	  induced	  morphological	  injury	  and	  apoptosis	  in	  HK-­‐2	  cells.	  
HK-­‐2	   cells	   were	   exposed	   to	   2.5	   mM,	   5	   mM	   or	   500	   mM	   H2O2	   for	   1-­‐hour	   and	   the	  
resulting	   morphological	   injury	   and	   apoptosis	   was	   assessed	   by	   phase	   contrast	  
microscopy	  and	  AnnV	  and	  PI	  staining	  measured	  by	  flow	  cytometry,	  respectively.	  HK-­‐2	  
cells	   were	   classified	   as	   non-­‐apoptotic	   (AnnV-­‐PI-­‐),	   early	   (AnnV+PI-­‐)	   or	   late	   apoptotic	  
(AnnV+PI+).	  Representative	  phase	  contract	  photomicrographs	  indicate	  that	  2.5mM	  and	  
5mM	  H2O2	  exposure	  induced	  morphological	  injury,	  indicated	  by	  cellular	  disruption	  and	  
irregular	   morphology,	   with	   limited	   apoptosis,	   evident	   by	   a	   large	   proportion	   of	   cells	  
being	   AnnV-­‐PI-­‐.	   A	   higher	   degree	   of	   injury,	   associated	   with	   increased	   numbers	   of	  
AnnV+PI+	   cells	  and	  distinct	  disruption	  of	   cells,	  was	   induced	  by	   incubation	   in	  500	  mM	  
H2O2.	  Representative	  data.	  
	  
	  
Figure	  3.8	  –	   IgM	  bound	  minimally	  to	   increasingly	  H2O2	   injured	  HK-­‐2	  cells.	  HK-­‐2	  cells	  
were	  exposed	  to	  2.5	  mM,	  5	  mM	  or	  500	  mM	  H2O2	  for	  1-­‐hour.	  Following	  this	  cells	  were	  
incubated	  in	  PBS	  or	  human	  serum	  (as	  a	  source	  of	  IgM)	  for	  1-­‐hour.	  Samples	  were	  then	  
stained	  with	  anti-­‐IgM	  and	  IgM	  binding	  was	  assessed	  by	  flow	  cytometry.	  Minimal	   IgM	  
binding	  was	  observed	  in	  HK-­‐2	  cells	   injured	  with	  H2O2.	  Representative	  histograms	  and	  
contour	  plots	  (n	  =	  3).	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3.8	   Antimcyin	   A	   exposure	   induced	  morphological	   injury	   and	   early	   apoptosis	   in	   HK-­‐2	  
cells	  
To	  obtain	  populations	  of	  early	  apoptotic	  HK-­‐2	  cells,	  injury	  was	  induced	  by	  exposure	  to	  
Antimycin	   A.	   Antimycin	   A	   is	   a	   secondary	   metabolite	   which	   along	   with	   2-­‐Deoxy-­‐D-­‐
Glucose	  chemically	  depletes	  ATP	  inducing	  oxidative	  stress	  via	  the	  release	  of	  superoxide	  
free	  radicals	  and	  nutrient	  starvation.	  Similar	  to	  H2O2	  the	  use	  of	  Antimcyin	  A	  to	  induce	  
cellular	   injury,	  with	  subsequent	   incubation	  in	  human	  serum	  to	  mimic	  ‘ischaemia’	  and	  
‘reperfusion’,	  respectively,	  is	  an	  accepted	  in	  vitro	  model	  of	  renal	  IRI	  (Iwata	  et	  al.,	  1995,	  
Lee	  and	  Emala,	  2002,	  Breggia	  and	  Himmelfarb,	  2008).	  A	  titration	  of	  Antimycin	  A	  was	  
performed	   to	   establish	   the	   concentrations	   necessary	   to	   induce	   increasing	  
morphological	  injury	  and	  increasing	  apoptosis,	  with	  populations	  of	  early	  apoptotic	  HK-­‐
2	  cells.	  HK-­‐2	  cells	  were	  exposed	  to	  between	  10	  µM	  to	  20	  µM	  Antimycin	  A	  for	  1-­‐hour	  or	  
3-­‐hours.	   Cellular	   morphology	   and	   apoptosis	   was	   evaluated.	   Exposure	   to	   10	   µM	  
Antimycin	   A	   for	   1-­‐hour	   and	   to	   10	   µM	   or	   20	   µM	   Antimcyin	   A	   for	   3-­‐hours	   induced	  
increasing	   morphological	   injury	   and	   apoptosis	   as	   evident	   in	   figure	   3.9.	   These	  
conditions	  were	  selected	  for	  future	  experiments.	  
	  
3.9	  IgM	  bound	  minimally	  to	  increasingly	  Antimcyin	  A	  injured	  HK-­‐2	  cells	  
Following	   establishment	   of	   conditions	   necessary	   to	   induce	   ‘ischaemic’	   injury	   by	  
Antimycin	  A,	  we	  then	  investigated	  whether	  IgM	  would	  bind	  to	  injured	  HK-­‐2	  cells	  that	  
have	  progressed	  through	  apoptosis.	  HK-­‐2	  cells	  were	  treated	  with	  10	  µM	  Antimycin	  A	  
for	   1-­‐hour	   or	   10	   µM	   or	   20	   µM	   Antimycin	   A	   for	   3-­‐hours	   to	   induce	   injury	   and	   were	  
incubated	  in	  PBS	  or	  human	  serum	  as	  a	  source	  of	  IgM	  for	  24-­‐hours.	  Samples	  were	  then	  
stained	  with	  anti-­‐IgM	  and	  IgM	  binding	  was	  assessed	  by	  flow	  cytometry.	  Despite	  HK-­‐2	  
cells	   appearing	   to	   progress	   through	   early	   apoptosis	   IgM	   binding	   was	   not	   detected	  
(Figure	  3.10).	   Levels	   of	   apoptosis	   and	   injury	  were	   similar	   to	   that	   illustrated	   in	   figure	  
3.9.	  These	  experiments	  were	  also	  repeated	  using	  both	  trypsin	  and	  non-­‐enzymatic	  cell	  
dissociation	   buffer	   to	   ensure	   that	   the	   negative	   result	   was	   not	   due	   to	   enzymatic	  
cleavage	  of	  cell	  surface	  antigens.	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Figure	  3.9	  –	  Antimycin	  A	  exposure	  induced	  morphological	  injury	  and	  apoptosis	  in	  HK-­‐
2	   cells.	  HK-­‐2	  cells	  were	  exposed	  to	  10	  µM	  Antimycin	  A	  for	  1-­‐hour,	  or	   incubated	   in	  10	  
µM	   or	   20	   µM	   Antimcyin	   A	   for	   3-­‐hours.	   The	   resulting	   morphological	   injury	   and	  
apoptosis	   was	   assessed	   by	   phase	   contrast	   microscopy	   and	   AnnV	   and	   PI	   staining	  
measured	   by	   flow	   cytometry,	   respectively.	   Cells	   were	   classified	   as	   non-­‐apoptotic	  
(AnnV-­‐PI-­‐),	  early	   (AnnV+PI-­‐)	  or	   late	  apoptotic	   (AnnV+PI+).	  HK-­‐2	  cells	  were	   incubated	   in	  
10	  µM	  Antimycin	  A	  for	  3-­‐hours	  to	  induce	  a	  morphological	  injury,	  indicated	  by	  cellular	  
disruption	   and	   irregular	   morphology,	   with	   limited	   apoptosis,	   evident	   by	   a	   large	  
proportion	  of	  cells	  being	  AnnV-­‐PI-­‐.	  A	  higher	  degree	  of	  injury,	  associated	  with	  increased	  
numbers	   of	   AnnV+PI+	   cells	   and	   distinct	   disruption	   of	   cells,	   was	   induced	   by	   a	   3-­‐hour	  
incubation	   in	  20	  µM	  Antimycin	  A.	  Transient	  early	  apoptotic	  populations	  of	  HK-­‐2	  cells	  
were	  observed	  in	  all	  Antimycin	  A	  exposed	  samples.	  Representative	  data.	  
	  
	  
Figure	   3.10	   –	   IgM	   bound	  minimally	   to	   increasingly	   Antimcyin	   A	   injured	  HK-­‐2	   cells.	  
Antimcyin	  A	  was	  used	  to	  induce	  injury	  in	  HK-­‐2	  cells.	  Following	  this	  cells	  were	  incubated	  
in	  PBS	  or	  human	  serum	  (as	  a	  source	  of	  IgM)	  for	  24-­‐hours.	  	  Samples	  were	  then	  stained	  
with	  an	  anti-­‐IgM	  antibody	  and	  IgM	  binding	  was	  assessed	  by	  flow	  cytometry.	  Minimal	  
IgM	  binding	  was	  observed	  in	  HK-­‐2	  cells	  injured	  with	  either	  10	  µM	  or	  20	  µM	  Antimcyin	  
A.	  Representative	  histograms	  (n	  =	  3).	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3.10	  Specific	   IgM	  staining	  evident	   following	   IHC	  detection	   in	  paraffin	  embedded	   liver	  
tissue	  
With	   data	   indicating	   that	   IgM	   antibodies	   do	   not	   bind	   injured	   tissue	   following	   renal	  
ischaemic	   injury	   we	   next	   sought	   to	   determine	   whether	   IgM	   might	   be	   involved	   in	  
hepatic	   ischaemic	  injury.	  To	  investigate	  this	  we	  first	  wanted	  to	  confirm	  that	  we	  were	  
able	  to	  specifically	  detect	  IgM	  in	  injured	  liver	  tissue.	  Trials	  of	  unconjugated	  polyclonal	  
goat	   anti-­‐IgM	  antibody	  demonstrated	  positive	   staining	   in	  normal	  paraffin	  embedded	  
spleen	  tissue,	  with	  normal	  liver	  and	  immunoglobulin	  deficient	  RAG-­‐1	  spleen	  and	  liver	  
tissue	  remaining	  IgM	  negative	  (Figure	  3.11A).	   In	  addition	  no	  staining	  was	  detected	  in	  
spleen	   and	   ischaemic	   liver	   tissue	   following	   incubation	   with	   a	   biotinylated	   antibody	  
alone	  indicating	  secondary	  antibody	  specificity	  (Figure	  3.11B).	  Also,	  anti-­‐IgM	  antibody	  
specificity	  was	  confirmed	  by	  exposing	  spleen	  and	  ischaemic	  liver	  tissue	  to	  goat	  serum	  
(as	  an	   isotype	   control)	  with	   subsequent	  anti-­‐IgM	  staining	   remaining	  negative	   (Figure	  
3.11B).	  
	  
Similar	   positive	   B220	   and	   IgM	   staining	   patterns	   evident	   in	   what	   appeared	   to	   be	  
germinal	  centers	  in	  serial	  paraffin	  embedded	  spleen	  sections	  stained	  for	  IgM	  or	  the	  B	  
cell	  marker	  B220	  further	  confirmed	  anti-­‐IgM	  specificity	  (Figure	  3.12).	  
	  
3.11	  IgM	  deposition	  accumulated	  over	  a	  period	  of	  24-­‐hours	  following	  hepatic	   IRI	  and	  
visibly	  declined	  by	  7-­‐days	  
To	   assess	   IgM	   deposition	   following	   hepatic	   ischaemic	   injury	   male	   C57BL/6	   mice	  
underwent	  50-­‐minutes	  of	   ischaemia	   induced	  by	   clamping	  of	   the	   left	   liver	   lobe,	  mice	  
were	   sacrificed	   at	   various	   time	   points	   between	   0-­‐hour	   and	   7-­‐days.	   James	   Richards	  
performed	   the	  hepatic	   IRI	  model	  and	  provided	   tissue	  used	   to	  assess	   IgM	  deposition.	  
Assessment	   of	   paraffin	   embedded	   anti-­‐IgM	   stained	   ischaemic	   liver	   tissue	  
demonstrated	   dramatic	   IgM	   staining	   clearly	   evident	   at	   1-­‐hour	   and	   appeared	   to	  
accumulate	   until	   24-­‐hours	   post	   hepatic	   IRI,	   but	  was	   nearly	   absent	   at	   7-­‐days	   (Figure	  
3.13A).	  Surprisingly,	  some	  IgM	  staining	  was	  detected	  at	  0-­‐hours	  following	  hepatic	  IRI,	  
with	  	  IgM	  	  appearing	  	  to	  	  infiltrate	  into	  	  the	  tissue	  	  from	  central	  	  vessels,	  	  this	  	  was	  	  also	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Figure	   3.11	   –	   Specific	   IgM	   staining	   evident	   in	  paraffin	   embed	   liver	   tissue	   following	  
IHC	  based	  detection.	  A)	  Trials	  of	  unconjugated	  IHC	  anti-­‐IgM	  antibody	  yielded	  positive	  
staining	   in	   normal	   spleen	   tissue,	  whilst	   normal	   liver	   and	  RAG	   spleen	   and	   liver	   tissue	  
remained	  IgM	  negative.	  B)	  Minimal	  staining	  was	  detected	  in	  spleen	  and	  ischaemic	  liver	  
tissue	  following	  incubation	  with	  a	  biotinylated	  secondary	  antibody	  alone,	  or	  incubation	  
with	   goat	   serum	   (as	   an	   isotype	   control)	   and	   subsequent	   anti-­‐IgM	   staining.	  
Magnification	  of	  all	  images:	  x100.	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Figure	  3.12	  –	  IgM	  and	  B220	  exhibit	  similar	  staining	  patterns	  in	  serial	  spleen	  sections.	  	  
To	  confirm	  anti-­‐IgM	  specificity	  serial	  paraffin	  embedded	  spleen	  tissue	  was	  stained	  for	  
the	   B	   cell	   marker	   B220	   or	   IgM.	   B220	   staining	   was	   evident	   in	   what	   appeared	   to	   be	  
germinal	  centers	  with	  IgM	  exhibiting	  a	  similar	  staining	  pattern	  in	  serial	  spleen	  sections.	  
	  
observed	  at	  1-­‐hour	  and	  24-­‐hours	  post	   ischaemia	  (Figure	  3.13A	  black	  arrows).	  No	  IgM	  
deposition	  was	  observed	  in	  normal	  or	  ischaemic	  RAG-­‐1	  liver	  tissue.	  These	  results	  were	  
confirmed	  following	  quantification	  of	  IgM	  deposition	  (expressed	  as	  IgM+	  staining	  area)	  
which	   revealed	   that	   IgM	   accumulation	   reached	   a	   maximum	   at	   24-­‐hours	   with	   31.3	  
±5.5%	  IgM+	  staining	  (Figure	  3.13B).	  Due	  to	  a	  small	  sample	  size	  for	  some	  time	  points	  the	  
results	  were	  not	  statistically	  analysed	  (Non-­‐injured,	  ischaemic	  RAG-­‐1	  and	  0-­‐hour	  to	  24-­‐
hour	  (n	  =	  2),	  48-­‐hours	  and	  7-­‐days	  (n	  =	  6)).	  
	  
3.12	  IgM	  deposition	  following	  hepatic	  IRI	  mapped	  to	  areas	  of	  liver	  injury	  
Inspection	   of	   serial	   H&E	   and	   anti-­‐IgM	   stained	   paraffin	   embedded	   liver	   sections	  
harvested	   at	   various	   time	   points	   between	   0-­‐hour	   and	   7-­‐days	   following	   hepatic	   IRI	  
revealed	  that	  IgM	  appeared	  to	  bind	  to	  areas	  of	  injured	  liver	  tissue.	  As	  indicated	  by	  grey	  
arrows	  in	  figure	  3.14	  IgM	  deposition	  occurred	  where	  injury	  was	  observed	  and	  this	  was	  








Figure	   3.13	   –	   IgM	   deposition	   accumulated	   over	   a	   period	   of	   24-­‐hours	   following	  
hepatic	   IRI	   and	   was	   visibly	   declined	   by	   7-­‐days.	   To	   assess	   IgM	   deposition	   following	  
hepatic	   ischaemic	   injury,	  male	   C57BL/6	   or	   RAG	  mice	   underwent	   50-­‐minutes	   of	   liver	  
ischaemia	  and	  were	   sacrificed	  at	   various	   time	  points	  between	  0-­‐hour	  and	  7-­‐days.	  A)	  
Representative	  photomicrographs	  of	  anti-­‐IgM	  stained	  paraffin	  embedded	  liver	  sections	  
revealed	  that	  IgM	  deposition	  was	  absent	  in	  normal	  and	  ischaemic	  RAG	  liver	  tissue.	  IgM	  
deposition	  was	  evident	  at	  1-­‐hour	  and	  accumulated	  until	  24-­‐hours	  following	  hepatic	  IRI,	  
and	  was	  nearly	   absent	   at	   7-­‐days.	   IgM	  deposition	  appeared	   to	  originate	   from	  central	  
veins	   (indicated	   by	   black	   arrows).	  B)	   Quantification	   of	   IgM	   deposition	   (expressed	   as	  
IgM+	   area)	   confirmed	   that	   IgM	   was	   present	   at	   0-­‐hour	   following	   hepatic	   IRI,	   and	  
accumulated	  to	  a	  maximum	  at	  24-­‐hours.	  By	  7-­‐days	  IgM	  deposition	  had	  declined.	  Data	  
expressed	   as	   ±SEM.	   Non-­‐injured,	   ischaemic	   RAG	   and	   0-­‐hour	   to	   24-­‐hour	   (n	   =	   2),	   48-­‐
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Figure	  3.14	  –	  IgM	  deposition	  following	  hepatic	  IRI	  mapped	  to	  areas	  of	  liver	  injury.	  To	  
assess	   IgM	   deposition	   following	   hepatic	   ischaemic	   injury,	   male	   C57BL/6	   mice	  
underwent	   50-­‐minutes	   of	   ischaemia	   and	   were	   sacrificed	   at	   various	   time	   points	  
between	  0-­‐hour	  and	  7-­‐days.	  Representative	  photomicrographs	  of	  serial	  H&E	  and	  anti-­‐
IgM	  antibody	  stained	  paraffin	  embedded	   liver	  sections	  demonstrated	   IgM	  deposition	  
in	  areas	  of	  liver	  injury	  (indicated	  by	  grey	  arrows	  in	  1-­‐hour	  post	  IRI).	  Magnification:	  x25.	  
Representative	  of	  all	  time	  points	  at	  which	  IgM	  deposition	  was	  detected.	  
	  
3.13	   IgM	   deposition	   mapped	   to	   areas	   of	   liver	   necrosis	   observed	   following	   ConA	  
induced	  liver	  injury	  
We	  then	  explored	  whether	  IgM	  deposition	  occurred	  in	  a	  murine	  model	  of	  AIH.	  AIH	  is	  a	  
chronic	   inflammatory	  condition	  characterised	  by	  progressive	  tissue	  necrosis,	  and	   loss	  
of	  self	  tolerance	  with	  the	  development	  of	  autoantibodies	  (Mieli-­‐Vergani	  and	  Vergani,	  
2011).	  AIH	  was	  induced	  in	  male	  C57BL/6	  mice	  by	  an	  intravenous	  injection	  of	  10	  mg/kg	  
ConA	   and	   24-­‐hours	   later	  mice	   were	   sacrificed.	   James	   Richards	   performed	   the	   ConA	  
model	   and	   provided	   tissue	   used	   to	   assess	   IgM	   deposition.	   Assessment	   of	   paraffin	  
embedded	   anti-­‐IgM	   stained	   ConA	   treated	   liver	   tissue	   demonstrated	   distinct	   IgM	  
staining,	   which	   as	   observed	   in	   hepatic	   IRI,	   also	   appeared	   to	  map	   to	   areas	   of	   tissue	  
necrosis	   evident	   in	  H&E	   stained	   serial	   liver	   sections	   (Figure	  3.15A).	  Quantification	  of	  
IgM	  staining	  (expressed	  as	  IgM+	  staining	  area)	  revealed	  that	  liver	  tissue	  harvested	  from	  
ConA	  treated	  C57BL/6	  mice	  was	  13.5±1.8%	  IgM+,	  whilst	   IgM	  deposition	  in	  RAG-­‐1	  and	  
non-­‐injured	   liver	   tissue	   remained	  minimal	   (Figure	  3.15B).	  Due	   to	  a	   small	   sample	   size	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for	  some	  time	  points	  the	  results	  were	  not	  statistically	  analysed	  (Non-­‐injured,	  RAG	  (n	  =	  
2),	  ConA	  (n	  =	  6)).	  
	  
	  
Figure	   3.15	   –	   IgM	   deposition	   that	   mapped	   to	   areas	   of	   liver	   necrosis	   observed	  
following	   ConA	   induced	   liver	   injury.	   IgM	   deposition	  was	   assessed	   in	  male	   C57BL/6	  
mice	  following	  ConA	  induced	  liver	  injury.	  A)	  Representative	  photomicrographs	  of	  serial	  
paraffin	   embedded	   liver	   sections	   stained	   with	   either	   H&E	   or	   anti-­‐IgM	   antibody	  
revealed	   that	   IgM	   deposition	   occurred	   in	   areas	   of	   liver	   necrosis	   (indicated	   by	   grey	  
arrows).	  B)	  Quantification	  of	   IgM	  deposition	  (expressed	  as	   IgM+	  area)	  confirmed	  that	  
IgM	  was	  present	  in	  ConA	  injured	  livers.	  Data	  expressed	  as	  ±SEM.	  Non-­‐injured,	  RAG	  (n	  =	  
2),	  ConA	  (n	  =	  6).	  Magnification:	  x25.	  	  
	  
3.14	  IgM	  positivity	  in	  ConA	  injured	  liver	  tissue	  is	  not	  due	  to	  B	  cell	  infiltration	  
To	  ensure	  that	  IgM	  positivity	   in	  ConA	  injured	  liver	  tissue	  was	  not	  due	  to	  detection	  of	  
membrane	  bound	   IgM	  on	   infiltrating	  B	  cells,	  as	  occurs	   in	  AIH	  patients,	  serial	  paraffin	  
embedded	   ConA	   injured	   liver	   tissue	  was	   stained	   for	   IgM	   or	   the	   B	   cell	  marker	   B220	  
(Vergani	  and	  Mieli-­‐Vergani,	  2003).	  IgM	  and	  B220	  illustrated	  disparate	  staining	  patterns	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(Figure	   3.16A)	   with	   quantification	   of	   B220	   staining	   (expressed	   as	   B220+	   area)	  
confirming	  that	  B	  cell	  infiltration	  was	  not	  present	  in	  ConA	  injured	  livers	  (Figure	  3.16B).	  
Due	   to	   a	   small	   sample	   size	   for	   some	   time	   points	   the	   results	   were	   not	   statistically	  
analysed	  (Non-­‐injured,	  RAG	  (n	  =	  2),	  ConA	  (n	  =	  6)).	  
	  
	  
Figure	  3.16	  –	  IgM	  positivity	  in	  ConA	  injured	  liver	  tissue	  is	  not	  due	  to	  B	  cell	  infiltration.	  	  
To	  assess	  whether	   IgM	  positivity	   in	  ConA	   injured	   liver	  tissue	  was	  due	  to	  detection	  of	  
membrane	  bound	  IgM	  on	  infiltrating	  B	  cells	  serial	  ConA	  injured	  liver	  tissue	  was	  stained	  
for	   IgM	   or	   the	   B	   cell	   marker	   B220.	   A)	   Representative	   photomicrographs	   of	   serial	  
paraffin	   embedded	   liver	   sections	   stained	  with	   either	   anti-­‐B220	   or	   anti-­‐IgM	   antibody	  
reveal	   that	   IgM	  and	  B220	   illustrated	  disparate	   staining	  patterns.	  B)	  Quantification	  of	  
B220	   staining	   (expressed	   as	   B220+	   area)	   confirmed	   that	   B	   cells	   infiltration	   was	   not	  
present	   in	   ConA	   injured	   livers.	   Spleen	   tissue	   was	   used	   as	   a	   positive	   control.	   Data	  




In	  this	  chapter	  we	  carefully	  characterised	  the	  kinetics	  of	  IgM	  deposition	  following	  renal	  
and	   hepatic	   ischaemic	   injury.	   We	   discovered	   striking	   differences.	   Whilst	   IgM	  
deposition	  was	  minimal	   following	  renal	   ischaemia,	   IgM	  rapidly	  accumulated	  over	   the	  
course	  of	  24-­‐hours	  post	  hepatic	   ischaemia	  with	  deposition	  evident	   in	  areas	  of	   tissue	  
injury.	  In	  additional,	  similar	  results	  were	  observed	  in	  a	  murine	  model	  of	  AIH	  with	  IgM	  
antibodies	  appearing	  to	  strongly	  bind	  areas	  of	  tissue	  necrosis.	  
	  
Despite	  published	  work	  in	  other	  organs	  and	  dramatic	  deposition	  following	  hepatic	  IRI,	  
minimal	   IgM	   deposition	   was	   observed	   following	   renal	   IRI	   despite	   the	   presence	   of	  
significant	  ATN.	  	  Furthermore,	  IgM	  antibodies	  did	  not	  bind	  injured	  human	  renal	  tubular	  
epithelial	   cells	   in	   vitro.	   The	   mechanisms	   underlying	   the	   differential	   nature	   of	   IgM	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binding	  to	   injured	   liver	  and	  kidney	   in	  vivo	  are	  unclear.	   IgM	  antibodies	  are	  unlikely	  to	  
play	  a	  crucial	  direct	  role	  in	  renal	  ischaemia;	  however,	  it	  is	  clear	  from	  this	  data	  that	  IgM	  
might	   play	   an	   important	   role	   in	   the	   pathogenesis	   of	   hepatic	   injury.	   In	   addition,	   our	  
hypothesis	   that	   apoptotic	   cell-­‐derived	   protection	   from	   renal	   IRI	   is	   due	   to	   reduced	  
levels	  of	  intravascular	  self-­‐reactive	  IgM	  is	  unlikely	  (Section	  1.9).	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Chapter	  4.	  Apoptotic	  cell	  administration	  to	  mice	   is	  either	  neutral	  or	  detrimental	   to	  




Renal	  IRI	  is	  an	  acute	  inflammatory	  process	  and	  a	  common	  cause	  of	  AKI	  in	  patients.	  The	  
administration	   of	   apoptotic	   cells	   has	   been	   shown	   to	   reduce	   inflammation	   in	   various	  
models	  including	  experimental	  arthritis,	  bleomycin	  lung	  injury,	  acute	  hepatitis	  and	  LPS-­‐
mediated	  shock	   (reviewed	   in	  Table	  1.2).	   Ischaemic	   injury	  also	   results	   in	  activation	  of	  
the	  coagulation	  cascade	  leading	  to	  microvascular	  congestion	  (Jennewein	  et	  al.,	  2011)	  –	  
a	   process	   that	   apoptotic	   cells	  may	   be	   able	   to	  modulate	   as	   PtdSer	   exposures	   allows	  
interaction	  with	  the	  coagulation	  cascade	  (Casciola-­‐Rosen	  et	  al.,	  1996).	  	  In	  view	  of	  these	  
previous	  studies	  apoptotic	  cell	  administration	  may	  represent	  a	  novel	  pretreatment	  for	  
AKI	   secondary	   to	   renal	   IRI	   and	  act	   to	   limit	   the	   resultant	   inflammation	  and	  modulate	  
microvascular	  congestion.	  
	  
Previous	   work	   in	   our	   lab	   suggested	   that	   intravenous	   administration	   of	   20x106	  
apoptotic	  cells	  to	  FVB/n	  or	  Balb/c	  mice	  24-­‐hours	  prior	  to	  inducing	  renal	  IRI	  ameliorated	  
renal	   function	   without	   affecting	   the	   ATN	   score	   24-­‐hours	   following	   IRI.	   In	   the	   work	  
described	  in	  this	  chapter	  we	  sought	  to	  validate	  these	  preliminary	  findings	  and	  explore	  
if	  modulation	  of	  coagulation	  status	  leading	  to	  improved	  intrarenal	  microvascular	  flow	  
might	   represent	   the	   underlying	  mechanism	   eliciting	   functional	   protection.	  We	  were	  
also	   interested	   in	  further	  exploring	  how	  apoptotic	  cells	  may	  be	  able	  to	   influence	  and	  
alter	  coagulation	  status.	  
	  
Please	  note	   that	   in	   this	  chapter	   the	  term	  apoptotic	  cells	   refers	  specifically	   to	  murine	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Results	  
	  
4.1	  Establishment	  and	  optimisation	  of	  an	  assay	  to	  detect	  platelet	  binding	  to	  apoptotic	  
cells	  
Platelets	  can	  greatly	  influence	  thrombogenicity	  as	  stimulated	  platelets	  are	  major	  sites	  
of	  thrombin	  generation,	  and	  are	  actively	  recruited	  to	  developing	  thrombus	  (Monroe	  et	  
al.,	   2002).	   As	   PtdSer	   exposure	   on	   apoptotic	   cells	   confers	   pro-­‐coagulant	   tendencies	  
(Pickering	  et	  al.,	   2008),	  we	  hypothesized	   that	  apoptotic	   cells	  may	  be	  able	   to	  directly	  
bind	  platelets.	  	  To	  confirm	  this	  we	  established	  and	  optimized	  an	  in	  vitro	  assay	  designed	  
to	   detect	   platelet-­‐apoptotic	   cell	   binding.	   Firstly	   methods	   of	   blood	   collection	   were	  
assessed	  to	  determine	  which	  would	  yield	  the	  best	  source	  of	  platelets.	  Total	  blood	  was	  
collected	   from	  male	   8-­‐week	   old	   Balb/c	   mice	   into	   0.38%	   sodium	   citrate	   (a	   common	  
anticoagulant	  used	  in	  platelet	  studies)	  and	  either	  used	  immediately	  as	  whole	  blood	  or	  
used	  to	  generate	  platelet	  rich	  plasma.	  Samples	  were	  analysed	  by	  flow	  cytometry	  FSC	  
SSC	  dot	  plots.	  FSC	  SSC	  dot	  plots	  of	  peripheral	  blood	  allow	  easy	  identification	  of	  blood	  
cell	  types	  as	  each	  lie	  in	  very	  distinct	  disparate	  regions.	  Platelet	  rich	  plasma	  resulted	  in	  
a	  poor	  peripheral	  blood	  FSC	  SSC	  dot	  plot,	  with	   limited	  events	  occurring	   in	  the	  region	  
defined	   as	   platelets,	   however	   analysis	   of	   1	   µL	   whole	   blood	   produced	   an	   improved	  
number	  of	  events	  (Figure	  4.1A).	  The	  volume	  of	  whole	  blood	  used	  was	   increased	  to	  5	  
µL,	   which	   yielded	   a	   very	   typical	   FSC	   SSC	   dot	   plot	   with	   many	   events	   designated	   as	  
platelets	   (Figure	   4.1A).	   Staining	   for	   the	   platelet	   surface	   integrin	   marker	   CD41	  
confirmed	   that	   this	   population	   was	   indeed	   platelets,	   as	   approximately	   96%	   events	  
were	  CD41+	  (Figure	  4.1B).	  An	  anti-­‐CD41	  titration	  was	  performed	  and	  a	  dilution	  of	  1:200	  
was	  selected,	  on	  the	  basis	  of	  median	  fluorescent	   intensity	  (MFI)	  of	  CD41+	  events,	   for	  
future	  experiments	  (Figure	  4.1C).	  Apoptotic	  cells	  were	  stained	  with	  the	  cell	  tracker	  CM	  
orange	   to	   enable	   identification	   during	   the	   assay	   and	   a	   concentration	   titration	   was	  
performed	  (Figure	  4.1D).	  Following	  this	  1	  µL/mL	  CM	  orange	  was	  selected,	  on	  the	  basis	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Figure	  4.1	  –	  Establishing	  and	  optimising	  an	  assay	  to	  detect	  murine	  platelet	  binding	  to	  
apoptotic	  cells.	  A)	  Citrated	  platelet	  rich	  plasma	  and	  1µL	  of	  whole	  blood	  as	  a	  source	  of	  
platelets	   resulted	   in	   a	   suboptimal	   peripheral	   blood	   FSC	   SSC	   dot	   plot	   as	   assessed	   by	  
flow	   cytometry.	   A	   typical	   peripheral	   blood	   FSC	   SSC	   dot	   plot	  with	   a	   region	   generally	  
identified	  as	  platelets	  was	  evident	  in	  5µL	  of	  whole	  blood.	  B)	  To	  confirm	  that	  the	  cells	  
within	   the	   region	   designated	   platelets	   on	   FSC	   SSC	   dot	   plots	   were	   indeed	   platelets	  
whole	   blood	   was	   stained	   with	   the	   platelet	   surface	   integrin	   marker	   CD41.	  
Approximately	  96%	  of	  events	   in	   this	   region	  were	  CD41+.	  An	   isotype	  control	  antibody	  
confirmed	  anti-­‐CD41	  specificity.	  C)	  An	  anti-­‐CD41	  titration	  was	  performed	  to	  determine	  
the	   correct	   antibody	   dilution	   for	   IgM	   detection.	   	   Median	   fluorescent	   intensity	   was	  
determined	  on	  cells	  gated	  for	  CD41	  positivity.	  D)	  A	  dilution	  series	  was	  performed	  for	  
cell	  tracker	  CM	  orange	  to	  determine	  the	  correct	  dilution	  necessary	  to	  stain	  apoptotic	  
cells.	   Median	   fluorescent	   intensity	   was	   determined	   on	   cells	   gated	   for	   CM	   orange	  
positivity.	  Representative	  of	  several	  experiments.	  
	  
4.2	  Apoptotic	  cells	  bind	  to	  CD41+	  platelets	  
With	   an	   assay	   optimised	   and	   established	   the	   ability	   of	   apoptotic	   cells	   to	   bind	   to	  
platelets	  in	  murine	  whole	  blood	  was	  determined.	  Platelets	  in	  5	  µL	  of	  whole	  blood	  were	  
stained	  with	   anti-­‐CD41	   antibody	   prior	   to	   30-­‐minute	   incubation	  with	   5x105	   apoptotic	  
cells	   labeled	  with	   the	   fluorescent	  cell	   tracker	  CM	  orange.	  Analysis	  was	  performed	  by	  
flow	   cytometry	   (Figure	   4.2A).	   CM	   orange+	   apoptotic	   cells	   (Figure	   4.2B)	   and	   CD41+	  
platelets	   (Figure	   4.2C)	   were	   identified	   and	   staining	   confirmed.	   Analysis	   of	   apoptotic	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cells	  and	  platelet	  interaction	  confirmed	  apoptotic	  cell-­‐platelet	  binding	  as	  indicated	  by	  
the	  presence	  of	  CM	  Orange+	  apoptotic	  cells	  that	  were	  also	  CD41+	  (Figure	  4.2D).	  
	  
	  
Figure	   4.2	   –	   Apoptotic	   cells	   bind	   to	   CD41+	   platelets.	   	   A)	   Overview	   of	   AC-­‐platelet	  
interaction	   assay.	   	   Platelets	   in	   whole	   blood	   were	   stained	   for	   the	   platelet	   surface	  
integrin	   marker	   CD41	   prior	   to	   incubation	   with	   apoptotic	   cells	   (ACs)	   labeled	   with	  
fluorescent	   cell	   tracker	   CM	   orange.	   	   Analysis	   was	   performed	   by	   flow	   cytometry.	   B)	  
Confirmation	   CM	  Orange	   staining	   of	   ACs.	  C)	   Confirmation	   of	   the	   presence	   of	   CD41+	  
platelets.	  D)	  AC-­‐platelet	  binding	   is	   indicated	  by	  the	  presence	  of	  CM	  Orange+	  ACs	  that	  
were	   also	   CD41+.	   The	   two	   populations	   evident	   represent	   differences	   in	   platelet-­‐ACs	  
cell	  size,	  which	  was	  assessed	  on	  FSC	  SSC	  dot	  plots.	  Representative	  of	  two	  experiments.	  
	  
4.3	  Establishment	  of	  a	  technique	  to	  count	  platelets	  in	  murine	  blood	  
Following	  the	  confirmation	  that	  apoptotic	  cells	  bind	  platelets	  we	  sought	  to	  establish	  a	  
technique	  that	  would	  enable	  us	  to	  quickly	  perform	  platelet	  counts	  in	  small	  volumes	  of	  
murine	  blood	  by	   flow	  cytometry.	   If	  apoptotic	   cell	  derived	   functional	  protection	   from	  
renal	   IRI	  was	   recapitulated	  we	   planned	   to	   use	   this	   technique	   to	   determine	  whether	  
platelets	   counts	   were	   indeed	   reduced	   in	   apoptotic	   cell	   treated	   mice	   as	   per	   our	  
hypothesis	   (Chapter	   1:	   Introduction	   Section	   1.9).	   We	   predicted	   that	   apoptotic	   cells	  
administered	   prior	   to	   renal	   IRI	   might	   bind	   platelets	   and	   transiently	   reduce	   counts,	  
therefore	   limiting	   platelet	   deposition	   post	   ischaemia	   such	   that	   microvascular	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congestion	  might	  be	   attenuated.	   To	  determine	  platelet	   counts	  CountBright	  Absolute	  
Counting	   Beads	   (Molecular	   Probes,	   Invitrogen),	   which	   are	   broadly	   fluorescent	   and	  
detectable	   by	   several	   flow	   cytometry	   channels,	   were	   added	   to	   5	   µL	   whole	   blood	  
(stained	  with	  anti-­‐CD41)	  or	  PBS	  (negative	  control).	  Platelets	  were	  identified	  by	  FSC	  SSC	  
dot	  plots	  as	  detailed	   in	  figure	  4.1A	  and	  CD41	  positivity	  confirmed	  these	  events	  to	  be	  
platelets	  (Figure	  4.3A).	  Beads	  were	  identified	  by	  FL3	  positivity	  (Figure	  4.3B).	  According	  
to	   the	   reference	   bead	   events	   and	   manufacturer’s	   instructions	   platelet	   counts	   were	  
determined	  in	  murine	  blood.	  Due	  to	  the	  inherent	  variation	  in	  platelet	  counts	  between	  
mice,	   replicate	   values	   of	   the	   same	   mouse	   were	   counted	   which	   illustrate	   minimal	  
variation	  (Figure	  4.3C).	  
	  
	  
Figure	  4.3	  –	  Establishing	  a	  technique	  to	  count	  platelets	   in	  murine	  blood	  in	  order	  to	  
assess	   whether	   counts	   were	   reduced	   following	   apoptotic	   cell	   administration.	   A)	  
Counting	  beads	  were	  added	  to	  PBS	  and	  whole	  blood	  samples.	  Platelets	  were	  identified	  
by	   FSC	   SSC	   dot	   plots	   as	   shown	   in	   figure	   4.1A	   and	   assessment	   of	   CD41	   positivity	  
confirmed	  these	  events	  were	  platelets.	  PBS	  and	  beads	  was	  used	  as	  a	  negative	  control.	  
B)	   Beads	   were	   identified	   by	   FL3	   positivity.	   C)	   Replicate	   platelet	   counts	   (µL-­‐1)	   in	   a	  
sample	  of	  murine	  whole	  blood	  and	  PBS.	  
	  
4.4	  Apoptotic	  cell	  administration	  to	  mice	  modulates	  thrombin	  generation	  
The	   inherent	   coagulability	   of	   plasma	   from	   mice	   treated	   with	   apoptotic	   cells	   was	  
examined	   to	   investigate	   whether	   coagulation	   was	  modified	   such	   that	  microvascular	  
congestion	   may	   be	   reduced	   following	   ischaemia.	   Thrombin	   is	   a	   key	   procoagulant	  
enzyme	   that,	   in	   addition	   to	   activating	   platelets,	   catalyzes	   the	   formation	   of	   fibrin	  
(Monroe	   et	   al.,	   2002).	   To	   investigate	   this	   a	   thrombin	   generation	   assay	   (TGA)	   was	  
performed	   on	   citrated	   platelet-­‐poor-­‐plasma	   obtained	   24-­‐hours	   after	   Balb/c	   mice	  
received	  	  PBS	  	  (n	  	  =	  	  6)	  	  or	  	  20x106	  	  early	  	  apoptotic	  	  cells	  	  (n	  	  =	  	  6)	  	  (approximately	  	  51%	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Figure	   4.4	   –	   Apoptotic	   cell	   (AC)	   administration	   to	   mice	   modulates	   thrombin	  
generation.	  A	   thrombin	   generation	   assay	   (TGA)	  was	   performed	   on	   citrated	   platelet-­‐
poor-­‐plasma	   obtained	   24-­‐hours	   after	   Balb/c	  mice	   received	   20x106	   early	   ACs	   or	   PBS.	  
Cell	   viability	   was	   assessed	   by	   AnnV	   and	   PI	   staining	   and	   flow	   cytometry.	   A)	   Early	  
apoptotic	  cells	  were	  approximately	  51%	  Annexin-­‐V+	  PI-­‐.	  B)	  TGA	  readouts:	  A	  =	  Lag	  time;	  
B	  =	  Peak	  Time;	  C	  =	  Peak;	  D	  =	  Tail;	  E	  =	  endogenous	  thrombin	  potential.	  C)	  Endogenous	  
thrombin	  potential	   remained	  similar	   in	  both	  PBS	  and	  AC	  treated	  mice.	  D)	  AC	  treated	  
mice	  exhibit	  significantly	  delayed	  thrombin	  generation.	  Data	  expressed	  as	  mean	  ±SEM	  
and	  analysed	  by	  student’s	  t-­‐test.	  *	  =	  P	  ≤	  0.05.	  P	  PBS	  (n	  =	  6),	  apoptotic	  cell	  (n	  =	  6).	  
	  
AnnV+PI+;	  Figure	  4.4A).	  The	  TGA	  was	  performed	  by	  Dr	  Roger	  Preston	  (Department	  of	  
Clinical	  Medicine,	  Trinity	  College	  Dublin).	   	   In	  a	  TGA	  a	  fluorogenic	  substrate	   is	  used	  to	  
measure	  thrombin	  generation;	  this	  is	  performed	  in	  parallel	  to	  a	  sample	  with	  a	  known	  
thrombin	  activity.	   	  The	   results	  of	   this	  assay	  are	  presented	  as	  a	   thrombogram	  (Figure	  
4.4B).	   In	   this	   figure	   A	   illustrates	   the	   lag	   time,	   also	   known	   as	   clotting	   time,	   which	  
represents	   the	  time	  until	   thrombin	   is	   first	  generated,	   the	  peak	  time	   indicated	  by	  the	  
letter	  B	  is	  the	  time	  taken	  until	  maximum	  thrombin	  generated.	  C	  represents	  the	  peak,	  
which	  is	  the	  maximum	  amount	  of	  thrombin	  generated	  during	  the	  assay,	  which	  tails	  off	  
as	   shown	   by	   D.	   The	   area	   under	   the	   curve,	   labeled	   E,	   represents	   the	   endogenous	  
thrombin	  potential	   that	   is	   the	  total	  amount	  of	   thrombin	  generated	  during	  the	  assay.	  
The	  TGA	   revealed	   that	  although	  early	  apoptotic	   cell-­‐treated	  mice	  produced	  a	   similar	  
amount	   of	   thrombin	   as	   control	   mice	   (Figure	   4.4C)	   its	   generation	   was	   delayed,	   as	  
indicated	  by	  a	  significantly	  elevated	  lag	  time	  (Student’s	  t-­‐test;	  P	  <	  0.05)	  (Figure	  4.4D).	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4.5	  Overview	  of	  in	  vivo	  renal	  IRI	  experiments	  
The	   remaining	   results	   presented	   in	   this	   chapter	   were	   obtained	   from	   in	   vivo	  
experiments	  that	  centered	  on	  the	  renal	  IRI	  murine	  model	  summarized	  in	  figure	  4.5.	  
	  
	  
Figure	  4.5	  –	  Overview	  of	  in	  vivo	  experiments.	  	  A)	  Investigation	  of	  baseline	  injury	  and	  
microvascular	  congestion	  1-­‐hour	  and	  24-­‐hours	  post	  renal	  IRI.	  	  Male	  Balb/c	  mice	  aged	  
8	  weeks	  underwent	  a	  right	  nephrectomy	  and	  the	  left	  renal	  pedicle	  was	  clamped	  for	  25-­‐
minutes.	  	  Following	  renal	  IRI	  mice	  were	  sacrificed	  at	  either	  1-­‐hour	  (n	  =	  4)	  or	  24-­‐hours	  
(n	  =	   4).	   	   Renal	   function	   and	   structure	  was	   assessed	   by	   plasma	   creatinine	   and	   acute	  
tubular	   necrosis	   (ATN),	   respectively.	   Microvascular	   congestion	   inferred	   from	   CD41	  
(platelet)	  and	  fibrin	  deposition	  was	  assessed	  via	  IHC.	  IgM	  deposition	  was	  also	  assessed	  
but	   is	   presented	   in	   chapter	   4.	   B)	   Renal	   injury	   titration.	   To	   assess	   the	   length	   of	  
ischaemia	  required	  to	  induce	  varying	  degrees	  of	  renal	  injury,	  male	  Balb/c	  mice	  aged	  8	  
weeks	  underwent	  a	  right	  nephrectomy	  and	  the	  left	  renal	  pedicle	  was	  clamped	  for	  20,	  
22	  or	  24-­‐minutes	  (n	  =	  4	  per	  group).	  	  Following	  renal	  IRI	  mice	  were	  sacrificed	  24-­‐hours	  
later	   and	   renal	   function,	   structure	   and	   microvascular	   congestion	   was	   assessed.	   C)	  
Investigation	   into	   the	   influence	  of	  apoptotic	   cells	  on	   renal	   injury.	  Male	  Balb/c	  mice	  
received	   an	   intravenous	   injection	   of	   either	   PBS	   (n	   =	   7-­‐8)	   or	   20x106	   early	   or	   late	  
apoptotic	   thymocytes	   (n	  =	  8),	   or	   20x106	   viable	   thymocytes	   (n	   =	   5)	   24-­‐hours	   prior	   to	  
renal	  IRI.	  	  Shams	  underwent	  a	  laparotomy	  (n	  =	  4).	  	  Mice	  were	  sacrificed	  24-­‐hours	  post	  
IRI	   and	   renal	   function,	   structure	   and	   microvascular	   congestion	   was	   assessed,	   along	  
with	  neutrophil	  infiltration	  inferred	  by	  Gr1	  IHC.	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4.6	  Twenty-­‐five	  minutes	  of	  ischaemia	  resulted	  in	  significant	  renal	  dysfunction	  with	  ATN	  
and	  fibrin	  and	  platelet	  deposition	  observed	  1-­‐hour	  following	  ischaemic	  injury	  
In	  preparation	  for	  experiments	  investigating	  the	  protective	  potential	  of	  apoptotic	  cells	  
in	   renal	   IRI	   we	   aimed	   to	   characterise	   and	   obtain	   baseline	   values	   of	   injury	   and	  
microvascular	  congestion	  24-­‐hours	   following	   ischaemic	   injury.	  We	  also	  examined	  the	  
time	   point	   of	   1-­‐hour	   post	   renal	   IRI	   with	   the	   view	   that	   future	   experiments	   may	   be	  
performed	   to	   try	   and	   further	   explore	   how	   apoptotic	   cells	   influence	   injury	   and	  
microvascular	  congestion	  at	  early	  time	  points.	  Male	  8-­‐week	  Balb/c	  mice	  underwent	  a	  
right	  nephrectomy	  and	  25-­‐minutes	  of	  ischaemia	  and	  were	  sacrificed	  at	  1-­‐hour	  (n	  =	  4)	  
or	  24-­‐hours	  (n	  =	  4)	  following	  surgery	  (Figure	  4.5A).	   	  An	  ischaemic	  time	  of	  25-­‐minutes	  
was	   selected	   as	   this	   was	   known	   to	   induce	   significant	   injury	   and	   was	   the	   standard	  
duration	  used	  in	  the	  lab.	  	  
	  
Mice	  sacrificed	  at	  1-­‐hour	  (n	  =	  4)	  had	  a	  normal	  plasma	  creatinine,	  those	  sacrificed	  at	  24-­‐
hours	  (n	  =	  4)	  had	  a	  significantly	  elevated	  plasma	  creatinine	  indicating	  renal	  dysfunction	  
(Student’s	   t-­‐test,	  P	  <0.05)	   (Figure	  4.6A).	   	  Widespread	   loss	  of	  healthy	   cells	  within	   the	  
OSOM	  occurred	  at	  both	  time	  points	  resulting	   in	  significant	  ATN	  for	  mice	  sacrificed	  at	  
both	   1	   and	   24-­‐hours	   (one-­‐way	   ANOVA,	  P	  <0.01	   and	  P	  <0.001,	   respectively)	   	   (Figure	  
4.6B).	  	  
	  
As	   fibrin	   and	   platelets	   accumulate	   in	   the	   microvasculature	   following	   renal	   IRI	   their	  
deposition	   was	   measured	   by	   IF	   and	   IHC,	   respectively,	   to	   evaluate	   whether	   these	  
readouts	  could	  be	  used	  to	  infer	  microvascular	  congestion.	  Whilst	  non-­‐injured	  kidneys	  
remained	  negative,	  fibrin	  staining	  was	  observed	  in	  the	  microvasculature	  of	   ischaemic	  
kidneys	  (Figure	  4.7).	  Quantification	  of	  fibrin	  positive	  staining	  illustrated	  that	  significant	  
fibrin	  deposition	  occurred	  1-­‐hour	  following	  renal	   IRI	  and	  was	  significantly	  reduced	  by	  
24-­‐hours	  (one-­‐way	  ANOVA,	  P	  <0.05)	  (Figure	  4.7).	  IHC	  staining	  for	  CD41	  demonstrated	  
that	  microvascular	   platelet	   deposition	   remained	   significantly	   elevated	   at	   1-­‐hour	   and	  
24-­‐hours	   following	   renal	   IRI	   (one-­‐way	   ANOVA,	   P	   <0.05)	   (Figure	   4.8).	   These	   data	  
confirm	   that	   fibrin	   and	   platelet	   deposition	   could	   be	   used	   as	   parameters	   to	   infer	  
microvascular	  congestion.	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Figure	  4.6	  -­‐	  Twenty-­‐five	  minutes	  of	  ischaemia	  resulted	  in	  significant	  renal	  failure	  and	  
ATN.	  To	  obtain	  baseline	  values	  of	  renal	  injury,	  fibrin	  and	  platelet	  deposition	  following	  
renal	  IRI	  8-­‐week	  old	  male	  Balb/c	  mice	  underwent	  a	  right	  nephrectomy	  and	  25-­‐minutes	  
of	  ischaemia.	  	  Mice	  were	  sacrificed	  either	  1-­‐hour	  (n	  =	  4)	  or	  24-­‐hours	  (n	  =	  4)	  following	  
renal	   IRI.	   	   A)	  Mice	   sacrificed	  24-­‐hours	  after	   renal	   IRI	  had	   significantly	   impaired	   renal	  
function,	  indicated	  by	  elevated	  plasma	  creatinine,	  in	  comparison	  to	  those	  sacrificed	  at	  
1-­‐hour.	   The	   dotted	   line	   represents	   normal	   plasma	   creatinine	   levels	   in	   healthy	  male	  
Balb/c	  mice	  aged	  8-­‐weeks.	  B)	  Scoring	  of	  ATN	  (expressed	  as	  the	  percentage	  of	  necrotic	  
tubules	   in	  the	  OSOM)	  demonstrated	  that	  mice	  sacrificed	  1-­‐hour	  and	  24-­‐hour	  post	   IRI	  
had	  significant	  ATN	  in	  comparison	  to	  non-­‐injured	  kidneys.	  	  Magnification:	  x200.	  	  Data	  
expressed	  as	  mean	  ±SEM	  and	  analysed	  by	  student	  t-­‐test	  or	  one-­‐way	  ANOVA.	  *	  =	  P	  ≤	  
0.05,	  **	  =	  P	  ≤	  0.01	  and	  ***	  =	  P	  ≤	  0.001	  
	  






Figure	  4.7	  -­‐	  Significant	  fibrin	  deposition	  occurs	  1-­‐hour	  following	  renal	  IRI.	  	  To	  obtain	  
baseline	  values	  of	  renal	  injury,	  fibrin	  and	  platelet	  deposition	  following	  renal	  IRI	  8-­‐week	  
old	  male	   Balb/c	  mice	   underwent	   a	   right	   nephrectomy	   and	   25-­‐minutes	   of	   ischaemia.	  	  
Mice	   were	   sacrificed	   either	   1-­‐hour	   (n	   =	   4)	   or	   24-­‐hours	   (n	   =	   4)	   following	   renal	   IRI.	  
Representative	  photomicrographs	  of	   the	  OSOM	   in	  non-­‐injured	   and	   ischaemic	   kidney	  
sections	  following	  fibrin	  IF	  staining	  reveals	  peritubular	  fibrin	  deposition.	  Quantification	  
by	  compute	  image	  analysis	  of	  fibrin	  staining	  (expressed	  as	  fibrin+	  area)	  demonstrates	  
that	  deposition	  occurs	  1-­‐hour	  following	  renal	  IRI	  with	  a	  significantly	  less	  deposition	  at	  
24-­‐hours.	  Magnification:	  x200.	   	  Data	  expressed	  as	  mean	  ±SEM	  and	  analysed	  by	  one-­‐










Figure	   4.8	   -­‐	   Significant	   platelet	   deposition	   was	   observed	   1-­‐hour	   and	   24-­‐hours	  
following	   renal	   IRI.	   	   To	   obtain	   baseline	   values	   of	   renal	   injury,	   fibrin	   and	   platelet	  
deposition	   following	   renal	   IRI	   8-­‐week	   old	   male	   Balb/c	   mice	   underwent	   a	   right	  
nephrectomy	  and	  25-­‐minutes	  of	  ischaemia.	  	  Mice	  were	  sacrificed	  either	  1-­‐hour	  (n	  =	  4)	  
or	  24-­‐hours	  (n	  =	  4)	  following	  renal	  IRI.	  Representative	  photomicrographs	  of	  the	  OSOM	  
in	   non-­‐injured	   and	   ischaemic	   kidney	   sections	   following	   platelet	   (CD41)	   IHC	   staining	  
reveal	   microvascular	   platelet	   deposition.	   Quantification	   by	   compute	   image	   analysis	  
platelet	   staining	   (expressed	   as	   platelet+	   area)	   demonstrates	   that	   significant	   platelet	  
deposition	   is	   observed	   at	   both	   1	   and	   24-­‐hours	   post	   renal	   IRI.	   Magnification:	   x200.	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4.7	   Renal	   dysfunction,	   injury	   and	   platelet	   deposition	   increased	   with	   prolonged	  
ischaemia	  
With	  baseline	   values	  obtained,	   a	   titration	  of	   ischaemia	  was	  performed	   to	  assess	   the	  
duration	  of	  ischaemia	  necessary	  to	  induce	  various	  degrees	  of	  renal	  injury	  in	  the	  hands	  
of	  a	  new	  operator.	  Male	  8-­‐week	  old	  Balb/c	  mice	  underwent	  a	  right	  nephrectomy	  and	  
20,	  22,	  or	  24-­‐mintues	  of	  ischaemia	  (n	  =	  4	  per	  group)	  and	  were	  sacrificed	  24-­‐hours	  later	  
(Figure	  4.5B).	  A	  progressive	   increase	   in	  the	  severity	  of	  renal	  dysfunction,	  assessed	  by	  
plasma	   creatinine,	   was	   evident	   as	   the	   duration	   of	   ischaemia	   increased	   by	   2-­‐minute	  
increments	   (Figure	   4.9A).	   The	   ATN	   score	   (Figure	   4.9B)	   follows	   a	   similar	   trend	   with	  
more	  severe	  ATN	  accompanying	  more	  prolonged	  ischaemia	  (Figure	  4.9C).	  
	  
	  
Figure	   4.9	   –	   Increased	   renal	   dysfunction	   and	   injury	   with	   increasing	   duration	   of	  
ischaemia.	  To	  assess	  the	  duration	  of	  ischaemia	  required	  to	  induce	  varying	  degrees	  of	  
renal	  injury	  8-­‐week	  old	  male	  Balb/c	  mice	  underwent	  a	  right	  nephrectomy	  and	  20,	  22	  or	  
24-­‐minutes	   of	   ischaemia	   (n	  =	   4	   per	   group).	  Mice	  were	   sacrificed	   24-­‐hours	   following	  
renal	   IRI.	   A)	   Plasma	   creatinine	   shows	   an	   increasing	   trend	   of	   elevation,	   indicating	  
increasing	   kidney	   dysfunction,	   as	   the	   length	   of	   ischaemia	   increased.	   The	   dotted	   line	  
represents	   normal	   renal	   function	   in	   healthy	   male	   Balb/c	   mice	   aged	   8-­‐weeks.	   	   B)	  
Representative	   photomicrographs	   (Magnification:	   x200)	   of	   the	   OSOM	   from	   H&E	  
stained	  kidney	  sections	  of	  non-­‐injured	  and	  ischaemic	  kidneys	  illustrate	  ATN.	  C)	  Formal	  
scoring	   of	   ATN	   (expressed	   as	   the	   proportion	   of	   necrotic	   tubules)	   confirms	   the	  
increased	   level	   of	   injury	   with	   increasing	   duration	   of	   ischaemia.	   Data	   expressed	   as	  
mean	  ±SEM	  and	  analysed	  by	  one-­‐way	  or	  two-­‐way	  ANOVA.	  ***	  =	  P	  ≤	  0.001	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Fibrin	   and	   platelet	   deposition	   was	   determined	   to	   confirm	   that	   microvascular	  
congestion	   occurred	   with	   all	   ischaemic	   periods.	   Although	   fibrin	   deposition	   occurred	  
with	   all	   ischaemic	   durations	   (Figure	   4.10A),	   quantification	   demonstrated	   that	  
deposition	   varied	   as	   the	   length	   of	   ischaemia	   increased	   (Figure	   4.10B).	   In	   contrast,	  
platelet	   deposition	   (Figure	   4.11A)	   followed	   an	   increasing	   trend	   with	   prolonged	  




Figure	  4.10	  –	  Fibrin	  deposition	  was	  evident	  as	  the	  duration	  of	   ischaemia	   increased.	  
To	  assess	  the	  lengths	  of	  ischaemia	  required	  to	  induce	  varying	  degrees	  of	  renal	  injury	  8-­‐
week	  old	  male	  Balb/c	  mice	  underwent	  a	  right	  nephrectomy	  and	  20,	  22	  or	  24-­‐minutes	  
of	   ischaemia	   (n	  =	  4	  per	  group).	  Mice	  were	   sacrificed	  24-­‐hours	   following	   renal	   IRI.	  A)	  
Representative	   photomicrographs	   (Magnification:	   x200)	   of	   the	   OSOM	   of	   kidney	  
sections	   of	   non-­‐injured	   and	   ischaemic	   kidneys	   illustrating	   fibrin	   deposition.	   B)	  
Quantification	   of	   fibrin	   IF	   staining	   (expressed	   as	   fibrin+	   area)	   demonstrates	   that	  
deposition	  varied	  as	  the	  length	  of	  ischaemia	  increased.	  Data	  expressed	  as	  mean	  ±SEM	  





Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  Chapter	  4:	  AC	  administration	  is	  detrimental	  to	  renal	  IRI	   99	  
	  
	  
Figure	  4.11	  –	  Increased	  platelet	  deposition	  with	  increasing	  duration	  of	  ischaemia.	  To	  
assess	  the	  duration	  of	  ischaemia	  required	  to	  induce	  varying	  degrees	  of	  renal	  injury	  8-­‐
week	  old	  male	  Balb/c	  mice	  underwent	  a	  right	  nephrectomy	  and	  20,	  22	  or	  24-­‐minutes	  
of	   ischaemia	   (n	  =	  4	  per	  group).	  Mice	  were	   sacrificed	  24-­‐hours	   following	   renal	   IRI.	  A)	  
Representative	   photomicrographs	   (Magnification:	   x200)	   of	   the	   OSOM	   of	   kidney	  
sections	   of	   non-­‐injured	   and	   ischaemic	   kidneys	   stained	   for	   CD41	   to	   illustrate	   platelet	  
deposition.	   B)	   Quantification	   of	   platelet	   IHC	   staining	   (expressed	   as	   platelet+	   area)	  
demonstrates	   that	   deposition	   increased	   as	   the	   length	   of	   ischaemia	   increased.	   Data	  
expressed	  as	  mean	  ±SEM	  and	  analysed	  by	  two-­‐way	  ANOVA.	  **	  =	  P	  ≤	  0.01	  
	  
	  
4.8	   Thymocytes	   used	   to	   generate	   apoptotic	   cells	   were	   either	   CD4+,	   CD8α+	   or	  
CD4+CD8α+	  
The	  phenotype	  of	  fresh	  thymocytes	  used	  to	  generate	  the	  apoptotic	  cells	  for	  use	  in	   in	  
vivo	  experiments	  was	  examined	  by	  assessing	  the	  expression	  of	  CD3,	  CD4,	  CD8	  (T	  cell	  
markers),	  B220	  (B	  cell	  marker)	  and	  CD11b	  (myeloid	  cell	  marker).	  The	  anti-­‐CD3	  antibody	  
produced	   poor	   staining	   indicating	   that	   only	   approximately	   61%	   of	   thymocytes	  were	  
CD3+	   (Figure	   4.12A).	   Despite	   this,	   minimal	   expression	   of	   B220	   (Figure	   4.12B)	   and	  
CD11b	   (Figure	   4.12C)	   confirmed	   that	   cell	   preparations	   consisted	   predominantly	   of	  
thymocytes,	  98%	  of	  which	  were	  either	  CD4+,	  CD8α+	  or	  CD4+CD8α+	  (Figure	  4.12D).	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Figure	   4.12	   -­‐	   Representative	   data	   illustrating	   the	   phenotype	   of	   thymocytes	   and	  
classification	   of	   early	   and	   late	   apoptotic	   cells.	   Freshly	   isolated	   thymocytes	   were	  
stained	   with	   CD3,	   CD11b,	   B220,	   CD4	   and	   CD8α	   and	   analysed	   by	   flow	   cytometry	   to	  
assess	  the	  phenotype	  of	  the	  cells	  used	  to	  generate	  apoptotic	  cells.	  Poor	  CD3	  staining	  
was	  observed	  with	  only	  61.7%	  of	  total	  cell	  population	  being	  CD3+	  (A).	  Minimal	  staining	  
for	  B220	   (B)	   and	  CD11b	   (C)	  was	   found.	  Approximately	  98%	  of	   cells	   gated	   to	  exclude	  
debris	   are	   lymphocytes	   and	   either	   CD4+,	   CD8α+	   or	   CD4+CD8α+	   (C).	   Prior	   to	  
administration	  of	  apoptotic	  cells	  to	  mice	  cell	  viability	  was	  assessed	  by	  Annexin-­‐V	  and	  
Propidium	   Iodide	   (PI)	   staining	   and	   flow	   cytometry.	   Overnight	   culture	   alone	   induced	  
predominantly	  early	  apoptotic	  cells	  (47%	  Annexin-­‐V+	  PI-­‐)(E)	  whilst	  the	  addition	  of	  1µM	  
dexamethasone	  elicited	  a	  population	  of	  late	  apoptotic	  cells	  (64.7%	  Annexin-­‐V+	  PI+)(F).	  
Data	  representative	  of	  all	  apoptotic	  cell	  preparations.	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4.9	  Apoptotic	  cell	  administration	  prior	  to	  moderate	  and	  mild	  renal	   IRI	   impaired	  renal	  
function	  
With	  data	  demonstrating	  apoptotic	  cells	  ability	  to	  modulate	  coagulation,	  the	  renal	  IRI	  
model	   characterised	   and	   apoptotic	   cells	   phenotyped	   we	   were	   ready	   to	   assess	   the	  
influence	   of	   apoptotic	   cell	   administration	   on	   renal	   ischaemic	   injury.	   To	   explore	   the	  
effects	   of	   apoptotic	   cells	   upon	   renal	   IRI	   either	   PBS	   or	   20×106	   predominantly	   early	  
apoptotic	   cells	   (Annexin-­‐V+	   PI-­‐,	   Figure	   4.12E)	   or	   predominantly	   late	   apoptotic	   cells	  
(Annexin-­‐V+	   PI+,	   Figure	   4.12F)	   were	   administered	   intravenously	   to	   mice	   24-­‐hours	  
before	   renal	   IRI.	  Mice	  were	   then	   sacrificed	   24-­‐hours	   later	   (Figure	   4.5C).	   In	   an	   initial	  
experiment	  early	  apoptotic	  cells	  were	  administered	  prior	   to	  25-­‐minutes	  of	   ischaemia	  
but	   no	   preservation	   of	   renal	   function	   was	   observed	   (Figure	   4.13A).	   Note	   that	   this	  
experiment	   was	   performed	   early	   during	   this	   thesis	   prior	   to	   the	   optimisation	   of	   this	  
model;	  as	  such	  the	  lab	  standard	  25-­‐minutes	  of	  ischaemia	  was	  used.	  The	  resulting	  level	  
of	   functional	   injury	   was	   unexpectedly	   high	  with	  markedly	   elevated	   levels	   of	   plasma	  
creatinine	   and	   blood	   urea	   nitrogen	   and	   thus	   unlikely	   to	   be	   responsive	   to	   any	  
therapeutic	   modulation.	   Further	   studies	   adopted	   a	   slightly	   reduced	   level	   of	   injury	  
(classified	   according	   to	   plasma	   creatinine)	   induced	   by	   24-­‐minutes	   or	   20-­‐minutes	   of	  
ischaemia.	   In	   light	   of	   work	   demonstrating	   that	   late	   apoptotic	   cells	   may	   exert	   anti-­‐
inflammatory	   effects	   (Miles	   et	   al.,	   2009)	   the	   influence	   of	   late	   apoptotic	   cells	   upon	  
moderate	  kidney	  dysfunction	  was	  examined.	   In	  addition,	  the	  preliminary	  studies	  that	  
demonstrated	   apoptotic	   cell	   derived	   protection	   from	   renal	   IRI	   appeared	   to	   use	  
apoptotic	  cells	  at	  a	  more	  advanced	  stage	  of	  cell	  death.	  However,	  the	  administration	  of	  
late	  apoptotic	   cells	   resulted	   in	  a	   significant	   increases	   in	  plasma	  creatinine	  and	  blood	  
urea	  nitrogen	   indicative	  of	  a	  worsening	  of	  kidney	   function	   (Student’s	   t-­‐test,	  P	  <0.05)	  
(Figure	   4.13B).	   This	   suggested	   that	   the	   administration	   of	   cells	   with	   significant	   PI	  
positivity	  was	   detrimental	   and	  we	   therefore	   focused	   upon	   early	   apoptotic	   cells	   in	   a	  
milder	   model	   of	   renal	   injury.	   Somewhat	   unexpectedly	   the	   administration	   of	   early	  
apoptotic	   cells	   also	   resulted	   in	   a	   significant	   increase	   in	   plasma	   creatinine	   with	   no	  
protection	  evident	  (Student’s	  t-­‐test,	  P	  <0.05)	  (Figure	  4.13C).	  On	  the	  basis	  of	  these	  data,	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we	   did	   not	   examine	   the	   effects	   of	   early	   apoptotic	   cells	   in	   moderate	   injury	   or	   late	  




Figure	  4.13	  -­‐	  Apoptotic	  cell	  (AC)	  administration	  prior	  to	  moderate	  and	  mild	  renal	  IRI	  
impaired	   renal	   function.	  Renal	   IRI	  was	   induced	   in	  8-­‐week	  old	  male	  Balb/c	  mice	  by	  a	  
right	  nephrectomy	  and	  ischaemia	  induced	  by	  occlusion	  of	  the	  left	  renal	  pedicle.	  Sham	  
mice	   underwent	   a	   laparotomy	   only.	   Either	   PBS	   or	   20x106	   early	   or	   late	   ACs	   were	  
administered	   intravenously	  24-­‐hours	  prior	   to	  mild	   (20-­‐minutes	   ischaemia),	  moderate	  
(24-­‐minutes)	  or	  severe	   (25-­‐minutes)	   ischaemic	   injury.	   	  Mice	  were	  sacrificed	  24-­‐hours	  
following	   IRI.	   A)	   Administration	   of	   early	   ACs	   did	   not	   preserve	   renal	   function	   from	  
severe	   IRI.	   B)	   In	   contrast,	   administration	   of	   late	   ACs	   significantly	   worsened	   renal	  
function	   in	  mice	  with	  moderate	   IRI.	  C)	  Similarly,	  early	  ACs	  administered	  prior	  to	  mild	  
ischaemia	   significantly	   worsened	   renal	   function.	   Analysed	   by	   one-­‐way	   ANOVA	   or	  
students	  t-­‐test	  *	  =	  P	  ≤	  0.05,	  ns	  =	  non-­‐significant.	  Sham	  (n	  =	  4),	  PBS	  (n	  =	  7-­‐8),	  AC	  (n	  =	  8).	  
	  
	  
4.10	  ATN	  following	  ischaemia	  was	  unaffected	  following	  apoptotic	  cell	  administration	  
ATN	  was	  evident	  with	  widespread	  tubular	   injury	   in	  the	   ischaemic	  kidneys	  of	  PBS	  and	  
apoptotic	   cell	   treated	  mice	   (Figure	   4.14A).	  Despite	   the	   deleterious	   effect	   of	   early	   or	  
late	   apoptotic	   cell	   administration	  upon	   renal	   function	   in	  mild	   or	  moderate	   renal	   IRI,	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Figure	   4.14	   -­‐	   Acute	   tubular	   necrosis	   (ATN)	   following	   ischaemia	   was	   unaffected	  
following	  apoptotic	  cell	  (AC)	  administration.	  Renal	  IRI	  was	  induced	  in	  8-­‐week	  old	  male	  
Balb/c	  mice	  by	  a	  right	  nephrectomy	  and	  ischaemia	  induced	  by	  occluding	  the	  left	  renal	  
pedicle	   for	   20	   (mild	   ischaemia),	   24	   (moderate)	   or	   25-­‐minutes	   (severe).	   Sham	   mice	  
underwent	  a	  laparotomy.	  Either	  PBS	  or	  20x106	  	  early	  or	  late	  ACs	  were	  administered	  24-­‐
hours	  prior	  to	  renal	  IRI.	  Mice	  were	  sacrificed	  24-­‐hours	  following	  IRI.	  A)	  Representative	  
images	  of	  the	  OSOM	  in	  non-­‐injured	  and	   ischaemic	  kidney	  sections	  stained	  with	  H&E.	  
Tubules	   within	   the	   OSOM	  were	   classified	   as	   necrotic	   (black	   arrow)	   or	   healthy	   (grey	  
arrow)	  according	  to	  cell	  morphology	  and	  integrity.	  (Magnification:	  x200;	  Scale	  Bar:	  50	  
µM)	   	  B)	  ATN	  scoring	  (expressed	  as	  the	  percentage	  of	  necrotic	  tubules)	  demonstrates	  
that	   the	   structural	   injury	   remained	   similar	   between	   PBS	   and	   AC	   treated	   mice	   with	  
severe,	   moderate	   and	  mild	   ischaemic	   injury.	   ●	   =	   Non-­‐injured	   kidney	   □	   =	   Ischaemic	  
kidney.	   Data	   expressed	   as	  mean	   ±SEM	   and	   analysed	   by	   two-­‐way	   ANOVA.	   ns	   =	   non-­‐
significant.	  Sham	  (n	  =	  4),	  PBS	  	  (n	  =	  7-­‐8),	  AC	  (n	  =	  8).	  
	  
4.11	  Administration	  of	  viable	  thymocytes	  prior	  to	  renal	   IRI	  had	  no	   influence	  on	  renal	  
function	  or	  ATN	  
It	  is	  evident	  from	  the	  lower	  left	  quadrants	  of	  figure	  4.12	  E	  &	  F	  that	  both	  early	  and	  late	  
apoptotic	  cells	  contained	  populations	  of	  viable	  non-­‐apoptotic	  cells	  and	  that	  these	  cells	  
might	   be	   responsible	   for	   the	   worsening	   of	   renal	   dysfunction.	   However,	   the	  
administration	  of	  20×106	  viable	  thymocytes	  (~95%	  Annexin-­‐V-­‐	  PI-­‐)	  (Figure	  4.15A)	  prior	  
to	   renal	   IRI	   had	   no	   significant	   effect	   upon	   renal	   function	   measured	   by	   plasma	  
creatinine	  (Figure	  4.15B)	  and	  blood	  urea	  nitrogen	  (Figure	  4.15C)	  or	  ATN	  (Figure	  4.15D).	  
	  
	  





Figure	  4.15	  -­‐	  Administration	  of	  viable	  thymocytes	  prior	  to	  renal	  IRI	  had	  no	  influence	  
on	   renal	   function	   or	   ATN.	   Dissociated	   thymocytes	   were	   prepared	   from	   4-­‐week	   old	  
male	  Balb/c	  mice.	  Cell	  viability	  was	  assessed	  by	  Annexin-­‐V	  and	  Propidium	   Iodide	   (PI)	  
staining	   and	   flow	   cytometry.	   Either	   PBS	   or	   20x106	  viable	   non-­‐apoptotic	   thymocytes	  
were	  administered	  to	  8-­‐week	  old	  male	  Balb/c	  mice	  24-­‐hours	  prior	  to	  renal	  IRI	  induced	  
by	  a	  right	  nephrectomy	  and	  occlusion	  of	  the	  left	  renal	  pedicle	  for	  20	  mins.	  	  Mice	  were	  
sacrificed	   24-­‐hours	   following	   IRI.	   A)	   Viable	   thymocytes	   were	   approximately	   94%	  
Annexin-­‐V-­‐	   PI-­‐.	  B	  &	   C)	  Administration	   of	   viable	   thymocytes	   prior	   to	   renal	   IRI	   had	   no	  
significant	   influence	  on	   renal	   function	  measured	  by	   plasma	   creatinine	   (B)	   and	  blood	  
urea	   nitrogen	   (C).	   D)	   Scoring	   of	   ATN	   (acute	   tubular	   necrosis)	   (expressed	   as	   the	  
percentage	  of	  necrotic	   tubules	   in	   the	  OSOM)	  demonstrates	   that	   the	  structural	   injury	  
remained	  similar	  between	  mice	  that	  received	  PBS	  or	  viable	  thymocytes	  prior	  to	  renal	  
IRI.	  ●	  =	  Non-­‐injured	  kidney	  □	  =	  Ischaemic	  kidney.	  Data	  expressed	  as	  mean	  ±SEM	  and	  





Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  Chapter	  4:	  AC	  administration	  is	  detrimental	  to	  renal	  IRI	  105	  
4.12	   Microvascular	   congestion	   remained	   unaffected	   following	   apoptotic	   cell	  
administration	  
The	   finding	  of	  unexpectedly	  worse	   renal	   function	  without	  an	   increased	  ATN	  score	   in	  
apoptotic	   cell	   treated	  mice	   suggested	   that	   apoptotic	   cells	   might	   have	   detrimentally	  
reduced	  renal	  microvascular	  flow,	  contrary	  to	  our	  hypothesis.	  The	  coagulation	  cascade	  
is	   activated	   following	   ischaemic	   injury	   (Jennewein	   et	   al.,	   2011)	   and	   the	  
microvasculature	  becomes	  congested	  with	  erythrocytes	  and	  platelet/fibrin	  aggregates	  
which	   aggravates	   tissue	   hypoxia	   and	   limits	   the	   perfusion	   of	   residual	   viable	   and	  
potentially	   functional	   nephrons	   (Patschan	   et	   al.,	   2012a,	   Eneström	   et	   al.,	   1988).	  
Apoptotic	  cells	  expressing	  PtdSer	  are	  pro-­‐coagulant	  and	  might	  therefore	  contribute	  to	  
this	   pro-­‐coagulant	   milieu	   (Casciola-­‐Rosen	   et	   al.,	   1996).	   To	   investigate	   this	   CD41+	  
platelet	  and	  fibrin	  deposition	  was	  assessed	  by	  IHC	  and	  IF,	  respectively.	  CD41+	  platelets	  
and	   fibrin	   deposition	   was	   observed	   in	   the	   OSOM	   of	   PBS	   and	   apoptotic	   cell	   treated	  
ischaemic	  kidneys	  (Figure	  4.16A	  &	  C),	  but	  no	  significant	  differences	  between	  apoptotic	  
cell	  treated	  and	  control	  mice	  were	  found	  following	  quantification	  (Figure	  4.16B	  &	  D).	  
Anti-­‐CD41	  specificity	  was	  confirmed	  using	  matched	  isotype	  control	  antibodies	  in	  non-­‐
injured	  and	  ischaemic	  kidney	  sections	  (Figure	  4.18).	  With	  the	  finding	  that	  apoptotic	  cell	  
administration	  did	  not	  influence	  microvascular	  congestion	  post	  IRI	  we	  did	  not	  use	  our	  
established	  flow	  cytometry	  assays	  (platelet-­‐apoptotic	  cell	  binding	  and	  platelet	  counts)	  
for	  any	  further	  investigation.	  
	  
4.13	   Neutrophil	   infiltration	   occurred	   following	   ischaemia	   but	   was	   unaffected	   by	  
apoptotic	  cell	  administration	  
With	   increased	  microvascular	   congestion	   not	   explaining	   this	   surprising	   result	   it	   was	  
speculated	   that	   apoptotic	   cell	   administration	   might	   have	   increased	   immune	   cell	  
infiltration	   thereby	   elevating	   pro-­‐inflammatory	   responses	   post	   renal	   IRI.	   Neutrophils	  
rapidly	   accumulate	   after	   renal	   ischaemic	   injury	   (Kinsey	   et	   al.,	   2008).	   They	   adhere	   to	  
the	  microvascular	   endothelium	  where	   they	  may	  obstruct	   the	   renal	  microvasculature	  
and	  potentially	  damage	  tubular	  cells	  by	  releasing	  reactive	  oxygen	  species	  (Friedewald	  
and	  Rabb,	  2004).	  To	  gain	  an	  insight	  into	  the	  inflammatory	  status,	  neutrophil	  infiltration	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Figure	  4.16	  -­‐	  Microvascular	  congestion	  remained	  unaffected	  following	  apoptotic	  cell	  
(AC)	  administration.	  Renal	  IRI	  was	  induced	  in	  8-­‐week	  old	  male	  Balb/c	  mice	  by	  a	  right	  
nephrectomy	  and	   ischaemia	   induced	  by	  occluding	   the	   left	   renal	   pedicle	   for	   20	   (mild	  
ischaemia),	   24	   (moderate)	   or	   25-­‐minutes	   (severe).	   Sham	   mice	   underwent	   a	  
laparotomy.	  PBS	  or	  20x106	  early	  or	  late	  ACs	  were	  administered	  24-­‐hours	  prior	  to	  renal	  
IRI.	  Mice	  were	  sacrificed	  24-­‐hours	  following	  IRI.	  A	  &	  C)	  Representative	   images	  of	  the	  
OSOM	  in	  non-­‐injured	  and	  ischaemic	  kidney	  sections	  following	  platelet	  (CD41)	   IHC	  (A)	  
and	  fibrin	  IF	  (C)	  staining.	  In	  ischaemic	  kidneys	  microvascular	  congestion	  was	  observed	  
as	  indicated	  by	  platelet	  and	  fibrin	  deposition.	  (CD41	  -­‐	  Magnification:	  x200	  &	  Scale	  Bar:	  
50	  µM;	  Fibrin	  -­‐	  Magnification:	  x400	  &	  Scale	  Bar:	  25	  µM)	  	  B	  &	  D)	  Scoring	  of	  platelet	  (B)	  
and	   fibrin	   (D)	   staining	   (expressed	   as	   platelet/fibrin+	   area)	   demonstrates	   that	  
microvascular	   congestion	   remained	   similar	   between	   PBS	   and	   AC	   treated	   mice	   with	  
severe,	   moderate	   and	  mild	   ischaemic	   injury.	   ●	   =	   Non-­‐injured	   kidney	   □	   =	   Ischaemic	  
kidney.	   Data	   expressed	   as	  mean	   ±SEM	   and	   analysed	   by	   two-­‐way	   ANOVA.	   ns	   =	   non-­‐
significant.	  Sham	  (n	  =	  4),	  PBS	  (n	  =	  7-­‐8),	  AC	  (n	  =	  8).	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was	  determined	  following	  IHC	  staining	  for	  Gr1.	  Neutrophil	  infiltration	  was	  observed	  in	  
the	   OSOM	   of	   all	   ischaemic	   kidneys	   of	   PBS	   and	   apoptotic	   cell	   treated	   mice	   (Figure	  
4.17A),	  however	  this	  remained	  equivalent	   in	  all	  apoptotic	  cell	   treated	  mice	  and	  their	  
corresponding	   PBS	   controls	   (Figure	   4.17B).	   Anti-­‐Gr1	   specificity	   was	   confirmed	   using	  





Figure	  4.17	  -­‐	  Neutrophil	  infiltration	  occurred	  following	  ischaemia	  but	  was	  unaffected	  
by	  apoptotic	  cell	  (AC)	  administration.	  Renal	  IRI	  was	  induced	  in	  8-­‐week	  old	  male	  Balb/c	  
mice	  by	  a	  right	  nephrectomy	  and	  ischaemia	  induced	  by	  occluding	  the	  left	  renal	  pedicle	  
for	  20	  (mild	  ischaemia),	  24	  (moderate)	  or	  25-­‐minutes	  (severe).	  Sham	  mice	  underwent	  
a	   laparotomy	   only.	   Either	   PBS	   or	   20x106	   early	   or	   late	   ACs	   were	   administered	  
intravenously	  24-­‐hours	  prior	  to	  renal	   IRI.	  Mice	  were	  sacrificed	  24-­‐hours	  following	  IRI.	  
A)	  Representative	   images	  of	   the	  OSOM	  in	  non-­‐injured	  and	   ischaemic	  kidney	  sections	  
following	   Gr1	   staining.	   In	   ischaemic	   kidneys	   neutrophil	   infiltration	   was	   observed	   in	  
areas	  of	  necrosis.	   (Magnification:	  x200;	  Scale	  Bar:	  50	  µM)	   	  B)	  Scoring	  of	  Gr1	  staining	  
(expressed	   as	   Gr1+	   area)	   demonstrates	   that	   neutrophil	   infiltration	   remained	   similar	  
between	  PBS	  and	  AC	  treated	  mice	  with	  severe,	  moderate	  and	  mild	  ischaemic	  injury.	  ●	  
=	   Non-­‐injured	   kidney	   □	   =	   Ischaemic	   kidney.	   Data	   expressed	   as	   mean	   ±SEM	   and	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Figure	   4.18	   -­‐	   Isotype	   controls	   for	  Gr1	   and	  CD41	  were	  negative	  on	  non-­‐injured	   and	  
ischaemic	   kidney.	   Renal	   IRI	  was	   induced	   in	   8-­‐week	   old	  male	   Balb/c	  mice	   by	   a	   right	  
nephrectomy	  and	   ischaemia	   induced	  by	  occluding	   the	   left	   renal	  pedicle	   for	  24	  mins.	  	  
Representative	   images	   of	   the	   OSOM	   in	   non-­‐injured	   and	   ischaemic	   kidney	   sections	  
following	   staining	   with	   isotype	   control	   antibodies	   for	   CD41	   and	   Gr1.	   Both	   isotype	  
control	   antibodies	   exhibit	   no	   staining	   in	   non-­‐injured	   and	   ischaemic	   kidneys.	  




In	   this	   chapter	  we	  examined	   if	  apoptotic	   cells	  administered	  prior	   to	   the	   induction	  of	  
renal	  ischaemia	  reperfusion	  injury	  were	  protective.	  In	  contrast	  to	  the	  preliminary	  data	  
and	  protection	  derived	   from	  apoptotic	  cell	  administration	  observed	   in	  other	  models,	  
our	   data	   indicates	   that	   apoptotic	   cells	   do	   not	   protect	   from	   renal	   ischaemic	   injury.	  
Indeed,	  depending	  upon	  the	  severity	  of	  the	  ischaemic	  injury,	  apoptotic	  cells	  may	  act	  to	  
further	  worsen	   renal	   function.	   These	   data	   represents	   an	   important	  message	   for	   the	  
field	  in	  that	  the	  administration	  of	  apoptotic	  cells	  is	  not	  inherently	  anti-­‐inflammatory	  in	  
all	  models	  of	  acute	  inflammation.	  Our	  data	  suggests	  that	  ‘apoptotic	  cell	  therapy’	  is	  not	  
translationally	   relevant	   for	   patients	   with	   acute	   kidney	   injury	   induced	   by	   ischaemic	  
injury.	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Interestingly,	   we	   found	   that	   apoptotic	   cells	   can	   modulate	   coagulation	   status,	   in	  
regards	   to	   thrombin	   generation;	   with	   apoptotic	   cell	   treated	   mice	   demonstrating	  
significantly	  delayed	  clotting	  times.	  In	  support	  of	  this,	  apoptotic	  cells	  were	  also	  found	  
to	  be	  able	   to	  bind	  platelets,	  which	  are	   instrumental	   in	   the	   regulation	  of	   coagulation	  
and	   thrombin	   generation	   (Monroe	   et	   al.,	   2002).	   	   Despite	   platelet/apoptotic	   cell	  
interaction	   and	   delayed	   thrombin	   having	   no	   discernable	   influence	   on	  microvascular	  
congestion	   following	   ischaemia,	   these	   data	   still	   provides	   further	   insight	   into	   how	  
apoptotic	  cells	  may	  alter	  coagulation	  status.	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Despite	   data	   presented	   in	   chapters	   3	   and	   4	   indicating	   that	   apoptotic	   thymocyte	  
administration	  prior	  to	  renal	   IRI	   is	  not	  protective,	  and	  that	  IgM	  antibodies	  deposition	  
was	   not	   prominent	   following	   renal	   ischaemic	   injury,	   IgM	   binding	   to	   injured	   or	  
apoptotic	  cells	  remained	  an	  intriguing	  area	  that	  we	  wanted	  to	  explore.	  We	  were	  also	  
optimistic	   that	   our	   studies	   in	   this	   area	   may	   provide	   us	   with	   an	   insight	   into	   the	  
mechanism	  behind	  the	  disparity	  between	  IgM	  deposition	  in	  ischaemic	  liver	  and	  kidney	  
tissue.	  
	  
IgM	   antibodies	   mediate	   and	   promote	   apoptotic	   cell	   clearance	   (Peng	   et	   al.,	   2005,	  
Ogden	  et	  al.,	  2005,	  Litvack	  et	  al.,	  2010,	  Litvack	  et	  al.,	  2011),	  and	  bind	  to	  a	  diverse	  range	  
of	  non-­‐self	  and	  self-­‐antigens	  	  (reviewed	  in	  Table	  1.3).	  Many	  of	  these	  are	  thought	  to	  be	  
antigens	   that	   have	   been	   modified	   or	   that	   are	   only	   accessible	   following	   apoptosis.	  
Although	  it	  has	  been	  suggested	  that	  IgM	  antibodies	  illustrate	  a	  distinct	  preference	  for	  
“late”	  apoptotic	  cells	   (Litvack	  et	  al.,	  2010,	  Fu	  et	  al.,	  2007,	  Zwart	  et	  al.,	  2004,	  Ciurana	  
and	  Hack,	  2006,	  Porcheray	  et	  al.,	  2013),	   it	   should	  be	  noted	  that	  heterogeneity	  exists	  
between	   investigators	   in	   the	   classification	   of	   “late”	   apoptotic	   cells.	   	   Restricting	  
classification	  to	  the	  use	  of	  AnnV	  and	  PI	  viability	  dyes	  alone,	  “late”	  apoptotic	  cells	  have	  
been	  classified	  as	  AnnV+PI-­‐,	  AnnV+PI+	  or	  simply	  PI+.	  	  Some	  would	  argue	  that	  PI+	  events	  
should	  be	  designated	  as	  cellular	  fragments.	  Despite	  this	  classification	  ambiguity	  it	  can	  
at	  least	  be	  concluded	  that	  IgM	  antibodies	  bind	  cells	  at	  an	  advanced	  stage	  of	  cell	  death.	  
	  
In	   this	   chapter	   we	   sought	   to	   carefully	   explore	   the	   binding	   of	   circulating	   IgM	   to	  
apoptotic	   cells,	   both	   human	   and	   murine,	   at	   different	   stages	   of	   apoptosis,	   with	  
thoughtful	   consideration	   to	   controls	   to	   ensure	   the	   specificity	   and	   accuracy	   of	   our	  
results.	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5.1	  Establishment	  of	  an	  assay	  to	  detect	  circulating	  IgM	  binding	  to	  cells	  
First,	   an	   IgM	   detection	   assay	   was	   established	   in	   order	   to	   characterise	   and	   explore	  
circulating	   IgM	   binding	   to	   non-­‐apoptotic	   and	   apoptotic	   cells.	   	   Initial	   experiments	  
induced	   apoptosis	   in	   murine	   thymocytes	   by	   a	   20-­‐hour	   incubation	   in	   RMPI	  
supplemented	  with	  1	  µM	  Dexamethasone	   (Dex),	  which	  elicited	  a	  predominately	   late	  
apoptotic	   cell	   population	   (78%	   AnnV+PI+)	   (Figure	   5.1A).	   To	   investigate	   IgM	   binding	  
apoptotic	   thymocytes	  were	   exposed	   to	   either	   PBS	   or	   undiluted	   Balb/c	   plasma	   (as	   a	  
source	   of	   IgM)	   for	   30-­‐minutes.	   Following	   this	   samples	   were	   incubated	   with	   a	  
fluorochrome	   conjugated	   anti-­‐IgM	   antibody	   for	   30-­‐minutes	   before	   IgM	   binding	   was	  
assessed	   by	   flow	   cytometry.	   Apoptotic	   thymocytes	   exposed	   to	   Balb/c	   plasma	  
demonstrated	   a	   shift	   towards	   IgM	   positivity	   compared	   to	   PBS	   treated	   samples,	  
indicating	  bound	   IgM	  (Figure	  5.1B).	  Following	  successful	  detection	  of	   IgM	  binding	  an	  
anti-­‐IgM	   antibody	   titration	   was	   performed	   to	   determine	   the	   optimum	   antibody	  
dilution	  for	  IgM	  detection.	  	  Median	  fluorescent	  intensity	  (MFI)	  was	  determined	  on	  cells	  
gated	  for	  IgM	  positivity	  in	  samples	  exposed	  to	  Balb/c	  plasma	  compared	  to	  PBS	  treated	  
samples.	   This	   demonstrated	   that	   a	   1:100	   dilution	   was	   appropriate	   as	   the	   MFI	   was	  
drastically	  reduced	  at	  a	  1:200	  dilution	  (Figure	  5.1C).	  Next	  a	  plasma	  dilution	  series	  was	  
performed	   to	   determine	   the	   optimum	   dilution	   necessary	   to	   allow	   binding	   and	  
detection	   of	   circulating	   IgM,	   but	   preserve	   plasma	   stock	   that	   was	   limited.	   MFI	   was	  
determined	   on	   cells	   gated	   for	   IgM	   positivity	   in	   samples	   exposed	   to	   Balb/c	   plasma	  
compared	  to	  PBS	  treated	  samples.	  On	  the	  basis	  of	  MFI	  a	  1:8	  dilution	  was	  selected	  as	  
dilutions	  1:5	  and	  1:10	  resulted	  in	  acceptable	  MFI	  values	  (Figure	  5.1D).	  Cell	  number	  was	  
not	   optimised	   as	   the	   standard	   500,000	   cells	   used	   for	   flow	   cytometry	   generated	  
acceptable	  results.	  
	  
With	   conditions	   for	   the	   assay	   optimised,	   a	   time	   course	   of	   apoptosis	   in	   murine	  
thymocytes	  was	  performed.	  This	  was	  performed	  to	  ascertain	  which	  conditions	  elicited	  
a	  cell	  population	  consisting	  of	  various	  levels	  of	  cell	  death	  (non-­‐apoptotic,	  early	  and	  late	  
apoptotic).	  	  This	  would	  	  allow	  	  the	  assessment	  of	  IgM	  binding	  to	  thymocytes	  at	  variable	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Figure	  5.1	  –	  Establishing	  and	  optimising	  an	  assay	  to	  detect	  circulating	  IgM	  binding	  to	  
cells.	  A)	  Murine	  thymocytes	  were	  rendered	  apoptotic	  by	  a	  20-­‐hour	  incubation	  with	  1	  
µM	   Dex,	   which	   resulted	   in	   a	   predominantly	   AnnV+	   PI+	   apoptotic	   cell	   population.	   B)	  
Apoptotic	  thymocytes	  were	  then	  exposed	  to	  either	  PBS	  or	  undiluted	  Balb/c	  plasma	  (as	  
a	   source	  of	   IgM).	   IgM	  binding	  was	   then	   assessed	  by	   flow	   cytometry.	  A	  marked	   shift	  
towards	  IgM	  positivity	  was	  observed	  in	  samples	  treated	  with	  Balb/c	  plasma	  compared	  
to	  PBS	  treated	  samples.	  C)	  An	  anti-­‐IgM	  antibody	  titration	  was	  performed	  to	  determine	  
the	   correct	   antibody	   dilution	   for	   IgM	   detection.	   	   Median	   fluorescent	   intensity	   was	  
determined	   on	   cells	   gated	   for	   IgM	   positivity	   in	   samples	   exposed	   to	   Balb/c	   plasma	  
compared	   to	   PBS	   treated	   samples.	   D)	   A	   plasma	   dilution	   series	   was	   performed	   to	  
determine	   the	   correct	   dilution	   necessary	   to	   allow	   IgM	   to	   bind,	   but	   preserve	   plasma	  
stock.	  Median	  fluorescent	  intensity	  was	  determined	  on	  cells	  gated	  for	  IgM	  positivity	  in	  
samples	  exposed	  to	  Balb/c	  plasma	  compared	  to	  PBS	  treated	  samples.	  
	  
stages	  of	  apoptosis.	  Dissociated	  murine	  thymocytes	  were	  incubated	  with	  RPMI	  alone,	  
or	  RMPI	  supplemented	  with	  1%	  FCS	  or	  1%	  BSA.	  	  Murine	  thymocytes	  were	  then	  aged	  or	  
treated	  with	  1µM	  Dex	  and	  sampled	  at	  0,	  4,	  8,	  16,	  20	  and	  24-­‐hours	  and	  apoptosis	  was	  
determined	  by	  AnnV	  and	  PI	  staining	  assessed	  by	  flow	  cytometry.	  	  A	  16-­‐hour	  incubation	  
in	  RMPI	  alone	  elicited	  a	  cell	  population	  of	  approximately	  35%	  AnnV-­‐PI-­‐,	  40%	  AnnV+PI-­‐,	  
25%	   AnnV+PI+	   (highlighted	   in	   blue	   in	   Figure	   5.2)	   and	   was	   selected	   for	   future	  
experiments.	   In	   addition,	   culture	   of	   murine	   thymocytes	   in	   RMPI	   eliminated	   any	  
potential	  pre-­‐exposure	  to	  cell	  culture	  serum	  protein	  supplements.	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Figure	   5.2	   –	   Time	   course	   of	   apoptosis	   in	   murine	   thymocytes.	   A	   time	   course	   of	  
apoptosis	  was	  performed	  to	  determine	  appropriate	  conditions	  necessary	   to	   induce	  a	  
cell	   population	  with	  mixed	   levels	   of	   apoptosis.	   Dissociated	  murine	   thymocytes	  were	  
incubated	   with	   RPMI	   alone,	   or	   RMPI	   supplemented	   with	   1%	   FCS	   or	   1%	   BSA.	  	  
Thymocytes	  were	  then	  aged	  or	  treated	  with	  1	  µM	  Dex	  and	  sampled	  at	  0,	  4,	  8,	  16,	  20	  
and	   24-­‐hours.	   Apoptosis	   was	   determined	   by	   AnnV	   and	   PI	   staining	   assessed	   by	   flow	  
cytometry.	   Selected	   time	   point	   and	   conditions	   used	   for	   future	   experiments	  was	   16-­‐
hours	  aged	  in	  RPMI	  alone	  (highlighted	  in	  blue).	  
	  
5.2	   Circulating	  murine	   IgM	   preferentially	   binds	   a	   distinct	   subpopulation	   of	   AnnV+PI+	  
thymocytes	  
We	  next	  examined	  IgM	  binding	  to	  murine	  thymocytes	  with	  mixed	  levels	  of	  apoptosis.	  
Thymocytes	  were	  exposed	  to	  either	  PBS,	  Balb/c	  plasma	  (as	  a	  source	  of	  circulating	  IgM)	  
or	   control	   plasma	   from	   immunoglobulin	   deficient	   RAG-­‐1	   mice.	   As	   previous	   work	  
suggested	  that	  IgM	  binds	  apoptotic	  cells	  (Litvack	  et	  al.,	  2010,	  Fu	  et	  al.,	  2007,	  Zwart	  et	  
al.,	  2004,	  Ciurana	  and	  Hack,	  2006,	  Porcheray	  et	  al.,	  2013),	  we	   therefore	   focused	  our	  
attention	   on	   AnnV+	   thymocytes	   and	   assessed	   the	   percentage	   of	   AnnV+IgM+	  
thymocytes	   (Figure	   5.3A-­‐B).	   IgM	   binding	   of	   thymocytes	   by	   control	   isotype	   antibody	  
(Mouse	  (Balb/c)	  IgM	  κ	  isotype	  control)	  or	  following	  incubation	  in	  RAG1-­‐deficient	  mice	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plasma	   or	   PBS	   remained	   non-­‐significant	   whilst	   samples	   exposed	   to	   Balb/c	   plasma	  
exhibited	  significant	  binding	  with	  32.1	  ±3.1%	  of	  cells	  being	  AnnV+IgM+	  (Kruskal–Wallis	  
one-­‐way	  ANOVA;	  P	  <	  0.0001;	  n	  =	  5	  isotype,	  n	  =	  6	  RAG1-­‐deficient	  mice	  plasma	  +	  Anti-­‐
IgM,	  n	  =	  8	  PBS	  +	  Anti-­‐IgM	  and	  Balb/c	  plasma	  +	  Anti-­‐IgM)	  (Figure	  5.3B).	  	  	  
	  
	  
Figure	   5.3	   -­‐	   IgM	   specifically	   binds	   to	   a	   distinct	   population	   of	   AnnV+	   murine	  
thymocytes.	   Murine	   thymocytes	   were	   rendered	   apoptotic	   by	   overnight	   culture.	  
Thymocytes	   were	   exposed	   to	   either	   murine	   anti-­‐human	   isotype	   control	   antibodies,	  
PBS,	   Balb/c	   plasma	   (as	   a	   source	   of	   IgM)	   or	   plasma	   from	   immunodeficient	   RAG-­‐1	  
deficient	   mice.	   IgM	   binding	   was	   assessed	   by	   flow	   cytometry.	   AnnV	   and	   PI	   staining,	  
assessed	  by	  flow	  cytometry,	  was	  used	  to	  determine	  the	  level	  of	  non-­‐apoptotic	  (AnnV-­‐
PI-­‐),	   early	   (AnnV+PI-­‐)	   or	   late	   apoptotic	   (AnnV+PI+)	   thymocytes.	   A)	   Representative	  
histograms	   illustrating	   IgM	  binding	   to	  AnnV+	   apoptotic	   thymocytes	  within	   treatment	  
groups.	  B)	  Apoptotic	   thymocytes	  were	  gated	  on	   the	  basis	  of	  AnnV	  positivity	  and	   the	  
percentage	   of	   AnnV+IgM+	   thymocytes	   was	   assessed.	   IgM	   binding	   in	   isotype,	   RAG1-­‐
deficient	   mice	   plasma	   and	   PBS	   treatment	   groups	   remained	   non-­‐significant	   whilst	  
samples	  exposed	  to	  Balb/c	  plasma	  exhibited	  significant	  binding.	  	  However,	  surprisingly	  
only	  approximately	  68%	  were	  IgM-­‐.	  	  
	  
Approximately	   68%	   of	   AnnV+	   cells	   were	   IgM-­‐	   and	   further	   examination	   of	   the	   cell	  
populations	  present	  within	  samples	  exposed	  to	  Balb/c	  plasma	  revealed	  three	  distinct	  
populations:	   AnnV-­‐IgM-­‐,	   AnnV+IgM-­‐	   and	   AnnV+IgM+	   cells	   (Figure	   5.4A).	   Analysis	   of	  
AnnV+IgM-­‐	   and	   AnnV+IgM+	   FSC/SSC	   contour	   plots	   revealed	   contrasting	   profiles,	   yet	  
comparable	   AnnV/PI	   staining	   (Figure	   5.4B).	   	   As	   expected	   the	   AnnV-­‐IgM-­‐	   population	  
exhibited	   no	   PI	   positivity.	   Interestingly,	   AnnV+IgM-­‐	   and	   AnnV+IgM+	   populations	  
demonstrated	   disparate	   FSC/SSC	   profiles,	   yet	   both	   populations	   were	   predominantly	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AnnV+PI+	   (Figure	   5.4B).	   Apoptotic	   thymocytes	   incrementally	   incubated	   in	   Balb/c	  
plasma	  indicated	  that	  circulating	  IgM	  bound	  rapidly	  to	  cells	  localised	  within	  the	  region	  
defined	  as	  AnnV+IgM+	  on	  FSC/SSC	  contour	  plots	  (n	  =	  4)	  (Figure	  5.4C).	  
	  
	  
Figure	   5.4	   -­‐	   IgM	   rapidly	   binds	   to	   a	   distinct	   population	   of	   AnnV+	   PI+	   murine	  
thymocytes.	   Murine	   thymocytes	   were	   rendered	   apoptotic	   by	   overnight	   culture.	  
Thymocytes	   were	   exposed	   to	   either	   murine	   anti-­‐human	   isotype	   control	   antibodies,	  
PBS,	   Balb/c	   plasma	   (as	   a	   source	   of	   IgM)	   or	   plasma	   from	   immunodeficient	   RAG-­‐1	  
deficient	   mice.	   IgM	   binding	   was	   assessed	   by	   flow	   cytometry.	   AnnV	   and	   PI	   staining,	  
assessed	  by	  flow	  cytometry,	  was	  used	  to	  determine	  the	  level	  of	  non-­‐apoptotic	  (AnnV-­‐
PI-­‐),	  early	   (AnnV+PI-­‐)	  or	   late	  apoptotic	   (AnnV+PI+)	   thymocytes.	  A)	  Samples	  exposed	   to	  
Balb/c	   plasma	   consisted	   of	   three	   distinct	   populations:	   AnnV-­‐IgM-­‐,	   AnnV+IgM-­‐	   and	  
AnnV+IgM+.	  B)	   The	   three	   distinct	   populations	   present	   in	   samples	   exposed	   to	   Balb/c	  
plasma	  were	  further	  characterised	  by	  examining	  the	  FSC/SSC	  profile	  and	  AnnV	  and	  PI	  
positivity.	  Although	  both	  AnnV+IgM-­‐	  and	  AnnV+IgM+	  populations	  were	  predominantly	  
AnnV+	  PI+	  they	  occupied	  distinct	  separate	  regions	  of	  FSC/SSC	  contour	  plots.	  C)	  Within	  
the	   AnnV+IgM+	   population	   IgM	   binding	   occurred	   rapidly.	   Data	   expressed	   as	   means	  
±SEM.	  
	  
These	  data	  suggested	  that	  murine	  IgM	  antibodies	  were	  appearing	  to	  bind	  to	  a	  distinct	  
subset	   of	   apoptotic	   thymocytes	   that	   have	   exposed	   PtdSer	   (AnnV	   positive)	   and	   a	  
distinct	  FSC	  SSC	  profile.	  Our	  next	  objectives	  at	  this	  point	  were:	  	  
a) confirm	  whether	   cell	   surface	   C3	   deposition	   accompanied	   IgM	  binding,	   in	   line	  
with	  other	  investigators	  findings,	  and	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b) further	   characterize	   these	   distinct	   populations	   of	   IgM-­‐	   and	   IgM+	   apoptotic	  
thymocytes.	  
To	   do	   this	  we	   aimed	   to	   determine	  whether	   these	   distinct	   populations	  were	   formed	  
due	  to	  the	  action	  of	  IgM	  antibody	  binding	  or	  complement	  mediated	  cell	  disruption	  or	  
whether	   the	   IgM+	   cells	   had	   any	   obvious	   morphological	   differences	   detectable	   by	  
microscopy.	  We	  hoped	   that	   through	   these	   studies	  we	  would	  be	  able	   to	  discern	  why	  
IgM	  antibodies	  appeared	  to	  bind	  such	  a	  distinct	  population	  of	  thymocytes.	  
	  
5.3	   C3	   deposition	   is	   present	   on	   aged	   AnnV-­‐IgM-­‐,	   AnnV+IgM-­‐	   and	   AnnV+IgM+	  murine	  
thymocytes	  
As	   previous	   studies	   illustrated,	   IgM	   binding	   is	   often	   accompanied	   by	   complement	  
deposition	  on	  the	  cell	  surface.	  We	  therefore	  sought	  to	  confirm	  whether	  C3	  deposition	  
occurred	   on	   IgM	   bound	   cells	   in	   our	   assay	   (Figure	   5.3A-­‐B).	   Murine	   apoptotic	  
thymocytes	   were	   incubated	   in	   PBS,	   Balb/c	   plasma	   (as	   a	   source	   of	   C3)	   or	   heat	  
inactivated	  Balb/c	  plasma.	  C3	  deposition	  was	  assessed	  by	  flow	  cytometry	  and	  sample	  
populations	   were	   identified	   and	   designated	   as	   detailed	   in	   Figure	   5.3	   and	   5.4.	   C3	  
deposition	  was	  detected	  on	  AnnV+IgM-	  and	  AnnV+IgM+	  	  aged	  cell	  populations	  incubated	  
in	  Balb/c	  plasma	  (Figure	  5.5A-­‐B).	  Interestingly	  and	  unexpectedly,	  aged	  thymocytes	  not	  
yet	   expressing	   PtdSer,	   and	   as	   such	   classified	   as	   AnnV-­‐,	  appeared	   to	   demonstrate	   C3	  
deposition.	   Intrigued	  by	   this	  we	  sought	   to	   investigate	  C3	  deposition	  on	   fresh	  murine	  
thymocytes	   exposed	   to	   Balb/c	   plasma	   immediately	   following	   dissociation	   (fresh).	   As	  
expected	  fresh	  thymocytes	  remained	  convincingly	  C3	  negative	  (Figure	  5A-­‐B).	  Minimal	  
C3	  deposition	  was	  detected	  in	  all	  samples	  exposed	  to	  PBS	  and	  heat	  inactivated	  plasma	  
(Figure	   5.5B,	   Representative	   histograms	   (n	   =	   2-­‐3)).	   Although	   admittedly	   brief	   this	  
finding	   is	   striking	   as	   despite	   a	   high	   daily	   burden	   of	   apoptotic	   cells	   is	   generated,	  	  
apoptotic	  cells	  are	  rarely	  observed	  in	  healthy	  tissue	  (Mochizuki	  et	  al.,	  1996,	  Scott	  et	  al.,	  
2001,	  Elliott	  et	  al.,	  2009,	  Yang	  et	  al.,	  2006,	  Schrijvers	  et	  al.,	  2005,	  Gregory	  and	  Devitt,	  
2004).	  This	  data	  suggests	  that	  membrane	  alterations	  occur	  before	  traditionally	  defined	  
apoptosis	  is	  evident,	  enabling	  complement	  opsonisation	  and	  subsequent	  phagocytosis	  
early	  than	  previously	  thought.	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Figure	   5.5	   –	   C3	   deposition	   present	   on	   aged	  AnnV-­‐IgM-­‐,	   AnnV+IgM-­‐	   and	  AnnV+IgM+.	  
Murine	  thymocytes	  were	  used	  immediately	  (fresh)	  or	  rendered	  apoptotic	  by	  overnight	  
culture	   before	   being	   incubated	   in	   PBS,	   Balb/c	   plasma	   (as	   a	   source	   of	   C3)	   or	   heat	  
inactivated	   Balb/c	   plasma.	   C3	   deposition	   was	   detected	   by	   flow	   cytometry.	   Sample	  
populations	   were	   identified	   and	   designated	   as	   detailed	   in	   figure	   5.3	   and	   5.4.	   	   A)	  
Representative	   histograms.	   B)	   C3	   deposition	   was	   detected	   on	   AnnV+IgM-	   and	  
AnnV+IgM+	  aged	  cell	  populations	   incubated	   in	  Balb/c	  plasma.	   Interestingly,	  AnnV-­‐IgM-	  
cell	   populations	   exposed	   to	   Balb/c	   plasma	   exhibited	   low	   C3	   deposition	   when	   used	  
fresh.	  However,	  some	  C3	  binding	  was	  evident	  in	  thymocytes	  aged	  in	  vitro	  despite	  the	  
absence	   of	   a	   well	   established	   marker	   of	   apoptosis	   (AnnV	   positivity).	   Minimal	   C3	  
deposition	  was	  detected	   in	  all	   samples	  exposed	   to	  PBS	  and	  heat	   inactivated	  plasma.	  
Representative	  histograms	  (n	  =	  2-­‐3).	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5.4	   Formation	   of	   AnnV+	   IgM+	   population	   located	   on	   FSC/SSC	   plots	   appears	   plasma	  
dependent	  
We	  next	  wanted	  to	  further	  characterise	  the	  three	  distinct	  cell	  populations	  evident	  on	  
FSC	   SSC	   contour	   plots,	   as	   described	   in	   figure	   5.4B.	   The	   formation	   of	   these	   three	  
populations	  appeared	  to	  be	  plasma	  dependent,	  as	  when	  diluted	  1:1000	  the	  apoptotic	  
thymocytes	  largely	  remain	  as	  one	  population	  (Figure	  5.6A).	  Fresh	  thymocytes	  exposed	  
to	   plasma	   also	   largely	   remained	   as	   one	   population	   (Figure	   5.6B).	   We	   were	   next	  
interested	   in	   investigating	   whether	   the	   formation	   of	   these	   three	   populations	   was	  
partly	  dependent	  upon	  complement	  mediated	  cell	  disruption.	  As	   illustrated	   in	   figure	  
5.5	  we	   found	   that	  C3	  was	  deposited	  on	   the	  cell	   surface	  of	   IgM+	  cells.	   	  However,	   the	  
populations	   were	   still	   present	   on	   FSC	   SSC	   contour	   plots	   of	   apoptotic	   murine	  
thymocytes	  exposed	  to	  heat	   inactivated	  Balb/c	  plasma	   (Figure	  5.6C).	   In	  addition,	   the	  
populations	   were	   present	   in	   samples	   exposed	   to	   immunodeficient	   RAG-­‐1	   plasma,	  
suggesting	   that	   formation	   of	   this	   population	   is	   immunoglobulin	   independent	   (Figure	  
5.6D).	  
	  
5.5	  Circulating	  IgM	  binds	  to	  murine	  apoptotic	  thymocytes	  with	  evidence	  of	  a	  disrupted	  
cell	  membrane	  
We	   explored	   whether	   apoptotic	   thymocytes	   that	   bound	   IgM	   demonstrated	   any	  
morphological	   features	   that	   might	   explain	   the	   disparity	   of	   IgM	   binding	   to	   AnnV+PI+	  
cells	   and	   the	   differing	   FSC/SSC	   profiles	   of	   the	   AnnV+IgM+	   and	   AnnV+IgM-­‐	   cell	  
populations.	  CellTracker	  Green	  labelled	  thymocytes	  were	  FACS	  sorted	  into	  AnnV-­‐IgM-­‐,	  
AnnV+IgM-­‐	  and	  AnnV+IgM+	  populations	  on	  the	  basis	  of	  FSC	  SSC	  populations	  (illustrated	  
in	  Figure	  5.4B)	  by	  FACS.	  Post	  FACS	  sorting	  checks	  were	  performed	  to	  assess	  whether	  
the	  fragile	  apoptotic	  thymocytes	  remained	  intact/morphologically	  normal	  according	  to	  
FSC	   SSC	   following	   a	   high-­‐pressure	   sort.	   Figure	   5.7	   indicates	   that	   all	   sorted	   cell	  
populations	  lie	  predominantly	  within	  their	  corresponding	  gate	  following	  FACS	  sorting.	  
The	   apoptotic	   AnnV+IgM-­‐	   population	   (Figure	   5.7	   –	   lower	   right	   yellow/orange	   boxed	  
panel)	   moved	   further	   towards	   the	   right,	   this	   is	   expected	   due	   to	   ongoing	   apoptosis	  
related	  morphological	  changes	  during	  FACS	  sorting.	  Sorted	  cells	  populations	  were	  then	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Figure	  5.6	   –	   Formation	  of	  AnnV+IgM+	  population	   located	  on	   FSC/SSC	  plots	   appears	  
plasma	  dependent.	  Murine	  thymocytes	  were	  rendered	  apoptotic	  by	  overnight	  culture	  
before	   being	   incubated	   in	   immunodeficient	   RAG-­‐1	   plasma,	   Balb/c	   plasma	   or	   heat	  
inactivated	  Balb/c	  plasma.	  Samples	  were	  then	  analysed	  by	  flow	  cytometry	  and	  FSC	  SSC	  
contour	   plots	   were	   examined	   to	   identify	   and	   gate	   the	   three	   distinct	   populations	   as	  
illustrated	  in	  figure	  5.4B.	  A)	  The	  formation	  of	  the	  three	  FSC	  SSC	  populations	  appears	  to	  
be	  plasma	  dependent,	  as	  when	  diluted	  1:1000	  the	  thymocytes	   largely	  remain	  as	  one	  
population	   on	   FSC	   SSC	   contour	   plots.	   B)	   Fresh	   thymocytes	   remain	   largely	   as	   one	  
population	  on	  FSC	  SSC	  contour	  plots.	  C)	  Heat	   inactivation	  of	  plasma	  does	  not	   inhibit	  
the	   formation	   of	   the	   three	   distinct	   populations.	  D)	   Formation	   of	   the	   three	   distinct	  
populations	   appears	   immunoglobulin	   independent,	   as	   the	   three	   distinct	   FSC	   SSC	  
populations	  remains	  present	   in	  samples	  exposed	  to	  RAG-­‐1	  plasma.	  Representative	  of	  
several	  experiments.	  
	  
examined	  by	  confocal	  microscopy.	  Unsurprisingly	  AnnV	  and	  IgM	  staining	  was	  absent	  in	  
sorted	   AnnV-­‐IgM-­‐	   cell	   populations	   (Figure	   5.8A).	   Similarly,	   AnnV+IgM-­‐	   cells	   only	  
displayed	  AnnV	   staining	   that	   appeared	   restricted	   to	   the	  membrane	  with	   no	   obvious	  
morphological	   differences	   to	   AnnV-­‐IgM-­‐	   cells	   	   (Figure	   5.8B).	   Some	   AnnV+IgM+	   cells	  
appeared	  disrupted	  with	   abnormal	   cellular	  morphology	   and	   some	   cells	   appearing	   to	  
have	   large	   ‘openings’	   in	   the	  membrane	   (Figure	  5.8C)	  Therefore,	  electron	  microscopy	  
was	  used	  to	  investigate	  the	  cellular	  and	  membrane	  morphology	  in	  detail	  (Figure	  5.9A-­‐
C).	  	  AnnV-­‐IgM-­‐	  cells	  	  (Figure	  5.9A)	  appeared	  	  non-­‐apoptotic	  	  with	  an	  	  intact	  	  membrane	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Figure	  5.7	  –	  Post	  FACS	  sorting	  checks	  demonstrate	  that	  sorted	  murine	  apoptotic	  cells	  
remain	   in	   designated	   pre-­‐sort	   defined	   populations.	   Murine	   thymocytes	   rendered	  
apoptotic	   by	   overnight	   culture	  were	   FACS	   sorted	   into	   AnnV+IgM+,	   AnnV+IgM-­‐,	   AnnV-­‐
IgM-­‐	   cell	   populations	   for	   confocal	   or	   electron	  microscopy	   studies.	   Post	   FACS	   sorted	  
FSC/SSC	   dot	   plots	   demonstrate	   that	   the	   apoptotic	   thymocytes	   remain	   within	   the	  
designated	  pre-­‐sort	  gates.	  
	  
whilst	   AnnV+IgM-­‐	   cells	   (Figure	   5.9B)	   exhibited	   nuclear	   pyknosis	   with	   preservation	   of	  
cytoplasmic	   and	   membrane	   integrity.	   However,	   the	   membrane	   of	   AnnV+IgM+	   cells	  
(Figure	  5.9C)	  was	  severely	  disrupted	  compared	  to	  either	  AnnV-­‐IgM-­‐	  cells	  or	  AnnV+IgM-­‐	  
cells.	   Despite	   marked	   membrane	   disruption	   AnnV+IgM+	   cells	   appeared	   to	   maintain	  
sufficient	   cellular	   integrity	   to	   prevent	   the	   overt	   loss	   of	   organelles,	   such	   as	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Figure	   5.8	   -­‐	   IgM	   bound	   murine	   apoptotic	   thymocytes	   appear	   disrupted.	   Murine	  
thymocytes	  were	  stained	  with	  a	  membrane	  cell	   tracker	  and	  then	  rendered	  apoptotic	  
by	   overnight	   culture.	   	   Thymocytes	   were	   then	   exposed	   to	   Balb/c	   plasma	   prior	   to	  
incubation	   with	   anti-­‐IgM	   antibody,	   AnnV	   and	   DAPI.	   	   On	   the	   basis	   of	   FSC/SSC	  
thymocytes	   were	   then	   sorted	   into	   AnnV-­‐IgM-­‐	   (A),	   AnnV+IgM-­‐	   (B)	   and	   AnnV+IgM+	   (C)	  
populations,	   as	   illustrated	   in	   figure	   5.4B,	   by	   FACS	   and	   examined	   by	   confocal	  
microscopy.	   A)	   AnnV-­‐IgM-­‐	   thymocytes	   were	   AnnV	   and	   IgM	   negative.	   B)	   AnnV+IgM-­‐	  
thymocytes	   exhibited	   AnnV	   membrane	   staining	   but	   remained	   IgM	   negative	   and	  
morphologically	   appeared	   intact.	   C)	   AnnV+IgM+	   thymocytes	   were	   AnnV	   positive	   and	  
appeared	  disrupted	  with	   irregular	  cellular	  morphology	  (arrowhead)	  with	  an	  apparent	  
IgM+	  membrane.	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Figure	   5.9	   -­‐	   IgM	   bound	  murine	   apoptotic	   thymocytes	   appear	   to	   have	   a	   disrupted	  
plasma	  membrane.	  Murine	  thymocytes	  were	  rendered	  apoptotic	  by	  overnight	  culture	  
and	   then	   exposed	   to	   Balb/c	   plasma	   prior	   to	   incubation	   with	   anti-­‐IgM	   antibody	   and	  
AnnV.	   	   On	   the	   basis	   of	   FSC/SSC	   thymocytes	   were	   then	   sorted	   into	   AnnV-­‐IgM-­‐	   (A),	  
AnnV+IgM-­‐	  (B)	  and	  AnnV+IgM+	  (C)	  populations,	  as	  illustrated	  in	  figure	  5.4B,	  by	  FACS	  and	  
examined	   by	   electron	   microscopy	   A)	   AnnV-­‐IgM-­‐	   cells	   appeared	   non-­‐apoptotic	   with	  
normal	   nuclei	   and	   intact	   plasma	   membranes.	   B)	   AnnV+IgM-­‐	   cells	   exhibited	   nuclear	  
pyknosis	   (PK,	   arrowed)	  with	  preservation	  of	   cytoplasmic	  and	  membrane	   integrity.	  C)	  
Electron	   microscopy	   studies	   confirmed	   that	   AnnV+IgM+	   cells	   had	   a	   disrupted	  
membrane	  (DM,	  arrowed)	  with	  cellular	  disorganisation,	  but	  retention	  of	  mitochondria	  
(Mt,	  arrowed).	  Representative	  images.	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5.6	  Circulating	  IgM	  binds	  strongly	  to	  saponin	  permeabilised	  murine	  thymocytes	  
In	  light	  of	  the	  previous	  results	  we	  hypothesized	  that	  circulating	  IgM	  may	  be	  interacting	  
with	   intracellular	   epitopes	   only	   accessible	   following	   significant	   loss	   of	   plasma	  
membrane	   integrity	   and	   that	   these	   epitopes	  were	   not	   necessarily	   generated	   during	  
apoptosis	   by	   caspases	   and	   other	   enzymes.	  We	   then	   examined	   whether	   IgM	   bound	  
non-­‐apoptotic	   thymocytes,	   which	   are	   consistently	   IgM	   negative,	   following	  
permeabilisation	   with	   saponin.	   IgM	   binding	   of	   permeabilised	   non-­‐apoptotic	  
thymocytes	  was	  assessed	  following	  exposure	  to	  PBS,	  or	  plasma	  from	  either	  Balb/c	  or	  
RAG-­‐1	   deficient	   mice	   (n	   =	   3	   per	   group).	   Saponin	   treated	   non-­‐apoptotic	   thymocytes	  
were	  PI+	   indicating	   successful	  permeabilisation	  and	  demonstrated	  a	  dramatic	   shift	   in	  
IgM	  positivity	  whilst	  control	  non-­‐saponin	  treated	  non-­‐apoptotic	  thymocytes	  remained	  
negative	  for	  both	  PI	  and	  IgM	  (Figure	  5.10A).	  	  
	  
We	   next	   assessed	   if	   IgM	   would	   bind	   more	   strongly	   to	   saponin	   treated	   apoptotic	  
thymocytes,	  a	  large	  percentage	  of	  which	  remain	  IgM	  negative	  as	  evident	  in	  figure	  5.4A	  
(n	   =	   4	   per	   group).	   A	   small	   proportion	   of	   apoptotic	   thymocytes	   were	   PI	   positive	  
representing	  late	  apoptotic	  thymocytes	  but	  nearly	  all	  cells	  became	  PI	  positive	  (>99%)	  
following	   permeabilisation	   with	   saponin	   (Figure	   5.10B).	   In	   the	   absence	   of	  
permeabilisation	   a	  minority	   of	   apoptotic	   thymocytes	   were	   IgM+	   representing	   the	   PI	  
positive	   population	   shown	   in	   figure	   5.10B.	   However,	   following	   permeabilisation	   the	  
majority	   of	   cells	   (>98%)	   became	   IgM	   positive	   (Figure	   5.10B).	   Inclusion	   of	   isotype	  
control	   IgM	   antibodies	   (Mouse	   (Balb/c)	   IgM	   κ	   isotype	   control)	   confirmed	   that	   IgM	  
binding	  of	  permeabilised	  cells	  was	  not	  due	  to	  a	  non-­‐specific	  interaction	  (Figure	  5.10A-­‐
B).	   Furthermore,	   confocal	  microscopy	   confirmed	   these	   results	   as	  permeabilised	  non-­‐
apoptotic	  thymocytes	  were	  AnnV+,	  indicating	  permeability,	  and	  IgM+.	  IgM	  appeared	  to	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Figure	   5.10	   -­‐	   IgM	   binds	   strongly	   to	   permeabilised	   non-­‐apoptotic	   and	   apoptotic	  
thymocytes.	  Non-­‐apoptotic	  and	  apoptotic	   thymocytes,	   induced	  by	  overnight	  culture,	  
were	  permeabilised	  with	  saponin	  prior	  to	  incubation	  with	  Balb/c	  plasma.	  Permeability	  
was	   confirmed	   by	   PI	   staining	   and	   IgM	   binding	   was	   assessed	   by	   flow	   cytometry.	   A)	  
Following	  permeablisation	  non-­‐apoptotic	  thymocytes	  were	  predominantly	  PI	  positive.	  
Non-­‐permeable	  non-­‐apoptotic	  thymocytes	  remained	  consistently	  IgM	  negative,	  whilst	  
the	  majority	  of	  permeable	  thymocytes	  were	  IgM	  positive.	  Inclusion	  of	  isotype	  control	  
IgM	  antibodies	  confirmed	  that	  IgM	  binding	  was	  not	  due	  to	  a	  non-­‐specific	  interaction	  of	  
IgM.	  B)	  A	  small	  proportion	  of	  apoptotic	  thymocytes	  were	  PI	  positive	  representing	  late	  
apoptotic	   thymocytes;	   however	   following	   permeabilisation	   with	   saponin	   the	   cell	  
population	  became	  PI	  positive.	   	  Whilst	  a	  minority	  of	  apoptotic	   thymocytes	  were	   IgM	  
positive,	   representing	   the	   AnnV+IgM+	   population	   discussed	   in	   figure	   5.3C-­‐E,	   with	  
permeabilisation	   the	   population	   became	   IgM	   positive.	   C)	   Confocal	   microscopy	  
demonstrates	  that	  permeabilised	  non-­‐apoptotic	  thymocytes	  were	  AnnV	  positive,	  used	  
to	  indicate	  permeability,	  with	  IgM	  appearing	  to	  bind	  the	  cellular	  membrane,	  with	  some	  
intracellular	  staining	  evident.	  Representative	  histograms	  (Non-­‐apoptotic	  thymocytes	  n	  
=	  3;	  Apoptotic	  thymocytes	  n	  =	  4).	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5.7	  A	  16-­‐hour	  incubation	  with	  0.5µM	  camptothecin	  elicited	  mixed	  levels	  of	  apoptosis	  
in	  human	  Jurkat	  cells	  
We	   then	   explored	   the	   relevance	   of	   these	   findings	   to	   human	   biology	   using	   human	  
Jurkat	  cells.	  As	  with	  the	  murine	  apoptotic	  cell	  studies	  we	  aimed	  to	  obtain	  a	  population	  
of	  Jurkat	  cells	  at	  various	  stages	  of	  apoptosis	  to	  probe	  IgM	  binding.	  	  Camptothecin	  was	  
used	   to	   induce	   apoptosis	   and	   a	   titration	   was	   performed.	   Human	   Jurkat	   cells	   at	   a	  
density	  of	  2x106/mL	  were	  treated	  with	  0,	  0.5,	  1.5	  and	  2	  µM	  camptothecin	  for	  16-­‐hours.	  	  
AnnV	  and	  PI	  staining,	  assessed	  by	  flow	  cytometry,	  was	  used	  to	  determine	  the	  level	  of	  
apoptosis.	  Untreated	   Jurkat	   cells	   remained	  AnnV-­‐PI-­‐;	  whilst	   all	   camptothecin	   treated	  
cells	   had	   a	   large	   but	   similar	   populations	   of	   AnnV+PI+	   cells,	   and	   a	   small	   transient	  
population	  that	  could	  be	  AnnV+PI-­‐	  (Figure	  5.11).	  The	  difference	  in	  AnnV+PI+	  population	  
sizes	  was	  negligible	  and	  the	  lower	  camptothecin	  concentration	  of	  0.5	  µM	  was	  selected	  
for	  future	  experiments	  as	  this	  induced	  an	  acceptable	  level	  of	  apoptosis.	  
	  
	  
Figure	   5.11	   –	   Titration	   of	   camptothecin	   induced	   apoptosis	   in	   human	   Jurkat	   cells.	  
Human	   Jurkat	   cells	  at	  a	  density	  of	  2x106/mL	  were	   treated	  with	  0,	  0.5,	  1.5	  and	  2	  µM	  
camptothecin	  for	  16-­‐hours	  to	  induce	  apoptosis.	  	  AnnV	  and	  PI	  staining,	  assessed	  by	  flow	  
cytometry,	   was	   used	   to	   determine	   the	   level	   of	   non-­‐apoptotic	   (AnnV-­‐PI-­‐),	   early	  
(AnnV+PI-­‐)	   or	   late	   apoptotic	   (AnnV+PI+)	   Jurkat	   cells.	   Non-­‐camptothecin	   Jurkat	   cells	  
remained	   AnnV-­‐PI-­‐;	   whilst	   all	   camptothecin	   treated	   cells	   had	   a	   large	   population	   of	  
AnnV+PI+	   cells,	   and	   a	   small	   transient	   population	   that	   could	   be	   AnnV+PI-­‐.	   Gates	  were	  
defined	  on	  the	  basis	  of	  single	  stained	  controls.	  Representative	  dot	  plots.	  	  
	  
5.8	  Circulating	  human	  IgM	  preferentially	  bind	  a	  subpopulation	  of	  AnnV+PI+	  Jurkat	  cells	  
We	  then	  aimed	  to	  ascertain	  whether	  human	  Jurkat	  cells	  would	  demonstrate	  a	  similar	  
IgM	  binding	  profile	  to	  that	  observed	   in	  murine	  thymocytes.	   Jurkat	  cells	  were	  treated	  
with	   camptothecin	   for	   16-­‐hours	   to	   induce	   apoptosis	   and	   exposed	   to	   PBS	   or	   30%	  
pooled	  normal	  human	  serum	  as	  a	  source	  of	  IgM.	  Apoptotic	  Jurkat	  cells	  were	  gated	  on	  
the	   basis	   of	   AnnV	   positivity	   and	   the	   percentage	   of	   AnnV+IgM+	   Jurkat	   cells	   was	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determined	  (Figure	  5.12A-­‐C).	  	  A	  significant	  proportion	  of	  apoptotic	  Jurkat	  cells	  exposed	  
to	   human	   serum	  were	   IgM+	   (Student’s	   t-­‐test;	  P	   <	   0.0001;	  n	   =	   4)	   compared	   to	   those	  
incubated	   in	  PBS	   (Figure	  5.12B).	  As	  observed	   in	  murine	  apoptotic	   thymocytes,	   Jurkat	  
cells	   exposed	   to	   human	   serum	   also	   consisted	   of	   three	   distinct	   populations	   (Figure	  
5.12C)	   including	   an	   AnnV-­‐IgM-­‐	   population	   that	   comprised	   of	   non-­‐apoptotic	   cells.	   In	  
addition,	  despite	  all	  AnnV+	  cells	  being	  PI+,	  two	  AnnV+	  populations	  were	  evident	  being	  
either	   AnnV+IgM-­‐	   or	   AnnV+IgM+.	   These	   AnnV+IgM-­‐	   and	   AnnV+IgM+	   cell	   populations	  
occupied	  relatively	  distinct	   regions	  of	  FSC/SSC	  contour	  plots	   (Figure	  5.12D),	  although	  
the	  downward	  shift	  of	  AnnV+IgM+	  cells	  in	  relation	  to	  AnnV+IgM-­‐	  cells	  was	  subtler	  than	  
that	  observed	  in	  murine	  thymocytes	  (Figure	  5.4B).	  	  
	  
	  
Figure	  5.12	  -­‐	  IgM	  binds	  AnnV+	  PI+	  human	  Jurkat	  cells.	  Human	  Jurkat	  cells	  were	  treated	  
with	   0.5	   µM	   camptothecin	   for	   16-­‐hours	   to	   induce	   apoptosis	   and	   exposed	   to	   PBS	   or	  
30%	   normal	   human	   serum	   as	   a	   source	   of	   IgM.	   AnnV	   and	   PI	   staining	   was	   used	   to	  
determine	   the	   level	   of	   non-­‐apoptotic	   (AnnV-­‐PI-­‐),	   early	   (AnnV+PI-­‐)	   or	   late	   apoptotic	  
(AnnV+PI+)	   Jurkat	   cells.	   Staining	   was	   assessed	   by	   flow	   cytometry.	  A)	   Representative	  
histogram	  illustrating	  IgM	  binding	  to	  AnnV+	  apoptotic	  Jurkat	  cells	  within	  human	  serum	  
and	  PBS	  treatment	  groups.	  	  B)	  Apoptotic	  Jurkat	  cells	  were	  gated	  on	  the	  basis	  of	  AnnV	  
positivity	  and	  the	  percentage	  of	  AnnV+IgM+	  Jurkat	  cells	  was	  assessed.	  	  Apoptotic	  Jurkat	  
cells	   exposed	   to	   human	   serum	   exhibited	   significant	   IgM	   binding.	   (n	   =	   4)	  C)	   Samples	  
exposed	   to	   human	   plasma	   consisted	   of	   three	   distinct	   populations:	   AnnV-­‐IgM-­‐,	  
AnnV+IgM-­‐	  and	  AnnV+IgM+.	  Apoptotic	  Jurkat	  cells	  were	  largely	  AnnV+PI+.	  D)	  The	  three	  
distinct	   populations	   present	   in	   samples	   exposed	   to	   human	   serum	   were	   further	  
characterised	  by	  examining	  FSC/SSC	  profiles.	  Although	  both	  AnnV+IgM-­‐	  and	  AnnV+IgM+	  
populations	   were	   AnnV+PI+	   they	   occupy	   distinct	   and	   separate	   regions	   of	   FSC/SSC	  
contour	  plots.	  	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  Chapter	  5:	  IgM	  binding	  requires	  membrane	  disruption	  127	  
5.9	   Circulating	   IgM	   binding	   to	   apoptotic	   human	   Jurkat	   cells	   appears	   membrane	  
restricted	  
The	   morphology	   of	   IgM	   bound	   apoptotic	   Jurkat	   cells	   was	   analysed	   by	   confocal	  
microscopy.	  As	   figure	  5.13	   illustrates	  apoptotic	   Jurkat	  cells	  exhibited	  AnnV	  and	  some	  
IgM	  positive	  staining	  that	  appeared	  restricted	  to	  the	  membrane,	  whilst	  non-­‐apoptotic	  
Jurkat	   cells	   displayed	   no	   positive	   staining	   as	   expected.	   Some	   IgM	   staining	   that	  
appeared	  intracellular	  was	  also	  evident.	  
	  
	  
Figure	   5.13	   -­‐	   IgM	   binding	   to	   apoptotic	   human	   Jurkat	   cells	   appears	   membrane	  
restricted.	  Human	  Jurkat	  cells	  were	  treated	  with	  camptothecin	  for	  16-­‐hours	  to	  induce	  
apoptosis.	   	   Jurkat	  cells	  were	   then	  exposed	  to	  30%	  human	  serum	  as	  a	  source	  of	   IgM.	  
Confocal	   microscopy	   revealed	   that	   whilst	   non-­‐apoptotic	   Jurkat	   cells	   remained	  
negative,	   late	   apoptotic	   Jurkat	   cells	   exhibited	   AnnV	   staining	   which	   appeared	   to	   be	  
restricted	   to	   the	  membrane.	  Non-­‐apoptotic	   Jurkat	   cells	  were	  also	   IgM	  negative.	   IgM	  
staining	  on	  late	  apoptotic	  Jurkat	  cells	  appeared	  in	  the	  region	  of	  the	  plasma	  membrane	  
with	  intracellular	  staining	  also	  evident.	  Representative	  images.	  
	  
5.10	  Circulating	  IgM	  binds	  strongly	  to	  saponin	  permeabilised	  human	  Jurkat	  cells	  
IgM	   binding	   to	   saponin	   permeabilised	   non-­‐apoptotic	   Jurkat	   cells	   was	   assessed	   to	  
determine	  if	  human	  IgM	  could	  bind	  intracellular	  epitopes	  within	  normal	  cells	  (n	  =	  3	  per	  
group).	   Following	  permeabilisation	  non-­‐apoptotic	   Jurkat	   cells	  were	  predominantly	   PI	  
and	   IgM	   positive	   (>98%),	   whilst	   non-­‐saponin	   treated	   non-­‐apoptotic	   Jurkat	   cells	  
remained	  consistently	  PI	  and	  IgM	  negative	  (Figure	  5.14A).	  Confocal	  microscopy	  further	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confirmed	   these	   results	   as	   permeabilised	   non-­‐apoptotic	   Jurkat	   cells	   were	   AnnV+,	  
indicating	  permeability,	  and	  IgM+	  with	  IgM	  appearing	  to	  bind	  in	  the	  region	  of	  the	  cell	  




Figure	   5.14	   -­‐	   IgM	   binds	   permeabilised	   non-­‐apoptotic	   human	   Jurkat	   cells.	   Non-­‐
apoptotic	  Jurkat	  cells	  were	  permeabilised	  with	  saponin	  prior	  to	  incubation	  with	  human	  
serum.	  A)	  Permeability	  was	  confirmed	  by	  PI	  staining	  and	  IgM	  binding	  was	  assessed	  by	  
flow	   cytometry.	   Following	   permeabilisation	   non-­‐apoptotic	   Jurkat	   cells	   were	  
predominantly	   PI	   positive.	   	   Non-­‐permeable	   non-­‐apoptotic	   Jurkat	   cells	   remained	  
consistently	   IgM	   negative,	   whilst	   permeable	   Jurkat	   cells	   were	   IgM	   positive.	  
Representative	   histograms	   (n	   =	   3	   per	   group).	   B)	   Confocal	   microscopy	   revealed	   that	  
permeabilised	  Jurkat	  cells	  exhibited	  AnnV	  staining	  that	  appears	  membrane	  restricted.	  
IgM	  appeared	  to	  bind	  strongly	   in	  the	  plasma	  membrane	  region,	  but	   intracellular	   IgM	  
staining	  was	  also	  evident.	  Representative	  images.	  
	  
5.11	  A	  2-­‐hour	  incubation	  with	  25	  µM	  H2O2	  elicited	  mixed	  levels	  of	  apoptosis	  in	  human	  
Jurkat	  cells	  
We	   sought	   to	   replicate	   the	   observed	   pattern	   of	   IgM	   binding	   to	   human	   Jurkat	   cells	  
using	  a	  different	  apoptosis-­‐inducing	  agent	  to	  further	  support	  our	  findings	  and	  confirm	  
that	  binding	  was	  not	   specific	   for	   apoptosis	   induced	  by	   camptothecin.	  H2O2	  was	   thus	  
used	   to	   induce	   apoptosis	   and	   a	   titration	   was	   performed.	   Human	   Jurkat	   cells	   at	   a	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density	  of	  2x106/mL	  were	  treated	  with	  0,	  0.5,	  2.5,	  5	  and	  25	  µM	  H2O2	  for	  1-­‐hour.	  AnnV	  
and	   PI	   staining,	   assessed	   by	   flow	   cytometry,	   was	   used	   to	   determine	   the	   level	   of	  
apoptosis.	   Non-­‐H2O2	   Jurkat	   cells	   remained	   AnnV-­‐PI-­‐	   (Figure	   5.15).	   	   The	   majority	   of	  
Jurkat	   cells	   treated	  with	   0.5	   to	   5	   µM	  H2O2	  remained	   AnnV-­‐PI-­‐	  similar	   to	   non-­‐treated	  
samples	   (data	   not	   shown).	  Only	   Jurkat	   cells	   treated	  with	   25	   µM	  H2O2	  demonstrated	  
apoptosis	   with	   a	   small	   AnnV+PI-­‐	   population.	   In	   light	   of	   this	   data	   Jurkat	   cells	   were	  
treated	  with	  25	  µM	  H2O2	  for	  2-­‐hours	  and	  this	  elicited	  a	  population	  with	  mixed	  levels	  of	  
apoptosis	   (approximately	   38%	   AnnV-­‐PI-­‐,	   30%	   AnnV+PI-­‐	   and	   25%	   AnnV+PI+).	   Future	  
experiments	  induced	  apoptosis	  in	  Jurkat	  cells	  by	  a	  2-­‐hour	  incubation	  in	  25	  µM	  H2O2.	  
	  
	  
Figure	  5.15	  –	  Titration	  of	  H2O2	  induced	  apoptosis	  in	  human	  Jurkat	  cells.	  Human	  Jurkat	  
cells	  at	  a	  density	  of	  2x106/mL	  were	  treated	  with	  0,	  0.5,	  1.5,	  2,	  5	  and	  25	  µM	  H2O2	  for	  1-­‐
hour	  to	  induce	  apoptosis.	  	  AnnV	  and	  PI	  staining,	  assessed	  by	  flow	  cytometry,	  was	  used	  
to	  determine	   the	   level	  of	  non-­‐apoptotic	   (AnnV-­‐PI-­‐),	   early	   (AnnV+PI-­‐)	  or	   late	  apoptotic	  
(AnnV+PI+)	   Jurkat	   cells.	   Non-­‐H2O2	   Jurkat	   cells	   remained	   AnnV-­‐PI-­‐.	   Jurkat	   cells	   treated	  
with	  0.5	   to	  5	  µM	  H2O2	  remained	  AnnV-­‐PI-­‐	   (not	   shown),	  only	   cells	   treated	  with	  25µM	  
H2O2	  had	   a	   small	   AnnV+PI-­‐	   population.	  On	   the	   basis	   of	   this	   Jurkat	   cells	  were	   treated	  
with	   25	   µM	   for	   2-­‐hours	  which	   induced	   a	   population	  with	  mixed	   levels	   of	   apoptosis.	  
Representative	  dot	  plots.	  
	  
5.12	   Circulating	   IgM	   appears	   to	   bind	   AnnV+PI+	   human	   Jurkat	   cells	   following	   H2O2	  
induced	  apoptosis,	  however	  FSC	  SSC	  contour	  plots	  of	  AnnV-­‐IgM-­‐	  cells	  appear	  abnormal	  
IgM	  binding	  to	  non-­‐apoptotic	  cells	  and	  Jurkat	  cells	  treated	  with	  25	  µM	  H2O2	  exposed	  
to	  PBS	  or	  human	  serum	  was	  assessed	  by	  flow	  cytometry.	  Apoptotic	  Jurkat	  cells	  were	  
gated	  on	  the	  basis	  of	  AnnV	  positivity	  and	  the	  percentage	  of	  AnnV+IgM+	  Jurkat	  cells	  was	  
determined	  (Figure	  5.16A-­‐C).	  Apoptotic	  Jurkat	  cells	  demonstrated	  a	  shift	  towards	  IgM	  
positivity	   (Figure	  5.16A).	  As	  previously	  observed	   in	   camptothecin	   treated	   Jurkat	   cells	  
(Figure	   5.15C),	   two	   distinct	   AnnV+	   populations	   were	   present,	   AnnV+IgM-­‐	   and	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AnnV+IgM+,	  with	   apoptotic	   Jurkat	   cells	   being	   predominantly	   AnnV+PI+	  (Figure	   5.16B).	  
Analysis	   of	   FSC	   SSC	   contour	   plots	   revealed	   that	   AnnV-­‐IgM-­‐	   (also	   PI-­‐)	   cells	   had	   an	  
abnormal	  morphology.	   	   As	   cells	   progress	   through	   apoptosis	   they	  move	   towards	   the	  
lower	   left	   portion	   of	   FSC	   SSC	   plots,	   reflecting	   a	   loss	   of	   complexity	   and	   cell	   size	  
indicative	   of	   apoptosis	   related	   morphological	   changes	   including	   cell	   shrinkage.	   The	  
H2O2	  AnnV-­‐IgM-­‐	  population	  located	  to	  a	  region	  in	  which	  cells	  at	  an	  advanced	  stage	  of	  
apoptosis	   are	  expected.	   	   This	   suggests	   that	  H2O2	  had	  adversely	  affected	   cells.	   It	  was	  
decided	  that	  the	  data	  obtained	  from	  this	  assay	  would	  be	  unreliable,	  and	  attempts	  to	  
replicate	  IgM	  binding	  to	  H2O2	  treated	  Jurkat	  cells	  were	  not	  continued.	  
	  
	  
Figure	   5.16	   –	   IgM	   appears	   to	   bind	   AnnV+PI+	   human	   Jurkat	   cells	   following	   H2O2	  
induced	   apoptosis,	   however	   FSC	   SSC	   contour	   plots	   of	   AnnV-­‐IgM-­‐	   cells	   appear	  
abnormal.	  Human	   Jurkat	   cells	   were	   treated	  with	   25	   µM	   H2O2	   for	   2-­‐hours	   to	   induce	  
apoptosis.	  	  Jurkat	  cells	  were	  then	  exposed	  to	  PBS	  or	  human	  serum	  (as	  a	  source	  of	  IgM).	  	  
IgM	  binding	  was	  then	  assessed	  by	  flow	  cytometry.	  AnnV	  and	  PI	  staining,	  assessed	  by	  
flow	   cytometry,	   was	   used	   to	   determine	   the	   level	   of	   non-­‐apoptotic	   (AnnV-PI-),	   early	  
(AnnV+PI-)	   or	   late	   apoptotic	   (AnnV+PI+)	   Jurkat	   cells.	   A)	   Representative	   histogram	  
illustrating	   IgM	  binding	  to	  AnnV+	  apoptotic	   Jurkat	  cells	  within	  human	  serum	  and	  PBS	  
treatment	  groups.	  B)	  Samples	  exposed	  to	  human	  plasma	  consisted	  of	  two	  populations:	  
AnnV+IgM-	   and	  AnnV+IgM+.	   Apoptotic	   Jurkat	   cells	  were	   largely	  AnnV+PI+.	  D)	   The	   two	  
populations	  present	   in	  samples	  exposed	  to	  human	  serum	  were	   further	  characterised	  
by	  examining	  FSC	  SSC.	  AnnV-­‐IgM-­‐	  cells	  had	  an	  abnormal	  FSC	  SSC	  contour	  plot	  indicative	  
of	   cell	   fragmentation	   and	   poor	   cellular	   morphology.	   Representative	   histograms	   and	  
contour	  plots	  (n	  =	  1	  (in	  triplicate)).	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5.13	  Circulating	  IgM	  in	  human	  serum	  binds	  saponin	  permeabilised	  human	  proximal	  
tubular	  epithelial	  cells	  
To	  determine	  if	  circulating	  IgM	  could	  interact	  with	  intracellular	  antigens	  present	  within	  
non-­‐lymphoid	   cells	   we	   examined	   IgM	   binding	   to	   saponin	   permeabilised	   human	  
proximal	   tubular	   epithelial	   (HK-­‐2)	   cells;	   a	   cell	   line	  derived	   from	  normal	   adult	   human	  
kidney	   (Ryan	   et	   al.,	   1994)	   (Figure	   5.17A).	   A	   distinct	   shift	   in	   PI	   positivity	   confirmed	  
permeabilisation	   of	   saponin	   treated	   HK-­‐2	   cells	   (Figure	   5.17B).	   Control	   non-­‐
permeabilised	   HK-­‐2	   cells	   remained	   consistently	   IgM-­‐	   whilst	   permeabilised	   HK-­‐2	   cells	  




Figure	  5.17	  -­‐	  IgM	  binds	  to	  permeable	  human	  proximal	  tubule	  epithelial	  (HK-­‐2)	  cells.	  
Non-­‐apoptotic	  HK-­‐2	  cells	  (A)	  were	  permeabilised	  with	  saponin	  prior	  to	  incubation	  with	  
human	  serum	  (as	  a	  source	  of	  IgM).	  Permeability	  was	  confirmed	  by	  PI	  staining	  and	  IgM	  
binding	  was	  assessed	  by	  flow	  cytometry.	  B)	  Saponin	  treated	  HK-­‐2	  cells	  demonstrated	  a	  
distinct	   shift	   in	  PI	  positivity	   indicating	  successful	  permeabilisation.	  C)	  Non-­‐permeable	  
HK-­‐2	  cells	  remained	  consistently	   IgM	  negative,	  whilst	  HK-­‐2	  cells	  treated	  with	  saponin	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5.14	  Circulating	  murine	  IgM	  specifically	  binds	  permeabilised	  erythrocytes	  
Confocal	  microscopy	  studies	  of	  AnnV+IgM+	  apoptotic	  thymocytes	  and	  apoptotic	  Jurkat	  
cells	   suggested	   IgM	   binding	   to	   the	   cell	   membrane	   together	   with	   some	   intracellular	  
binding	   and	   it	   was	   thus	   possible	   that	   IgM	   also	   bound	   intracellular	   organelles.	   We	  
therefore	  used	  murine	  erythrocytes	  as	  a	  simple	  anucleate	  target	  with	  no	  intracellular	  
organelles	   and	   determined	   if	   circulating	   IgM	   bound	   permeabilised	   erythrocytes.	  
Murine	  erythrocytes	  were	  studied	  due	  to	   the	  availability	  of	  both	  control	  murine	   IgM	  
isotype	  antibodies	  and	  RAG1-­‐deficient	  mice	  plasma	  to	  evaluate	   the	  specificity	  of	  any	  
IgM	  binding	  seen.	  Erythrocytes	  were	  stained	  with	  the	  erythrocyte	  marker	  Ter-­‐119	  prior	  
to	  permeabilisation	  with	  saponin.	  Ter-­‐119	  positivity	  was	  used	  to	  identify	  erythrocytes	  
(Figure	   5.18A).	   Successful	   permeabilisation	   of	   saponin	   treated	   erythrocytes	   was	  
confirmed	   by	   AnnV	   positivity	   (Figure	   5.18B)	   and	   the	   percentage	   of	   Ter-­‐119+	   IgM+	  
erythrocytes	   was	   assessed	   (Figure	   5.18C-­‐D).	   IgM	   binding	   to	   control	   and	   saponin	  
treated	  erythrocytes	   in	   isotype	   antibody	   treated	  or	  RAG1-­‐deficient	  mice	  plasma	  and	  
PBS	   treatment	   groups	   remained	   non-­‐significant	   whilst	   permeabilised	   erythrocytes	  
exposed	  to	  Balb/c	  plasma	  exhibited	  significant	  binding	  with	  43.1	  ±8.4%	  of	  erythrocytes	  
being	  IgM+	  (two-­‐way	  ANOVA;	  P	  <	  0.0001;	  n	  =	  4).	  
	  
5.15	  IgM	  binding	  to	  apoptotic	  murine	  and	  apoptotic	  Jurkat	  cells	  appears	  to	  be	  calcium	  
independent	  
In	   chapter	   4	   data	   presented	  demonstrated	   that	   ischaemic	   injured	  HK-­‐2	   cells	   did	   not	  
bind	   IgM.	   Earlier	   IgM	   studies	   suggested	   that	   IgM	   binding	   might	   be	   influenced	   by	  
calcium	   (McMullen	   et	   al.,	   2006).	   As	   the	   cell	   dissociation	   buffer	   and	   trypsin	   used	   to	  
detach	  the	  HK-­‐2	  cells	  were	  diluted	  in	  EDTA	  (calcium	  chelator)	  (final	  concentration	  0.4	  
mM	  EDTA)	  this	  may	  have	  resulted	  in	  IgM	  failing	  to	  remain	  bound	  thus	  leading	  to	  a	  false	  
negative	   result.	   To	   assess	   whether	   the	   EDTA	   impaired	   IgM	   binding,	   our	   robust	   IgM	  
binding	   detection	   assay	   was	   used	   to	   assess	   IgM	   positivity	   of	   apoptotic	   murine	  
thymocytes	  and	  human	  Jurkat	  cells	  exposed	  to	  EDTA-­‐diluted	  Balb/c	  plasma	  or	  EDTA-­‐
diluted	   human	   serum,	   respectively.	   The	   results	   suggest	   that	   it	   is	   unlikely	   that	   EDTA	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influenced	  the	  previous	  findings	  as	  both	  apoptotic	  cell	  types	  incubated	  in	  EDTA-­‐diluted	  




Figure	  5.18	  -­‐	  IgM	  binds	  permeabilised	  murine	  erythrocytes.	  Murine	  erythrocytes	  were	  
stained	  with	   the	  erythrocyte	  marker	   Ter-­‐119	  prior	   to	  permeabilisation	  with	   saponin.	  	  
Annexin-­‐V	   (AnnV)	   staining	   was	   used	   to	   confirm	   permeability.	   Non-­‐permeable	   and	  
permeable	   erythrocytes	   were	   then	   exposed	   to	   either	   murine	   IgM	   isotype	   control	  
antibodies,	  PBS,	  Balb/c	  plasma	  (as	  a	  source	  of	   IgM)	  or	  plasma	  from	  immunodeficient	  
RAG1-­‐deficient	  mice.	  Staining	  was	  assessed	  by	  flow	  cytometry.	  A)	  Both	  non-­‐permeable	  
and	   permeable	   erythrocytes	   were	   identified	   and	   gated	   on	   the	   basis	   of	   Ter-­‐119	  
positivity.	  B)	   Permeable	   Ter-­‐119+	   erythrocytes	   demonstrated	   a	   distinct	   shift	   in	  AnnV	  
positivity	   indicating	   successful	   permeabilisation.	   C)	   Non-­‐permeable	   and	   permeable	  
erythrocytes	  were	  gated	  on	  the	  basis	  of	  Ter-­‐119	  positivity	  and	  the	  percentage	  of	  IgM+	  
erythrocytes	  was	  assessed.	  IgM	  binding	  to	  non-­‐permeable	  and	  permeable	  erythrocytes	  
in	   isotype	   antibody	   treated,	   RAG1-­‐deficient	  mice	   plasma	   and	   PBS	   treatment	   groups	  
remained	  non-­‐significant.	  Permeable	  erythrocytes	  exposed	  to	  Balb/c	  plasma	  exhibited	  
significant	   binding	   (n	   =	   4	   per	   group).	   D)	   Representative	   histograms	   illustrating	   IgM	  
binding	  to	  non-­‐permeable	  and	  permeable	  Ter-­‐119+	  erythrocytes	  within	  the	  treatment	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Figure	   5.19	   –	   IgM	   binding	   to	   apoptotic	   murine	   and	   apoptotic	   Jurkat	   cells	   is	   still	  
detectable	   following	   EDTA-­‐diluted	   plasma	   incubation.	   A)	  Murine	   thymocytes	   were	  
rendered	   apoptotic	   by	   overnight	   culture.	   Thymocytes	  were	   exposed	   to	  murine	   anti-­‐
human	   isotype	  control	  antibodies,	  PBS,	  Balb/c	  plasma	   (as	  a	   source	  of	   IgM)	  or	  Balb/c	  
plasma	  diluted	   in	   EDTA.	   IgM	  binding	  was	  detected	   in	  both	  EDTA-­‐diluted	  and	  normal	  
Balb/c	  plasma.	  B)	  Human	  Jurkat	  cells	  were	  treated	  with	  0.5	  µM	  camptothecin	  for	  16-­‐
hours	  to	  induce	  apoptosis.	  	  Jurkat	  cells	  were	  then	  exposed	  to	  PBS	  or	  human	  serum	  as	  a	  
source	  of	   IgM	  or	   human	   serum	  diluted	   in	   EDTA.	   	   IgM	  binding	  was	   then	   assessed	  by	  
flow	   cytometry.	   IgM	   binding	  was	   detected	   in	   both	   EDTA-­‐diluted	   and	   normal	   human	  




In	   this	   chapter,	   we	   have	   carefully	   characterised	   IgM	   binding	   to	   cells	   undergoing	  
apoptosis	  and	  demonstrate	  robust	  binding	  of	  both	  human	  and	  murine	  IgM	  to	  a	  subset	  
of	   cells	   that	   have	   exposed	   PtdSer	   (AnnV	   positive)	   and	   exhibit	   loss	   of	   membrane	  
integrity	   (PI	   positive).	   Confocal	   and	   electron	   microscopy	   studies	   indicate	   that	   IgM	  
binds	  to	  cells	  at	  a	  morphologically	  advanced	  stage	  of	  apoptosis	  with	  evident	  disruption	  
of	   the	   plasma	   membrane.	   IgM	   binding	   thus	   requires	   loss	   of	   plasma	   membrane	  
integrity	  allowing	  access	  to	  cytoplasmic	  or	  cell	  membrane	  antigens.	  In	  view	  of	  the	  non-­‐
redundant	   role	   for	   circulating	   IgM	   antibodies	   in	   the	   removal	   of	   dying	   cells	   and	   the	  
prevention	   of	   autoimmunity,	   our	   findings	   provide	   important	   insights	   into	   the	  
mechanism	   behind	   the	   preferential	   binding	   of	   IgM	   to	   subsets	   of	   apoptotic	   cells.	  
Importantly,	   we	   show	   that	   IgM	   strongly	   binds	   non-­‐apoptotic	   cells	   and	   erythrocytes	  
that	  have	  undergone	  membrane	  permeabilisation	  suggesting	  that	  the	  epitopes	  bound	  
are	  present	  within	  normal	  cells	  and	  not	  necessarily	  generated	  by	  the	  apoptotic	  process	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per	  se.	  These	  findings	  suggest	  an	  important	  role	  for	  IgM	  in	  the	  recognition	  of	  nucleated	  
cells	  and	  erythrocytes	  that	  have	  lost	  significant	  membrane	  integrity.	  These	  studies	  are	  
thus	   relevant	   to	   the	   potential	   in	   vivo	   role	   of	   IgM	  antibodies	   in	   cell	   clearance	   during	  
conditions	   characterised	   by	   severe	   cell	   damage	   such	   as	   ischaemic	   injury,	   sepsis	   and	  
thrombotic	  microangiopathies.	  
	  
The	   finding	   of	   C3	   deposition	   being	   present	   on	   aged	   AnnV-­‐	   murine	   thymocytes,	   but	  
absent	   on	   fresh	   AnnV-­‐	   thymocytes	   is	   quite	   interesting.	   Following	   traditional	   AnnV	  
classification	  aged	  AnnV-­‐	   cells	  would	  not	  be	  classified	  as	  apoptotic,	  as	   they	  have	  not	  
yet	  exposed	  PtdSer,	  and	  would	  likely	  not	  be	  recognised	  by	  phagocytes.	  Yet	  fresh	  AnnV-­‐
PI-­‐	  remained	  C3	  negative	  suggesting	  that	  additional	  novel	  membrane	  alterations	  occur	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Chapter	  6.	  Discussion	  
	  
AKI	   induced	   by	   renal	   IRI	   is	   characterised	   by	   renal	   dysfunction,	   ATN,	   microvascular	  
congestion	   and	   inflammation.	   The	   administration	   of	   exogenous	   apoptotic	   cells	   has	  
been	   shown	   to	   reduce	   inflammation	   in	  experimental	  models	  of	   LPS-­‐mediated	   shock,	  
CIA,	   lung	   and	   liver	   inflammation.	   Preliminary	   data	   suggested	   that	   the	   intravenous	  
administration	  of	  20x106	  apoptotic	  thymocytes	  to	  FVB/n	  or	  Balb/c	  mice	  24-­‐hours	  prior	  
to	   renal	   IRI	  protected	   renal	   function	  without	  affecting	  ATN	  24-­‐hours	   following	   IRI.	   In	  
addition	   it	   appeared	   that	   IgM	   antibodies	   were	   deposited	   in	   the	   kidney	   30-­‐minutes	  
following	   reperfusion.	   This	   thesis	   aimed	   to	   confirm	   these	   early	   finding	   and	   explore	  
underlying	  testable	  hypothetical	  mechanisms.	  These	  examined	  if	  functional	  protection	  
was	  conferred	  by	  apoptotic	  cell	  modulation	  of	  (a)	  circulating	  IgM	  antibodies,	  which	  are	  
pathogenic	   in	   ischaemic	   injury	   in	   other	   organs	   or	   (b)	   coagulation	   status	   leading	   to	  
improved	  intrarenal	  microvascular	  blood	  flow.	  	  
	  
6.1	   IgM	   antibody	   deposition	   is	   minimal	   following	   renal	   ischaemic	   injury,	   but	   is	  
dramatic	  following	  hepatic	  ischaemia	  and	  in	  a	  model	  of	  AIH	  
	  
IgM	  antibodies	  have	  an	  established	  role	  in	  the	  pathogenesis	  of	  intestinal,	  cardiac	  and	  
skeletal	   muscle	   ischaemia	   where	   they	   bind	   neo-­‐epitopes	   created	   in	   the	   injured	  
reperfused	   tissue	   leading	   to	   complement	   activation	   that	   augments	   tissue	   injury.	  We	  
sought	   to	   explore	   whether	   circulating	   IgM	   may	   be	   involved	   in	   the	   development	   of	  
renal	  and	  hepatic	  ischaemia.	  We	  discovered	  striking	  differences	  in	  the	  kinetics	  of	  IgM	  
deposition	  following	  both	  renal	  and	  hepatic	  ischaemic	  injury,	  and	  in	  a	  mouse	  model	  of	  
AIH.	  Whilst	   IgM	  was	  minimally	   detected	  at	   24-­‐hours	   following	   renal	   injury,	   dramatic	  
IgM	  deposition	  occurred	  24-­‐hours	  following	  both	  hepatic	  IRI	  and	  induction	  of	  AIH.	  
	  
6.1.1	   IgM	   antibodies	   are	   unlikely	   to	   play	   a	   direct	   role	   in	   the	   pathogenesis	   of	   renal	  
ischaemia	  
In	   contrast	   to	   the	   numerous	   confirmatory	   studies	   illustrating	   how	   IgM	   antibodies	  
augment	   intestinal,	   cardiac	   and	   skeletal	   muscle	   ischaemia,	   studies	   regarding	   IgM	   in	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renal	   IRI	   are	   limited	   and	   contradictory	   (Burne-­‐Taney	   et	   al.,	   2003,	   van	   der	   Pol	   et	   al.,	  
2011,	   Lobo	   et	   al.,	   2012,	   Renner	   et	   al.,	   2010,	   Park	   et	   al.,	   2002).	   	   Park	   et	   al.,	   (2002)	  
reported	   that	   Ig	   are	   not	   involved	   in	   renal	   IRI	   pathogenesis.	   This	   was	   based	   upon	  
histological	  examination	  revealing	  the	  absence	  of	  Ig	  in	  kidneys	  harvested	  1-­‐30-­‐minutes	  
following	  bilateral	  renal	  IRI	  in	  C57BL/6	  mice,	  and	  a	  lack	  of	  protection	  observed	  in	  RAG-­‐
1	  mice.	  However,	  despite	  published	  work	  demonstrating	  the	  pathogenic	  nature	  of	  IgM	  
in	   tissue	   ischaemia,	   a	   paper	   published	   in	   2012	   by	   Lobo	   et	   al.,	   suggested	   that	   IgM	  
antibodies	  were	   in	   fact	  protective	  after	  renal	   IRI	  and	  cardiac	  allograft	  rejection.	  sIgM	  
KO	  mice	  had	  more	  pronounced	  renal	  inflammation	  and	  dysfunction	  following	  bilateral	  
renal	  IRI.	  Following	  reconstitution	  with	  purified	  IgM	  Lobo	  et	  al,.	  observed	  attenuation	  
of	  renal	  inflammation.	  This	  protection	  was	  thought	  to	  be	  the	  result	  of	  IgM	  antibodies	  
limiting	   T	   cell	   differentiation	   into	   pro-­‐inflammatory	   Th-­‐1	   and	   Th-­‐17	   cells.	   This	   effect	  
was	   accompanied	   by	   inhibition	   of	   TLR4	   induced	   NF-­‐kB	   nuclear	   translocation	   with	   a	  
subsequent	  reduction	  in	  inflammatory	  pathways.	  It	  is	  important	  to	  note	  that	  the	  sIgM	  
KO	  mice	  used	  in	  this	  study	  develop	  a	  clear	  autoimmune	  phenotype	  similar	  to	  SLE	  (Boes	  
et	   al.,	   2000,	   Ehrenstein	   et	   al.,	   2000)	  with	   elevated	  production	  of	   IgG	  autoantibodies	  
and	   the	  development	  of	   glomerulonephritis	   (Boes	  et	   al.,	   2000).	   This	   complicates	   the	  
study	  of	  renal	  injury	  in	  these	  mice	  and	  comparison	  of	  injury	  to	  wild	  type	  mice	  is	  not	  a	  
clear-­‐cut	  approach.	  	  
	  
The	  ambiguity	  surrounding	  the	  role	  of	   immunoglobulins	  in	  renal	  IRI	   is	  best	   illustrated	  
by	  two	  contradictory	  studies	  by	  Burne-­‐Taney	  et	  al.,	   (2003)	  and	  Renner	  et	  al.,	   (2010).	  
Both	  studies	  induced	  bilateral	  renal	  ischaemia	  in	  B-­‐cell	  deficient	  µMT	  mice,	  but	  while	  
Renner	   et	   al.,	   observed	   increased	   renal	   dysfunction,	   Burne-­‐Taney	   et	   al.,	   found	   µMT	  
mice	  to	  be	  significantly	  protected	  from	  renal	  dysfunction.	  Our	  data	  in	  wild-­‐type	  Balb/c	  
mice	  suggest	  that	  IgM	  is	  unlikely	  to	  play	  a	  key	  direct	  role	  in	  the	  pathogenesis	  of	  renal	  
IRI.	   Although	   statistically	   significantly	   IgM	   deposition	   was	   detected	   at	   1-­‐hour,	   the	  
deposition	  was	  minimal	  and	  unlikely	  to	  have	  critical	  biological	  functional	  relevance.	  In	  
addition,	   despite	   technical	   problems	   reducing	   the	   sample	   size,	   we	   also	   observed	  
minimal	  C3	  deposition.	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We	  were	  unable	  to	  confirm	  the	  findings	  of	  van	  der	  Pol	  et	  al.,	  (2011)	  who	  demonstrated	  
IgM	   binding,	   and	   subsequent	   C3	   binding,	   to	   hypoxic	   human	   immortalized	   proximal	  
tubular	   epithelial	   HK-­‐2	   cells.	   We	   used	   an	   assay	   similar	   to	   the	   hypoxia	   based	   one	  
described,	  but	  induced	  oxidative	  injury	  by	  treatment	  with	  H2O2	  and	  an	  additional	  ATP	  
depletion	   assay	   using	   Antimycin	   A.	   Despite	   evident	   cellular	   apoptosis	   and	   a	   clear	  
morphological	  injury,	  similar	  to	  that	  described	  by	  van	  der	  Pol	  et	  al.,	  IgM	  antibodies	  did	  
not	   convincingly	  bind	   to	   injured	  HK-­‐2	  cells	   following	  H2O2	  or	  Antimycin	  A	   treatment.	  
These	   negative	   results	   were	   not	   due	   to	   the	   influence	   of	   EDTA	   or	   cleavage	   of	   IgM	  
bound	   cell	   surface	   neo-­‐epitopes.	   It	   is	   possible	   that	   the	   mode	   of	   cellular	   injury	   can	  
alter/create	   different	   neo-­‐epitopes	   to	   which	   IgM	   antibodies	   are	   able	   to	   bind	   thus	  
explaining	  the	  detection	  of	  IgM	  binding	  to	  HK-­‐2	  cells	  injured	  by	  hypoxia	  by	  van	  der	  Pol	  
et	  al.	  It	  is,	  however,	  important	  to	  note	  that	  van	  der	  Pol	  et	  al.,	  concluded	  that	  IgM	  and	  
C3	   bound	   to	   hypoxic	   HK-­‐2	   cells	   on	   the	   basis	   of	   an	  MFI	   of	   approximately	   35,	   which	  
would	  not	  be	  considered	  biologically	  relevant	  by	  some	  researchers.	  
	  
The	   totality	   of	   our	   data	   suggests	   that	   IgM	   antibodies	   are	   unlikely	   to	   be	   directly	  
involved	  in	  the	  development	  of	  renal	  injury	  following	  ischaemia.	  One	  possibility	  is	  that	  
the	   lack	   of	   marked	   IgM	   deposition	   in	   vivo	   detected	   in	   kidney	   sections	   may	   be	  
secondary	   to	   the	   sloughing	   of	   tubular	   cell	   that	   occurs	   following	   the	   ischaemic	   insult	  
(Bonventre	   and	   Yang,	   2011,	   Basile	   et	   al.,	   2012).	   Tubular	   cells	   undergo	   necrosis	   and	  
may	  be	  shed	   into	  the	  tubular	   lumen	  and	  may	  thus	  be	   lost	  before	   IgM	  antibodies	  are	  
able	  to	  bind.	  This	  seems	  unlikely	  as,	  despite	  remaining	  present	  throughout	  our	  in	  vitro	  
assays,	   and	   progressing	   through	   apoptosis	   (Antimycin	   A	   treatment)	   or	   undergoing	  
apparent	  primary	  necrosis	  (H2O2	  treatment),	  human	  IgM	  failed	  to	  convincingly	  bind	  to	  
injured	  HK-­‐2	   cells.	   It	   can	  be	   appreciated	   from	   the	  morphologically	   injury	   induced	  by	  
500mM	  H2O2	  and	  20µM	  Antimycin	  A	  that	  the	  HK-­‐2	  cells	  had	  drastically	  ‘rounded’.	  It	  is	  
possible,	  though	  unlikely,	  that	  this	  perhaps	  prevented	  access	  of	  the	  detection	  antibody	  
to	  IgM	  bound	  epitopes.	  
	  
IgM	   is	  a	  potent	  activator	  of	   the	  classical	   complement	   cascade	  and	   intestinal,	   cardiac	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and	   skeletal	   muscle	   ischaemia	   are	   known	   to	   have	   strong	   complement	   involvement,	  
most	  notably	  by	  the	  classical	  pathway	  (Chan	  et	  al.,	  2004,	  Weisman	  et	  al.,	  1990a,	  Hill	  et	  
al.,	   1992,	   Lindsay	   et	   al.,	   1992,	  Weiser	   et	   al.,	   1996,	  Williams	   et	   al.,	   1999).	   However,	  
similar	   to	   IgM,	   the	   involvement	   of	   complement	   in	   renal	   IRI	   is	   also	   controversial.	  
Evidence	   is	   accumulating	   towards	   a	   dominant	   role	   for	   the	   alternative	   pathway,	  
(Thurman	  et	   al.,	   2003,	   Zhou	  et	   al.,	   2000b,	   Thurman	  et	   al.,	   2005,	  Miwa	  et	   al.,	   2013),	  
while	  other	  studies	   implicate	  MBL	  (van	  der	  Pol	  et	  al.,	  2012)	  or	  suggest	  no	  major	  role	  
for	  complement	  (Park	  et	  al.,	  2001).	  Interestingly	  we	  did	  not	  find	  marked	  C3	  deposition,	  
which	   is	  generated	   following	  classical	  or	  alternative	  pathway	  activation,	   in	   ischaemic	  
kidneys.	  
	  
It	   is	   worth	   noting	   that	   the	   majority	   of	   studies	   establishing	   IgM	   antibodies	   to	   be	  
pathogenic	  in	  intestinal,	  cardiac	  and	  skeletal	  ischaemia	  originate	  from	  one	  group,	  with	  
supporting	   papers	   produced	   by	   affiliated	   groups	   (Austen	   et	   al.,	   2004,	   Zhang	   et	   al.,	  
2004,	  Zhang	  et	  al.,	  2006a,	  Williams	  et	  al.,	  1999,	  Chan	  et	  al.,	  2004,	  Weiser	  et	  al.,	  1996,	  
Zhang	  et	  al.,	  2006b,	  Zhang	  and	  Carroll,	  2007,	  Haas	  et	  al.,	  2010,	  Chan	  et	  al.,	  2006).	  With	  
the	  exception	  of	  different	  experimental	  readouts	  depending	  upon	  the	  ischaemic	  tissue	  
type,	   and	   in	   vitro	   work,	   this	   group	   systematically	   studied	   IgM	   and	   complement	  
deposition	   in	   wild	   type,	   reconstituted	   RAG-­‐1	   mice	   and	   complement	   deficient	   mice	  
using	  similar	  techniques.	  This	  group	  discovered	  that	  a	  single	  IgM	  clone	  produced	  by	  a	  
B-­‐1	   cell	   hybridoma	   (IgMcm-­‐22)	   bound	   NMHC-­‐II	   and	   restored	   intestinal	   and	   cardiac	  
ischaemic	   injury	   in	   RAG-­‐1	   mice.	   A	   non-­‐affiliated	   study	   by	   Kulik	   et	   al.,	   (2009)	   also	  
described	   an	   IgM	   clone	   (mAb	   B4)	   that	   was	   able	   to	   bind	   annexin	   IV	   and	   restore	  
intestinal	  injury	  in	  RAG-­‐1	  mice.	  This	  is	  something	  that	  we	  had	  hoped	  to	  achieve	  in	  the	  
renal	  IRI	  model,	  but	  was	  not	  pursued	  in	  light	  of	  our	  negative	  results	  indicating	  that	  IgM	  
antibodies	   were	   not	   present	   following	   ischaemia.	   In	   contrast	   to	   studies	   of	   IgM	  
antibodies	  in	  intestinal,	  cardiac	  and	  skeletal	  muscle	  ischaemia,	  our	  data	  suggests	  that	  
IgM	  is	  unlikely	  to	  play	  a	  direct	  crucial	  role	   in	  renal	   IRI.	   It	  appears	  that	  IgM	  antibodies	  
are	  not	   likely	   to	  be	   targets	  of	  novel	   therapeutics	   in	   the	   treatment	  of	  AKI	   induced	  by	  
renal	  IRI.	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6.1.2	  IgM	  antibodies	  may	  be	  involved	  in	  the	  development	  of	  hepatic	  ischaemic	  injury	  
and	  AIH	  
Unlike	  renal	  IRI	  there	  is	  no	  preceding	  ambiguity	  regarding	  the	  role	  of	  IgM	  antibodies	  in	  
hepatic	   IRI,	   as	   their	   role	   is	   simply	   unknown.	   Although	   the	   role	   of	   Ig	   during	   and	  
following	   hepatic	   IRI	   has	   not	   been	   directly	   studied,	   studies	   indicate	   that	   injury	   is	  
reduced	  in	  RAG-­‐1	  mice	  suggesting	  that	  Ig	  may	  be	  partly	  involved	  in	  injury	  pathogenesis	  
(Lappas	  et	  al.,	  2006,	  Feng	  et	  al.,	  2012).	  	  
	  
In	   chapter	   3	   we	   determined	   whether	   IgM	   antibodies	   bound	   to	   injured	   liver	   tissue	  
harvested	  between	  0-­‐hour	  and	  7-­‐days	  following	  hepatic	   IRI	  using	  robust,	  specific	  and	  
carefully	  controlled	  IHC.	  The	  results	  were	  striking	  and	  in	  stark	  contrast	  to	  our	  renal	  IRI	  
data.	  IgM	  was	  detected	  at	  0-­‐hours	  and	  accumulated	  progressively	  up	  to	  24-­‐hours	  post	  
ischaemia,	  but	  appeared	  to	  have	  been	  resolved	  by	  7-­‐days.	  Moreover,	  tissue	  injury	  and	  
IgM	   deposition	   illustrated	   a	   similar	   pattern	   and	   this	   finding	   does	   suggest	   that	   IgM	  
antibodies	   were	   indeed	   binding	   to	   damaged	   tissue	   that	   may	   have	   neo-­‐epitopes	  
created/exposed	   following	   IRI.	   The	   finding	   of	   IgM	   deposition	   at	   0-­‐hours	   following	  
hepatic	   ischaemia	  not	  only	   suggests	   that,	   residual	  blood	  prior	   to	   full	   reperfusion	  has	  
sufficient	   IgM	   to	   allow	   binding	   detection,	   but	   indicates	   that	   neo-­‐epitopes	   may	   be	  
created/exposed	  during	  the	  ischaemic	  period.	  However,	  additional	  work	  is	  required	  to	  
firmly	   establish	   this.	   It	  may	   be	  worth	   studying	   early	   time	   points	   in	   other	  models	   of	  
ischaemia,	   as	   a	   similar	   finding	  was	   described	   during	   skeletal	   ischaemia	   (Chan	   et	   al.,	  
2004).	  Other	  papers	  predominately	  study	  a	  24-­‐hour	  time	  point	  following	  reperfusion.	  
	  
The	  pattern	  of	  IgM	  deposition	  following	  hepatic	  ischaemia	  was	  intriguing	  as	  it	  seemed	  
to	   locate	   to	   the	   regions	  of	   the	   liver	   that	  may	  be	  vulnerable	   to	  hypoxic	   injury.	  Tissue	  
injury	  was	  first	  evident	  around	  blood	  vessels	  with	  IgM	  appearing	  to	  infiltrate	  into	  the	  
tissue	  at	  0-­‐hours	  following	  ischaemia.	  Both	  the	  injury	  and	  IgM	  staining	  became	  more	  
pronounced	  in	  these	  regions	  at	  later	  time	  points.	  	  
	  
It	  is	  possible	  to	  speculate	  that	  IgM	  antibodies	  may	  be	  involved,	  at	  least	  partially,	  in	  the	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development	  of	  hepatic	  IRI,	  similar	  to	  intestinal,	  cardiac	  and	  skeletal	  muscle	  ischaemia.	  
Studies	   demonstrate	   a	   strong	   role	   for	   complement	   in	   hepatic	   IRI	   with	   the	  
administration	   of	   recombinant	   sCR1,	   a	   C3	   inhibitor	   that	   blocks	   all	   complement	  
pathways,	  attenuating	  injury	  in	  rats	  following	  hepatic	  IRI	  (Chavez-­‐Cartaya	  et	  al.,	  1995,	  
Lehmann	   et	   al.,	   2001,	   Lehmann	   et	   al.,	   1998).	   Similarly,	   C3	   deficient	   mice	   exhibit	  
attenuated	  injury	  following	  hepatic	  ischaemia	  (He	  et	  al.,	  2009a,	  He	  et	  al.,	  2009b)	  whilst	  
inhibition	  of	  the	  classical	  pathway	  reduces	  hepatic	  ischaemic	  injury	  in	  rats	  (Heijnen	  et	  
al.,	   2006).	   Some	   studies	   suggest	   that	   all	   3	   complement	   pathways	   are	   involved	  
(Arumugam	   et	   al.,	   2004),	   all	   culminating	   in	   C5b-­‐9	  membrane	   attack	   complex	   (MAC)	  
formation	  in	  cell	  membranes	  that	  kills	  liver	  cells	  (Fondevila	  et	  al.,	  2008).	  These	  studies	  
indirectly	   support	   the	   possible	   involvement	   of	   IgM	   antibodies	   in	   hepatic	   IRI	   as	   IgM	  
binding	  may	  be	  upstream	  of	  complement	  activation.	  Although	  the	  role	  of	   IgM	  during	  
hepatic	   ischaemia	   requires	   further	   study	   a	   recent	   study	   by	  Diepnhorst	  et	   al.,	   (2014)	  
described	   IgM	   deposition	   following	   hepatic	   IRI	   similar	   to	   our	   data.	   However	   in	   this	  
study	   IgM	   reached	   a	   maximum	   at	   12-­‐hours	   and	   was	   reduced	   by	   24-­‐hours.	   C3	  
deposition	   followed	   a	   similar	   trend.	   The	   study	   did	   not	   examine	   what	   role	   IgM	  
antibodies	  may	  play	  during	  injury.	  
	  
It	  was	  important	  to	  determine	  whether	  IgM	  antibody	  deposition	  was	  found	  in	  a	  non-­‐
ischaemic	  form	  of	  hepatic	  injury	  in	  order	  to	  determine	  whether	  IgM	  may	  be	  involved	  in	  
other	  forms	  of	  tissue	  injury.	  AIH,	  a	  chronic	  inflammatory	  condition,	  is	  characterised	  by	  
the	  presence	  of	  autoantibodies	   that	  are	   thought	   to	  contribute	   to	  antibody-­‐mediated	  
cellular	   cytotoxicity	   and	   complement	   mediated	   tissue	   injury	   (Liberal	   et	   al.,	   2013,	  
Krawitt,	  2006,	  Mieli-­‐Vergani	  and	  Vergani,	  2011).	  Although	  the	  pathogenesis	  is	  thought	  
to	   center	   around	   augmented	   pro-­‐inflammatory	   CD4+	   and	   CD8+	   T-­‐cell	   cytokine	  
production,	  autoantibody	  generation	   is	  a	   characteristic	  of	   the	  ConA	  mouse	  model	  of	  
AIH	   (Wang	   et	   al.,	   2012,	   Sass	   et	   al.,	   2002,	   Nakano	   et	   al.,	   2013).	   Interestingly,	   we	  
demonstrated	  dramatic	  IgM	  deposition	  in	  ConA	  injured	  liver	  tissue.	  The	  pattern	  of	  IgM	  
deposition	  was	  very	  similar	  to	  that	  observed	  following	  hepatic	  IRI	  with	  IgM	  antibodies	  
deposited	   in	   areas	   of	   tissue	   necrosis	   suggesting	   neo-­‐epitopes	  were	   created/exposed	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during	  or	  following	  injury.	  
	  
We	  have	  not	  extensively	  studied	  the	  role	  of	  IgM	  antibodies	  during	  hepatic	  ischaemia,	  
or	   the	  mouse	  model	   of	   AIH.	   However,	   the	   detection	   of	   dramatic	   IgM	   deposition	   in	  
both	  models	  suggests	   that	   it	  may	  play	  a	   role	   in	   the	  pathogenesis	  of	   injury	  as	  well	  as	  
possibly	   the	   subsequent	   tissue	   repair.	   Whether	   IgM	   antibodies	   are	   protective,	  
detrimental	  or	  neutral	  is	  yet	  to	  be	  determined.	  
	  
6.1.3	  Future	  Direction	  
Firstly,	   the	   low	   sample	   size	   of	   ischaemic	   and	   ConA	   injured	   liver	   tissue	   was	   a	  major	  
limitation	   of	   these	   data	   and	   prevented	   any	   formal	   statistical	   analysis.	   This	   must	   be	  
rectified	   before	   any	  meaningful	   conclusions	   can	   be	   drawn.	   In	   addition,	   it	   would	   be	  
important	   to	  examine	   the	  human	  relevance	  of	   these	  data	  by	  assessing	   IgM	  antibody	  
deposition	   in	   liver	  biopsy	  tissue	  harvested	  from	  patients.	  Possible	  tissue	  biopsy	  to	  be	  
studied	  could	  include	  liver	  transplantation,	  AIH	  liver	  or	  paracetamol	  injured	  liver	  (as	  a	  
source	  of	   necrotic	   tissue).	  Alternatively,	   another	  possibility	  would	  be	   to	  use	  primary	  
human	   hepatocytes	   or	   human	   embryonic	   stem	   cell-­‐derived	   hepatocytes	   (Medine	   et	  
al.,	  2011)	   in	  an	  assay	  similar	  to	  that	  used	  to	  assess	   IgM	  binding	  to	  HK-­‐2	  cells.	  Also,	   if	  
biopsy	   tissue	   is	   available	   it	   is	   crucial	   to	   determine	   whether	   AIH	   patients	   also	  
demonstrate	   IgM	   binding	   to	   injured	   liver	   tissue,	   as	   autoantibodies	   in	   AIH	   are	  
predominantly	   IgG	   (Krawitt,	  2006).	   It	   is	  equally	   important	   to	  confirm	  that	   in	  humans	  
hepatic	  ischaemia	  activates,	  at	  least	  in	  part,	  the	  classical	  complement	  pathway,	  as	  this	  
has	  not	  been	  extensively	  studied	  (Straatsburg	  et	  al.,	  2000).	  
	  
These	   data	   suggest	   that	   IgM	   antibodies	   may	   be	   involved	   in	   hepatic	   ischaemia	   and	  
ConA	  induced	  AIH	  and	  their	  exact	  role	  be	  it	  pathogenic,	  protective	  or	  neutral	  needs	  to	  
be	   dissected.	   This	   should	   consist	   of	   a	   systematic	   study	   utilizing	   various	   wild	   type,	  
complement	   deficient	   and	   RAG-­‐1	   mice	   with	   subsequent	   IgM	   reconstitution.	   If	   IgM	  
reconstitution	   restores	   the	   injury	   phenotype	   in	   RAG-­‐1	  mice	   this	   would	   suggest	   that	  
IgM	  has	  a	  pathogenic	  role.	  In	  contrast,	  failure	  to	  restore	  injury	  may	  indicate	  that	  IgM	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binding	   is	  a	  neutral	  event	  assuming	  that	  sufficient	   IgM	  can	  be	  replaced.	   It	   is	  possible	  
that	  sIgM	  KO	  mice	  could	  be	  used	  in	  these	  studies	  although	  their	  tendency	  to	  develop	  
SLE	   and	   altered	   immune	   state	  may	   complicate	   data	   interpretation	   in	   ConA	   induced	  
AIH.	  An	  assessment	  of	  the	  deposition	  of	  key	  complement	  proteins	  including	  C3,	  C4	  and	  
MBL	   with	   regards	   to	   the	   location	   of	   IgM	   binding	   should	   also	   be	   determined	   as	  
colocalisation	  would	  suggest	  that	  IgM	  is	  involved	  in	  the	  activation	  of	  complement.	  
	  
How	  can	  we	  explain	  the	  differential	  deposition	  of	  IgM	  antibodies	  in	  injured	  renal	  and	  
liver	   tissue?	   A	   rigorous	   assessment	   of	   endothelial	   permeability	   following	   ischaemic	  
injury	  may	  shed	  light	  onto	  the	  disparate	  kinetics	  of	  IgM	  antibody	  deposition	  following	  
renal	  and	  hepatic	   IRI.	  During	   intestinal	  and	  skeletal	  muscle	   ischaemia	  Williams	  et	  al.,	  
(1999)	  and	  Chan	  et	  al.,	  (2004),	  respectively,	  reported	  that	  extravasation	  of	  125I-­‐labeled	  
bovine	  serum	  albumin	  and	  IgM	  binding	  to	  injured	  tissue	  followed	  a	  similar	  trend.	  	  This	  
indicated	   that	   the	  microvascular	   endothelial	   cells	   need	   to	   be	   sufficiently	   permeable	  
before	  IgM	  antibodies	  enter	  the	  tissue	  from	  the	  circulation	  to	  allow	  binding	  to	  occur.	  A	  
similar	   line	   of	   investigation	   could	   be	   conducted	   for	   both	   renal	   and	   hepatic	   IRI,	   and	  
possibly	   ConA	   induced	  AIH.	   If	   feasible	   in	   place	   of	   125I-­‐labeled	   bovine	   serum	   albumin	  
radiolabeled	  IgM	  antibodies	  could	  be	  used.	  This	  would	  be	  more	  informative	  given	  the	  
size	  disparity	  between	  albumin	   (MW	  69	  kDa)	  and	   IgM	   (MW	  970	  kDa).	   It	  may	  be	   the	  
case	  that	  IgM	  is	  readily	  able	  to	  enter	  the	  injured	  liver	  tissue	  but	  that	   it	   is	  not	  able	  to	  
pass	  through	  the	  renal	  microvasculature.	  	  
	  
These	   data	   has	   led	   us	   to	   conclude	   that	   IgM	   antibodies	   are	   unlikely	   to	   be	   directly	  
involved	   in	   the	  pathogenesis	  of	   renal	   ischaemic	   injury.	   It	   is	   clear	   that	   further	   studies	  
dissecting	   the	   role	   of	   complement	   during	   renal	   IRI	   are	   required.	   A	   thorough	   study	  
utilizing	  various	  wild	  type,	  complement	  deficient	  mice	  and	  complement	  inhibitors	  with	  
carefully	   controlled	   IHC	   is	   necessary.	   If	   these	   studies	   confirm	   that	   the	   alternative	  
pathway	   is	  dominant	  throughout	  renal	   ischaemia	  then	  this	  would	  clarify	  the	  absence	  
of	  IgM	  antibodies.	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6.2	   Apoptotic	   cell	   administration	   to	   mice	   modulates	   thrombin	   generation	   but	   is	  
detrimental	  to	  renal	  function	  following	  renal	  ischaemia	  reperfusion	  injury	  	  
	  
Exogenous	   apoptotic	   cell	   administration	   has	   been	   shown	   to	   reduce	   inflammation	   in	  
experimental	  models	  of	  LPS-­‐induced	  shock,	  CIA,	  bleomycin-­‐induced	  lung	  inflammation	  
and	  LPS-­‐induced	  hepatitis	  (Lee	  et	  al.,	  2012,	  Gray	  et	  al.,	  2007,	  Ren	  et	  al.,	  2008,	  Zhang	  et	  
al.,	   2011).	   With	   preliminary	   data	   suggesting	   that	   the	   administration	   of	   20x106	  
apoptotic	   thymocytes	  protected	  mice	   from	  renal	  dysfunction,	  but	  not	  ATN,	   following	  
renal	  IRI	  we	  aimed	  to	  validate	  these	  early	  findings.	  We	  also	  intended	  to	  further	  explore	  
the	   ability	   of	   apoptotic	   cells	   to	   influence	   coagulation	   status.	   We	   discovered	   that	  
despite	  apoptotic	  cells	  being	  able	  to	  modulate	  thrombin	  generation,	  and	  in	  contrast	  to	  
our	  preliminary	  data,	  apoptotic	  cell	  administration	  was	  not	  able	  to	  protect	  mice	  from	  
renal	  IRI.	  
	  
6.2.1	  ‘Apoptotic	  cell	  therapy’	  is	  not	  translationally	  relevant	  for	  patients	  with	  ischaemic	  
AKI	  
Although	   apoptotic	   cell	   administration	   is	   able	   to	   reduce	   inflammation	   in	   diverse	  
experimental	  models	  (Lee	  et	  al.,	  2012,	  Gray	  et	  al.,	  2007,	  Ren	  et	  al.,	  2008,	  Zhang	  et	  al.,	  
2011,	  Huynh	  et	  al.,	  2002,	  Marriott	  et	  al.,	  2006,	  Sun	  et	  al.,	  2004),	  the	  data	  presented	  in	  
chapter	  4	  indicates	  that	  apoptotic	  cells	  do	  not	  protect	  mice	  from	  renal	  IRI.	  	  Whilst	  early	  
apoptotic	   cells	   had	   no	   effect	   on	   severe	   renal	   IRI,	   the	   administration	   of	   early	   or	   late	  
apoptotic	   cells	   prior	   to	  mild	   or	  moderate	   renal	   IRI	   respectively	   resulted	   in	   a	   further	  
increase	  in	  plasma	  creatinine	  indicative	  of	  worse	  renal	  failure.	  	  This	  adverse	  effect	  was	  
not	  the	  result	  of	  increased	  structural	  injury	  as	  ATN	  scores	  were	  comparable	  in	  PBS	  and	  
apoptotic	  cell-­‐treated	  mice.	  	  	  
	  
While	   therapeutic	   interventions	   in	   the	   renal	   IRI	   model	   usually	   modulate	   both	   renal	  
function	   and	   structure,	   functional	   protection	   alone	   has	   been	   observed	   in	   mice	  
administered	  hemeoxygenase-­‐1	  overexpressing	  macrophages	  (Ferenbach	  et	  al.,	  2010).	  
This	   protection	   was	   considered	   to	   be	   secondary	   to	   a	   dramatic	   reduction	   in	   CD41+	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platelet	  accumulation	  with	   improved	  microvascular	  blood	  flow	  and	  perfusion	  of	  non-­‐
injured	   functioning	   nephrons.	   	   As	   plasma	   creatinine	   values	  were	   higher	   in	   apoptotic	  
cell	   treated	   mice	   than	   PBS	   treated	   controls	   in	   this	   study,	   it	   was	   hypothesised	   that	  
apoptotic	   cell	   treated	   mice	   might	   exhibit	   an	   additional	   worsening	   of	   microvascular	  
blood	   flow	  post	   ischaemia.	   	  However,	   this	  was	   found	  to	  be	  unlikely	  as	  microvascular	  
congestion,	  inferred	  by	  renal	  fibrin	  and	  CD41+	  platelet	  IHC	  staining,	  was	  comparable	  in	  
all	  PBS	  treated	  and	  apoptotic	  cell	  treated	  mice.	  
	  
It	   is	   surprising	   that	  early	  apoptotic	   cells	  aggravated	   renal	   function	  as	  early	  apoptotic	  
cells	   have	   generally	   been	   regarded	   as	   anti-­‐inflammatory	   in	   comparison	   to	   late	  
apoptotic	  cells	  which	  have	  been	  generally	  considered	  to	  be	  pro-­‐inflammatory	  (Savill	  et	  
al.,	  2002).	  	  However,	  Gray	  et	  al.,	  found	  apoptotic	  cells	  at	  an	  early	  or	  advanced	  stage	  of	  
apoptosis	   provided	   equal	   protection	   from	   CIA	   (Gray	   et	   al.,	   2007).	   	   Importantly,	  
apoptotic	  cell-­‐derived	  protection	  does	  not	  appear	  to	  be	  restricted	  to	  one	  cell	  type.	  The	  
administration	  of	  between	  10x106	  to	  30x106	  apoptotic	  neutrophils	   (Ren	  et	  al.,	  2008),	  
thymocytes	   (Gray	  et	   al.,	   2007),	   splenocytes	   (Zhang	  et	   al.,	   2011)	   and	  human	   Jurkat	   T	  
cells	   (Lee	   et	   al.,	   2012,	   Huynh	   et	   al.,	   2002)	   have	   all	   elicited	   protection	   from	  
inflammation	  in	  mice.	  In	  this	  thesis	  20x106	  apoptotic	  thymocytes	  were	  administered	  to	  
mice	  24-­‐hours	  prior	  to	  renal	  IRI	  and	  it	  is	  unlikely	  that	  either	  the	  apoptotic	  cell	  type	  or	  
number	  contributed	  to	  the	  neutral	  or	  detrimental	  effect	  on	  renal	  function.	  	  
	  
Apoptosis	  and	  necrosis	  are	  key	  events	  in	  renal	  tubular	  cells	  following	  ischaemic	  injury	  
(Daemen	   et	   al.,	   2002)	   with	   inhibition	   of	   apoptosis	   attenuating	   renal	   inflammation	  
(Daemen	   et	   al.,	   1999).	   	   However,	   the	   level	   of	   ATN	   did	   not	   differ	   between	   PBS	   and	  
apoptotic	   cell-­‐treated	   mice	   indicating	   that	   increased	   necrosis/apoptosis	   of	   renal	  
tubular	   cells	   did	   not	   occur	   following	   ischaemic	   injury.	   	   Furthermore,	   no	   discernable	  
difference	   in	   neutrophil	   infiltration	   was	   observed,	   suggesting	   that	   apoptotic	   cell	  
administration	  did	  not	  result	  in	  increased	  renal	  inflammation.	  
	  
Despite	  previously	  published	  work	  demonstrating	  the	  striking	  ability	  of	  apoptotic	  cells	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to	  modulate	  inflammation	  in	  multiple	  organs	  (Fadok	  et	  al.,	  1998,	  Gray	  et	  al.,	  2007,	  Lee	  
et	   al.,	   2012,	  Ren	  et	   al.,	   2008,	   Zhang	  et	   al.,	   2011,	  Huynh	  et	   al.,	   2002,	  Marriott	   et	   al.,	  
2006,	  Sun	  et	  al.,	  2004)	  these	  data	  indicate	  that	  both	  early	  and	  late	  apoptotic	  cells	  were	  
not	  protective	   in	   renal	   IRI.	   	   Indeed,	  depending	  upon	  the	  severity	  of	   ischaemic	   injury,	  
the	   administration	   of	   both	   early	   and	   late	   apoptotic	   cells	   may	   further	   impair	   renal	  
function	   with	   this	   effect	   unlikely	   to	   be	   secondary	   to	   any	   contaminating	   viable	   non-­‐
apoptotic	  cells	  in	  the	  cell	  populations	  administered.	  
	  
These	  studies	  have	  not	  extensively	  probed	  the	  potential	  mechanisms	   involved	   in	   the	  
worsening	  of	  acute	  kidney	  dysfunction	  by	  early	  or	  late	  apoptotic	  cells.	  Apoptotic	  cells	  
express	   PtdSer	   which,	   in	   addition	   to	   being	   involved	   in	   the	   phagocytic	   removal	   of	  
apoptotic	  cells,	  may	  activate	  the	  coagulation	  system	  (Vance	  and	  Steenbergen,	  2005).	  
Also,	  thymocytes	  typically	  undergo	  marked	  cell	  blebbing	  during	  the	  apoptotic	  process	  
and	   it	   is	   possible	   that	   they	  may	   generate	  many	  millions	   of	   small	  microparticles	   that	  
express	  PtdSer	  following	  intravenous	  administration.	  It	  is	  thus	  possible	  that	  apoptotic	  
cell	  administration	  might	  modulate	  the	  coagulation	  status	  of	  recipient	  mice	  and	  affect	  
the	   microvascular	   response	   to	   renal	   IRI.	   In	   support	   of	   this	   we	   demonstrated	  
platelet/apoptotic	   cell	   interaction	   in	   vitro	   and	   delayed	   thrombin	   generation	   in	  
apoptotic	  cell	  treated	  mice	  not	  undergoing	  renal	  IRI.	  Interestingly,	  we	  did	  see	  a	  trend	  
to	  increased	  platelet	  and	  fibrin	  deposition	  in	  mild	  renal	  IRI	  following	  administration	  of	  
early	  apoptotic	  cells	  and	  moderate	  renal	  IRI	  following	  administration	  of	  late	  apoptotic	  
cells	  but	  it	  was	  non-­‐significant.	  	  
	  
Early	  apoptotic	  cells	  contained	  some	  PI	  positive	  cells	  that	  have	  lost	  membrane	  integrity	  
whilst	   the	   majority	   of	   late	   apoptotic	   cells	   were	   PI	   positive.	   Admittedly	   we	   did	   not	  
undertake	  a	  direct	  head-­‐to-­‐head	  comparison	  of	  the	  effects	  of	  early	  and	  late	  apoptotic	  
cells,	  and	  it	  is	  possible	  that	  the	  adverse	  effects	  of	  late	  apoptotic	  cells	  might	  involve	  the	  
release	  of	   intracellular	  damage-­‐associated	  molecular	  pattern	  molecules	  such	  as	  high-­‐
mobility	  group	  box	  chromosomal	  protein	  1	  that	  may	  activate	  cells	  via	  Toll-­‐like	  receptor	  
4	  (Zhao	  et	  al.,	  2014).	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In	   contrast	   to	   the	   apoptotic	   cell-­‐derived	   protection	   observed	   in	   other	   diverse	  
inflammatory	   models,	   these	   data	   indicate	   ‘apoptotic	   cell	   therapy’	   does	   not	   have	  
translational	   relevance	   for	   patients	   with	   AKI	   induced	   by	   IRI.	   It	   was	   hoped	   that	  
apoptotic	   cells	   could	   be	   administered	   to	   patients	   prior	   to	   surgery,	   such	   as	   cardiac	  
surgery,	   in	   an	   attempt	   to	   limit	   pot-­‐operative	  AKI.	   It	   thus	   appears	   that	   apoptotic	   cell	  
administration	  is	  not	  inherently	  anti-­‐inflammatory	  in	  all	  models	  of	  acute	  inflammation.	  
	  
6.2.2	  Apoptotic	  cells	  modulate	  blood	  coagulation	  	  
The	   influence	   of	   apoptotic	   cells	   on	   coagulation	   status	   is	   a	   thought	   provoking	   yet	  
overlooked	  area.	   Exposure	  of	   PtdSer	   confers	   apoptotic	   cells	  with	   a	   striking	   ability	   to	  
influence	  diverse	  pathways,	  but	  most	  notably	  in	  this	  thesis	  –	  coagulation	  status	  (Vance	  
and	  Steenbergen,	  2005).	  It	  is	  known	  that	  phospholipids	  promote	  blood	  coagulation	  by	  
acting	   as	   catalytic	   surfaces	   that	   facilitate	   interactions	   between	   coagulation	   factors	  
(Barton,	  1967,	  Zwaal	  et	  al.,	  1998,	  Pickering	  et	  al.,	  2008).	  PtdSer	  is	  able	  to	  regulate	  the	  
central	  blood	  clotting	  cascade	  protein	  thrombin	  and	  is	  considered	  a	  potent	  modulator	  
of	  coagulation	  (Zwaal	  et	  al.,	  1998,	  Gerads	  et	  al.,	  1990,	  Casciola-­‐Rosen	  et	  al.,	  1996).	  For	  
instance	   PtdSer	   externalisation	   on	   activated	   platelets	   is	   known	   to	   promote	   the	  
conversion	  of	  prothrombin	  to	  thrombin	  via	  coagulation	  factor	  Xa	  (Bevers	  et	  al.,	  1983,	  
Monroe	  et	  al.,	  2002).	  Platelets	  are	   important	  regulators	  of	  coagulation	  and	  thrombin	  
generation	  and	  interestingly	  we	  found	  that	  apoptotic	  thymocytes	  were	  able	  to	  bind	  to	  
murine	  platelets	   in	  vitro.	  Such	  an	  interaction	  could	  lead	  to	  an	  extensive	  amplification	  
of	  catalytic	  surfaces	  available	  to	  coagulation	  factors.	  
	  
In	  a	  Russell	  viper	  venom	  assay	  apoptotic	  HeLa	  cells	  and	  human	  endothelial	  cells	  were	  
found	  to	  be	  considerably	  procoagulant	  by	  Casciola-­‐Rosen	  et	  al.,	  (1996).	  We	  discovered	  
that	   apoptotic	   thymocyte	   treated	   mice	   exhibited	   significantly	   delayed	   thrombin	  
generation,	   whilst	   the	   total	   amount	   of	   thrombin	   produced	   remained	   unchanged.	  
Although	   preliminary,	   this	   data	   hints	   towards	   another	   pathway	   whereby	   apoptotic	  
cells	  may	  be	  able	  to	  influence	  coagulation	  status.	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With	   apoptotic	   cells	   rich	   in	   externalised	   phospholipids	   able	   to	   interact	   with	  
coagulation	  cascade	  factors,	  that	  in	  addition	  to	  PtdSer	  include	  phosphatidylcholine	  and	  
phosphatidylethanolamine,	   it	   is	   widely	   accepted	   that	   apoptotic	   cells	   influence	  
coagulation.	  Despite	  this,	  however,	  the	  numbers	  of	  studies	  that	  directly	  show	  or	  study	  
the	  effects	  of	  apoptotic	  cells	  modulation	  of	  coagulation	  are	  limited	  (Casciola-­‐Rosen	  et	  
al.,	   1996).	   Although	  brief	   these	  data	   further	   confirm	   that	   apoptotic	   cells	   are	   able	   to	  
significantly	   alter	   coagulation	   status.	   With	   the	   increased	   prevalence	   of	   studies	  
interested	  in	  ‘apoptotic	  cell	  therapy’,	  this	  is	  a	  topic	  that	  merits	  further	  investigation.	  
	  
6.2.3	  Future	  Direction	  	  
In	  regards	  to	  apoptotic	  cells	  and	  coagulation	  it	  would	  be	  useful	  to	  discern	  whether	  the	  
observed	   phenotype	   was	   the	   result	   of	   PtdSer	   exposure	   alone,	   other	   apoptotic	   cell-­‐
coagulation	   protein	   interactions	   or	   a	   combination.	   Casciola-­‐Rosen	   et	   al.,	   (1996)	  
revealed	   that	   the	   ability	   of	   apoptotic	   HeLa	   cells	   and	   human	   endothelial	   cells	   to	  
influence	   coagulation	   was	   solely	   due	   to	   PtdSer	   exposure.	   Anti-­‐PtdSer	   antibody	  
abolished	   any	   procoagulant	   effect.	   A	   similar	   approach	   could	   be	   adopted	   for	   future	  
experiments	   in	   which	   the	   coagulability	   of	   plasma	   samples	   from	   mice	   receiving	  
apoptotic	  cells	  treated	  with	  various	  anti-­‐phospholipid	  antibodies	  is	  assessed.	  It	  is	  also	  
important	  to	  confirm	  that	  our	  results	  are	  not	  restricted	  to	  apoptotic	  thymocytes,	  and	  
that	   non-­‐apoptotic	   cells	   do	   not	   alter	   coagulation.	   In	   addition,	   although	   technically	  
more	  challenging,	  it	  is	  crucial	  that	  the	  human	  relevance	  of	  these	  finding	  is	  determined.	  
One	   such	   approach	   could	   be	   to	   treat	   human	   blood	   samples	   with	   human	   apoptotic	  
Jurkat	   cells,	   or	   apoptotic	   neutrophils	   and	  measure	   coagulability	   by	   a	   TGA.	  However,	  
careful	   consideration	   regarding	   the	   selection	   of	   the	   anti-­‐coagulants	   used	   in	   the	  
collection	  of	  blood	  is	  required.	  
	  
6.3	  Circulating	  IgM	  antibodies	  requires	  membrane	  disruption	  to	  bind	  apoptotic	  and	  
non-­‐apoptotic	  cells,	  and	  may	  promote	  the	  clearance	  of	  disrupted	  nucleated	  cells	  and	  
erythrocytes	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Circulating	   IgM	   antibodies	   play	   a	   non-­‐redundant	   role	   in	   apoptotic	   cell	   clearance,	  
evident	  by	  the	  development	  of	  autoimmune	  disease	  in	  IgM-­‐deficient	  mice	  (Boes	  et	  al.,	  
2000,	  Ehrenstein	  et	  al.,	  2000).	  IgM	  binding	  to	  late	  apoptotic	  cells	  (Litvack	  et	  al.,	  2010,	  
Fu	  et	  al.,	  2007,	  Zwart	  et	  al.,	  2004,	  Ciurana	  and	  Hack,	  2006,	  Porcheray	  et	  al.,	  2013)	  leads	  
to	  complement	  activation	  and	  subsequent	  opsonisation	  of	   IgM+	  cells	  by	  complement	  
components	  that	  may	  be	  recognised	  by	  phagocytes	  (Chen	  et	  al.,	  2009c,	  Quartier	  et	  al.,	  
2005,	  Chen	  et	  al.,	  2009a,	  Ogden	  et	  al.,	  2005).	   In	  chapter	  5	  we	  carefully	  explored	  the	  
binding	   of	   circulating	   IgM	   to	   apoptotic	   cells,	   both	   human	   and	   murine,	   at	   different	  
apoptotic	   stages.	   We	   demonstrated	   that	   IgM	   antibody	   binding	   requires	   significant	  
plasma	  membrane	  disruption	  thereby	  allowing	  access	  to	  cytoplasmic	  or	  cell	  membrane	  
antigens.	  
	  
6.3.1	  Circulating	   IgM	  antibodies	   illustrate	  a	  preference	  for	   late	  apoptotic	  cells	  due	  to	  
plasma	  membrane	  disruption	  	  
Apoptosis	  consists	  of	  multiple	  temporal	  stages	  defined	  by	  morphological	  changes	  such	  
as	   nuclear	   pyknosis,	   cytoplasmic	   vacuolation,	   cell	   shrinkage	   and	   the	   presence	   or	  
absence	  of	  plasma	  membrane	  integrity	  (Elmore,	  2007,	  Kerr	  et	  al.,	  1972,	  Galluzzi	  et	  al.,	  
2007).	   A	   key	   finding	   of	   this	   work	   is	   that	   IgM	   binds	   a	   subpopulation	   of	   AnnV+PI+	  
apoptotic	  thymocytes	  with	  IgM+	  cells	  exhibiting	  a	  different	  FSC/SSC	  profile	  to	  AnnV+PI+	  
apoptotic	   thymocytes	   that	   were	   IgM-­‐.	   IgM	   binding	   specificity	   was	   confirmed	   by	   the	  
absence	   of	   binding	   to	   AnnV+PI+	   thymocytes	   in	   experiments	   using	   immunoglobulin-­‐
deficient	  plasma	  from	  RAG1-­‐deficient	  mice	  or	  isotype	  IgM	  antibodies.	  
	  
These	   data	   suggested	   a	   fundamental	   difference	   in	   the	   properties	   of	   IgM+AnnV+PI+	  
apoptotic	   thymocytes,	  with	   potential	   epitopes	   bound	   by	   IgM	  either	   being	   absent	   or	  
inaccessible	  in	  IgM-­‐AnnV+PI+	  thymocytes.	  Confocal	  microscopy	  imaging	  analysis	  of	  FACS	  
sorted	  cells	  suggested	  that	  IgM	  may	  bind	  the	  cell	  membrane	  of	  AnnV+IgM+	  thymocytes	  
and	  that	  the	  membrane	  of	  these	  cells	  was	  disrupted.	   	  Electron	  microscopy	  studies	  of	  
FACS	   sorted	   cells	   were	   therefore	   undertaken,	   revealing	   important	   morphological	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features	  of	  these	  distinct	  cell	  populations.	  Non-­‐apoptotic	  AnnV-­‐PI-­‐	  IgM-­‐	  cells	  exhibited	  a	  
normal	  nucleus	   together	  with	  organelles	  and	  an	   intact	  plasma	  membrane.	  Apoptotic	  
AnnV+PI+	   IgM-­‐	   cells	   exhibited	   a	   pyknotic	   nucleus	   with	   intracellular	   organelles	   and	   a	  
predominantly	   intact	   cell	  membrane.	  Apoptotic	  AnnV+PI+	  IgM+	  cells	   exhibited	  nuclear	  
pyknosis	   and	   intracellular	   organelles	   accompanied	   by	   marked	   disruption	   of	   the	   cell	  
membrane	  with	  obvious	  ‘holes’	  evident.	  The	  profound	  morphological	  changes	  evident	  
in	  these	  IgM+	  apoptotic	  AnnV+PI+	  cells	  are	  likely	  to	  account	  for	  their	  different	  FSC/SSC	  
profile	  evident	  on	  flow	  cytometry.	  
	  
These	   flow	   cytometry	   and	   morphological	   studies	   of	   IgM+	   or	   IgM-­‐	   apoptotic	   cells	  
suggest	  that	  the	  binding	  of	   IgM	  (MW	  970kDa)	  requires	  physical	  access	  to	  the	  cellular	  
interior	  via	  a	  severely	  disrupted	  cell	  membrane.	  Such	  access	  is	  not	  provided	  by	  the	  loss	  
of	  cell	  membrane	   integrity	   that	   is	  defined	  by	  positive	  staining	  with	  propidium	   iodide	  
(MW	  0.67kDa).	  This	  model	   is	   schematically	  depicted	   in	  Figure	  6.1	   in	  which	  apoptotic	  
cells	   undergo	   a	   progressive	   and	   increasing	   loss	   of	   cell	   membrane	   integrity	   that	  
culminates	  in	  large	  pentameric	  IgM	  (Czajkowsky	  and	  Shao,	  2009,	  Feinstein	  and	  Munn,	  
1969)	  molecules	  being	  able	  to	  access	  and	  bind	  internal	  epitopes.	  
	  
The	  relevance	  of	  our	  carefully	  controlled	  murine	  IgM	  binding	  data	  to	  human	  cells	  was	  
provided	   by	   similar	   findings	   in	   studies	   of	   apoptotic	   Jurkat	   cells.	   IgM	   binding	   was	  
confined	  to	  a	  subset	  of	  apoptotic	  AnnV+PI+	  Jurkat	  cells	   that	  also	  exhibited	  a	  different	  
FSC/SSC	   profile	   to	   IgM-­‐AnnV+PI+	   cells.	   Similar	   to	   thymocytes,	   confocal	   microscopy	  
suggested	  that	  IgM	  bound	  to	  apoptotic	  cells	  with	  plasma	  membrane	  disruption.	  
	  
Our	   confocal	   imaging	   studies	   appeared	   to	   suggest	   that	   IgM	  antibodies	   bound	   in	   the	  
region	  of	  the	  plasma	  membrane.	  However,	  we	  were	  not	  able	  to	  confirm	  this	  or	  discern	  
which	  side	  of	  the	  plasma	  membrane	  IgM	  bound.	  	  The	  combined	  diameter	  of	  the	  mean	  
plasma	   membrane	   (≈4-­‐7nM)	   and	   pentameric	   IgM	   (≈30nM)	   (Czajkowsky	   and	   Shao,	  
2009)	   is	   beyond	   the	   standard	   distance	   in	   which	   techniques	   such	   as	   fluorescence	  
resonance	  energy	  transfer	  (FRET)	  and	  immunogold	  are	  typically	  used.	  We	  decided	  that	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convincing	   confirmatory	   localisation	  of	   IgM	  binding	  by	   FRET	  or	   immunogold	   labeling	  
might	   be	   possible,	   but	   would	   be	   extremely	   challenging	   and	   was	   unfortunately	   not	  
possible	  to	  perform	  during	  this	  thesis	  due	  to	  time	  constraints.	  	  
	  
6.3.2	   Epitopes	   bound	   by	   circulating	   IgM	   antibodies	   do	   not	   need	   to	   be	   modified	   by	  
apoptosis	  	  
A	  key	  question	  concerned	  the	  nature	  of	  the	  epitopes	  recognized	  by	  IgM	  and	  whether	  
these	   epitopes	   were	   generated	   de	   novo	   during	   apoptosis	   by	   caspases	   or	   other	  
enzymes,	   or	   by	   other	   forms	   of	   cell	   stress,	   such	   as	   oxidation.	   Examination	   of	   IgM	  
binding	   to	   saponin	  permeabilised	  cells	   revealed	   that	  all	   thymocytes	  became	  strongly	  
IgM+	   following	   permeabilisation	   irrespective	   of	  whether	   they	  were	   non-­‐apoptotic	   or	  
apoptotic.	   Moreover	   no	   significant	   binding	   of	   IgM	   control	   isotype	   antibody	   was	  
evident.	  Also,	  non-­‐apoptotic	  Jurkat	  cells	  and	  human	  renal	  tubular	  (HK-­‐2)	  cells	  became	  
strongly	   IgM+	   following	   permeabilisation	   providing	   relevance	   to	   human	  disease.	   This	  
also	  indicated	  that	  the	  presence	  of	  intracellular	  epitopes	  capable	  of	  IgM	  recognition	  is	  
not	  confined	  to	  lymphoid	  cells.	  	  
	  
Experiments	   examining	   IgM	   binding	   to	   permeabilised	   murine	   erythrocytes	   were	  
undertaken	   as	   these	   cells	   represent	   a	   structurally	   simple	   target.	   Erythrocytes	   are	  
anucleate	   with	   few	   organelles	   and	   a	   biochemically	   less	   complicated	   cell	   membrane	  
compared	   to	   nucleated	   cells,	   such	   as	   lymphocytes.	   We	   found	   that	   IgM	   bound	   a	  
significant	   proportion	   of	   permeabilised	   erythrocytes.	   Specificity	   of	   IgM	   binding	   was	  
again	  demonstrated	  by	  the	  complete	  lack	  of	  binding	  of	  isotype	  IgM	  antibody	  and	  the	  
absence	   of	   IgM	   binding	   to	   erythrocytes	   incubated	   in	   RAG1-­‐deficient	   plasma.	   These	  
data	  suggested	  that	  at	  least	  a	  proportion	  of	  epitopes	  recognised	  and	  bound	  by	  IgM	  are	  
cell	  membrane	  associated.	  	  
	  
It	   can	   be	   appreciated	   from	   Table	   1.3	   that	   IgM	   antibodies	   bind	   a	   diverse	   range	   of	  
epitopes.	   Although	   it	   is	   clear	   that	   studies	   predominantly	   report	   binding	   to	  
phospholipids	  that	  are	  modified	  during	  the	  apoptotic	  process	  such	  as	  by	  oxidation.	  Our	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Figure	  6.1	  -­‐	  Schematic	  diagram	  of	  IgM	  binding	  to	  apoptotic	  or	  disrupted	  cells.	  As	  cells	  
progress	  through	  apoptosis	  IgM	  binding	  occurs	  at	  a	  point	  following	  phosphatidylserine	  
exposure	  (AnnV	  binding)	  and	  loss	  of	  membrane	  integrity	  (PI	  binding).	  At	  this	  point	  IgM	  
is	  able	  to	  bind	  intracellular	  cell	  membrane	  or	  cytoplasmic	  antigens.	  	  Similarly,	  IgM	  may	  
bind	   any	   cells	   including	   lymphocytes	   or	   erythrocytes	   that	   have	   lost	   cellular	   integrity	  
and	   have	   become	   permeable	   following	   cell	   necrosis	   or	   fragmentation.	   IgM	   binding	  
represents	  an	  important	  signal	  for	  phagocytosis	  and	  thus	  promotes	  engulfment	  of	  cells	  
(including	  nuclear	  material	  and	  organelles)	  before	  complete	  cellular	  disintegration	  that	  
would	  promote	  the	  development	  of	  autoimmunity.	  
	  
data	  suggests	  that	  IgM	  bound	  epitopes,	  such	  as	  membrane	  phospholipids,	  do	  not	  need	  
to	   have	   been	  modified	   during	   apoptosis	   for	   IgM	   to	   bind.	   	   This	   is	   quite	   a	   pertinent	  
finding	  as	  work	  by	  Kim	  et	  al.,	   (2002)	   indicates	   that	   IgM	  binding	  occurs	   following	   the	  
activation	  of	  a	  specific	  phospholipase	  (iPLA2).	  This	  phospholipase	  remodels	  apoptotic	  
cell	  membranes	  exposing	   IgM	  bound	  phospholipids.	  This	   further	  supports	   the	  notion	  
that	  IgM	  binding	  is	  restricted	  by	  accessibility	  to	  IgM	  bound	  epitopes.	  
	  
One	   point	   of	   concern	   for	   these	   studies	  was	   the	   use	   of	   saponin	   to	   permeabilise	   the	  
plasma	   membrane	   and	   whether	   this	   artificially	   modified	   or	   damaged	   membrane	  
phospholipids.	  This	  is	  unlikely	  to	  have	  occurred.	  Unlike	  organic	  solvents	  methanol	  and	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acetone	   that	   permeablise	   by	   dissolving	   lipids,	   or	   the	   non-­‐ionic	   detergent	   Triton-­‐X,	  
which	  extracts	  proteins	  and	  lipids,	  saponin,	   is	  a	  plant	  glycoside	  detergent	  that	   is	  able	  
to	  permeablise	  by	  solubilizing	  cholesterol	  (Jamur	  and	  Oliver,	  2010,	  Jacob	  et	  al.,	  1991).	  
This	   allows	   saponin	   to	   selectively	   leave	   approximately	   1µM	   sized	   holes	   in	   the	  
membrane,	   leaving	  membrane	   architecture	   and	   antigens	   as	  well	   as	   and	   intracellular	  
antigens	  largely	  unaltered	  (Hudder	  et	  al.,	  2003,	  Jamur	  and	  Oliver,	  2010,	  Seeman	  et	  al.,	  
1973,	  Jacob	  et	  al.,	  1991).	  
	  
6.3.3	  IgM	  binding	  may	  promote	  the	  clearance	  of	  nucleated	  cells	  and	  erythrocytes	  that	  
have	  significantly	  disrupted	  membrane	  integrity	  
These	   data	   indicate	   that	   IgM	   is	   able	   to	   recognise	   and	   bind	   epitopes	   present	   within	  
both	  normal	  and	  apoptotic	  nucleated	  cells.	  This	  suggests	  that	  IgM	  bound	  epitopes	  are	  
not	  generated	  by	  the	  activation	  of	  caspase	  cascades	  associated	  with	  apoptosis.	  Indeed,	  
the	   presence	   of	   such	   apoptosis-­‐independent	   epitopes	   within	   normal	   cells	   could	  
provide	   the	   substrate	   for	   IgM	  binding	   to	   cells	   that	   have	  undergone	   any	   form	  of	   cell	  
lysis	   such	   as	   primary	   necrosis	   secondary	   to	   ischaemia	   etc.	   or	   cell	   injury	   induced	   by	  
granzyme/perforin	  or	   complement	   (Figure	  6.1).	   The	  binding	  of	   IgM	   to	  permeabilised	  
erythrocytes	   is	   intriguing	   as	   previous	   work	   has	   shown	   that	   natural	   autologous	   IgG1	  
antibodies	   and	   complement	   are	   implicated	   in	   the	   recognition	   and	   clearance	   of	  
senescent	   erythrocytes	   (Lutz	   and	   Bogdanova,	   2013).	   Furthermore,	   natural	   IgM	  
antibodies	  have	  been	  shown	  to	  bind	  exosomes	  derived	  from	  reticulocytes	  (Blanc	  et	  al.,	  
2007a).	  There	  is	  little	  data	  available	  regarding	  the	  clearance	  of	  the	  fragmented	  normal	  
erythrocytes	   generated	   in	   patients	   with	   conditions	   such	   as	   microangiopathic	  
haemolytic	  anaemia.	  These	  fragmented	  erythrocytes	  may	  account	  for	  up	  to	  6.9%	  of	  all	  
circulating	  erythrocytes	  (Toba	  et	  al.,	  2004)	  and	  thus	  represent	  a	  significant	  cellular	  load	  
that	   requires	   clearance	   by	   the	   reticuloendothelial	   system.	   Based	   upon	   our	  
observations,	  we	  would	   speculate	   that	   IgM	  might	   play	   a	   role	   in	   the	   recognition	   and	  
clearance	  of	  damaged	  erythrocytes	  that	  exhibit	  significant	  disruption	  of	  cell	  membrane	  
integrity	  (Figure	  6.1),	  though	  this	  will	  require	  further	  studies.	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In	   conclusion,	   these	   flow	   cytometric	   and	   morphological	   studies	   indicate	   that	  
circulating	  IgM	  specifically	  binds	  to	  cells	  that	  have	  progressed	  through	  apoptosis	  such	  
that	   they	   have	   developed	  marked	   plasma	  membrane	   disruption	   that	   allows	   IgM	   to	  
access	   intracellular	   epitopes.	   Studies	   of	   IgM	   binding	   to	   permeabilised	   lymphoid	   and	  
parenchymal	   tissue	   cells	   indicate	   that	   both	   normal	   and	   apoptotic	   cells	   possess	  
intracellular	   epitopes	   that	   can	   be	   recognised	   by	   IgM.	   Lastly,	   permeabilised	  
erythrocytes	  also	  exhibit	  specific	   IgM	  binding.	  The	  totality	  of	   these	  data	  suggest	   that	  
an	   important	   function	   of	   circulating	   IgM	   is	   to	   recognise	   and	   tag	   any	   nucleated	  
circulating	  or	  resident	  tissue	  cell	  or	  erythrocytes	  that	  is	  severely	  damaged	  and	  exhibits	  
significant	   plasma	  membrane	   disruption.	   Subsequent	   activation	   of	   complement	   and	  
opsonisation	  would	  promote	  clearance	  of	  these	  severely	  damaged	  cells	  by	  phagocytes.	  
Further	  work	  is	  required	  to	  define	  the	  role	  of	  circulating	  IgM	  in	  the	  specific	  clearance	  
of	  nucleated	  cells	  and	  erythrocytes	  with	  severely	  compromised	  cell	  membranes	  in	  vivo	  
in	  conditions	  such	  as	  ischemic	  injury,	  sepsis	  and	  thrombotic	  microangiopathies.	  
	  
6.3.4	  Complement	  protein	  C3	  binds	  to	  aged	  thymocytes	  prior	  to	  PtdSer	  exposure	  
The	   efficiency	   of	   phagocytosis	   appears	   to	   be	   impressive	   as,	   despite	   an	   incidence	   of	  
over	  109	  apoptotic	  cells	  per	  day,	   it	   is	   rare	  to	  observe	  apoptotic	  cells	   in	  normal	  tissue	  
(Mochizuki	   et	   al.,	   1996,	   Scott	   et	   al.,	   2001,	   Elliott	   et	   al.,	   2009,	   Yang	   et	   al.,	   2006,	  
Schrijvers	   et	   al.,	   2005,	  Gregory	   and	  Devitt,	   2004).	   Reports	   in	  Caenorhabditis	   elegans	  
indicated	   that	   apoptotic	   cells	  might	   be	   cleared	   before	   advanced	   stages	   of	   apoptosis	  
are	  reached.	  These	  studies	  aided	  the	  discovery	  of	  ‘find-­‐me’	  and	  ‘eat-­‐me’	  signals	  on	  the	  
apoptotic	  cell	  plasma	  membrane	  that	  act	  to	  communicate	  their	  status	  to	  phagocytes	  
(Reddien	  et	  al.,	  2001,	  Hoeppner	  et	  al.,	  2001,	  Ravichandran,	  2003,	  Lauber	  et	  al.,	  2003).	  
A	  crucial	  and	  widely	  accepted	  ‘eat-­‐me’	  signal	  and	  hallmark	  of	  early	  apoptosis	  is	  PtdSer,	  
exposure	   of	   which	   on	   apoptotic	   cell	   surfaces	   appears	   a	   requirement	   for	   clearance	  
(Fadok	   et	   al.,	   2000,	   Fadok	   et	   al.,	   2001,	   Fadok	   et	   al.,	   1992,	   Kagan	   et	   al.,	   2002).	  
Complement	   proteins	   are	   also	   involved	   in	   apoptotic	   cell	   recognition,	   promoting	  
clearance	   by	   acting	   as	   molecular	   bridges	   between	   apoptotic	   and	   phagocyte	   cell	  
surfaces	  although	  this	  is	  thought	  to	  occur	  late	  during	  apoptosis	  (Gaipl	  et	  al.,	  2001).	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Unsurprisingly	   we	   found	   that	   C3	   bound	   to	   thymocytes	   that	   had	   exposed	   PtdSer	   on	  
their	   cell	   surface	   and	   would	   be	   considered	   apoptotic	   (AnnV+).	   However,	   it	   was	  
surprising	   to	  detect	  C3	  bound	   to	   thymocytes	  not	   yet	   expressing	  PtdSer	   (AnnV-­‐)	  with	  
the	  extent	  of	  deposition	  being	  markedly	  elevated	  in	  comparison	  to	  fresh	  thymocytes.	  
This	   suggests	   that	  molecular	   determinants	   on	  dying	   cell	   plasma	  membranes	  may	  be	  
recognised	   by	   complement	   proteins	   very	   early	   during	   apoptosis	   and	   prior	   to	   PtdSer	  
exposure.	   	   With	   C3b	   present	   at	   low	   levels	   in	   the	   serum,	   due	   to	   spontaneous	  
conversion	   of	   C3	   to	   C3b,	   cells	   express	   membrane	   bound	   complement	   regulatory	  
proteins.	   These	   regulators,	   such	   as	   CD59	   and	   complement	   decay-­‐accelerating	   factor	  
(DAF	   or	   CD55)	   actively	   prevent	   C3b	   binding	   to	   protect	   the	   cell	   from	   complement	  
activation	   (Zipfel	   and	   Skerka,	   2009,	   Spendlove	   et	   al.,	   2006,	   Kimberley	   et	   al.,	   2007).	  
During	  apoptosis	  these	  membrane	  complement	  regulators	  are	  lost	  meaning	  that	  C3b	  is	  
able	  to	  bind	  and	  facilitate	  cell	  clearance	  by	  opsonization	  (Zipfel	  and	  Skerka,	  2009).	  It	  is	  
possible	   to	  hypothesise	   that	  phagocytes	  may	  be	  able	   to	  clear	  dying	  cells	  earlier	   than	  
what	  is	  currently	  thought.	  These	  data,	  despite	  an	  admittedly	  low	  sample	  size,	  are	  quite	  
intriguing	  and	  requires	  further	  investigation.	  
	  
6.3.5	  Future	  Direction	  
As	  discussed	  these	  studies	  did	  not	  define	  the	  epitopes	  bound	  by	  IgM	  antibodies	  on	  the	  
plasma	   membrane	   or	   decipher	   which	   aspect	   of	   the	   plasma	   membrane	   binds	   IgM.	  
However,	  on	  the	  basis	  of	  permeable	  cell	  experiments,	  it	  is	  likely	  that	  IgM	  bound	  to	  the	  
inner	  plasma	  membrane	  though	  this	  should	  be	  confirmed	  in	  future	  studies.	  However,	  
this	  is	  likely	  to	  be	  technically	  challenging.	  Although	  once	  optimized,	  techniques	  such	  as	  
immunogold	  labeling	  or	  FRET	  could	  be	  used	  to	  dissect	  whether	  IgM	  antibodies	  used	  in	  
these	   studies	   bound	   to	   phospholipids	   or	   intracellular	   membrane	   proteins.	  
Alternatively,	   it	  may	  be	  possible	  to	  discern	  which	  cellular	  region	  (membrane,	  nuclear	  
or	  cytoplasm)	  IgM	  antibodies	  bound.	  
	  
It	   is	   well	   established	   that	   IgM	   binding	   promotes	   opsonisation	   of	   IgM+	   cells	   by	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complement	   components	  and	   subsequent	  phagocytosis	   (Chen	  et	  al.,	   2009c,	  Quartier	  
et	   al.,	   2005,	   Chen	   et	   al.,	   2009a,	   Ogden	   et	   al.,	   2005).	   Further	   work	   is	   necessary	   to	  
demonstrate	   that	   AnnV+IgM+	   are	   actively	   cleared	   by	   phagocytes	   in	   preference	   to	  
AnnV+IgM-­‐	  cells.	  The	  generation	  of	  an	  adequate	  number	  of	  AnnV+IgM+	  cells	  to	  enable	  
electron	   microscopy	   was	   challenging,	   factoring	   in	   their	   fragile	   nature	   and	   the	  
experimental	  length,	  and	  it	  may	  be	  difficult	  to	  acquire	  enough	  of	  these	  cells	  to	  enable	  
phagocytosis	  assays.	  The	  same	  is	  true	  for	  permeabilised	  erythrocytes.	  
	  
These	   data	   suggest	   that	   circulating	   IgM	   may	   be	   involved	   in	   the	   clearance	   of	  
fragmented	   normal	   erythrocytes	   generated	   in	   patients	   with	   conditions	   such	   as	  
microangiopathic	  haemolytic	  anaemia.	  Therefore,	   it	  must	  be	   confirmed	   that	   IgM	  are	  
also	  able	  to	  recognise	  and	  bind	  to	  permeabilised	  or	  damaged	  human	  erythrocytes.	  Due	  
to	  antibody	  ‘stickiness’	  of	  erythrocytes	  in	  this	  thesis	  we	  opted	  to	  study	  IgM	  binding	  to	  
permeabilised	   murine	   erythrocytes	   due	   to	   the	   availability	   of	   isotype	   antibody	   and	  
RAG-­‐1	   plasma	   controls	   to	   ensure	   specificity	   of	   binding.	   Controls	   to	   ensure	   the	  
specificity	  of	   human	  erythrocyte	  experiments	   could	   include	   the	  use	  of	   IgM	  depleted	  
human	  plasma/serum.	  
	  
Further	  studies	  probing	  C3	  deposition	  on	  fresh,	  aged	  and	  apoptotic	  murine	  thymocytes	  
are	   of	   course	   necessary	   to	   enable	   formal	   statistical	   analysis.	   It	   should	   also	   be	  
confirmed	   that	   human	   Jurkat	   cells	   exhibit	   a	   similar	   finding,	   and	   whether	   other	  
complement	   proteins,	   such	   as	   C1q,	   also	   bind	   prior	   to	   PtdSer	   exposure.	   Once	   this	   is	  
confirmed	  macrophage	   phagocytic	   assay	  will	   need	   to	   be	   performed	   to	   demonstrate	  
the	  relevance	  of	  this	  finding	  for	  dead	  cell	  clearance.	  
	  
6.4	  Overall	  Summary	  of	  Major	  Findings	  
	  
This	  thesis	  set	  out	  to	  determine	  if	  preliminary	  data	  suggesting	  that	  apoptotic	  cells	  were	  
able	   to	   limit	   renal	   dysfunction	   post	   renal	   ischaemia	  was	   the	   result	   of	   either	   of	   two	  
hypothetical	  mechanisms	  of	  apoptotic	  cell-­‐mediated	  functional	  protection.	  These	  were	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to	  examine	  whether	  functional	  protection	  was	  conferred	  by	  apoptotic	  cell	  modulation	  
of	   (a)	   circulating	   IgM	   antibodies,	   which	   are	   pathogenic	   in	   ischaemic	   injury	   in	   other	  
organs	   or	   (b)	   coagulation	   status	   leading	   to	   improved	   intrarenal	  microvascular	   blood	  
flow.	  
	  
It	   became	   apparent	   that	   IgM	   antibodies	  were	   unlikely	   to	   play	   a	   direct	   role	   in	   injury	  
pathogenesis,	   as	   IgM	  was	   not	   detected	   following	   renal	   IRI.	   This	   was	   found	   to	   be	   in	  
stark	   contrast	   to	   the	   dramatic	   deposition	   of	   IgM	   antibodies	   following	   hepatic	  
ischaemia	  and	  in	  a	  mouse	  model	  of	  AIH.	  The	  reason	  for	  this	  disparity	  remains	  unclear.	  
It	  is	  possible	  that	  tissue	  accessibility	  may	  be	  a	  factor.	  Our	  cellular	  in	  vitro	  investigation	  
indicates	   that	   the	  preferential	  binding	  of	   IgM	  antibodies	   to	   late	  apoptotic	  cells	  could	  
be	   the	   result	   of	   apoptotic	   related	  membrane	   disruption	   that	   enables	   IgM	   to	   access	  
intracellular	  antigens.	  
	  
As	  it	  was	  unlikely	  that	  administered	  apoptotic	  cells	  reduced	  self-­‐reactive	  IgM	  antibody	  
levels	   thereby	   limiting	   complement	   augmented	   injury	   post	   ischaemia,	   as	   per	   our	  
hypothesis,	  we	   focused	  our	  attention	  upon	  the	  ability	  of	  apoptotic	  cells	   to	  modulate	  
coagulation	   status.	   We	   discovered	   that	   as	   well	   as	   binding	   platelets,	   apoptotic	   cells	  
were	  able	  to	  delay	  thrombin	  generation.	  Despite	  this,	  unexpectedly,	  and	  in	  contrast	  to	  
preliminary	   data,	   we	   found	   apoptotic	   cell	   administration	   to	   be	   neutral	   to	   renal	  
functional	  following	  ischaemia,	  and	  depending	  upon	  injury	  severity	  may	  further	  impair	  
renal	  dysfunction.	  
	  
These	   data	   indicate	   that	   IgM	   antibodies	   are	   not	   likely	   to	   be	   targets	   of	   novel	  
therapeutics,	   and	   that	   ‘apoptotic	   cell	   therapy’	   is	   not	   translationally	   relevant	   in	   the	  




Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   158	  
References	  
	  
ALPER,	   C.	   A.,	   JOHNSON,	   A.	   M.,	   BIRTCH,	   A.	   G.	   &	   MOORE,	   F.	   D.	   1969.	   Human	   C'3:	  
evidence	  for	  the	  liver	  as	  the	  primary	  site	  of	  synthesis.	  Science,	  163,	  286-­‐8.	  
ANANIA,	   C.,	   GUSTAFSSON,	   T.,	   HUA,	   X.,	   SU,	   J.,	   VIKSTROM,	   M.,	   DE	   FAIRE,	   U.,	  
HEIMBURGER,	   M.,	   JOGESTRAND,	   T.	   &	   FROSTEGARD,	   J.	   2010.	   Increased	  
prevalence	  of	  vulnerable	  atherosclerotic	  plaques	  and	  low	  levels	  of	  natural	  IgM	  
antibodies	   against	   phosphorylcholine	   in	   patients	   with	   systemic	   lupus	  
erythematosus.	  Arthritis	  Res	  Ther,	  12,	  R214.	  
ARAGNO,	  M.,	  CUTRIN,	  J.	  C.,	  MASTROCOLA,	  R.,	  PERRELLI,	  M.	  G.,	  RESTIVO,	  F.,	  POLI,	  G.,	  
DANNI,	  O.	  &	  BOCCUZZI,	  G.	  2003.	  Oxidative	  stress	  and	  kidney	  dysfunction	  due	  to	  
ischemia/reperfusion	   in	   rat:	   attenuation	   by	   dehydroepiandrosterone.	   Kidney	  
Int,	  64,	  836-­‐43.	  
ARUMUGAM,	  T.	  V.,	  SHIELS,	  I.	  A.,	  WOODRUFF,	  T.	  M.,	  GRANGER,	  D.	  N.	  &	  TAYLOR,	  S.	  M.	  
2004.	  The	  role	  of	  the	  complement	  system	  in	  ischemia-­‐reperfusion	  injury.	  Shock,	  
21,	  401-­‐9.	  
AUSTEN,	  W.	  G.,	  JR.,	  ZHANG,	  M.,	  CHAN,	  R.,	  FRIEND,	  D.,	  HECHTMAN,	  H.	  B.,	  CARROLL,	  M.	  
C.	   &	   MOORE,	   F.	   D.,	   JR.	   2004.	   Murine	   hindlimb	   reperfusion	   injury	   can	   be	  
initiated	  by	  a	  self-­‐reactive	  monoclonal	  IgM.	  Surgery,	  136,	  401-­‐6.	  
AVRAMEAS,	   S.	   1991.	   Natural	   autoantibodies:	   from	   'horror	   autotoxicus'	   to	   'gnothi	  
seauton'.	  Immunol	  Today,	  12,	  154-­‐9.	  
AVRAMEAS,	   S.,	   DIGHIERO,	   G.,	   LYMBERI,	   P.	   &	   GUILBERT,	   B.	   1983.	   Studies	   on	   natural	  
antibodies	  and	  autoantibodies.	  Ann	  Immunol	  (Paris),	  134D,	  103-­‐13.	  
BARTON,	   P.	   G.	   1967.	   Sequence	   theories	   of	   blood	   coagulation	   re-­‐evaluated	   with	  
reference	  to	  lipid-­‐protein	  interactions.	  Nature,	  215,	  1508-­‐9.	  
BASILE,	  D.	  P.	  2011.	  A	  GAP	  in	  our	  knowledge	  of	  vascular	  signaling	  in	  acute	  kidney	  injury.	  
Kidney	  international,	  80,	  233-­‐235.	  
BASILE,	   D.	   P.,	   ANDERSON,	   M.	   D.	   &	   SUTTON,	   T.	   A.	   2012.	   Pathophysiology	   of	   acute	  
kidney	  injury.	  Compr	  Physiol,	  2,	  1303-­‐53.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   159	  
BECHERUCCI,	  F.,	  MAZZINGHI,	  B.,	  RONCONI,	  E.,	  PEIRED,	  A.,	  LAZZERI,	  E.,	  SAGRINATI,	  C.,	  
ROMAGNANI,	  P.	  &	  LASAGNI,	  L.	  2009.	  The	  role	  of	  endothelial	  progenitor	  cells	  in	  
acute	  kidney	  injury.	  Blood	  purification,	  27,	  261-­‐270.	  
BELLOMO,	  R.,	  KELLUM,	  J.	  A.	  &	  RONCO,	  C.	  2012.	  Acute	  kidney	  injury.	  Lancet,	  380,	  756-­‐
766.	  
BERNAL,	   W.,	   AUZINGER,	   G.,	   DHAWAN,	   A.	   &	   WENDON,	   J.	   2010.	   Acute	   liver	   failure.	  
Lancet,	  376,	  190-­‐201.	  
BERNAL,	  W.	  &	  WENDON,	  J.	  2013.	  Acute	  liver	  failure.	  N	  Engl	  J	  Med,	  369,	  2525-­‐2534.	  
BEVERS,	   E.	   M.,	   COMFURIUS,	   P.	   &	   ZWAAL,	   R.	   F.	   1983.	   Changes	   in	   membrane	  
phospholipid	  distribution	  during	  platelet	  activation.	  Biochim	  Biophys	  Acta,	  736,	  
57-­‐66.	  
BLANC,	   L.,	   BARRES,	   C.,	   BETTE-­‐BOBILLO,	   P.	  &	   VIDAL,	  M.	   2007a.	   Reticulocyte-­‐secreted	  
exosomes	   bind	   natural	   IgM	   antibodies:	   involvement	   of	   a	   ROS-­‐activatable	  
endosomal	  phospholipase	  iPLA2.	  Blood,	  110,	  3407-­‐16.	  
BLANC,	   L.,	   BARRES,	   C.,	   BETTE-­‐BOBILLO,	   P.	  &	  VIDAL,	  M.	   2007b.	   Reticulocyte-­‐secreted	  
exosomes	   bind	   natural	   IgM	   antibodies:	   involvement	   of	   a	   ROS-­‐activatable	  
endosomal	  phospholipase	  iPLA2.	  Blood,	  110,	  3407-­‐3416.	  
BOES,	  M.,	  SCHMIDT,	  T.,	  LINKEMANN,	  K.,	  BEAUDETTE,	  B.	  C.,	  MARSHAK-­‐ROTHSTEIN,	  A.	  &	  
CHEN,	   J.	   2000.	   Accelerated	   development	   of	   IgG	   autoantibodies	   and	  
autoimmune	  disease	  in	  the	  absence	  of	  secreted	  IgM.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A,	  
97,	  1184-­‐9.	  
BONVENTRE,	  J.	  V.	  &	  YANG,	  L.	  2011.	  Cellular	  pathophysiology	  of	  ischemic	  acute	  kidney	  
injury.	  J	  Clin	  Invest,	  121,	  4210-­‐21.	  
BONVENTRE,	   J.	   V.	   &	   ZUK,	   A.	   2004.	   Ischemic	   acute	   renal	   failure:	   an	   inflammatory	  
disease?	  Kidney	  international,	  66,	  480-­‐485.	  
BREGGIA,	  A.	  C.	  &	  HIMMELFARB,	   J.	  2008.	  Primary	  mouse	  renal	   tubular	  epithelial	   cells	  
have	  variable	  injury	  tolerance	  to	  ischemic	  and	  chemical	  mediators	  of	  oxidative	  
stress.	  Oxid	  Med	  Cell	  Longev,	  1,	  33-­‐8.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   160	  
BRILES,	   D.	   E.,	   FORMAN,	   C.,	   HUDAK,	   S.	  &	   CLAFLIN,	   J.	   L.	   1982.	   Anti-­‐phosphorylcholine	  
antibodies	   of	   the	   T15	   idiotype	   are	  optimally	   protective	   against	   Streptococcus	  
pneumoniae.	  J	  Exp	  Med,	  156,	  1177-­‐85.	  
BRILES,	  D.	  E.,	  NAHM,	  M.,	  SCHROER,	  K.,	  DAVIE,	  J.,	  BAKER,	  P.,	  KEARNEY,	  J.	  &	  BARLETTA,	  
R.	   1981.	   Antiphosphocholine	   antibodies	   found	   in	   normal	   mouse	   serum	   are	  
protective	   against	   intravenous	   infection	   with	   type	   3	   streptococcus	  
pneumoniae.	  J	  Exp	  Med,	  153,	  694-­‐705.	  
BURNE-­‐TANEY,	  M.	  J.,	  ASCON,	  D.	  B.,	  DANIELS,	  F.,	  RACUSEN,	  L.,	  BALDWIN,	  W.	  &	  RABB,	  H.	  
2003.	   B	   cell	   deficiency	   confers	   protection	   from	   renal	   ischemia	   reperfusion	  
injury.	  Journal	  of	  immunology	  (Baltimore,	  Md.	  :	  1950),	  171,	  3210-­‐3215.	  
BUSCHE,	  M.	  N.,	  PAVLOV,	  V.,	  TAKAHASHI,	  K.	  &	  STAHL,	  G.	  L.	  2009.	  Myocardial	  ischemia	  
and	  reperfusion	  injury	   is	  dependent	  on	  both	  IgM	  and	  mannose-­‐binding	  lectin.	  
American	  journal	  of	  physiology.	  Heart	  and	  circulatory	  physiology,	  297,	  H1853-­‐9.	  
CAMPBELL,	  N.	  A.	  &	  REECE,	  J.	  B.	  2011.	  Campbell	  Biology,	  San	  Francisco,	  Calif:	  Benjamin	  
Cummings.	  
CAMUS,	  S.	  M.,	  GAUSSERÈS,	  B.,	  BONNIN,	  P.,	  LOUFRANI,	  L.,	  GRIMAUD,	  L.,	  CHARUE,	  D.,	  
DE	  MORAES,	   J.	  A.,	  RENARD,	   J.-­‐M.,	  TEDGUI,	  A.,	  BOULANGER,	  C.	  M.,	  THARAUX,	  
P.-­‐L.	  &	  BLANC-­‐BRUDE,	  O.	  P.	  2012.	  Erythrocyte	  microparticles	  can	  induce	  kidney	  
vaso-­‐occlusions	  in	  a	  murine	  model	  of	  sickle	  cell	  disease.	  Blood,	  120,	  5050-­‐5058.	  
CASALI,	   P.	  &	  NOTKINS,	  A.	   L.	   1989.	   CD5+	  B	   lymphocytes,	   polyreactive	   antibodies	   and	  
the	  human	  B-­‐cell	  repertoire.	  Immunol	  Today,	  10,	  364-­‐8.	  
CASCIOLA-­‐ROSEN,	   L.,	   ROSEN,	   A.,	   PETRI,	  M.	   &	   SCHLISSEL,	  M.	   1996.	   Surface	   blebs	   on	  
apoptotic	   cells	   are	   sites	   of	   enhanced	   procoagulant	   activity:	   implications	   for	  
coagulation	   events	   and	   antigenic	   spread	   in	   systemic	   lupus	   erythematosus.	  
Proceedings	   of	   the	   National	   Academy	   of	   Sciences	   of	   the	   United	   States	   of	  
America,	  93,	  1624-­‐1629.	  
CHAN,	  R.	  K.,	  DING,	  G.,	  VERNA,	  N.,	  IBRAHIM,	  S.,	  OAKES,	  S.,	  AUSTEN,	  W.	  G.,	  HECHTMAN,	  
H.	  B.	  &	  MOORE,	  F.	  D.	  2004.	  IgM	  binding	  to	  injured	  tissue	  precedes	  complement	  
activation	  during	  skeletal	  muscle	   ischemia-­‐reperfusion.	  The	  Journal	  of	  surgical	  
research,	  122,	  29-­‐35.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   161	  
CHAN,	   R.	   K.,	   VERNA,	   N.,	   AFNAN,	   J.,	   ZHANG,	   M.,	   IBRAHIM,	   S.,	   CARROLL,	   M.	   C.	   &	  
MOORE,	   F.	   D.	   2006.	   Attenuation	   of	   skeletal	   muscle	   reperfusion	   injury	   with	  
intravenous	  12	  amino	  acid	  peptides	  that	  bind	  to	  pathogenic	  IgM.	  Surgery,	  139,	  
236-­‐243.	  
CHAVEZ-­‐CARTAYA,	  R.	  E.,	  DESOLA,	  G.	  P.,	  WRIGHT,	   L.,	   JAMIESON,	  N.	  V.	  &	  WHITE,	  D.	   J.	  
1995.	  Regulation	  of	  the	  complement	  cascade	  by	  soluble	  complement	  receptor	  
type	   1.	   Protective	   effect	   in	   experimental	   liver	   ischemia	   and	   reperfusion.	  
Transplantation,	  59,	  1047-­‐52.	  
CHEN,	  G.,	  ZHANG,	  D.,	  FUCHS,	  T.	  A.,	  MANWANI,	  D.,	  WAGNER,	  D.	  D.	  &	  FRENETTE,	  P.	  S.	  
2014.	   Heme-­‐induced	   neutrophil	   extracellular	   traps	   contribute	   to	   the	  
pathogenesis	  of	  sickle	  cell	  disease.	  Blood,	  123,	  3818-­‐3827.	  
CHEN,	  Y.,	  KHANNA,	  S.,	  GOODYEAR,	  C.	  S.,	  PARK,	  Y.	  B.,	  RAZ,	  E.,	  THIEL,	  S.,	  GRONWALL,	  C.,	  
VAS,	   J.,	   BOYLE,	   D.	   L.,	   CORR,	   M.,	   KONO,	   D.	   H.	   &	   SILVERMAN,	   G.	   J.	   2009a.	  
Regulation	  of	  dendritic	  cells	  and	  macrophages	  by	  an	  anti-­‐apoptotic	  cell	  natural	  
antibody	   that	   suppresses	   TLR	   responses	   and	   inhibits	   inflammatory	   arthritis.	   J	  
Immunol,	  183,	  1346-­‐59.	  
CHEN,	   Y.,	   PARK,	   Y.	   B.,	   PATEL,	   E.	   &	   SILVERMAN,	   G.	   J.	   2009b.	   IgM	   antibodies	   to	  
apoptosis-­‐associated	   determinants	   recruit	   C1q	   and	   enhance	   dendritic	   cell	  
phagocytosis	  of	  apoptotic	  cells.	  Journal	  of	  immunology	  (Baltimore,	  Md.	  :	  1950),	  
182,	  6031-­‐6043.	  
CHEN,	   Y.,	   PARK,	   Y.	   B.,	   PATEL,	   E.	   &	   SILVERMAN,	   G.	   J.	   2009c.	   IgM	   antibodies	   to	  
apoptosis-­‐associated	   determinants	   recruit	   C1q	   and	   enhance	   dendritic	   cell	  
phagocytosis	  of	  apoptotic	  cells.	  J	  Immunol,	  182,	  6031-­‐43.	  
CHIKAZAWA,	   M.,	   OTAKI,	   N.,	   SHIBATA,	   T.,	   YASUEDA,	   T.,	   MATSUDA,	   T.	   &	   UCHIDA,	   K.	  
2013.	  An	  apoptosis-­‐associated	  mammary	  protein	  deficiency	  leads	  to	  enhanced	  
production	   of	   IgM	   antibodies	   against	   multiple	   damage-­‐associated	  molecules.	  
PloS	  one,	  8,	  e68468.	  
CHOU,	  M.-­‐Y.,	  FOGELSTRAND,	  L.,	  HARTVIGSEN,	  K.,	  HANSEN,	  L.	  F.,	  WOELKERS,	  D.,	  SHAW,	  
P.	  X.,	  CHOI,	   J.,	  PERKMANN,	  T.,	  BÄCKHED,	  F.,	  MILLER,	  Y.	   I.,	  HÖRKKÖ,	  S.,	  CORR,	  
M.,	   WITZTUM,	   J.	   L.	   &	   BINDER,	   C.	   J.	   2009a.	   Oxidation-­‐specific	   epitopes	   are	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   162	  
dominant	  targets	  of	  innate	  natural	  antibodies	  in	  mice	  and	  humans.	  The	  Journal	  
of	  clinical	  investigation,	  119,	  1335-­‐1349.	  
CHOU,	  M.	  Y.,	  FOGELSTRAND,	  L.,	  HARTVIGSEN,	  K.,	  HANSEN,	  L.	  F.,	  WOELKERS,	  D.,	  SHAW,	  
P.	  X.,	  CHOI,	   J.,	  PERKMANN,	  T.,	  BACKHED,	  F.,	  MILLER,	  Y.	   I.,	  HORKKO,	  S.,	  CORR,	  
M.,	   WITZTUM,	   J.	   L.	   &	   BINDER,	   C.	   J.	   2009b.	   Oxidation-­‐specific	   epitopes	   are	  
dominant	  targets	  of	  innate	  natural	  antibodies	  in	  mice	  and	  humans.	  J	  Clin	  Invest,	  
119,	  1335-­‐49.	  
CIURANA,	  C.	   L.	   F.	  &	  HACK,	  C.	   E.	  2006.	  Competitive	  binding	  of	  pentraxins	  and	   IgM	   to	  
newly	  exposed	  epitopes	  on	  late	  apoptotic	  cells.	  Cellular	   immunology,	  239,	  14-­‐
21.	  
COLMAN,	  R.	  W.	  1969.	  Fragmentation	  of	  erythrocytes.	  N	  Engl	  J	  Med,	  280,	  563.	  
CONNOLLY,	   A.	   M.,	   PESTRONK,	   A.,	   MEHTA,	   S.,	   YEE,	   W.	   C.,	   GREEN,	   B.	   J.,	   FELLIN,	   C.,	  
OLNEY,	   R.	   K.,	   MILLER,	   R.	   G.	   &	   DEVOR,	   W.	   N.	   1997.	   Serum	   IgM	   monoclonal	  
autoantibody	   binding	   to	   the	   301	   to	   314	   amino	   acid	   epitope	   of	   beta-­‐tubulin:	  
clinical	   association	   with	   slowly	   progressive	   demyelinating	   polyneuropathy.	  
Neurology,	  48,	  243-­‐8.	  
CVETKOVIC,	   J.	   T.,	  WALLBERG-­‐JONSSON,	   S.,	   AHMED,	   E.,	   RANTAPAA-­‐DAHLQVIST,	   S.	   &	  
LEFVERT,	  A.	  K.	  2002.	  Increased	  levels	  of	  autoantibodies	  against	  copper-­‐oxidized	  
low	  density	  lipoprotein,	  malondialdehyde-­‐modified	  low	  density	  lipoprotein	  and	  
cardiolipin	   in	   patients	   with	   rheumatoid	   arthritis.	   Rheumatology	   (Oxford),	   41,	  
988-­‐95.	  
CZAJKOWSKY,	   D.	   M.	   &	   SHAO,	   Z.	   2009.	   The	   human	   IgM	   pentamer	   is	   a	   mushroom-­‐
shaped	  molecule	  with	  a	  flexural	  bias.	  Proceedings	  of	  the	  National	  Academy	  of	  
Sciences	  of	  the	  United	  States	  of	  America,	  106,	  14960-­‐14965.	  
DAEMEN,	  M.	   A.,	   VAN	   'T	   VEER,	   C.,	   DENECKER,	   G.,	   HEEMSKERK,	   V.	   H.,	  WOLFS,	   T.	   G.,	  
CLAUSS,	   M.,	   VANDENABEELE,	   P.	   &	   BUURMAN,	   W.	   A.	   1999.	   Inhibition	   of	  
apoptosis	  induced	  by	  ischemia-­‐reperfusion	  prevents	  inflammation.	  The	  Journal	  
of	  clinical	  investigation,	  104,	  541-­‐549.	  
DAEMEN,	   M.	   A.	   R.	   C.,	   DE	   VRIES,	   B.	   &	   BUURMAN,	   W.	   A.	   2002.	   Apoptosis	   and	  
inflammation	  in	  renal	  reperfusion	  injury.	  Transplantation,	  73,	  1693-­‐1700.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   163	  
DAHA,	  M.	  R.	  &	  VAN	  KOOTEN,	  C.	  2000.	  Is	  the	  proximal	  tubular	  cell	  a	  proinflammatory	  
cell?	  Nephrology,	  dialysis,	  transplantation	  :	  official	  publication	  of	  the	  European	  
Dialysis	   and	  Transplant	  Association	   -­‐	   European	  Renal	  Association,	   15	   Suppl	   6,	  
41-­‐43.	  
DHALIWAL,	  G.,	   CORNETT,	   P.	   A.	  &	   TIERNEY,	   L.	  M.	   2004.	  Hemolytic	   anemia.	  American	  
family	  physician,	  69,	  2599-­‐2606.	  
DIEPENHORST,	  G.	  M.,	  DE	  GRAAF,	  W.,	  NIESSEN,	  H.	  W.,	  VAN	  VLIET,	  A.	  K.,	  HACK,	  C.	  E.	  &	  
VAN	   GULIK,	   T.	   M.	   2014.	   Immunoglobulin	   M,	   C-­‐reactive	   protein	   and	  
complement	  activation	  in	  rat	  hepatic	  ischemia-­‐reperfusion	  injury.	  Eur	  Surg	  Res,	  
52,	  50-­‐62.	  
DIEUDÉ,	   M.,	   SENÉCAL,	   J.-­‐L.,	   RAUCH,	   J.,	   HANLY,	   J.	   G.,	   FORTIN,	   P.,	   BRASSARD,	   N.	   &	  
RAYMOND,	   Y.	   2002.	   Association	   of	   autoantibodies	   to	   nuclear	   lamin	   B1	   with	  
thromboprotection	   in	   systemic	   lupus	   erythematosus:	   lack	   of	   evidence	   for	   a	  
direct	  role	  of	  lamin	  B1	  in	  apoptotic	  blebs.	  Arthritis	  and	  rheumatism,	  46,	  2695-­‐
2707.	  
EHRENSTEIN,	   M.	   R.,	   COOK,	   H.	   T.	   &	   NEUBERGER,	   M.	   S.	   2000.	   Deficiency	   in	   serum	  
immunoglobulin	  (Ig)M	  predisposes	  to	  development	  of	  IgG	  autoantibodies.	  J	  Exp	  
Med,	  191,	  1253-­‐8.	  
EHRENSTEIN,	  M.	  R.	  &	  NOTLEY,	  C.	  A.	  2010.	  The	  importance	  of	  natural	   IgM:	  scavenger,	  
protector	  and	  regulator.	  Nature	  reviews.	  Immunology,	  10,	  778-­‐786.	  
ELLIOTT,	  M.	  R.,	  CHEKENI,	  F.	  B.,	  TRAMPONT,	  P.	  C.,	  LAZAROWSKI,	  E.	  R.,	  KADL,	  A.,	  WALK,	  
S.	  F.,	  PARK,	  D.,	  WOODSON,	  R.	  I.,	  OSTANKOVICH,	  M.,	  SHARMA,	  P.,	  LYSIAK,	  J.	  J.,	  
HARDEN,	   T.	   K.,	   LEITINGER,	   N.	   &	   RAVICHANDRAN,	   K.	   S.	   2009.	   Nucleotides	  
released	   by	   apoptotic	   cells	   act	   as	   a	   find-­‐me	   signal	   to	   promote	   phagocytic	  
clearance.	  Nature,	  461,	  282-­‐6.	  
ELLIOTT,	  M.	  R.	  &	  RAVICHANDRAN,	  K.	  S.	  2010.	  Clearance	  of	  apoptotic	  cells:	  implications	  
in	  health	  and	  disease.	  The	  Journal	  of	  cell	  biology,	  189,	  1059-­‐1070.	  
ELMORE,	   S.	   2007.	   Apoptosis:	   a	   review	   of	   programmed	   cell	   death.	   Toxicologic	  
pathology,	  35,	  495-­‐516.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   164	  
ELTZSCHIG,	   H.	   K.	   &	   ECKLE,	   T.	   2011.	   Ischemia	   and	   reperfusion-­‐-­‐from	   mechanism	   to	  
translation.	  Nat	  Med,	  17,	  1391-­‐401.	  
ENESTRÖM,	  S.,	  DRUID,	  H.	  &	  RAMMER,	  L.	  1988.	  Fibrin	  deposition	  in	  the	  kidney	  in	  post-­‐
ischaemic	   renal	   damage.	   British	   journal	   of	   experimental	   pathology,	   69,	   387-­‐
394.	  
EPPIHIMER,	  M.	   J.	   &	   GRANGER,	   D.	   N.	   1997.	   Ischemia/reperfusion-­‐induced	   leukocyte-­‐
endothelial	  interactions	  in	  postcapillary	  venules.	  Shock,	  8,	  16-­‐25.	  
ERWIG,	   L.	   P.	  &	  HENSON,	   P.	  M.	   2007.	   Immunological	   consequences	   of	   apoptotic	   cell	  
phagocytosis.	  Am	  J	  Pathol,	  171,	  2-­‐8.	  
FADEEL,	   B.	   2004.	   Plasma	   membrane	   alterations	   during	   apoptosis:	   role	   in	   corpse	  
clearance.	  Antioxid	  Redox	  Signal,	  6,	  269-­‐75.	  
FADOK,	   V.	   A.,	   BRATTON,	   D.	   L.,	   KONOWAL,	   A.,	   FREED,	   P.	   W.,	   WESTCOTT,	   J.	   Y.	   &	  
HENSON,	  P.	  M.	  1998.	  Macrophages	  that	  have	   ingested	  apoptotic	  cells	   in	  vitro	  
inhibit	   proinflammatory	   cytokine	   production	   through	   autocrine/paracrine	  
mechanisms	   involving	   TGF-­‐beta,	   PGE2,	   and	   PAF.	   The	   Journal	   of	   clinical	  
investigation,	  101,	  890-­‐898.	  
FADOK,	  V.	  A.,	  BRATTON,	  D.	  L.,	  ROSE,	  D.	  M.,	  PEARSON,	  A.,	  EZEKEWITZ,	  R.	  A.	  &	  HENSON,	  
P.	  M.	   2000.	   A	   receptor	   for	   phosphatidylserine-­‐specific	   clearance	   of	   apoptotic	  
cells.	  Nature,	  405,	  85-­‐90.	  
FADOK,	  V.	  A.,	  DE	  CATHELINEAU,	  A.,	  DALEKE,	  D.	   L.,	  HENSON,	  P.	  M.	  &	  BRATTON,	  D.	   L.	  
2001.	   Loss	   of	   phospholipid	   asymmetry	   and	   surface	   exposure	   of	  
phosphatidylserine	   is	   required	   for	   phagocytosis	   of	   apoptotic	   cells	   by	  
macrophages	  and	  fibroblasts.	  J	  Biol	  Chem,	  276,	  1071-­‐7.	  
FADOK,	   V.	   A.,	   VOELKER,	   D.	   R.,	   CAMPBELL,	   P.	   A.,	   COHEN,	   J.	   J.,	   BRATTON,	   D.	   L.	   &	  
HENSON,	   P.	   M.	   1992.	   Exposure	   of	   phosphatidylserine	   on	   the	   surface	   of	  
apoptotic	   lymphocytes	   triggers	   specific	   recognition	   and	   removal	   by	  
macrophages.	  Journal	  of	  immunology	  (Baltimore,	  Md.	  :	  1950),	  148,	  2207-­‐2216.	  
FEINSTEIN,	  A.	  &	  MUNN,	  E.	  A.	  1969.	  Conformation	  of	  the	  free	  and	  antigen-­‐bound	  IgM	  
antibody	  molecules.	  Nature,	  224,	  1307-­‐9.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   165	  
FENG,	   M.,	   LI,	   G.,	   QIAN,	   X.,	   FAN,	   Y.,	   HUANG,	   X.,	   ZHANG,	   F.	   &	   LU,	   L.	   2012.	   IL-­‐17A-­‐
producing	   NK	   cells	   were	   implicated	   in	   liver	   injury	   induced	   by	   ischemia	   and	  
reperfusion.	  Int	  Immunopharmacol,	  13,	  135-­‐40.	  
FERENBACH,	  D.	  A.,	  RAMDAS,	  V.,	  SPENCER,	  N.,	  MARSON,	  L.,	  ANEGON,	  I.,	  HUGHES,	  J.	  &	  
KLUTH,	  D.	  C.	  2010.	  Macrophages	  expressing	  heme	  oxygenase-­‐1	   improve	  renal	  
function	   in	   ischemia/reperfusion	   injury.	  Molecular	  therapy	  :	  the	   journal	  of	  the	  
American	  Society	  of	  Gene	  Therapy,	  18,	  1706-­‐1713.	  
FONDEVILA,	   C.,	   SHEN,	   X.	   D.,	   TSUCHIHASHI,	   S.,	   UCHIDA,	   Y.,	   FREITAS,	   M.	   C.,	   KE,	   B.,	  
BUSUTTIL,	   R.	   W.	   &	   KUPIEC-­‐WEGLINSKI,	   J.	   W.	   2008.	   The	   membrane	   attack	  
complex	  (C5b-­‐9)	  in	  liver	  cold	  ischemia	  and	  reperfusion	  injury.	  Liver	  Transpl,	  14,	  
1133-­‐41.	  
FRIEDEWALD,	  J.	  J.	  &	  RABB,	  H.	  2004.	  Inflammatory	  cells	  in	  ischemic	  acute	  renal	  failure.	  
Kidney	  international,	  66,	  486-­‐491.	  
FU,	  M.,	  FAN,	  P.-­‐S.,	  LI,	  W.,	  LI,	  C.-­‐X.,	  XING,	  Y.,	  AN,	  J.-­‐G.,	  WANG,	  G.,	  FAN,	  X.-­‐L.,	  GAO,	  T.-­‐W.,	  
LIU,	  Y.-­‐F.	  &	  IKEDA,	  S.	  2007.	  Identification	  of	  poly-­‐reactive	  natural	  IgM	  antibody	  
that	   recognizes	   late	   apoptotic	   cells	   and	   promotes	   phagocytosis	   of	   the	   cells.	  
Apoptosis	  :	  an	  international	  journal	  on	  programmed	  cell	  death,	  12,	  355-­‐362.	  
FURUICHI,	  K.,	  WADA,	  T.,	  KANEKO,	  S.	  &	  MURPHY,	  P.	  M.	  2008.	  Roles	  of	  chemokines	   in	  
renal	  ischemia/reperfusion	  injury.	  Front	  Biosci,	  13,	  4021-­‐8.	  
GAIPL,	   U.	   S.,	   KUENKELE,	   S.,	   VOLL,	   R.	   E.,	   BEYER,	   T.	   D.,	   KOLOWOS,	   W.,	   HEYDER,	   P.,	  
KALDEN,	  J.	  R.	  &	  HERRMANN,	  M.	  2001.	  Complement	  binding	  is	  an	  early	  feature	  
of	   necrotic	   and	   a	   rather	   late	   event	   during	   apoptotic	   cell	   death.	   Cell	   Death	  
Differ,	  8,	  327-­‐34.	  
GAIPL,	  U.	  S.,	  VOLL,	  R.	  E.,	  SHERIFF,	  A.,	  FRANZ,	  S.,	  KALDEN,	  J.	  R.	  &	  HERRMANN,	  M.	  2005.	  
Impaired	   clearance	   of	   dying	   cells	   in	   systemic	   lupus	   erythematosus.	  
Autoimmunity	  reviews,	  4,	  189-­‐194.	  
GALLUZZI,	   L.,	   MAIURI,	   M.	   C.,	   VITALE,	   I.,	   ZISCHKA,	   H.,	   CASTEDO,	  M.,	   ZITVOGEL,	   L.	   &	  
KROEMER,	  G.	  2007.	  Cell	  death	  modalities:	  classification	  and	  pathophysiological	  
implications.	  Cell	  Death	  Differ,	  14,	  1237-­‐43.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   166	  
GEORGE,	   J.	  N.	  &	  NESTER,	   C.	  M.	   2014.	   Syndromes	   of	   thrombotic	  microangiopathy.	  N	  
Engl	  J	  Med,	  371,	  654-­‐66.	  
GERADS,	   I.,	   GOVERS-­‐RIEMSLAG,	   J.	   W.,	   TANS,	   G.,	   ZWAAL,	   R.	   F.	   &	   ROSING,	   J.	   1990.	  
Prothrombin	   activation	   on	   membranes	   with	   anionic	   lipids	   containing	  
phosphate,	  sulfate,	  and/or	  carboxyl	  groups.	  Biochemistry,	  29,	  7967-­‐74.	  
GERSHOV,	   D.,	   KIM,	   S.,	   BROT,	   N.	   &	   ELKON,	   K.	   B.	   2000.	   C-­‐Reactive	   protein	   binds	   to	  
apoptotic	   cells,	  protects	   the	   cells	   from	  assembly	  of	   the	   terminal	   complement	  
components,	   and	   sustains	   an	   antiinflammatory	   innate	   immune	   response:	  
implications	  for	  systemic	  autoimmunity.	  J	  Exp	  Med,	  192,	  1353-­‐64.	  
GLADWIN,	   M.	   T.,	   KANIAS,	   T.	   &	   KIM-­‐SHAPIRO,	   D.	   B.	   2012.	   Hemolysis	   and	   cell-­‐free	  
hemoglobin	   drive	   an	   intrinsic	   mechanism	   for	   human	   disease.	   The	   Journal	   of	  
clinical	  investigation,	  122,	  1205-­‐1208.	  
GLADWIN,	  M.	  T.	  &	  OFORI-­‐ACQUAH,	  S.	  F.	  2014.	  Erythroid	  DAMPs	  drive	  inflammation	  in	  
SCD.	  Blood,	  123,	  3689-­‐3690.	  
GRAY,	  M.,	  MILES,	   K.,	   SALTER,	  D.,	  GRAY,	  D.	  &	  SAVILL,	   J.	   2007.	  Apoptotic	   cells	   protect	  
mice	   from	   autoimmune	   inflammation	   by	   the	   induction	   of	   regulatory	   B	   cells.	  
Proceedings	   of	   the	   National	   Academy	   of	   Sciences	   of	   the	   United	   States	   of	  
America,	  104,	  14080-­‐14085.	  
GREENE,	   E.	   L.	   &	   PALLER,	   M.	   S.	   1994.	   Calcium	   and	   free	   radicals	   in	  
hypoxia/reoxygenation	  injury	  of	  renal	  epithelial	  cells.	  Am	  J	  Physiol,	  266,	  F13-­‐20.	  
GREGORY,	  C.	  D.	  &	  DEVITT,	  A.	  2004.	  The	  macrophage	  and	  the	  apoptotic	  cell:	  an	  innate	  
immune	  interaction	  viewed	  simplistically?	  Immunology,	  113,	  1-­‐14.	  
GRÖNWALL,	  C.,	  AKHTER,	  E.,	  OH,	  C.,	  BURLINGAME,	  R.	  W.,	  PETRI,	  M.	  &	  SILVERMAN,	  G.	  J.	  
2012.	   IgM	   autoantibodies	   to	   distinct	   apoptosis-­‐associated	   antigens	   correlate	  
with	  protection	   from	  cardiovascular	  events	  and	  renal	  disease	   in	  patients	  with	  
SLE.	  Clinical	  immunology	  (Orlando,	  Fla.),	  142,	  390-­‐398.	  
HAAS,	  M.	  S.,	  ALICOT,	  E.	  M.,	  SCHUERPF,	  F.,	  CHIU,	  I.,	  LI,	  J.,	  MOORE,	  F.	  D.	  &	  CARROLL,	  M.	  
C.	  2010.	  Blockade	  of	   self-­‐reactive	   IgM	  significantly	   reduces	   injury	   in	  a	  murine	  
model	  of	  acute	  myocardial	  infarction.	  Cardiovascular	  research,	  87,	  618-­‐627.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   167	  
HART,	  S.	  P.,	  SMITH,	  J.	  R.	  &	  DRANSFIELD,	  I.	  2004.	  Phagocytosis	  of	  opsonized	  apoptotic	  
cells:	  roles	  for	  'old-­‐fashioned'	  receptors	  for	  antibody	  and	  complement.	  Clin	  Exp	  
Immunol,	  135,	  181-­‐5.	  
HARTVIGSEN,	  K.,	  CHOU,	  M.	  Y.,	  HANSEN,	  L.	  F.,	  SHAW,	  P.	  X.,	  TSIMIKAS,	  S.,	  BINDER,	  C.	  J.	  &	  
WITZTUM,	  J.	  L.	  2009.	  The	  role	  of	  innate	  immunity	  in	  atherogenesis.	  J	  Lipid	  Res,	  
50	  Suppl,	  S388-­‐93.	  
HE,	   S.,	   ATKINSON,	   C.,	   EVANS,	   Z.,	   ELLETT,	   J.	   D.,	   SOUTHWOOD,	   M.,	   ELVINGTON,	   A.,	  
CHAVIN,	  K.	  D.	  &	  TOMLINSON,	  S.	  2009a.	  A	  role	  for	  complement	  in	  the	  enhanced	  
susceptibility	  of	  steatotic	   livers	  to	   ischemia	  and	  reperfusion	  injury.	  J	   Immunol,	  
183,	  4764-­‐72.	  
HE,	   S.,	  ATKINSON,	  C.,	  QIAO,	  F.,	  CIANFLONE,	  K.,	  CHEN,	  X.	  &	  TOMLINSON,	  S.	  2009b.	  A	  
complement-­‐dependent	  balance	  between	  hepatic	   ischemia/reperfusion	   injury	  
and	  liver	  regeneration	  in	  mice.	  J	  Clin	  Invest,	  119,	  2304-­‐16.	  
HEIJNEN,	  B.	  H.,	  STRAATSBURG,	  I.	  H.,	  PADILLA,	  N.	  D.,	  VAN	  MIERLO,	  G.	  J.,	  HACK,	  C.	  E.	  &	  
VAN	   GULIK,	   T.	   M.	   2006.	   Inhibition	   of	   classical	   complement	   activation	  
attenuates	   liver	   ischaemia	   and	   reperfusion	   injury	   in	   a	   rat	   model.	   Clin	   Exp	  
Immunol,	  143,	  15-­‐23.	  
HELLBERG,	   P.	  O.,	   BAYATI,	   A.,	   KÄLLSKOG,	  O.	  &	  WOLGAST,	  M.	   1990.	   Red	   cell	   trapping	  
after	   ischemia	  and	   long-­‐term	  kidney	  damage.	   Influence	  of	  hematocrit.	  Kidney	  
international,	  37,	  1240-­‐1247.	  
HESKETH,	  E.	  E.,	  CZOPEK,	  A.,	  CLAY,	  M.,	  BORTHWICK,	  G.,	   FERENBACH,	  D.,	  KLUTH,	  D.	  &	  
HUGHES,	  J.	  2014.	  Renal	  ischaemia	  reperfusion	  injury:	  a	  mouse	  model	  of	  injury	  
and	  regeneration.	  Journal	  of	  visualized	  experiments	  :	  JoVE.	  
HILL,	   J.,	   LINDSAY,	   T.	   F.,	  ORTIZ,	   F.,	   YEH,	  C.	  G.,	  HECHTMAN,	  H.	  B.	  &	  MOORE,	   F.	  D.,	   JR.	  
1992.	   Soluble	   complement	   receptor	   type	   1	   ameliorates	   the	   local	   and	   remote	  
organ	   injury	   after	   intestinal	   ischemia-­‐reperfusion	   in	   the	   rat.	   J	   Immunol,	   149,	  
1723-­‐8.	  
HOEPPNER,	   D.	   J.,	   HENGARTNER,	   M.	   O.	   &	   SCHNABEL,	   R.	   2001.	   Engulfment	   genes	  
cooperate	  with	  ced-­‐3	  to	  promote	  cell	  death	  in	  Caenorhabditis	  elegans.	  Nature,	  
412,	  202-­‐6.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   168	  
HUDDER,	  A.,	  NATHANSON,	  L.	  &	  DEUTSCHER,	  M.	  P.	  2003.	  Organization	  of	  mammalian	  
cytoplasm.	  Mol	  Cell	  Biol,	  23,	  9318-­‐26.	  
HUYNH,	  M.	   L.,	   FADOK,	   V.	   A.	   &	   HENSON,	   P.	  M.	   2002.	   Phosphatidylserine-­‐dependent	  
ingestion	  of	  apoptotic	  cells	  promotes	  TGF-­‐beta1	  secretion	  and	  the	  resolution	  of	  
inflammation.	  J	  Clin	  Invest,	  109,	  41-­‐50.	  
IWATA,	  M.,	  HERRINGTON,	  J.	  &	  ZAGER,	  R.	  A.	  1995.	  Protein	  synthesis	  inhibition	  induces	  
cytoresistance	   in	   cultured	   human	   proximal	   tubular	   (HK-­‐2)	   cells.	  Am	   J	   Physiol,	  
268,	  F1154-­‐63.	  
JACOB,	  M.	  C.,	   FAVRE,	  M.	  &	  BENSA,	   J.	   C.	   1991.	  Membrane	   cell	   permeabilization	  with	  
saponin	  and	  multiparametric	  analysis	  by	  flow	  cytometry.	  Cytometry,	  12,	  550-­‐8.	  
JAMUR,	  M.	  &	  OLIVER,	  C.	  2010.	  Permeabilization	  of	  Cell	  Membranes.	   In:	  OLIVER,	  C.	  &	  
JAMUR,	   M.	   C.	   (eds.)	   Immunocytochemical	   Methods	   and	   Protocols.	   Humana	  
Press.	  
JANG,	  H.	  R.,	  GANDOLFO,	  M.	  T.,	  KO,	  G.	  J.,	  SATPUTE,	  S.	  R.,	  RACUSEN,	  L.	  &	  RABB,	  H.	  2010.	  
B	  cells	   limit	   repair	  after	   ischemic	  acute	  kidney	   injury.	   Journal	  of	   the	  American	  
Society	  of	  Nephrology	  :	  JASN,	  21,	  654-­‐665.	  
JENNEWEIN,	  C.,	  TRAN,	  N.,	  PAULUS,	  P.,	  ELLINGHAUS,	  P.,	  EBLE,	  J.	  A.	  &	  ZACHAROWSKI,	  K.	  
2011.	  Novel	  aspects	  of	   fibrin(ogen)	  fragments	  during	   inflammation.	  Molecular	  
medicine	  (Cambridge,	  Mass.),	  17,	  568-­‐573.	  
KAGAN,	  V.	  E.,	  GLEISS,	  B.,	  TYURINA,	  Y.	  Y.,	  TYURIN,	  V.	  A.,	  ELENSTROM-­‐MAGNUSSON,	  C.,	  
LIU,	  S.	  X.,	  SERINKAN,	  F.	  B.,	  ARROYO,	  A.,	  CHANDRA,	  J.,	  ORRENIUS,	  S.	  &	  FADEEL,	  
B.	  2002.	  A	  role	  for	  oxidative	  stress	  in	  apoptosis:	  oxidation	  and	  externalization	  of	  
phosphatidylserine	   is	   required	   for	  macrophage	   clearance	   of	   cells	   undergoing	  
Fas-­‐mediated	  apoptosis.	  J	  Immunol,	  169,	  487-­‐99.	  
KAUSHAL,	  G.	  P.,	  BASNAKIAN,	  A.	  G.	  &	  SHAH,	  S.	  V.	  2004.	  Apoptotic	  pathways	  in	  ischemic	  
acute	  renal	  failure.	  Kidney	  Int,	  66,	  500-­‐6.	  
KERR,	   J.	   F.,	   WYLLIE,	   A.	   H.	   &	   CURRIE,	   A.	   R.	   1972.	   Apoptosis:	   a	   basic	   biological	  
phenomenon	  with	  wide-­‐ranging	  implications	  in	  tissue	  kinetics.	  British	  journal	  of	  
cancer,	  26,	  239-­‐257.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   169	  
KERR,	   M.,	   BEDFORD,	   M.,	   MATTHEWS,	   B.	   &	   O'DONOGHUE,	   D.	   2014.	   The	   economic	  
impact	  of	  acute	  kidney	  injury	  in	  England.	  Nephrology,	  dialysis,	  transplantation	  :	  
official	   publication	   of	   the	   European	   Dialysis	   and	   Transplant	   Association	   -­‐	  
European	  Renal	  Association,	  29,	  1362-­‐1368.	  
KHATOON,	   F.,	   MOINUDDIN,	   ALAM,	   K.	   &	   ALI,	   A.	   2012.	   Physicochemical	   and	  
immunological	   studies	   on	   4-­‐hydroxynonenal	   modified	   HSA:	   implications	   of	  
protein	  damage	  by	   lipid	  peroxidation	  products	   in	  the	  etiopathogenesis	  of	  SLE.	  
Hum	  Immunol,	  73,	  1132-­‐9.	  
KIM,	   J.	   2010.	   Identification	   of	   a	   human	   monoclonal	   natural	   IgM	   antibody	   that	  
recognizes	   early	   apoptotic	   cells	   and	   promotes	   phagocytosis.	   Hybridoma	  
(Larchmt),	  29,	  275-­‐81.	  
KIM,	   S.	   J.,	   GERSHOV,	   D.,	  MA,	   X.,	   BROT,	   N.	   &	   ELKON,	   K.	   B.	   2002.	   I-­‐PLA(2)	   activation	  
during	  apoptosis	  promotes	  the	  exposure	  of	  membrane	  lysophosphatidylcholine	  
leading	   to	  binding	  by	  natural	   immunoglobulin	  M	  antibodies	   and	   complement	  
activation.	  The	  Journal	  of	  experimental	  medicine,	  196,	  655-­‐665.	  
KIMBERLEY,	   F.	   C.,	   SIVASANKAR,	   B.	   &	   PAUL	  MORGAN,	   B.	   2007.	   Alternative	   roles	   for	  
CD59.	  Mol	  Immunol,	  44,	  73-­‐81.	  
KINA,	  T.,	   IKUTA,	  K.,	   TAKAYAMA,	  E.,	  WADA,	  K.,	  MAJUMDAR,	  A.	   S.,	  WEISSMAN,	   I.	   L.	  &	  
KATSURA,	   Y.	   2000.	   The	  monoclonal	   antibody	   TER-­‐119	   recognizes	   a	   molecule	  
associated	  with	  glycophorin	  A	  and	  specifically	  marks	  the	  late	  stages	  of	  murine	  
erythroid	  lineage.	  Br	  J	  Haematol,	  109,	  280-­‐7.	  
KINDT,	  T.	  J.,	  GOLDSBY,	  R.	  A.,	  OSBORNE,	  B.	  A.	  &	  KUBY,	  J.	  2007.	  Kuby	  immunology,	  New	  
York,	  W.H.	  Freeman.	  
KINSEY,	   G.	   R.,	   LI,	   L.	   &	   OKUSA,	   M.	   D.	   2008.	   Inflammation	   in	   acute	   kidney	   injury.	  
Nephron.	  Experimental	  nephrology,	  109,	  e102-­‐7.	  
KRAWITT,	  E.	  L.	  2006.	  Autoimmune	  hepatitis.	  N	  Engl	  J	  Med,	  354,	  54-­‐66.	  
KULIK,	   L.,	   FLEMING,	   S.	   D.,	   MORATZ,	   C.,	   REUTER,	   J.	   W.,	   NOVIKOV,	   A.,	   CHEN,	   K.,	  
ANDREWS,	  K.	  A.,	  MARKARYAN,	  A.,	  QUIGG,	  R.	  J.,	  SILVERMAN,	  G.	  J.,	  TSOKOS,	  G.	  
C.	  &	  HOLERS,	  V.	  M.	  2009.	  Pathogenic	  natural	  antibodies	  recognizing	  annexin	  IV	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   170	  
are	  required	  to	  develop	  intestinal	  ischemia-­‐reperfusion	  injury.	  J	  Immunol,	  182,	  
5363-­‐73.	  
KUMAR,	   S.,	   ALLEN,	   D.	   A.,	   KIESWICH,	   J.	   E.,	   PATEL,	   N.	   S.,	   HARWOOD,	   S.,	  MAZZON,	   E.,	  
CUZZOCREA,	   S.,	   RAFTERY,	  M.	   J.,	   THIEMERMANN,	   C.	  &	   YAQOOB,	  M.	  M.	   2009.	  
Dexamethasone	   ameliorates	   renal	   ischemia-­‐reperfusion	   injury.	   J	   Am	   Soc	  
Nephrol,	  20,	  2412-­‐25.	  
KYRIAKIDES,	  C.,	  WANG,	  Y.,	  AUSTEN,	  W.	  G.,	  JR.,	  FAVUZZA,	  J.,	  KOBZIK,	  L.,	  MOORE,	  F.	  D.,	  
JR.	  &	  HECHTMAN,	  H.	  B.	  2001.	  Moderation	  of	  skeletal	  muscle	  reperfusion	  injury	  
by	   a	   sLe(x)-­‐glycosylated	   complement	   inhibitory	   protein.	   Am	   J	   Physiol	   Cell	  
Physiol,	  281,	  C224-­‐30.	  
LAMEIRE,	  N.	  H.,	  BAGGA,	  A.,	  CRUZ,	  D.,	  DE	  MAESENEER,	  J.,	  ENDRE,	  Z.,	  KELLUM,	  J.	  A.,	  LIU,	  
K.	  D.,	  MEHTA,	  R.	  L.,	  PANNU,	  N.,	  VAN	  BIESEN,	  W.	  &	  VANHOLDER,	  R.	  2013.	  Acute	  
kidney	  injury:	  an	  increasing	  global	  concern.	  Lancet,	  382,	  170-­‐179.	  
LAPPAS,	   C.	  M.,	   DAY,	   Y.	   J.,	  MARSHALL,	  M.	   A.,	   ENGELHARD,	   V.	   H.	   &	   LINDEN,	   J.	   2006.	  
Adenosine	  A2A	  receptor	  activation	  reduces	  hepatic	  ischemia	  reperfusion	  injury	  
by	  inhibiting	  CD1d-­‐dependent	  NKT	  cell	  activation.	  J	  Exp	  Med,	  203,	  2639-­‐48.	  
LAUBER,	  K.,	  BOHN,	  E.,	  KROBER,	  S.	  M.,	  XIAO,	  Y.	  J.,	  BLUMENTHAL,	  S.	  G.,	  LINDEMANN,	  R.	  
K.,	  MARINI,	  P.,	  WIEDIG,	  C.,	  ZOBYWALSKI,	  A.,	  BAKSH,	  S.,	  XU,	  Y.,	  AUTENRIETH,	  I.	  
B.,	   SCHULZE-­‐OSTHOFF,	   K.,	   BELKA,	   C.,	   STUHLER,	   G.	   &	   WESSELBORG,	   S.	   2003.	  
Apoptotic	  cells	  induce	  migration	  of	  phagocytes	  via	  caspase-­‐3-­‐mediated	  release	  
of	  a	  lipid	  attraction	  signal.	  Cell,	  113,	  717-­‐30.	  
LEE,	  A.	  Y.	  &	  LEVINE,	  M.	  N.	  1999.	  The	  thrombophilic	  state	  induced	  by	  therapeutic	  agents	  
in	  the	  cancer	  patient.	  Seminars	  in	  thrombosis	  and	  hemostasis,	  25,	  137-­‐145.	  
LEE,	   H.	   T.	   &	   EMALA,	   C.	   W.	   2002.	   Preconditioning	   and	   adenosine	   protect	   human	  
proximal	  tubule	  cells	  in	  an	  in	  vitro	  model	  of	  ischemic	  injury.	  J	  Am	  Soc	  Nephrol,	  
13,	  2753-­‐61.	  
LEE,	  Y.-­‐J.,	  MOON,	  C.,	  LEE,	  S.-­‐H.,	  PARK,	  H.-­‐J.,	  SEOH,	  J.-­‐Y.,	  CHO,	  M.-­‐S.	  &	  KANG,	  J.	  L.	  2012.	  
Apoptotic	   cell	   instillation	   after	   bleomycin	   attenuates	   lung	   injury	   through	  
hepatocyte	  growth	  factor	  induction.	  The	  European	  respiratory	  journal,	  40,	  424-­‐
435.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   171	  
LEHMANN,	   T.	   G.,	   KOEPPEL,	   T.	   A.,	   KIRSCHFINK,	  M.,	   GEBHARD,	  M.	  M.,	   HERFARTH,	   C.,	  
OTTO,	   G.	   &	   POST,	   S.	   1998.	   Complement	   inhibition	   by	   soluble	   complement	  
receptor	   type	   1	   improves	   microcirculation	   after	   rat	   liver	   transplantation.	  
Transplantation,	  66,	  717-­‐22.	  
LEHMANN,	  T.	  G.,	  KOEPPEL,	  T.	  A.,	  MUNCH,	  S.,	  HEGER,	  M.,	  KIRSCHFINK,	  M.,	  KLAR,	  E.	  &	  
POST,	   S.	   2001.	   Impact	   of	   inhibition	   of	   complement	   by	   sCR1	   on	   hepatic	  
microcirculation	  after	  warm	  ischemia.	  Microvasc	  Res,	  62,	  284-­‐92.	  
LEIBUNDGUT,	  G.,	  WITZTUM,	  J.	  L.	  &	  TSIMIKAS,	  S.	  2013.	  Oxidation-­‐specific	  epitopes	  and	  
immunological	   responses:	   Translational	   biotheranostic	   implications	   for	  
atherosclerosis.	  Current	  opinion	  in	  pharmacology.	  
LIBERAL,	   R.,	   GRANT,	   C.	   R.,	   MIELI-­‐VERGANI,	   G.	   &	   VERGANI,	   D.	   2013.	   Autoimmune	  
hepatitis:	  a	  comprehensive	  review.	  J	  Autoimmun,	  41,	  126-­‐39.	  
LINDSAY,	   T.	   F.,	   HILL,	   J.,	   ORTIZ,	   F.,	   RUDOLPH,	   A.,	   VALERI,	   C.	   R.,	   HECHTMAN,	   H.	   B.	   &	  
MOORE,	  F.	  D.,	  JR.	  1992.	  Blockade	  of	  complement	  activation	  prevents	  local	  and	  
pulmonary	  albumin	  leak	  after	  lower	  torso	  ischemia-­‐reperfusion.	  Ann	  Surg,	  216,	  
677-­‐83.	  
LITVACK,	  M.	  L.,	  DJIADEU,	  P.,	  RENGANATHAN,	  S.	  D.	  S.,	  SY,	  S.,	  POST,	  M.	  &	  PALANIYAR,	  N.	  
2010.	  Natural	  IgM	  and	  innate	  immune	  collectin	  SP-­‐D	  bind	  to	  late	  apoptotic	  cells	  
and	   enhance	   their	   clearance	   by	   alveolar	   macrophages	   in	   vivo.	   Molecular	  
immunology,	  48,	  37-­‐47.	  
LITVACK,	  M.	  L.,	  POST,	  M.	  &	  PALANIYAR,	  N.	  2011.	  IgM	  promotes	  the	  clearance	  of	  small	  
particles	  and	  apoptotic	  microparticles	  by	  macrophages.	  PloS	  one,	  6,	  e17223.	  
LOBO,	   P.	   I.,	   BAJWA,	   A.,	   SCHLEGEL,	   K.	   H.,	   VENGAL,	   J.,	   LEE,	   S.	   J.,	   HUANG,	   L.,	   YE,	   H.,	  
DESHMUKH,	   U.,	  WANG,	   T.,	   PEI,	   H.	   &	   OKUSA,	  M.	   D.	   2012.	   Natural	   IgM	   Anti-­‐
Leukocyte	  Autoantibodies	  Attenuate	  Excess	   Inflammation	  Mediated	  by	   Innate	  
and	   Adaptive	   Immune	   Mechanisms	   Involving	   Th-­‐17.	   Journal	   of	   immunology	  
(Baltimore,	  Md.	  :	  1950),	  188,	  1675-­‐1685.	  
LOBO,	   P.	   I.,	   SCHLEGAL,	   K.	   H.,	   VENGAL,	   J.,	   OKUSA,	   M.	   D.	   &	   PEI,	   H.	   2010.	   Naturally	  
occurring	   IgM	   anti-­‐leukocyte	   autoantibodies	   inhibit	   T-­‐cell	   activation	   and	  
chemotaxis.	  Journal	  of	  clinical	  immunology,	  30	  Suppl	  1,	  S31-­‐6.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   172	  
LUTZ,	  H.	  U.	  &	  BOGDANOVA,	  A.	  2013.	  Mechanisms	  tagging	  senescent	  red	  blood	  cells	  for	  
clearance	  in	  healthy	  humans.	  Front	  Physiol,	  4,	  387.	  
LUTZ,	   J.,	  THÜRMEL,	  K.	  &	  HEEMANN,	  U.	  2010.	  Anti-­‐inflammatory	  treatment	  strategies	  
for	   ischemia/reperfusion	   injury	   in	   transplantation.	   Journal	   of	   inflammation	  
(London,	  England),	  7,	  27.	  
MADI,	  A.,	  BRANSBURG-­‐ZABARY,	  S.,	  KENETT,	  D.	  Y.,	  BEN-­‐JACOB,	  E.	  &	  COHEN,	  I.	  R.	  2012.	  
The	   natural	   autoantibody	   repertoire	   in	   newborns	   and	   adults:	   a	   current	  
overview.	  Adv	  Exp	  Med	  Biol,	  750,	  198-­‐212.	  
MADI,	  A.,	  HECHT,	  I.,	  BRANSBURG-­‐ZABARY,	  S.,	  MERBL,	  Y.,	  PICK,	  A.,	  ZUCKER-­‐TOLEDANO,	  
M.,	   QUINTANA,	   F.	   J.,	   TAUBER,	   A.	   I.,	   COHEN,	   I.	   R.	   &	   BEN-­‐JACOB,	   E.	   2009.	  
Organization	   of	   the	   autoantibody	   repertoire	   in	   healthy	   newborns	   and	   adults	  
revealed	  by	  system	  level	  informatics	  of	  antigen	  microarray	  data.	  Proc	  Natl	  Acad	  
Sci	  U	  S	  A,	  106,	  14484-­‐9.	  
MARRIOTT,	   H.	   M.,	   HELLEWELL,	   P.	   G.,	   CROSS,	   S.	   S.,	   INCE,	   P.	   G.,	   WHYTE,	   M.	   K.	   &	  
DOCKRELL,	  D.	  H.	  2006.	  Decreased	  alveolar	  macrophage	  apoptosis	  is	  associated	  
with	   increased	   pulmonary	   inflammation	   in	   a	  murine	  model	   of	   pneumococcal	  
pneumonia.	  J	  Immunol,	  177,	  6480-­‐8.	  
MASON,	  J.,	  WELSCH,	  J.	  &	  TORHORST,	  J.	  1987.	  The	  contribution	  of	  vascular	  obstruction	  
to	   the	   functional	   defect	   that	   follows	   renal	   ischemia.	  Kidney	   international,	   31,	  
65-­‐71.	  
MASSBERG,	   S.,	   ENDERS,	   G.,	   LEIDERER,	   R.,	   EISENMENGER,	   S.,	   VESTWEBER,	   D.,	  
KROMBACH,	   F.	   &	   MESSMER,	   K.	   1998.	   Platelet-­‐endothelial	   cell	   interactions	  
during	  ischemia/reperfusion:	  the	  role	  of	  P-­‐selectin.	  Blood,	  92,	  507-­‐515.	  
MCMULLEN,	  M.	  E.,	  HART,	  M.	  L.,	  WALSH,	  M.	  C.,	  BURAS,	  J.,	  TAKAHASHI,	  K.	  &	  STAHL,	  G.	  L.	  
2006.	   Mannose-­‐binding	   lectin	   binds	   IgM	   to	   activate	   the	   lectin	   complement	  
pathway	  in	  vitro	  and	  in	  vivo.	  Immunobiology,	  211,	  759-­‐66.	  
MEDINE,	   C.	   N.,	   LUCENDO-­‐VILLARIN,	   B.,	   ZHOU,	   W.,	   WEST,	   C.	   C.	   &	   HAY,	   D.	   C.	   2011.	  
Robust	   generation	   of	   hepatocyte-­‐like	   cells	   from	   human	   embryonic	   stem	   cell	  
populations.	  Journal	  of	  visualized	  experiments	  :	  JoVE,	  e2969.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   173	  
MENDES-­‐BRAZ,	  M.,	   ELIAS-­‐MIRO,	  M.,	   JIMENEZ-­‐CASTRO,	  M.	  B.,	   CASILLAS-­‐RAMIREZ,	  A.,	  
RAMALHO,	  F.	  S.	  &	  PERALTA,	  C.	  2012.	  The	  current	  state	  of	  knowledge	  of	  hepatic	  
ischemia-­‐reperfusion	   injury	   based	   on	   its	   study	   in	   experimental	   models.	   J	  
Biomed	  Biotechnol,	  2012,	  298657.	  
MERCOLINO,	   T.	   J.,	   ARNOLD,	   L.	   W.	   &	   HAUGHTON,	   G.	   1986.	   Phosphatidyl	   choline	   is	  
recognized	   by	   a	   series	   of	   Ly-­‐1+	   murine	   B	   cell	   lymphomas	   specific	   for	  
erythrocyte	  membranes.	  J	  Exp	  Med,	  163,	  155-­‐65.	  
MIELI-­‐VERGANI,	   G.	   &	   VERGANI,	   D.	   2011.	   Autoimmune	   hepatitis.	   Nature	   reviews.	  
Gastroenterology	  &	  hepatology,	  8,	  320-­‐9.	  
MILES,	   K.,	   CLARKE,	   D.	   J.,	   LU,	   W.,	   SIBINSKA,	   Z.,	   BEAUMONT,	   P.	   E.,	   DAVIDSON,	   D.	   J.,	  
BARR,	   T.	   A.,	   CAMPOPIANO,	   D.	   J.	   &	   GRAY,	   M.	   2009.	   Dying	   and	   necrotic	  
neutrophils	  are	  anti-­‐inflammatory	  secondary	  to	  the	  release	  of	  alpha-­‐defensins.	  
Journal	  of	  immunology	  (Baltimore,	  Md.	  :	  1950),	  183,	  2122-­‐2132.	  
MITTAL,	  M.,	   SIDDIQUI,	  M.	   R.,	   TRAN,	   K.,	   REDDY,	   S.	   P.	   &	  MALIK,	   A.	   B.	   2014.	   Reactive	  
oxygen	   species	   in	   inflammation	   and	   tissue	   injury.	   Antioxid	   Redox	   Signal,	   20,	  
1126-­‐67.	  
MIWA,	   T.,	   SATO,	   S.,	   GULLIPALLI,	   D.,	   NANGAKU,	   M.	   &	   SONG,	   W.	   C.	   2013.	   Blocking	  
properdin,	   the	   alternative	   pathway,	   and	   anaphylatoxin	   receptors	   ameliorates	  
renal	   ischemia-­‐reperfusion	   injury	   in	   decay-­‐accelerating	   factor	   and	   CD59	  
double-­‐knockout	  mice.	  J	  Immunol,	  190,	  3552-­‐9.	  
MOCHIZUKI,	  H.,	  GOTO,	  K.,	  MORI,	  H.	  &	  MIZUNO,	  Y.	   1996.	  Histochemical	  detection	  of	  
apoptosis	  in	  Parkinson's	  disease.	  J	  Neurol	  Sci,	  137,	  120-­‐3.	  
MONROE,	   D.	   M.,	   HOFFMAN,	   M.	   &	   ROBERTS,	   H.	   R.	   2002.	   Platelets	   and	   thrombin	  
generation.	  Arteriosclerosis,	  thrombosis,	  and	  vascular	  biology,	  22,	  1381-­‐1389.	  
MOORE,	  K.	  1999.	  Renal	   failure	   in	  acute	   liver	   failure.	  Eur	   J	  Gastroenterol	  Hepatol,	  11,	  
967-­‐75.	  
MORRELL,	   C.	   N.,	   SUN,	   H.,	   SWAIM,	   A.	   M.	   &	   BALDWIN,	   W.	   M.	   2007.	   Platelets	   an	  
inflammatory	   force	   in	   transplantation.	   American	   journal	   of	   transplantation	   :	  
official	   journal	   of	   the	   American	   Society	   of	   Transplantation	   and	   the	   American	  
Society	  of	  Transplant	  Surgeons,	  7,	  2447-­‐2454.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   174	  
MUNSHI,	   R.,	   HSU,	   C.	   &	   HIMMELFARB,	   J.	   2011.	   Advances	   in	   understanding	   ischemic	  
acute	  kidney	  injury.	  BMC	  medicine,	  9,	  11.	  
NAKANO,	  T.,	  GOTO,	  S.,	   LAI,	  C.-­‐Y.,	  HSU,	  L.-­‐W.,	  TSENG,	  H.-­‐P.,	  CHEN,	  K.-­‐D.,	  CHIU,	  K.-­‐W.,	  
WANG,	   C.-­‐C.,	   CHENG,	   Y.-­‐F.	   &	   CHEN,	   C.-­‐L.	   2013.	   Induction	   of	   antinuclear	  
antibodies	  by	  de	  novo	  autoimmune	  hepatitis	   regulates	  alloimmune	  responses	  
in	   rat	   liver	   transplantation.	   Clinical	   &	   developmental	   immunology,	   2013,	  
413928.	  
OGDEN,	  C.	  A.,	  DECATHELINEAU,	  A.,	  HOFFMANN,	  P.	  R.,	   BRATTON,	  D.,	  GHEBREHIWET,	  
B.,	   FADOK,	   V.	   A.	   &	   HENSON,	   P.	   M.	   2001.	   C1q	   and	   mannose	   binding	   lectin	  
engagement	  of	  cell	  surface	  calreticulin	  and	  CD91	  initiates	  macropinocytosis	  and	  
uptake	  of	  apoptotic	  cells.	  J	  Exp	  Med,	  194,	  781-­‐95.	  
OGDEN,	  C.	  A.,	  KOWALEWSKI,	  R.,	  PENG,	  Y.,	  MONTENEGRO,	  V.	  &	  ELKON,	  K.	  B.	  2005.	  IGM	  
is	   required	   for	  efficient	  complement	  mediated	  phagocytosis	  of	  apoptotic	  cells	  
in	  vivo.	  Autoimmunity,	  38,	  259-­‐264.	  
OPELZ,	  G.	  &	  TERASAKI,	  P.	  I.	  1978.	  Improvement	  of	  kidney-­‐graft	  survival	  with	  increased	  
numbers	  of	  blood	  transfusions.	  N	  Engl	  J	  Med,	  299,	  799-­‐803.	  
OPELZ,	  G.,	  VANRENTERGHEM,	  Y.,	  KIRSTE,	  G.,	  GRAY,	  D.	  W.,	  HORSBURGH,	  T.,	  LACHANCE,	  
J.	  G.,	  LARGIADER,	  F.,	  LANGE,	  H.,	  VUJAKLIJA-­‐STIPANOVIC,	  K.,	  ALVAREZ-­‐GRANDE,	  
J.,	   SCHOTT,	   W.,	   HOYER,	   J.,	   SCHNUELLE,	   P.,	   DESCOEUDRES,	   C.,	   RUDER,	   H.,	  
WUJCIAK,	   T.	   &	   SCHWARZ,	   V.	   1997.	   Prospective	   evaluation	   of	   pretransplant	  
blood	  transfusions	  in	  cadaver	  kidney	  recipients.	  Transplantation,	  63,	  964-­‐7.	  
OXBURGH,	  L.	  &	  DE	  CAESTECKER,	  M.	  P.	  2012.	  Ischemia-­‐reperfusion	  injury	  of	  the	  mouse	  
kidney.	  Methods	  Mol	  Biol,	  886,	  363-­‐79.	  
PARK,	  P.,	  HAAS,	  M.,	  CUNNINGHAM,	  P.	  N.,	  ALEXANDER,	  J.	  J.,	  BAO,	  L.,	  GUTHRIDGE,	  J.	  M.,	  
KRAUS,	  D.	  M.,	  HOLERS,	  V.	  M.	  &	  QUIGG,	  R.	  J.	  2001.	   Inhibiting	  the	  complement	  
system	  does	  not	  reduce	  injury	  in	  renal	  ischemia	  reperfusion.	  J	  Am	  Soc	  Nephrol,	  
12,	  1383-­‐90.	  
PARK,	   P.,	   HAAS,	  M.,	   CUNNINGHAM,	   P.	   N.,	   BAO,	   L.,	   ALEXANDER,	   J.	   J.	   &	  QUIGG,	   R.	   J.	  
2002.	   Injury	   in	   renal	   ischemia-­‐reperfusion	   is	   independent	   from	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   175	  
immunoglobulins	   and	   T	   lymphocytes.	   American	   journal	   of	   physiology.	   Renal	  
physiology,	  282,	  F352-­‐7.	  
PARK,	  S.	  W.,	  KIM,	  J.	  Y.,	  HAM,	  A.,	  BROWN,	  K.	  M.,	  KIM,	  M.,	  D'AGATI,	  V.	  D.	  &	  LEE,	  H.	  T.	  
2012.	   A1	   adenosine	   receptor	   allosteric	   enhancer	   PD-­‐81723	   protects	   against	  
renal	  ischemia-­‐reperfusion	  injury.	  Am	  J	  Physiol	  Renal	  Physiol,	  303,	  F721-­‐32.	  
PATSCHAN,	   D.,	   PATSCHAN,	   S.	   &	   MÜLLER,	   G.	   A.	   2012a.	   Inflammation	   and	  
microvasculopathy	   in	   renal	   ischemia	   reperfusion	   injury.	   Journal	   of	  
transplantation,	  2012,	  764154.	  
PATSCHAN,	  D.,	  PATSCHAN,	  S.	  &	  MÜLLER,	  G.	  A.	  2012b.	  Microvasculopathy	  in	   ischemic	  
acute	   kidney	   injury:	   consequences	   and	   therapeutic	   implications.	   Panminerva	  
medica,	  54,	  45-­‐52.	  
PENG,	  Y.,	  KOWALEWSKI,	  R.,	  KIM,	  S.	  &	  ELKON,	  K.	  B.	  2005.	  The	  role	  of	  IgM	  antibodies	  in	  
the	   recognition	   and	   clearance	   of	   apoptotic	   cells.	  Molecular	   immunology,	   42,	  
781-­‐787.	  
PICKERING,	  W.,	   GRAY,	   E.,	   GOODALL,	   A.	   H.	   &	   BARROWCLIFFE,	   T.	  W.	   2008.	   Effects	   of	  
apoptosis	  and	  lipid	  peroxidation	  on	  T-­‐lymphoblastoid	  phospholipid-­‐dependent	  
procoagulant	   activity.	   Journal	   of	   thrombosis	   and	   haemostasis	   :	   JTH,	   6,	   1122-­‐
1130.	  
PORCHERAY,	  F.,	  FRASER,	  J.	  W.,	  GAO,	  B.,	  MCCOLL,	  A.,	  DEVITO,	  J.,	  DARGON,	   I.,	  HELOU,	  
Y.,	  WONG,	  W.,	  GIROUARD,	  T.	  C.,	  SAIDMAN,	  S.	  L.,	  COLVIN,	  R.	  B.,	  PALMISANO,	  A.,	  
MAGGIORE,	   U.,	   VAGLIO,	   A.,	   SMITH,	   R.	   N.	   &	   ZORN,	   E.	   2013.	   Polyreactive	  
antibodies	   developing	   amidst	   humoral	   rejection	   of	   human	   kidney	   grafts	   bind	  
apoptotic	  cells	  and	  activate	  complement.	  Am	  J	  Transplant,	  13,	  2590-­‐600.	  
QUARTIER,	  P.,	  POTTER,	  P.	  K.,	  EHRENSTEIN,	  M.	  R.,	  WALPORT,	  M.	  J.	  &	  BOTTO,	  M.	  2005.	  
Predominant	  role	  of	   IgM-­‐dependent	  activation	  of	   the	  classical	  pathway	   in	  the	  
clearance	  of	  dying	  cells	  by	  murine	  bone	  marrow-­‐derived	  macrophages	  in	  vitro.	  
European	  journal	  of	  immunology,	  35,	  252-­‐260.	  
RADHI,	  M.	  &	  CARPENTER,	  S.	  L.	  2012.	  Thrombotic	  microangiopathies.	  ISRN	  hematology,	  
2012,	  310596.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   176	  
RAMESH,	   G.	   &	   REEVES,	   W.	   B.	   2004.	   Inflammatory	   cytokines	   in	   acute	   renal	   failure.	  
Kidney	  international.	  Supplement,	  S56-­‐61.	  
RAPAKA,	  R.	  R.,	  RICKS,	  D.	  M.,	  ALCORN,	  J.	  F.,	  CHEN,	  K.,	  KHADER,	  S.	  A.,	  ZHENG,	  M.,	  PLEVY,	  
S.,	  BENGTEN,	  E.	  &	  KOLLS,	  J.	  K.	  2010.	  Conserved	  natural	  IgM	  antibodies	  mediate	  
innate	   and	  adaptive	   immunity	   against	   the	  opportunistic	   fungus	  Pneumocystis	  
murina.	  J	  Exp	  Med,	  207,	  2907-­‐19.	  
RAVICHANDRAN,	  K.	  S.	  2003.	  "Recruitment	  signals"	  from	  apoptotic	  cells:	  invitation	  to	  a	  
quiet	  meal.	  Cell,	  113,	  817-­‐20.	  
REDDIEN,	   P.	   W.,	   CAMERON,	   S.	   &	   HORVITZ,	   H.	   R.	   2001.	   Phagocytosis	   promotes	  
programmed	  cell	  death	  in	  C.	  elegans.	  Nature,	  412,	  198-­‐202.	  
REN,	  Y.,	  XIE,	  Y.,	   JIANG,	  G.,	  FAN,	  J.,	  YEUNG,	  J.,	  LI,	  W.,	  TAM,	  P.	  K.	  H.	  &	  SAVILL,	   J.	  2008.	  
Apoptotic	  cells	  protect	  mice	  against	  lipopolysaccharide-­‐induced	  shock.	  Journal	  
of	  immunology	  (Baltimore,	  Md.	  :	  1950),	  180,	  4978-­‐4985.	  
RENNER,	  B.,	  STRASSHEIM,	  D.,	  AMURA,	  C.	  R.,	  KULIK,	  L.,	  LJUBANOVIC,	  D.,	  GLOGOWSKA,	  
M.	  J.,	  TAKAHASHI,	  K.,	  CARROLL,	  M.	  C.,	  HOLERS,	  V.	  M.	  &	  THURMAN,	  J.	  M.	  2010.	  
B	   cell	   subsets	   contribute	   to	   renal	   injury	   and	   renal	   protection	   after	  
ischemia/reperfusion.	   Journal	   of	   immunology	   (Baltimore,	   Md.	   :	   1950),	   185,	  
4393-­‐4400.	  
RIEDEMANN,	  N.	  C.	  &	  WARD,	  P.	  A.	  2003.	  Complement	   in	   ischemia	   reperfusion	   injury.	  
The	  American	  journal	  of	  pathology,	  162,	  363-­‐367.	  
ROSENES,	  Z.,	  MOK,	  Y.-­‐F.,	  YANG,	  S.,	  GRIFFIN,	  M.	  D.	  W.,	  MULHERN,	  T.	  D.,	  HATTERS,	  D.	  
M.,	   HENSEL,	   F.	   &	   HOWLETT,	   G.	   J.	   2013.	   Simultaneous	   Binding	   of	   the	   Anti-­‐
Cancer	   IgM	  Monoclonal	   Antibody	   PAT-­‐SM6	   to	   Low	   Density	   Lipoproteins	   and	  
GRP78.	  PloS	  one,	  8,	  e61239.	  
ROUHL,	   R.	   P.,	   VAN	   OOSTENBRUGGE,	   R.	   J.,	   THEUNISSEN,	   R.	   O.,	   KNOTTNERUS,	   I.	   L.,	  
STAALS,	   J.,	   HENSKENS,	   L.	   H.,	   KROON,	   A.	   A.,	   DE	   LEEUW,	   P.	   W.,	   LODDER,	   J.,	  
TERVAERT,	   J.	  W.	  &	  DAMOISEAUX,	   J.	  G.	  2010.	  Autoantibodies	  against	  oxidized	  
low-­‐density	  lipoprotein	  in	  cerebral	  small	  vessel	  disease.	  Stroke,	  41,	  2687-­‐9.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   177	  
RYAN,	  M.	   J.,	   JOHNSON,	   G.,	   KIRK,	   J.,	   FUERSTENBERG,	   S.	  M.,	   ZAGER,	   R.	   A.	   &	   TOROK-­‐
STORB,	  B.	  1994.	  HK-­‐2:	  an	  immortalized	  proximal	  tubule	  epithelial	  cell	  line	  from	  
normal	  adult	  human	  kidney.	  Kidney	  Int,	  45,	  48-­‐57.	  
SASS,	  G.,	  HEINLEIN,	  S.,	  AGLI,	  A.,	  BANG,	  R.,	  SCHÜMANN,	  J.	  &	  TIEGS,	  G.	  2002.	  Cytokine	  
expression	  in	  three	  mouse	  models	  of	  experimental	  hepatitis.	  Cytokine,	  19,	  115-­‐
120.	  
SAVILL,	  J.	  1994.	  Apoptosis	  in	  disease.	  Eur	  J	  Clin	  Invest,	  24,	  715-­‐23.	  
SAVILL,	   J.,	   DRANSFIELD,	   I.,	   GREGORY,	   C.	  &	  HASLETT,	   C.	   2002.	   A	   blast	   from	   the	   past:	  
clearance	   of	   apoptotic	   cells	   regulates	   immune	   responses.	   Nature	   reviews.	  
Immunology,	  2,	  965-­‐975.	  
SCHRIJVERS,	  D.	  M.,	  DE	  MEYER,	  G.	  R.,	  KOCKX,	  M.	  M.,	  HERMAN,	  A.	  G.	  &	  MARTINET,	  W.	  
2005.	   Phagocytosis	   of	   apoptotic	   cells	   by	   macrophages	   is	   impaired	   in	  
atherosclerosis.	  Arterioscler	  Thromb	  Vasc	  Biol,	  25,	  1256-­‐61.	  
SCOTT,	  R.	  S.,	  MCMAHON,	  E.	   J.,	  POP,	  S.	  M.,	  REAP,	  E.	  A.,	  CARICCHIO,	  R.,	  COHEN,	  P.	   L.,	  
EARP,	   H.	   S.	   &	   MATSUSHIMA,	   G.	   K.	   2001.	   Phagocytosis	   and	   clearance	   of	  
apoptotic	  cells	  is	  mediated	  by	  MER.	  Nature,	  411,	  207-­‐11.	  
SEEMAN,	  P.,	  CHENG,	  D.	  &	   ILES,	  G.	  H.	  1973.	  Structure	  of	  membrane	  holes	   in	  osmotic	  
and	  saponin	  hemolysis.	  J	  Cell	  Biol,	  56,	  519-­‐27.	  
SENECAL,	   J.	   L.,	   RAUCH,	   J.,	   GRODZICKY,	   T.,	   RAYNAULD,	   J.	   P.,	   UTHMAN,	   I.,	   NAVA,	   A.,	  
GUIMOND,	  M.	  &	  RAYMOND,	  Y.	  1999.	  Strong	  association	  of	  autoantibodies	   to	  
human	  nuclear	  lamin	  B1	  with	  lupus	  anticoagulant	  antibodies	  in	  systemic	  lupus	  
erythematosus.	  Arthritis	  Rheum,	  42,	  1347-­‐53.	  
SERHAN,	  C.	  N.	  &	  SAVILL,	  J.	  2005.	  Resolution	  of	  inflammation:	  the	  beginning	  programs	  
the	  end.	  Nature	  immunology,	  6,	  1191-­‐1197.	  
SHAW,	  P.	  X.,	  GOODYEAR,	  C.	  S.,	  CHANG,	  M.	  K.,	  WITZTUM,	  J.	  L.	  &	  SILVERMAN,	  G.	  J.	  2003.	  
The	   autoreactivity	   of	   anti-­‐phosphorylcholine	   antibodies	   for	   atherosclerosis-­‐
associated	  neo-­‐antigens	  and	  apoptotic	  cells.	  J	  Immunol,	  170,	  6151-­‐7.	  
SHAW,	  P.	  X.,	  HÖRKKÖ,	  S.,	  CHANG,	  M.	  K.,	  CURTISS,	  L.	  K.,	  PALINSKI,	  W.,	  SILVERMAN,	  G.	  J.	  
&	  WITZTUM,	   J.	   L.	   2000.	   Natural	   antibodies	  with	   the	   T15	   idiotype	  may	   act	   in	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   178	  
atherosclerosis,	   apoptotic	   clearance,	   and	  protective	   immunity.	  The	   Journal	   of	  
clinical	  investigation,	  105,	  1731-­‐1740.	  
SHI,	  C.	  &	  PAMER,	  E.	  G.	  2011.	  Monocyte	  recruitment	  during	  infection	  and	  inflammation.	  
Nat	  Rev	  Immunol,	  11,	  762-­‐74.	  
SIMONSON,	   S.	   G.,	   ZHANG,	   J.,	   CANADA,	   A.	   T.,	   JR.,	   SU,	   Y.	   F.,	   BENVENISTE,	   H.	   &	  
PIANTADOSI,	  C.	  A.	  1993.	  Hydrogen	  peroxide	  production	  by	  monoamine	  oxidase	  
during	   ischemia-­‐reperfusion	   in	   the	   rat	   brain.	   J	   Cereb	   Blood	   Flow	  Metab,	   13,	  
125-­‐34.	  
SMIT	  SIBINGA,	  C.	  T.	  1999.	  Immune	  effects	  of	  blood	  transfusion.	  Curr	  Opin	  Hematol,	  6,	  
442-­‐5.	  
SORICE,	  M.,	  CIRCELLA,	  A.,	  MISASI,	  R.,	  PITTONI,	  V.,	  GAROFALO,	  T.,	  CIRELLI,	  A.,	  PAVAN,	  
A.,	  PONTIERI,	  G.	  M.	  &	  VALESINI,	  G.	  2000.	  Cardiolipin	  on	  the	  surface	  of	  apoptotic	  
cells	   as	   a	   possible	   trigger	   for	   antiphospholipids	   antibodies.	  Clin	   Exp	   Immunol,	  
122,	  277-­‐84.	  
SPENDLOVE,	   I.,	   RAMAGE,	   J.	   M.,	   BRADLEY,	   R.,	   HARRIS,	   C.	   &	   DURRANT,	   L.	   G.	   2006.	  
Complement	  decay	  accelerating	  factor	  (DAF)/CD55	  in	  cancer.	  Cancer	   Immunol	  
Immunother,	  55,	  987-­‐95.	  
STRAATSBURG,	  I.	  H.,	  BOERMEESTER,	  M.	  A.,	  WOLBINK,	  G.	  J.,	  VAN	  GULIK,	  T.	  M.,	  GOUMA,	  
D.	  J.,	  FREDERIKS,	  W.	  M.	  &	  HACK,	  C.	  E.	  2000.	  Complement	  activation	  induced	  by	  
ischemia-­‐reperfusion	   in	   humans:	   a	   study	   in	   patients	   undergoing	   partial	  
hepatectomy.	  J	  Hepatol,	  32,	  783-­‐91.	  
SUN,	  E.,	  GAO,	  Y.,	  CHEN,	  J.,	  ROBERTS,	  A.	  I.,	  WANG,	  X.,	  CHEN,	  Z.	  &	  SHI,	  Y.	  2004.	  Allograft	  
tolerance	  induced	  by	  donor	  apoptotic	  lymphocytes	  requires	  phagocytosis	  in	  the	  
recipient.	  Cell	  Death	  Differ,	  11,	  1258-­‐64.	  
SUTTON,	  T.	  A.,	  FISHER,	  C.	  J.	  &	  MOLITORIS,	  B.	  A.	  2002.	  Microvascular	  endothelial	  injury	  
and	   dysfunction	   during	   ischemic	   acute	   renal	   failure.	  Kidney	   international,	   62,	  
1539-­‐1549.	  
TCHAIKOVSKI,	  S.	  N.,	  VAN	  VLIJMEN,	  B.	  J.	  M.,	  ROSING,	  J.	  &	  TANS,	  G.	  2007.	  Development	  
of	   a	   calibrated	  automated	   thrombography	  based	   thrombin	   generation	   test	   in	  
mouse	  plasma.	  Journal	  of	  thrombosis	  and	  haemostasis	  :	  JTH,	  5,	  2079-­‐2086.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   179	  
THURMAN,	   J.	   M.	   2007.	   Triggers	   of	   inflammation	   after	   renal	   ischemia/reperfusion.	  
Clinical	  immunology	  (Orlando,	  Fla.),	  123,	  7-­‐13.	  
THURMAN,	  J.	  M.,	  LJUBANOVIC,	  D.,	  EDELSTEIN,	  C.	  L.,	  GILKESON,	  G.	  S.	  &	  HOLERS,	  V.	  M.	  
2003.	   Lack	   of	   a	   functional	   alternative	   complement	   pathway	   ameliorates	  
ischemic	  acute	  renal	  failure	  in	  mice.	  J	  Immunol,	  170,	  1517-­‐23.	  
THURMAN,	  J.	  M.,	  LUCIA,	  M.	  S.,	  LJUBANOVIC,	  D.	  &	  HOLERS,	  V.	  M.	  2005.	  Acute	  tubular	  
necrosis	   is	   characterized	   by	   activation	   of	   the	   alternative	   pathway	   of	  
complement.	  Kidney	  Int,	  67,	  524-­‐30.	  
TIEGS,	  G.,	  HENTSCHEL,	   J.	  &	  WENDEL,	  A.	   1992.	  A	  T	   cell-­‐dependent	  experimental	   liver	  
injury	  in	  mice	  inducible	  by	  concanavalin	  A.	  The	  Journal	  of	  clinical	  investigation,	  
90,	  196-­‐203.	  
TOBA,	   K.,	   TSUCHIYAMA,	   J.,	   HASHIMOTO,	   S.,	   ICHIDA,	   T.,	   KATO,	   K.,	   WATANABE,	   K.,	  
FURUKAWA,	   T.,	   NARITA,	   M.,	   TAKAHASHI,	   M.	   &	   AIZAWA,	   Y.	   2004.	   Sensitive	  
measurement	  of	  fragmented	  red	  cell	  population	  using	  flow	  cytometry,	  and	  its	  
application	   for	   estimating	   thrombotic	   microangiopathy	   after	   stem	   cell	  
transplantation.	  Cytometry	  B	  Clin	  Cytom,	  58,	  39-­‐46.	  
TSIANTOULAS,	  D.,	  GRUBER,	  S.	  &	  BINDER,	  C.	  J.	  2012.	  B-­‐1	  cell	  immunoglobulin	  directed	  
against	  oxidation-­‐specific	  epitopes.	  Frontiers	  in	  immunology,	  3,	  415.	  
TU,	  Z.,	  LI,	  Q.,	  CHOU,	  H.	  S.,	  HSIEH,	  C.	  C.,	  MEYERSON,	  H.,	  PETERS,	  M.	  G.,	  BU,	  H.,	  FUNG,	  J.	  
J.,	  QIAN,	  S.,	  LU,	  L.	  &	  LIN,	  F.	  2011.	  Complement	  mediated	  hepatocytes	  injury	  in	  a	  
model	  of	  autoantibody	  induced	  hepatitis.	  Immunobiology,	  216,	  528-­‐34.	  
TUOMINEN,	   A.,	   MILLER,	   Y.	   I.,	   HANSEN,	   L.	   F.,	   KESÄNIEMI,	   Y.	   A.,	   WITZTUM,	   J.	   L.	   &	  
HÖRKKÖ,	  S.	  2006.	  A	  natural	  antibody	   to	  oxidized	  cardiolipin	  binds	   to	  oxidized	  
low-­‐density	   lipoprotein,	   apoptotic	   cells,	   and	   atherosclerotic	   lesions.	  
Arteriosclerosis,	  thrombosis,	  and	  vascular	  biology,	  26,	  2096-­‐2102.	  
VAN	   DER	   POL,	   P.,	   ROOS,	   A.,	   BERGER,	   S.	   P.,	   DAHA,	  M.	   R.	   &	   VAN	   KOOTEN,	   C.	   2011.	  
Natural	  IgM	  antibodies	  are	  involved	  in	  the	  activation	  of	  complement	  by	  hypoxic	  
human	   tubular	   cells.	   American	   journal	   of	   physiology.	   Renal	   physiology,	   300,	  
F932-­‐40.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   180	  
VAN	   DER	   POL,	   P.,	   SCHLAGWEIN,	   N.,	   VAN	   GIJLSWIJK,	   D.	   J.,	   BERGER,	   S.	   P.,	   ROOS,	   A.,	  
BAJEMA,	   I.	  M.,	  DE	  BOER,	  H.	  C.,	  DE	  FIJTER,	   J.	  W.,	  STAHL,	  G.	   L.,	  DAHA,	  M.	  R.	  &	  
VAN	   KOOTEN,	   C.	   2012.	   Mannan-­‐binding	   lectin	   mediates	   renal	  
ischemia/reperfusion	   injury	   independent	   of	   complement	   activation.	   Am	   J	  
Transplant,	  12,	  877-­‐87.	  
VAN	  HINSBERGH,	  V.	  W.	  M.	  2012.	  Endothelium-­‐-­‐role	   in	   regulation	  of	   coagulation	  and	  
inflammation.	  Seminars	  in	  immunopathology,	  34,	  93-­‐106.	  
VAN	   PROOIJEN,	   H.	   C.,	   VISSER,	   J.	   J.,	   VAN	   OOSTENDORP,	   W.	   R.,	   DE	   GAST,	   G.	   C.	   &	  
VERDONCK,	   L.	   F.	   1994.	   Prevention	   of	   primary	   transfusion-­‐associated	  
cytomegalovirus	  infection	  in	  bone	  marrow	  transplant	  recipients	  by	  the	  removal	  
of	  white	  cells	  from	  blood	  components	  with	  high-­‐affinity	  filters.	  Br	  J	  Haematol,	  
87,	  144-­‐7.	  
VANCE,	   J.	   E.	   &	   STEENBERGEN,	   R.	   2005.	   Metabolism	   and	   functions	   of	  
phosphatidylserine.	  Progress	  in	  lipid	  research,	  44,	  207-­‐234.	  
VAS,	   J.,	   GRÖNWALL,	   C.,	  MARSHAK-­‐ROTHSTEIN,	   A.	  &	   SILVERMAN,	  G.	   J.	   2012.	  Natural	  
antibody	  to	  apoptotic	  cell	  membranes	  inhibits	  the	  proinflammatory	  properties	  
of	  lupus	  autoantibody	  immune	  complexes.	  Arthritis	  and	  rheumatism,	  64,	  3388-­‐
3398.	  
VERGANI,	   D.	   &	   MIELI-­‐VERGANI,	   G.	   2003.	   Autoimmune	   hepatitis.	   Autoimmunity	  
reviews,	  2,	  241-­‐7.	  
VINAY,	   K.,	   ABBAS,	   A.	   K.	   &	   ASTER,	   J.	   C.	   2012.	  Robbins	   Basic	   Pathology,	   Philadelphia,	  
Elsevier.	  
WANG,	  H.	  X.,	  LIU,	  M.,	  WENG,	  S.	  Y.,	  LI,	  J.	  J.,	  XIE,	  C.,	  HE,	  H.	  L.,	  GUAN,	  W.,	  YUAN,	  Y.	  S.	  &	  
GAO,	   J.	   2012.	   Immune	  mechanisms	  of	  Concanavalin	  A	  model	   of	   autoimmune	  
hepatitis.	  World	  J	  Gastroenterol,	  18,	  119-­‐25.	  
WANG,	   J.,	  WEISS,	   I.,	   SVOBODA,	  K.	  &	  KWAAN,	  H.	  C.	  2001.	  Thrombogenic	   role	  of	   cells	  
undergoing	  apoptosis.	  British	  journal	  of	  haematology,	  115,	  382-­‐391.	  
WEI,	   Q.	   &	   DONG,	   Z.	   2012.	   Mouse	   model	   of	   ischemic	   acute	   kidney	   injury:	   technical	  
notes	  and	  tricks.	  Am	  J	  Physiol	  Renal	  Physiol,	  303,	  F1487-­‐94.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   181	  
WEISER,	  M.	  R.,	  WILLIAMS,	  J.	  P.,	  MOORE,	  F.	  D.,	  KOBZIK,	  L.,	  MA,	  M.,	  HECHTMAN,	  H.	  B.	  &	  
CARROLL,	   M.	   C.	   1996.	   Reperfusion	   injury	   of	   ischemic	   skeletal	   muscle	   is	  
mediated	   by	   natural	   antibody	   and	   complement.	   The	   Journal	   of	   experimental	  
medicine,	  183,	  2343-­‐2348.	  
WEISMAN,	  H.	  F.,	  BARTOW,	  T.,	  LEPPO,	  M.	  K.,	  MARSH,	  H.	  C.,	  CARSON,	  G.	  R.,	  CONCINO,	  
M.	   F.,	   BOYLE,	  M.	   P.,	   ROUX,	   K.	   H.,	  WEISFELDT,	  M.	   L.	   &	   FEARON,	   D.	   T.	   1990a.	  
Soluble	  human	  complement	   receptor	   type	  1:	   in	   vivo	   inhibitor	  of	   complement	  
suppressing	  post-­‐ischemic	  myocardial	  inflammation	  and	  necrosis.	  Science	  (New	  
York,	  N.Y.),	  249,	  146-­‐151.	  
WEISMAN,	   H.	   F.,	   BARTOW,	   T.,	   LEPPO,	   M.	   K.,	   MARSH,	   H.	   C.,	   JR.,	   CARSON,	   G.	   R.,	  
CONCINO,	  M.	  F.,	  BOYLE,	  M.	  P.,	  ROUX,	  K.	  H.,	  WEISFELDT,	  M.	  L.	  &	  FEARON,	  D.	  T.	  
1990b.	   Soluble	   human	   complement	   receptor	   type	   1:	   in	   vivo	   inhibitor	   of	  
complement	  suppressing	  post-­‐ischemic	  myocardial	  inflammation	  and	  necrosis.	  
Science,	  249,	  146-­‐51.	  
WELLMANN,	   U.,	   LETZ,	   M.,	   HERRMANN,	   M.,	   ANGERMULLER,	   S.,	   KALDEN,	   J.	   R.	   &	  
WINKLER,	   T.	   H.	   2005.	   The	   evolution	   of	   human	   anti-­‐double-­‐stranded	   DNA	  
autoantibodies.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A,	  102,	  9258-­‐63.	  
WILLIAMS,	   J.	   P.,	   PECHET,	   T.	   T.,	   WEISER,	   M.	   R.,	   REID,	   R.,	   KOBZIK,	   L.,	   MOORE,	   F.	   D.,	  
CARROLL,	   M.	   C.	   &	   HECHTMAN,	   H.	   B.	   1999.	   Intestinal	   reperfusion	   injury	   is	  
mediated	   by	   IgM	   and	   complement.	   Journal	   of	   applied	   physiology	   (Bethesda,	  
Md.	  :	  1985),	  86,	  938-­‐942.	  
WITTE,	   T.	   2008.	   IgM	   antibodies	   against	   dsDNA	   in	   SLE.	  Clin	   Rev	   Allergy	   Immunol,	   34,	  
345-­‐7.	  
WYLLIE,	   A.	   H.,	   KERR,	   J.	   F.	   &	   CURRIE,	   A.	   R.	   1980.	   Cell	   death:	   the	   significance	   of	  
apoptosis.	  Int	  Rev	  Cytol,	  68,	  251-­‐306.	  
YANG,	  S.	  K.,	  ATTIPOE,	  S.,	  KLAUSNER,	  A.	  P.,	  TIAN,	  R.,	  PAN,	  D.,	  RICH,	  T.	  A.,	  TURNER,	  T.	  T.,	  
STEERS,	  W.	  D.	  &	   LYSIAK,	   J.	   J.	   2006.	   In	   vivo	  detection	  of	   apoptotic	   cells	   in	   the	  
testis	   using	   fluorescence	   labeled	   annexin	   V	   in	   a	   mouse	   model	   of	   testicular	  
torsion.	  J	  Urol,	  176,	  830-­‐5.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   182	  
YOSHIDA,	   T.,	   SUGIURA,	   H.,	  MITOBE,	  M.,	   TSUCHIYA,	   K.,	   SHIROTA,	   S.,	   NISHIMURA,	   S.,	  
SHIOHIRA,	  S.,	  ITO,	  H.,	  NOBORI,	  K.,	  GULLANS,	  S.	  R.,	  AKIBA,	  T.	  &	  NITTA,	  K.	  2008.	  
ATF3	  protects	  against	  renal	  ischemia-­‐reperfusion	  injury.	  J	  Am	  Soc	  Nephrol,	  19,	  
217-­‐24.	  
ZACHAROWSKI,	   K.,	   OTTO,	   M.,	   HAFNER,	   G.,	   MARSH,	   H.	   C.,	   JR.	   &	   THIEMERMANN,	   C.	  
1999.	   Reduction	   of	   myocardial	   infarct	   size	   with	   sCR1sLe(x),	   an	   alternatively	  
glycosylated	   form	   of	   human	   soluble	   complement	   receptor	   type	   1	   (sCR1),	  
possessing	  sialyl	  Lewis	  x.	  Br	  J	  Pharmacol,	  128,	  945-­‐52.	  
ZHAI,	   Y.,	   PETROWSKY,	   H.,	   HONG,	   J.	   C.,	   BUSUTTIL,	   R.	  W.	  &	   KUPIEC-­‐WEGLINSKI,	   J.	  W.	  
2013.	   Ischaemia-­‐reperfusion	   injury	   in	   liver	   transplantation-­‐-­‐from	   bench	   to	  
bedside.	  Nature	  reviews.	  Gastroenterology	  &	  hepatology,	  10,	  79-­‐89.	  
ZHANG,	  M.,	  ALICOT,	  E.	  M.,	  CHIU,	   I.,	  LI,	   J.,	  VERNA,	  N.,	  VORUP-­‐JENSEN,	  T.,	  KESSLER,	  B.,	  
SHIMAOKA,	   M.,	   CHAN,	   R.,	   FRIEND,	   D.,	   MAHMOOD,	   U.,	   WEISSLEDER,	   R.,	  
MOORE,	  F.	  D.	  &	  CARROLL,	  M.	  C.	  2006a.	  Identification	  of	  the	  target	  self-­‐antigens	  
in	  reperfusion	  injury.	  The	  Journal	  of	  experimental	  medicine,	  203,	  141-­‐152.	  
ZHANG,	  M.,	  AUSTEN,	  W.	  G.,	  CHIU,	  I.,	  ALICOT,	  E.	  M.,	  HUNG,	  R.,	  MA,	  M.,	  VERNA,	  N.,	  XU,	  
M.,	  HECHTMAN,	  H.	  B.,	  MOORE,	  F.	  D.	  &	  CARROLL,	  M.	  C.	  2004.	  Identification	  of	  a	  
specific	  self-­‐reactive	  IgM	  antibody	  that	  initiates	  intestinal	  ischemia/reperfusion	  
injury.	  Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  of	  the	  United	  States	  of	  
America,	  101,	  3886-­‐3891.	  
ZHANG,	  M.	  &	  CARROLL,	  M.	   C.	   2007.	  Natural	   antibody	  mediated	   innate	   autoimmune	  
response.	  Molecular	  immunology,	  44,	  103-­‐110.	  
ZHANG,	  M.,	  MICHAEL,	  L.	  H.,	  GROSJEAN,	  S.	  A.,	  KELLY,	  R.	  A.,	  CARROLL,	  M.	  C.	  &	  ENTMAN,	  
M.	  L.	  2006b.	  The	  role	  of	  natural	  IgM	  in	  myocardial	  ischemia-­‐reperfusion	  injury.	  
Journal	  of	  molecular	  and	  cellular	  cardiology,	  41,	  62-­‐67.	  
ZHANG,	   M.,	   XU,	   S.,	   HAN,	   Y.	   &	   CAO,	   X.	   2011.	   Apoptotic	   cells	   attenuate	   fulminant	  
hepatitis	   by	   priming	   Kupffer	   cells	   to	   produce	   interleukin-­‐10	   through	  
membrane-­‐bound	  TGF-­‐β.	  Hepatology	  (Baltimore,	  Md.),	  53,	  306-­‐316.	  
	  
Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  References	   183	  
ZHAO,	  H.,	  PEREZ,	  J.	  S.,	  LU,	  K.,	  GEORGE,	  A.	  J.	  T.	  &	  MA,	  D.	  2014.	  Role	  of	  Toll-­‐like	  receptor-­‐
4	   in	   renal	  graft	   ischemia-­‐reperfusion	   injury.	  AJP:	  Renal	  Physiology,	   306,	   F801-­‐
11.	  
ZHOU,	  W.,	  FARRAR,	  C.	  A.,	  ABE,	  K.,	  PRATT,	  J.	  R.,	  MARSH,	  J.	  E.,	  WANG,	  Y.,	  STAHL,	  G.	  L.	  &	  
SACKS,	  S.	  H.	  2000a.	  Predominant	   role	   for	  C5b-­‐9	   in	   renal	   ischemia/reperfusion	  
injury.	  The	  Journal	  of	  clinical	  investigation,	  105,	  1363-­‐1371.	  
ZHOU,	  W.,	  FARRAR,	  C.	  A.,	  ABE,	  K.,	  PRATT,	  J.	  R.,	  MARSH,	  J.	  E.,	  WANG,	  Y.,	  STAHL,	  G.	  L.	  &	  
SACKS,	  S.	  H.	  2000b.	  Predominant	  role	   for	  C5b-­‐9	   in	  renal	   ischemia/reperfusion	  
injury.	  J	  Clin	  Invest,	  105,	  1363-­‐71.	  
ZIEGLER,	   U.	   &	   GROSCURTH,	   P.	   2004.	   Morphological	   features	   of	   cell	   death.	  News	   in	  
physiological	   sciences	   :	  an	   international	   journal	  of	  physiology	  produced	   jointly	  
by	   the	   International	   Union	   of	   Physiological	   Sciences	   and	   the	   American	  
Physiological	  Society,	  19,	  124-­‐128.	  
ZIPFEL,	  P.	  F.	  &	  SKERKA,	  C.	  2009.	  Complement	   regulators	  and	   inhibitory	  proteins.	  Nat	  
Rev	  Immunol,	  9,	  729-­‐40.	  
ZONG,	  W.	  X.	  &	  THOMPSON,	  C.	  B.	  2006.	  Necrotic	  death	  as	  a	  cell	  fate.	  Genes	  Dev,	  20,	  1-­‐
15.	  
ZWAAL,	  R.	  F.,	  COMFURIUS,	  P.	  &	  BEVERS,	  E.	  M.	  1998.	  Lipid-­‐protein	  interactions	  in	  blood	  
coagulation.	  Biochim	  Biophys	  Acta,	  1376,	  433-­‐53.	  
ZWART,	  B.,	  CIURANA,	  C.,	  RENSINK,	   I.,	  MANOE,	  R.,	  HACK,	  C.	  E.	  &	  AARDEN,	  L.	  A.	  2004.	  
Complement	  activation	  by	  apoptotic	  cells	  occurs	  predominantly	  via	  IgM	  and	  is	  




Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  Appendix	  of	  publications	   184	  
Appendix	  of	  publications	  
	  
Publications	  included	  are	  as	  follows:	  
	  
Hesketh	   EE,	   Kluth	   DC,	   Hughes	   J:	   Apoptotic	   cell	   administration	   is	   detrimental	   in	   murine	  
renal	  ischaemia	  reperfusion	  injury.	  Journal	  of	  inflammation	  (London,	  England)	  2014,	  11:31.	  
	  
Hesketh	   EE,	   Czopek	   A,	   Clay	   M,	   Borthwick	   G,	   Ferenbach	   D,	   Kluth	   D,	   Hughes	   J:	   Renal	  
ischaemia	   reperfusion	   injury:	   a	   mouse	   model	   of	   injury	   and	   regeneration.	   JoVE	   2014,	  
88:e51816	  
	  
	   	  
	  








































































































Emily	  E.	  Hesketh	  PhD	  Thesis	  –	  Appendix	  of	  publications	   200	  
	  
